<SEC-DOCUMENT>0001193125-18-102138.txt : 20180329
<SEC-HEADER>0001193125-18-102138.hdr.sgml : 20180329
<ACCEPTANCE-DATETIME>20180329170133
ACCESSION NUMBER:		0001193125-18-102138
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20180516
FILED AS OF DATE:		20180329
DATE AS OF CHANGE:		20180329
EFFECTIVENESS DATE:		20180329

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MANNKIND CORP
		CENTRAL INDEX KEY:			0000899460
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133607736
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50865
		FILM NUMBER:		18723714

	BUSINESS ADDRESS:	
		STREET 1:		30930 RUSSELL RANCH ROAD
		STREET 2:		SUITE 301
		CITY:			WESTLAKE VILLAGE
		STATE:			CA
		ZIP:			91362
		BUSINESS PHONE:		818-661-5000

	MAIL ADDRESS:	
		STREET 1:		30930 RUSSELL RANCH ROAD
		STREET 2:		SUITE 301
		CITY:			WESTLAKE VILLAGE
		STATE:			CA
		ZIP:			91362
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d536430ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(RULE 14a-101) </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE
14A INFORMATION </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp; ) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Pursuant to &#167; 240.14a-12</TD></TR></TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>MANNKIND
CORPORATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified in its Charter) </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s)
Filing Proxy Statement, if Other Than the Registrant) </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:9pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:9pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:9pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:9pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:9pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:9pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:9pt">Fee paid previously with preliminary materials:</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:9pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:9pt">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Amount previously paid:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:9pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:9pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Filing Party:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:9pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:9pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MANNKIND CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>30930 Russell Ranch Road, Suite 301 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Westlake Village, California 91362 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">(818)&nbsp;661-5000</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held On Wednesday, May&nbsp;16, 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Stockholder: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You are cordially invited to
attend the Annual Meeting of Stockholders of MannKind Corporation, a Delaware corporation (&#147;MannKind&#148;). The meeting will be held on Wednesday, May&nbsp;16, 2018 at 10:00&nbsp;a.m. U.S. Pacific Time at the office of MannKind at 30930
Russell Ranch Road, Suite 301, Westlake Village, California 91362 for the following purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">To elect the seven nominees named herein as directors to serve for the ensuing year and until their successors are elected; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">To approve the MannKind Corporation 2018 Equity Incentive Plan; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">To approve an amendment to the MannKind Corporation 2004 Employee Stock Purchase Plan to, among other things, increase the number of shares authorized for issuance under the 2004 Employee Stock Purchase Plan by
3,000,000 shares; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top">To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind&#146;s proxy statement for the Annual Meeting; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top">To ratify the selection by the Audit Committee of the Board of Directors of Deloitte&nbsp;&amp; Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December&nbsp;31,
2018;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top">To transact such other business as may properly come before the meeting or any adjournment or postponement thereof. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These items of business are more fully described in the proxy statement accompanying this notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The record date for the Annual Meeting is March&nbsp;19, 2018. Only stockholders of record on that date may vote at the meeting or any
adjournment thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders of MannKind Corporation to
be Held on May&nbsp;16, 2018 at 10:00 a.m. U.S. Pacific time at the office of MannKind Corporation located at 30930 Russell Ranch Road, Suite 301, Westlake Village, California 91362. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The proxy statement and annual report to stockholders are available at <U>www.mannkindcorp.com</U>. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g536430g09k79.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Thomson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Corporate Vice President, General Counsel and Secretary</I></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Westlake Village, California </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;29, 2018 </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>You are cordially invited to attend the meeting in person. Whether or not you expect to attend the
meeting, please vote by proxy pursuant to the instructions set forth herein as promptly as possible in order to ensure your representation at the meeting. Even if you have voted by proxy, you may still vote in person if you attend the meeting.
Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>All visitors to the MannKind Westlake Village corporate site will be required to present a government-issued photo identification. Thank you, in advance,
for your cooperation. </B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MANNKIND CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>30930 Russell Ranch Road, Suite 301 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Westlake Village, California 91362 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">(818)&nbsp;661-5000</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE
2018 ANNUAL MEETING OF STOCKHOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To be held on May&nbsp;16, 2018 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why did I receive a notice regarding the availability of proxy materials on the internet? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to rules adopted by the Securities and Exchange Commission (the &#147;SEC&#148;), we have elected to provide access to our proxy
materials over the internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials (the &#147;Notice&#148;) because the Board of Directors (sometimes referred to as the &#147;Board&#148;) of MannKind Corporation
(sometimes referred to as, &#147;we,&#148; &#147;us,&#148; the &#147;Company&#148; or &#147;MannKind&#148;) is soliciting your proxy to vote at the 2018 Annual Meeting of Stockholders (the &#147;Annual Meeting&#148;), including any adjournments or
postponements of the Annual Meeting. You are invited to attend the annual meeting to vote on the proposals described in this proxy statement. However, you do not need to attend the meeting to vote your shares. All stockholders will have the ability
to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to access the proxy materials over the internet or to request a printed copy may be found in the
Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notice is expected to be first mailed to our stockholders of record entitled to vote at the Annual Meeting on or about
April&nbsp;4, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Will I receive any other proxy materials by mail? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may send you a proxy card, along with a second Notice, on or after April&nbsp;14, 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who can vote at the Annual Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only
stockholders of record at the close of business on March&nbsp;19, 2018 (the &#147;record date&#148;) will be entitled to vote at the Annual Meeting. On this record date, there were 123,011,353 shares of common stock outstanding and entitled to vote.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stockholder of Record: Shares&nbsp;Registered in Your Name </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If on the record date your shares were registered directly in your name with MannKind&#146;s transfer agent, Computershare, then you are a
stockholder of record. As a stockholder of record, you may vote in person at the meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy pursuant to the instructions set forth below to ensure your
vote is counted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Beneficial Owner: Shares&nbsp;Registered in the Name of a Broker or Bank </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If on the record date your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer, or other similar
organization, then you are the beneficial owner of shares held in &#147;street name&#148; and Notice is being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of
voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent on how to vote the shares in your account. You are also invited to attend the Annual Meeting. However, because you are not the stockholder
of record, you may not vote your shares in person at the Annual Meeting unless you request and obtain a valid proxy from your broker or other agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What am I voting on? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management is presenting five proposals for stockholder vote. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal&nbsp;1. Election of Seven Directors </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The first proposal to be voted on is the election of the seven nominees named herein as directors for a
<FONT STYLE="white-space:nowrap">one-year</FONT> term. The Board has nominated these seven people as directors. You may find information about these nominees, as well as information about MannKind&#146;s Board of Directors and its committees,
director compensation and other related matters beginning on page&nbsp;7. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may vote &#147;For&#148; all the nominees,
&#147;Withhold&#148; your votes as to all nominees or &#147;Withhold&#148; your votes as to specific nominees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors
unanimously recommends a vote FOR all the director nominees named herein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal&nbsp;2. Approval of MannKind&#146;s 2018 Equity Incentive Plan
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The second proposal to be voted on is to approve MannKind&#146;s 2018 Equity Incentive Plan (&#147;2018 Plan&#148;), which was adopted
by the Board of Directors on February&nbsp;21, 2018, subject to stockholder approval. The 2018 Plan is intended to be the successor to and continuation of MannKind&#146;s 2013 Equity Incentive Plan (the &#147;2013 Plan&#148;) which includes
amendments to, among other things, increase the aggregate number of shares of common stock authorized for issuance and other amendments that align the 2018 Plan with ISS guidelines and changes. You may find information about this proposal beginning
on page&nbsp;16. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may vote &#147;For&#148; or &#147;Against&#148; the proposal or &#147;Abstain&#148; from voting on the proposal.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors unanimously recommends a vote FOR Proposal 2. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal&nbsp;3. Approval of an Amendment to MannKind&#146;s 2004 Employee Stock Purchase Plan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The third proposal to be voted on is to approve an amendment to MannKind&#146;s 2004 Employee Stock Purchase Plan (&#147;ESPP&#148;) to, among
other things, increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. You may find information about this proposal beginning on page&nbsp;30. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may vote &#147;For&#148; or &#147;Against&#148; the proposal or &#147;Abstain&#148; from voting on the proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors unanimously recommends a vote FOR Proposal 3. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal&nbsp;4. Advisory Vote on Executive Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fourth proposal to be voted on is an advisory vote by the stockholders of MannKind regarding the compensation of the Company&#146;s named
executive officers as described in this proxy statement, including the disclosures under &#147;Compensation Discussion and Analysis,&#148; the compensation tables and the narrative discussion following the compensation tables. The Company is seeking
the stockholders&#146; approval, on an advisory basis, of the compensation of the named executive officers. You may find information about this proposal beginning on page&nbsp;36. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may vote &#147;For&#148; or &#147;Against&#148; the proposal or &#147;Abstain&#148; from voting on the proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors unanimously recommends a vote FOR Proposal 4. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal 5. Ratification of Selection by the Audit Committee of the Board of Directors of
Deloitte&nbsp;&amp; Touche LLP as the Company&#146;s Independent Registered Public Accounting Firm for the Fiscal Year Ending December&nbsp;31,&nbsp;2018 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fifth proposal to be voted on is to ratify the selection by the Audit Committee of the Board of Deloitte&nbsp;&amp; Touche LLP as the
Company&#146;s independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2018. It is expected that representatives of Deloitte&nbsp;&amp; Touche LLP will attend the Annual Meeting and be available to make a statement
or respond to appropriate questions. You may find information about this proposal beginning on page&nbsp;38. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may vote &#147;For&#148;
or &#147;Against&#148; the proposal or &#147;Abstain&#148; from voting on the proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors unanimously recommends a
vote FOR Proposal 5. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if another matter is properly brought before the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are
properly brought before the Annual Meeting, it is the intention of the persons named in the proxy to vote on those matters in accordance with their best judgment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I vote? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The procedures for voting
are fairly simple: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stockholder of Record: Shares&nbsp;Registered in Your Name </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a stockholder of record, you may vote in person at the Annual Meeting, vote by proxy over the telephone, vote by proxy through the
internet or vote by proxy using a proxy card that you may request or that we may elect to deliver at a later time. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still
attend the Annual Meeting and vote in person if you have already voted by proxy. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To vote in person, come to the Annual Meeting and we will give you a ballot when you arrive. For directions to the meeting, please visit the following web address: <U> </U></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><U>http://www.google.com/maps/place/30930+Russell+Ranch+Rd,+Westlake+Village,+CA+91362</U>. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To vote using the proxy card, simply complete, sign and date the proxy card that may be delivered and return it promptly in the envelope provided. Your signed proxy card must be received by 5:00&nbsp;PM
U.S.&nbsp;Eastern time on May&nbsp;15, 2018 to be counted. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To vote over the telephone, dial toll-free <FONT STYLE="white-space:nowrap">(866)&nbsp;437-3716</FONT> using a touch-tone phone and follow the recorded instructions. You will be asked to provide the control number from
the Notice. Your vote must be received by 5:00&nbsp;PM U.S.&nbsp;Eastern time on May&nbsp;15, 2018 to be counted. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To vote through the internet, go to http://www.proxypush.com/mnkd to complete an electronic proxy card. You will be asked to provide the control number from the Notice. Your vote must be received by 5:00&nbsp;PM
U.S.&nbsp;Eastern time on May&nbsp;15, 2018 to be counted. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We provide internet proxy voting to allow you to vote your
shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet
access providers and telephone companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Beneficial Owner: Shares&nbsp;Registered in the Name of Broker or Bank </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should have received a Notice
containing voting instructions from that organization rather than from MannKind. Simply follow the voting instructions in the Notice to ensure that your vote is counted. To vote in person at the Annual Meeting, you must obtain a valid proxy from
your broker, bank, or other agent. Follow the instructions from your broker or bank included with these proxy materials, or contact your broker or bank to request a proxy form. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes do I have? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On each matter
to be voted upon, you have one vote for each share of common stock you owned as of the record date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if I return a proxy card or otherwise vote by
proxy but do not make specific choices? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you voted by proxy without marking any voting selections, your shares will be voted
&#147;For&#148; the election of each of the seven nominees for director listed in Proposal&nbsp;1, &#147;For&#148; the approval of the 2018 Plan in Proposal 2, &#147;For&#148; the amendment of the ESPP in Proposal 3, &#147;For&#148; the advisory
vote on executive compensation as provided in Proposal 4, and &#147;For&#148; the ratification of the selection of Deloitte&nbsp;&amp; Touche LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2018
as provided in Proposal 5. If any other matter is properly presented at the Annual Meeting, your proxy (one of the individuals named on your proxy card) will vote your shares using his or her best judgment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who is paying for this proxy solicitation? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit
proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We will also reimburse brokerage firms, banks and other agents for the cost of
forwarding proxy materials to beneficial owners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have retained Morrow Sodali LLC to assist in the solicitation. We will
pay Morrow Sodali LLC approximately $9,500 plus <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses, for its assistance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What does it mean if I receive more than one Notice? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you receive more than one Notice, your shares are registered in more than one name or are registered in different accounts. Please follow
the voting instructions with respect to <B>each</B> Notice to ensure that all of your shares are voted. Similarly, if you are a stockholder of record and you receive more than one Notice, your shares are registered in more than one name. Please
follow the voting instructions with respect to <B>each</B> Notice to ensure that all of your shares are voted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Can I change my vote after submitting
my proxy? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are a stockholder of record,
you may revoke your proxy in any one of the following ways: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may send a written notice that you are revoking your proxy to MannKind&#146;s Corporate Secretary at 30930 Russell Ranch Road, Suite 301, Westlake Village, California 91362. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may grant another proxy by telephone or through the internet. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may submit another properly completed proxy card with a later date. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may attend the Annual Meeting and vote in person. Simply attending the Annual Meeting will not, by itself, revoke your proxy. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your most current proxy, whether submitted by proxy card, telephone or internet, is the one that is counted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How are votes counted? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Votes will be
counted by the inspector of election appointed for the meeting, who will separately count, with respect to the proposal to elect directors, votes &#147;For,&#148; &#147;Withhold&#148; and broker <FONT STYLE="white-space:nowrap">non-votes;</FONT> and
with respect to other proposals, &#147;For&#148; and &#147;Against&#148; votes, abstentions and, if applicable, broker <FONT STYLE="white-space:nowrap">non-votes.</FONT> Abstentions will be counted towards the vote total for each proposal, except
with respect to the election of directors, and will have the same effect as &#147;Against&#148; votes. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect and will not be counted towards the vote total for any proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What are &#147;broker <FONT STYLE="white-space:nowrap">non-votes&#148;?</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> occur when a beneficial owner of shares held in street name does not give instructions
to the broker or nominee holding the shares as to how to vote on matters deemed <FONT STYLE="white-space:nowrap">&#147;non-routine.&#148;</FONT> Generally, if shares are held in street name (shares are held by your broker as your nominee), the
beneficial owner of the shares is entitled to give voting instructions to the broker or nominee holding the shares. If you do not give instructions to your broker, your broker can vote your shares with respect to matters that are considered to be
&#147;routine,&#148; but not with respect to <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> matters. Under the rules and interpretations of the New York Stock Exchange, <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT>
matters are generally those involving a matter that may substantially affect the rights or privileges of stockholders, such as mergers or stockholder proposals, election of directors (even if not contested) and executive compensation, including the
stockholder advisory votes on executive compensation. Proposals 1, 2, 3 and 4 regarding the election of directors, the approval of the 2018 Plan, the amendment of the ESPP, and the advisory vote regarding executive compensation, respectively, are <FONT
STYLE="white-space:nowrap">non-routine</FONT> matters. Proposal 5 to ratify Deloitte&nbsp;&amp; Touche LLP as our independent registered public accounting firm is a routine matter. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes are needed to approve each proposal? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the election of directors, the seven nominees receiving the most &#147;For&#148; votes (among votes properly cast in person or by proxy)
will be elected. Only votes &#147;For&#148; or &#147;Withhold&#148; will affect the outcome. Only the seven nominees named herein have been properly nominated for election as directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposals 2 3, 4 and 5 regarding, respectively, adoption of the 2018 Plan, approval of an amendment to the ESPP, approval on an advisory basis
of the compensation of the Company&#146;s named executive officers and ratification of the Audit Committee&#146;s selection of the independent registered public accounting firm, must receive a &#147;For&#148; vote from the majority of shares present
and entitled to vote either in person or by proxy in order to be approved. If you &#147;Abstain&#148; from voting on any of these proposals, it will have the same effect as an &#147;Against&#148; vote. Broker
<FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What is the quorum requirement? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A quorum of stockholders is necessary to hold a valid Annual Meeting. A quorum will be present if at least a majority of the outstanding shares
entitled to vote are represented by stockholders present at the Annual Meeting or by proxy. On the record date, there were 123,011,353 shares outstanding and entitled to vote. Thus, 61,505,677 shares must be represented by stockholders present at
the Annual Meeting or by proxy to have a quorum. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is
submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the Annual Meeting. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will be counted towards the quorum requirement. If there is no
quorum, the chairman of the Annual Meeting or a majority of the votes present at the Annual Meeting may adjourn the meeting to another date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How can I
find out the results of the voting at the Annual Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preliminary voting results will be announced at the Annual Meeting. Final
voting results will be published in a current report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> that we expect to file no later than four business days following the date of the Annual Meeting. If final voting results are not available
to us in time to file a <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> on or before such date, we intend to file a <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> to publish preliminary results and, within four business days after the
final results are known to us, file an additional <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> to publish the final results. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>When are
stockholder proposals due for next year&#146;s annual meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To be considered for inclusion in MannKind&#146;s proxy material for
next year&#146;s annual meeting, your proposal must be submitted in writing by December&nbsp;5, 2018 to Attn: Corporate Secretary, MannKind Corporation, 30930 Russell Ranch Road, Suite 301, Westlake Village, California 91362. If you wish to submit a
proposal that is not to be included in MannKind&#146;s proxy materials or nominate a director, you must do so not later than February&nbsp;15, 2019 and not earlier than January&nbsp;16, 2019. You are also advised to review the Company&#146;s Amended
and Restated Bylaws, which contain additional requirements about advance notice of stockholder proposals and director nominations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL&nbsp;1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION OF DIRECTORS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MannKind&#146;s Board of Directors consists of seven directors. There are seven nominees for director this year, all of whom were nominated by
our Board of Directors. Each director to be elected will hold office until the next annual meeting of stockholders and until his successor is elected, or until the director&#146;s earlier death, resignation or removal. All nominees listed below are
currently our directors and were previously elected by our stockholders at the 2017 Annual Meeting of Stockholders. It is our policy that directors are invited and expected to attend annual meetings. All directors, except Messrs. Kresa and Nordhoff,
attended the 2017 Annual Meeting of Stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Directors are elected by a plurality of the votes properly cast in person or by proxy.
The seven nominees receiving the highest number of affirmative votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the seven nominees named below. If any nominee
becomes unavailable for election as a result of an unexpected occurrence, your shares may be voted for the election of a substitute nominee proposed by our Nominating and Corporate Governance Committee. Each person nominated for election has agreed
to serve if elected. Our management has no reason to believe that any nominee will be unable to serve. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOMINEES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a brief biography of each nominee for director and a discussion of the specific experience, qualifications, attributes or
skills of each nominee that led our Board of Directors to conclude that each nominee should serve as a member of the Board. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="42%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position Held With the Company</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kent Kresa(1)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairman of the Board of Directors</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Castagna, Pharm.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer and Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald&nbsp;J. Consiglio(2)(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael&nbsp;A. Friedman,&nbsp;M.D.(1)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David H. MacCallum(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Henry L. Nordhoff(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James S. Shannon, M.D., MRCP (UK)(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">(1) Member of the Compensation Committee. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">(2) Member of the Nominating and Corporate Governance Committee. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">(3) Member of the Audit Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Kent Kresa</I> has been a member of our Board of Directors since June 2004 and has served as Chairman of the Board since February 2017.
From November 2011 until his appointment as our Chairman, Mr.&nbsp;Kresa served on our Board of Directors as our lead independent director. Mr.&nbsp;Kresa is Chairman Emeritus of Northrop Grumman Corporation, a defense company and from September
1990 until October 2003, he was also its Chairman. He also served as Chief Executive Officer of Northrop Grumman Corporation from January 1990 until March 2003 and as its President from 1987 until September 2001. From 2003 to August 2010,
Mr.&nbsp;Kresa served as a director of General Motors Company (or its predecessor). From December 2005 to April 2010, Mr.&nbsp;Kresa served as a director of Avery Dennison Corporation. Mr.&nbsp;Kresa has been a member of the Caltech Board of
Trustees since 1994. Mr.&nbsp;Kresa has served on the board of Fluor Corporation since 2003, and he also serves on the boards of several <FONT STYLE="white-space:nowrap">non-profit</FONT> organizations and universities. As a graduate of
Massachusetts Institute of Technology, he received a B.S. in 1959, an M.S. in 1961, and an E.A.A. in 1966, all in aeronautics and astronautics. The Board believes that Mr.&nbsp;Kresa&#146;s business experience, including his experience as a director
and executive officer of Northrop Grumman, and his service on other public company boards, combined with his business acumen and judgment provide our Board with valuable operational expertise and leadership and qualifies him to serve on our Board of
Directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Michael E. Castagna, Pharm.D.</I> has served as our Chief Executive Officer and as one of
our directors since May 2017. Mr.&nbsp;Castagna also served as a Corporate Vice President, Chief Commercial Officer from March 2016 until May 2017. From November 2012 until he joined the Company, Mr.&nbsp;Castagna was at Amgen, Inc., where he
initially served as Vice President, Global Lifecycle Management and was most recently Vice President, Global Commercial Lead for Amgen&#146;s Biosimilar Business Unit. From 2010 to 2012, he was Executive Director, Immunology, at Bristol-Myers Squibb
Co. Before BMS, Mr.&nbsp;Castagna served as Vice President&nbsp;&amp; Head, Biopharmaceuticals, North America, at Sandoz. He has also held positions with commercial responsibilities at EMD (Merck) Serono, Pharmasset and DuPont Pharmaceuticals. He
received his pharmacy degree from University of the Sciences-Philadelphia College of Pharmacy, a Doctor of Pharmacy from Massachusetts College of Pharmacy&nbsp;&amp; Sciences and an MBA from The Wharton School of Business at the University of
Pennsylvania. The Board believes that Mr.&nbsp;Castagna&#146;s knowledge and extensive experience with commercial pharmaceutical companies, combined with his business acumen and judgment, provide our Board with valuable operational expertise and
leadership and qualifies him to serve on our Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Ronald J. Consiglio</I> has been one of our directors since October
2003. Since 1999, Mr.&nbsp;Consiglio has been the managing director of Synergy Trading, a securities-trading partnership. From 1999 to 2001, Mr.&nbsp;Consiglio was Executive Vice President and Chief Financial Officer of Trading Edge, Inc., a
national automated bond-trading firm. From January 1993 to 1998 Mr.&nbsp;Consiglio served as Chief Executive Officer of Angeles Mortgage Investment Trust, a publicly traded Real Estate Investment Trust. His prior experience includes serving as
Senior Vice President and Chief Financial Officer of Cantor Fitzgerald&nbsp;&amp; Co. and as a member of its board of directors. Mr.&nbsp;Consiglio has served as a member of the board of trustees for the Metropolitan West Funds since 2003.
Mr.&nbsp;Consiglio is a certified public accountant and holds a bachelor&#146;s degree in accounting from California State University at Northridge. The Board believes that Mr.&nbsp;Consiglio&#146;s knowledge and understanding of accounting and
finance, his experience as a board member and executive officer at financial services firms, combined with his business acumen and judgment provide our Board with valuable accounting, financial and operational expertise and leadership and qualifies
him to serve on our Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Michael A. Friedman,</I><I></I><I>&nbsp;M.D.</I> has been one of our directors since December
2003. In 2014, Dr.&nbsp;Friedman completed a decade of service as the President and Chief Executive Officer of the City of Hope National Medical Center. Previously, from September&nbsp;2001 until April 2003, Dr.&nbsp;Friedman held the position of
Senior Vice President of Research and Development, Medical and Public Policy, for Pharmacia Corporation and, from July 1999 until September 2001, was a senior vice president of Searle, a subsidiary of Monsanto Company. From 1995 until June 1999,
Dr.&nbsp;Friedman served as Deputy Commissioner for Operations for the Food and Drug Administration, and was Acting Commissioner and Lead Deputy Commissioner from 1997 to 1998. He joined the board of Celgene Corporation in February 2011 and the
board of Smith&nbsp;&amp; Nephew plc in April 2013. Dr.&nbsp;Friedman received a bachelor of arts degree, magna cum laude, from Tulane University, New Orleans, Louisiana, and a doctorate in medicine from the University of Texas, Southwestern Medical
School. The Board believes Dr.&nbsp;Friedman&#146;s business experience, including his experience as an executive officer at biopharmaceutical companies and a leading clinical and research center specializing in cancer and diabetes, and his service
at the Food and Drug Administration, combined with his business acumen and judgment provide our Board with valuable scientific and operational expertise and leadership and qualifies him to serve on our Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>David H. </I><I>MacCallum</I> has been one of our directors since June 2004. Since 2002, Mr.&nbsp;MacCallum has served as the Managing
Partner of Outer Islands Capital, a hedge fund specializing in health care investments. From June 1999 until November 2001, he was Global Head of Health Care investment banking for Salomon Smith Barney, part of Citigroup, a financial institution.
Prior to joining Salomon Smith Barney, he was Executive Vice President and Head of the Health Care group at ING Barings Furman Selz LLC, an investment banking firm and subsidiary of ING Group, a Dutch financial institution, from April 1998 to June
1999. Prior to that, Mr.&nbsp;MacCallum formed the Life Sciences group at UBS Securities, an investment banking firm, where he was Managing Director and Global Head of Life Sciences from May 1994 to April 1998. Before joining UBS Securities, he
built the health care practice at Hambrecht&nbsp;&amp; Quist, an investment banking firm, where he was </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Head of Health Care and <FONT STYLE="white-space:nowrap">Co-Head</FONT> of Investment Banking. From 2005 to October 2010, Mr.&nbsp;MacCallum served as a director of Zymogenetics, Inc. From 2002
to 2008, he served as a director of Vital Signs, Inc. Mr.&nbsp;MacCallum received an A.B. degree from Brown University and an M.B.A. degree from New York University. He is a Chartered Financial Analyst. The Board believes that
Mr.&nbsp;MacCallum&#146;s knowledge and understanding of accounting and finance, his business experience in the investment banking industry, combined with his business acumen and judgment provide our Board with valuable accounting, financial and
operational expertise and leadership and qualifies him to serve on our Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Henry L. Nordhoff</I> has been one of our
directors since March 2005. He has served as a director of BioTime, Inc. since June 2013 and as a director of Asterias Biotherapeutics, Inc. since October 2013. Mr.&nbsp;Nordhoff retired as Chairman of the Board of
<FONT STYLE="white-space:nowrap">Gen-Probe</FONT> Incorporated, a clinical diagnostic and blood screening company, at the end of 2011, after serving as its Chairman since September 2002. He also served as Chief Executive Officer and President of <FONT
STYLE="white-space:nowrap">Gen-Probe</FONT> from July 1994 until May 2009. Prior to joining <FONT STYLE="white-space:nowrap">Gen-Probe,</FONT> he was President and Chief Executive Officer of TargeTech, Inc., a gene therapy company that was merged
into Immune Response Corporation. Prior to that, Mr.&nbsp;Nordhoff was at Pfizer, Inc. in senior positions in Brussels, Seoul, Tokyo and New York. He received a B.A. in international relations and political economy from Johns Hopkins University and
an M.B.A. from Columbia University. The Board believes that Mr.&nbsp;Nordhoff&#146;s business experience, including his experience as a director and executive officer at pharmaceutical and biotech companies, combined with his business acumen and
judgment provide our Board with valuable operational expertise and leadership and qualifies him to serve on our Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>James S. Shannon</I>, <I>M.D., MRCP (UK)</I> rejoined our board in May 2015 after previously serving as a director from February 2010 until
April 2012. From May 2012 until his retirement in April 2015, Dr.&nbsp;Shannon was the Chief Medical Officer of GlaxoSmithKline. He formerly held the position of Global Head of Pharma Development at Novartis AG, based in Basel, Switzerland from 2005
until 2008. After joining Sandoz in 1994 as Head of Drug Regulatory Affairs, Dr.&nbsp;Shannon led the Integration Office for R&amp;D overseeing the creation of the Novartis R&amp;D groups from those of Ciba-Geigy Ltd and Sandoz. Following the merger
he was appointed Head of the Cardiovascular Strategic Team and subsequently became Global Head of Project Management before being appointed Global Head of Clinical Development and Medical Affairs in 1999, a position that he held until 2005 when he
was appointed to Head Pharma Development. Between 2008 and joining GSK, Dr.&nbsp;Shannon served on the boards of a number of companies, including Biotie, Circassia, Crucell, Endocyte and MannKind. He also sat on the board of Cerimon Pharmaceuticals
where he held the position of interim Chief Executive Officer and President from January 2009 until April 2010. He first entered the pharmaceutical industry in 1987 joining Sterling Winthrop Inc., working initially in Europe and subsequently in the
USA, where he held positions of increasing responsibility in the management of research and development ultimately serving as Senior Vice-President, Clinical Development. Dr.&nbsp;Shannon is trained in Medicine and Cardiology. He received his
undergraduate and postgraduate degrees at Queen&#146;s University of Belfast and is a Member of the Royal College of Physicians (UK).&nbsp;The Board believes that Dr.&nbsp;Shannon&#146;s business experience and his extensive experience in drug
development, combined with his business acumen and judgment provide our Board with valuable scientific and operational expertise and leadership and qualifies him to serve on our Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> R<SMALL>ECOMMENDS</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A <SMALL>VOTE</SMALL> <SMALL>FOR</SMALL> <SMALL>THE</SMALL> E<SMALL>LECTION</SMALL> <SMALL>OF</SMALL> <SMALL>ALL</SMALL>
D<SMALL>IRECTOR</SMALL> N<SMALL>OMINEES</SMALL> <SMALL>NAMED</SMALL> <SMALL>ABOVE</SMALL> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATE GOVERNANCE PRINCIPLES AND BOARD AND COMMITTEE MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>NDEPENDENCE</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required under the Nasdaq Stock Market (&#147;Nasdaq&#148;) listing standards, a majority of the members of a listed company&#146;s board of
directors must qualify as &#147;independent,&#148; as affirmatively determined by the board of directors. Our Board of Directors consults with the Company&#146;s counsel to ensure that the Board&#146;s determinations are consistent with all relevant
securities and other laws and regulations regarding the definition of &#147;independent,&#148; including those set forth in pertinent listing standards of Nasdaq, as in effect time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consistent with these considerations, after review of all relevant transactions or relationships between each director or any of his family
members and the Company, its senior management and its independent auditors, the Board of Directors affirmatively has determined that all of the Company&#146;s directors other than Mr.&nbsp;Castagna is independent within the meaning of the
applicable Nasdaq listing standards. Mr.&nbsp;Castagna was determined not to be independent under applicable Nasdaq listing standards due to his position as an executive officer of our company. In making this determination, the Board found that none
of the directors has a material or other disqualifying relationship with the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>NFORMATION</SMALL> R<SMALL>EGARDING</SMALL>
<SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> <SMALL>AND</SMALL> <SMALL>ITS</SMALL> C<SMALL>OMMITTEES</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are committed to maintaining the highest standards of business conduct and ethics. Our Board of Directors has adopted a Code of Business
Conduct and Ethics and adheres to corporate governance guidelines to assure that the Board will have the necessary authority and practices in place to review and evaluate our business operations as needed and to make decisions that are independent
of our management. The guidelines are also intended to align the interests of directors and management with those of our stockholders. The charters for various Board committees set forth the practices the Board will follow with respect to board
composition and selection, board meetings and involvement of senior management, Chief Executive Officer performance evaluation and succession planning, and board committees and compensation. Our Board of Directors adopted these measures to, among
other things, reflect changes to the Nasdaq listing standards and SEC rules adopted to implement provisions of the Sarbanes-Oxley Act of 2002, as amended. Our Code of Business Conduct and Ethics, as well as the charters for each committee of the
Board, may be viewed on our website at <I>www.mannkindcorp.com.</I> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>B<SMALL>OARD</SMALL> L<SMALL>EADERSHIP</SMALL> S<SMALL>TRUCTURE</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors is currently chaired by Mr.&nbsp;Kresa. As a general policy, our Board of Directors believes that separation of the
positions of Chairman and Chief Executive Officer reinforces the independence of the Board of Directors from management, creates an environment that encourages objective oversight of management&#146;s performance and enhances the effectiveness of
the Board of Directors as a whole. As such, Mr.&nbsp;Castagna serves as our Chief Executive Officer while Mr.&nbsp;Kresa serves as our Chairman of the Board of Directors but is not an officer. We expect and intend the positions of Chairman of the
Board of Directors and Chief Executive Officer to continue to be held by separate individuals in the future. If in the future we conclude there is a compelling reason for the positions of Chairman of the Board and Chief Executive Officer to be
occupied by the same individual, we would expect to appoint one of our other directors to the position of lead independent director to help reinforce the independence of the Board from management. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>R<SMALL>OLE</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>IN</SMALL> R<SMALL>ISK</SMALL> O<SMALL>VERSIGHT</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the key functions of our Board of Directors is informed oversight of the Company&#146;s risk management process. The Board of Directors
does not have a standing risk management committee, but rather administers this oversight function directly through the Board as a whole, as well as through various standing committees that address risks inherent in their respective areas of
oversight. In particular, our Board is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
responsible for monitoring and assessing strategic risk exposure, including a determination of the nature and level of risk appropriate for the Company. Our Audit Committee has the responsibility
to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken.
Our Compensation Committee reviews and approves individual and corporate performance goals, advises the Board regarding the adoption, modification, or termination of compensation plans and policies and assesses and monitors whether any of our
compensation policies and programs has the potential to encourage excessive risk-taking. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>OMMITTEES</SMALL> <SMALL>OF</SMALL>
<SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has three standing
committees: an Audit Committee, a Compensation Committee, and a Nominating and Corporate Governance Committee. All three committees operate under written charters adopted by our Board, all of which are available on our website at
<I>www.mannkindcorp.com.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the committees has authority to engage legal counsel or other experts or consultants, as it deems
appropriate to carry out its responsibilities. The Board of Directors has determined that each member of each committee meets the applicable rules and regulations regarding &#147;independence&#148; and that each member is free of any relationship
that would interfere with his or her individual exercise of independent judgment with regard to the Company. Below is a description of each committee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Audit Committee consists of Mr.&nbsp;Consiglio (chair), Mr.&nbsp;MacCallum and Mr.&nbsp;Nordhoff, each of whom is an independent member of
our Board of Directors (as determined by our Board based on its annual review of the independence requirement of Audit Committee members provided in Rule&nbsp;5605(c)(2)(A)(i) and (ii)&nbsp;of the Nasdaq listing standards). Our Audit Committee was
established by the Board in accordance with Section&nbsp;3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), to oversee the Company&#146;s corporate accounting and financial reporting processes and audits
of its financial statements. The functions of this committee include, among others: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">evaluating the independent registered public accounting firm&#146;s qualifications, independence and performance; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">determining the engagement of the independent registered public accounting firm; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">approving the retention of the independent registered public accounting firm to perform any proposed permissible <FONT STYLE="white-space:nowrap">non-audit</FONT> services; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">monitoring the rotation of partners of the independent registered public accounting firm on our engagement team as required by law; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing our financial statements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing our critical accounting policies and estimates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">discussing with management and the independent registered public accounting firm the results of the annual audit and the review of our quarterly financial statements;&nbsp;and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and evaluating, at least annually, the performance of the Audit Committee and its members, including compliance of the Audit Committee with its charter. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Mr.&nbsp;Consiglio qualifies as an &#147;audit committee financial expert,&#148; as that term is
defined in applicable SEC rules. In making such determinations, the Board of Directors made a qualitative assessment of Mr.&nbsp;Consiglio&#146;s level of knowledge and experience based on a number of factors, including his formal education and
experience. Both our independent registered public accounting firm </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and internal financial personnel regularly meet privately with our Audit Committee and have unrestricted access to this committee. Our Audit Committee charter can be found on our corporate
website at <I>www.mannkindcorp.com.</I> The Audit Committee met eleven times during 2017. The report of the Audit Committee is included herein on page&nbsp;69. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee consists of Mr.&nbsp;Kresa (chair), Dr.&nbsp;Friedman and Dr.&nbsp;Shannon, each of whom is an independent member of
our Board of Directors (as independence is currently defined in Rule&nbsp;5605(a)(2) of the Nasdaq listing standards). The functions of this committee include, among others: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and recommending policy relating to compensation and benefits of our officers and employees, including reviewing and approving corporate goals and objectives relevant to compensation of our Chief Executive
Officer and other senior officers, evaluating the performance of these officers in light of those goals and objectives, and recommending compensation of these officers based on such evaluations; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">administering our benefit plans and the issuance of stock options and other awards under our stock plans; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">recommending the type and amount of compensation to be paid or awarded to members of our Board of Directors, including consulting, retainer, meeting, committee and committee chair fees and stock option grants or awards;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and approving the terms of any employment agreements, severance arrangements, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-of-control</FONT></FONT> protections and any other
compensatory arrangements for our executive officers;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and evaluating, at least annually, the performance of the Compensation Committee and its members, including compliance of the Compensation Committee with its charter. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Typically, the Compensation Committee meets at least quarterly and with greater frequency if necessary. The Compensation Committee met five times during 2017.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The processes and procedures of the Compensation Committee with respect to executive compensation are described in greater detail in the
&#147;Compensation Discussion and Analysis&#148; section of this proxy statement. Our Compensation Committee charter can be found on our corporate website at <I>www.mannkindcorp.com.</I> The report of the Compensation Committee is included herein on
page&nbsp;68. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Nominating and Corporate Governance Committee consists of Dr.&nbsp;Friedman (chair), Mr.&nbsp;Consiglio and Mr.&nbsp;Kresa, each of whom is
an independent member of our Board of Directors (as independence is currently defined in Rule&nbsp;5605(a)(2) of the Nasdaq listing standards). The functions of this committee include, among others: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">planning for succession with respect to the position of Chief Executive Officer and other senior officers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and recommending nominees for election as directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">assessing the performance of the Board of Directors and monitoring committee evaluations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">suggesting, as appropriate, <FONT STYLE="white-space:nowrap">ad-hoc</FONT> committees of the Board of Directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">developing guidelines for board composition;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and evaluating, at least annually, the performance of the Nominating and Corporate Governance Committee and its members, including compliance of the Nominating and Corporate Governance Committee with its
charter. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Nominating and Corporate Governance Committee charter can be found on our corporate
website at <I>www.mannkindcorp.com.</I> The Nominating and Corporate Governance Committee did not meet during 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>ONSIDERATION</SMALL>
<SMALL>OF</SMALL> D<SMALL>IRECTOR</SMALL> N<SMALL>OMINEES</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Director Qualifications </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee believes that candidates for director should have certain minimum qualifications, including
being able to read and understand basic financial statements, being over 21&nbsp;years of age and having the highest personal integrity and ethics. The Nominating and Corporate Governance Committee also intends to consider such factors as possessing
relevant expertise upon which to be able to offer advice and guidance to management, having sufficient time to devote to the affairs of the Company, demonstrated excellence in his or her field, having the ability to exercise sound business judgment
and having the commitment to rigorously represent the long-term interests of the Company&#146;s stockholders. However, the Nominating and Corporate Governance Committee retains the discretion to modify these qualifications from time to time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Evaluating Nominees for Director </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee review candidates for director nominees in the context of the current composition of the
Board of Directors, the operating requirements of the Company and the long-term interests of the Company&#146;s stockholders. In conducting this assessment, the Nominating and Corporate Governance Committee considers age, skills, and such other
factors as it deems appropriate given the current needs of the Board of Directors and the Company, to maintain a balance of knowledge, experience and capability. In the case of incumbent directors, the Nominating and Corporate Governance Committee
reviews such directors&#146; overall service to the Company during their term, including the number of meetings attended, level of participation, quality of performance, and any other relationships and transactions that might impair such
directors&#146; independence. In the case of new director candidates, the Nominating and Corporate Governance Committee also determines whether the nominee would be independent for Nasdaq purposes, which determination is based upon applicable Nasdaq
listing standards, applicable SEC rules and regulations and the advice of counsel, if necessary. The Nominating and Corporate Governance Committee also focuses on issues of diversity, such as diversity of gender, race and national origin, education,
professional experience and differences in viewpoints and skills. The Nominating and Corporate Governance Committee does not have a formal policy with respect to diversity; however, the Board of Directors and the Nominating and Corporate Governance
Committee believe that it is important that directors represent diverse viewpoints. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee
uses its network of contacts to compile a list of potential candidates, but may also engage, if it deems appropriate, a professional search firm. The Nominating and Corporate Governance Committee conducts any appropriate and necessary inquiries into
the backgrounds and qualifications of possible candidates after considering the function and needs of the Board. The Nominating and Corporate Governance Committee meets to discuss and consider such candidates&#146; qualifications and then selects a
nominee for recommendation to the Board by majority vote. To date, the Nominating and Corporate Governance Committee has not paid a fee to any third party to assist in the process of identifying or evaluating director candidates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder Nominations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee will consider director candidates recommended by stockholders. The Nominating and Corporate
Governance Committee does not intend to alter the manner in which it evaluates candidates, including the minimum criteria set forth above, based on whether a candidate was recommended by a stockholder or not. Stockholders who wish to recommend
individuals for consideration by the Nominating and Corporate Governance Committee to become nominees for election to the Board of Directors </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
must do so by delivering at least 120&nbsp;days prior to the anniversary date of the mailing of MannKind&#146;s proxy statement for its last annual meeting of stockholders a written
recommendation to the Nominating and Corporate Governance Committee, c/o&nbsp;MannKind Corporation, 30930 Russell Ranch Road, Suite 301, Westlake Village, California 91362, Attn: Corporate Secretary. Each submission must set forth: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the name and address of the MannKind stockholder on whose behalf the submission is made; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the number of MannKind shares that are owned beneficially by such stockholder as of the date of the submission; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the full name of the proposed candidate; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a description of the proposed candidate&#146;s business experience for at least the previous five years; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">complete biographical information for the proposed candidate;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a description of the proposed candidate&#146;s qualifications as a director. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each submission
must be accompanied by the written consent of the proposed candidate to be named as a nominee and to serve as a director if elected. To date, the Nominating and Corporate Governance Committee has not received a timely nomination of a candidate for
election as a director at any annual meeting from a stockholder or group of stockholders holding more than 5% of our voting stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>M<SMALL>EETINGS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors met 14 times during the last fiscal year. Each director attended 75% or more of the aggregate number of the meetings of
the Board and of the committees on which he served, held during the period for which he was a director or committee member. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>E<SMALL>XECUTIVE</SMALL>
S<SMALL>ESSIONS</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required under applicable Nasdaq listing standards, our independent directors meet in regularly scheduled
executive sessions at which only independent directors are present. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>S<SMALL>TOCKHOLDER</SMALL> C<SMALL>OMMUNICATIONS</SMALL> <SMALL>WITH</SMALL>
<SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s Board of Directors has adopted a
formal process by which stockholders may communicate with the Board or any of its directors. Stockholders who wish to communicate with the Board or an individual director may send a written communication to the Board or such director
c/o&nbsp;MannKind Corporation, 30930 Russell Ranch Road, Suite 301, Westlake Village, California 91362, Attn: Corporate Secretary. Communications also may be sent by <FONT STYLE="white-space:nowrap">e-mail</FONT> to the following address:
board@mannkindcorp.com. Each communication must set forth the name and address of the MannKind stockholder on whose behalf the communication is sent. Each communication will be screened by MannKind&#146;s Corporate Secretary to determine whether it
is appropriate for presentation to the Board of Directors or such director. Examples of inappropriate communications include junk mail, mass mailings, product complaints, product inquiries, new product suggestions, resumes, job inquiries, surveys,
business solicitations and advertisements, as well as unduly hostile, threatening, illegal, unsuitable, frivolous, patently offensive or otherwise inappropriate material. Communications determined by the Corporate Secretary to be appropriate for
presentation to the Board of Directors or such director will be submitted to the Board of Directors or such director on a periodic basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The screening procedures have been approved by a majority of the independent directors of the Board. All communications directed to the Audit
Committee in accordance with the Company&#146;s Code of Business Conduct and Ethics that relate to questionable accounting or auditing matters involving the Company will be promptly and directly forwarded to the Audit Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>ODE</SMALL> <SMALL>OF</SMALL> B<SMALL>USINESS</SMALL> C<SMALL>ONDUCT</SMALL> <SMALL>AND</SMALL>
E<SMALL>THICS</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a Code of Business Conduct and Ethics Policy that applies to our directors and employees
(including our principal executive officer, principal financial officer, principal accounting officer and controller), and have posted the text of the policy on our website ( <I>www.mannkindcorp.com</I> ) in connection with &#147;Investors&#148;
materials. In addition, we intend to promptly disclose on our website (i)&nbsp;the nature of any amendment to the policy that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or
persons performing similar functions and (ii)&nbsp;the nature of any waiver, including an implicit waiver, from a provision of the policy that is granted to one of these specified individuals, the name of such person who is granted the waiver and
the date of the waiver. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>OMPENSATION</SMALL> C<SMALL>OMMITTEE</SMALL> I<SMALL>NTERLOCKS</SMALL> <SMALL>AND</SMALL> I<SMALL>NSIDER</SMALL>
P<SMALL>ARTICIPATION</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended December&nbsp;31, 2017, Mr.&nbsp;Kresa and Drs. Friedman and&nbsp;Shannon
served on our Compensation Committee. None of Mr.&nbsp;Kresa or Drs.&nbsp;Friedman or Shannon has ever been one of our officers or employees. During 2017, none of our executive officers served as a member of the Board of Directors or Compensation
Committee of any other entity that had one or more executive officers who served on our Board of Directors or Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
October&nbsp;10, 2017 we entered into a securities purchase agreement with the Kresa Family Foundation, of which Kent Kresa is the President. Pursuant to the terms of the securities purchase agreement, we sold the Kresa Family Foundation an
aggregate of 166,600 shares of our common stock in a registered direct offering at a purchase price of $6.00 per share, resulting in net proceeds to us of $999,600. The offering of shares of common stock was made pursuant to our effective
registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3&nbsp;(File</FONT> <FONT STYLE="white-space:nowrap">No.&nbsp;333-210792),&nbsp;previously</FONT> filed with and declared effective by the Securities and Exchange Commission, and
a prospectus supplement thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL OF THE MANNKIND CORPORATION 2018 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are asking our stockholders to approve the MannKind Corporation 2018 Equity Incentive Plan, or the 2018 Plan, at the annual meeting. The
2018 Plan was approved by our Board of Directors, or Board, on February&nbsp;21, 2018, subject to approval by our stockholders. The 2018 Plan is intended to be the successor to the MannKind Corporation 2013 Equity Incentive Plan, or the 2013 Plan.
The 2018 Equity Incentive Plan is intended to meet the Company&#146;s objective of balancing stockholder concerns about dilution with the need to provide appropriate incentives to achieve Company performance objectives. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why We are Asking our Stockholders to Approve the 2018 Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently, we maintain the 2013 Plan to grant stock options, restricted stock units and other stock awards in order to provide long-term
incentives to our employees, directors, and consultants. Our board of directors decided to adopt and seek approval for the 2018 Plan as the successor to and continuation of the 2013 Plan because it wanted to update the plan provisions to conform
with current market practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of the 2018 Plan by our stockholders will allow us to continue to grant stock options, restricted
stock unit awards and other awards at levels determined appropriate by our Board or Compensation Committee. The 2018 Plan will also allow us to utilize a broad array of equity incentives in order to secure and retain the services of our employees,
directors and consultants, and to provide long-term incentives that align the interests of our employees, directors and consultants with the interests of our stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Requested Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to adjustment
for certain changes in our capitalization, if this Proposal 2 is approved by our stockholders, the aggregate number of shares of our common stock that may be issued under the 2018 Plan will not exceed the sum of (i)&nbsp;the number of unallocated
shares remaining available for the grant of new awards under the 2013 Plan as of the effective date of the 2018 Plan (which is equal to 1,388,179 shares as of March&nbsp;19, 2018), (ii) 12,000,000 new shares, and (iii)&nbsp;certain shares subject to
outstanding awards granted under the 2013 Plan and our MannKind Corporation 2004 Equity Incentive Plan (together, the &#147;Prior Plans&#148;) that may become available for grant under the 2018 Plan as such shares become available from time to time
(as further described below in &#147;Description of the 2018 Equity Incentive Plan &#150; Shares Available for Awards&#148;).</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on
historic grant practices, our Board has estimated that such aggregate number of shares should be sufficient to cover awards for the next two years. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why You Should Vote to Approve the 2018 Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Equity Awards Are an Important Part of Our Compensation Philosophy </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board believes that the issuance of equity awards is a key element underlying our ability to attract, retain and motivate key personnel, <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors, consultants and advisors, and better aligns the interests of our personnel, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, consultants and advisors with those of our
stockholders. The 2018 Plan will allow us to continue to provide performance-based incentives to our eligible employees, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, consultants and advisors. Therefore, the Board believes that the
2018 Plan is in the best interests of the Company and its stockholders and recommends a vote in favor of this Proposal 2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>We Have
Experienced and Expect to Continue to Experience Substantial Growth in Our Business </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the last 18 months, we have substantially
expanded our commercial operations, including recruiting our own specialty sales force to promote Afrezza. The Board now believes that the 2018 Plan is necessary to ensure </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that the number of shares available for issuance is sufficient to allow us to continue to attract and retain the services of talented individuals essential to our long-term growth and financial
success. To date, we have relied significantly on equity incentives in the form of stock option awards and restricted stock unit awards to attract and retain key employees, and we believe that equity incentives are necessary for us to remain
competitive in the marketplace for executive talent and other employees. The adoption of the 2018 Plan and new share reserve of 12,000,000 shares will address the depletion to the 2013 Plan&#146;s available share reserve that has occurred as a
result of the recent corporate developments discussed above. In particular, an immediate increase to the share reserve will provide the Board with flexibility to make annual equity awards to eligible employees and new hires through the next two
years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>We Manage Our Equity Incentive Award Use Carefully, and Dilution Is Reasonable </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation philosophy reflects broad-based eligibility for equity incentive awards, and we grant awards to substantially all of our
employees. However, we recognize that equity awards dilute existing stockholders, and, therefore, we must responsibly manage the growth of our equity compensation program. We are committed to effectively monitoring our equity compensation share
reserve, including our &#147;burn rate,&#148; to ensure that we maximize stockholders&#146; value by granting the appropriate number of equity incentive awards necessary to attract, reward, and retain employees and
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors. The tables below show our responsible overhang and burn rate percentages. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>The Size of Our Share Reserve Request Is Reasonable </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the 2018 Plan is approved by our stockholders, we expect to have approximately 13,388,179 shares available for grant after our annual
meeting (based on shares available as of March&nbsp;19, 2018), which we anticipate being a pool of shares sufficient for grants through <FONT STYLE="white-space:nowrap">mid-2020,</FONT> and necessary to provide a predictable amount of equity for
attracting, retaining, and motivating employees. Our overall shares available to grant plus prior awards granted represent a market-aligned 18% of shares outstanding, where many of the outstanding awards are in the form of stock options where any
management value derived has been directly aligned with shareholders.&nbsp;The size of our request is also reasonable in light of the equity granted to our employees and directors over the past year. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Key Plan Features </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2018 Plan includes
provisions that are designed to protect our stockholders&#146; interests and to reflect corporate governance best practices including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>No single trigger accelerated vesting upon change in control</I>. The 2018 Plan does not provide for any automatic mandatory vesting of awards upon a change in control. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>No liberal share counting or recycling of appreciation awards</I>. The following shares will not become available again for issuance under the 2018 Plan: (i)&nbsp;shares underlying stock options or stock appreciation
rights that are reacquired or withheld (or not issued) by us to satisfy the exercise or purchase price of a stock award; (ii)&nbsp;shares underlying stock options or stock appreciation rights that are reacquired or withheld (or not issued) by us to
satisfy a tax withholding obligation in connection with a stock award; and (iii)&nbsp;any shares repurchased by us on the open market with the proceeds of the exercise or purchase price of a stock option or a stock appreciation right.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Fungible share counting.</I> The 2018 Plan contains a &#147;fungible share counting&#148; structure, whereby
the number of shares of our common stock available for issuance under the 2018 Plan will be reduced by (i)&nbsp;one share for each share issued pursuant to a stock option or stock appreciation right with an exercise price that is at least 100% of
the fair market value of our common stock on the date of grant (an &#147;Appreciation Award&#148;) granted under the 2018 Plan and (ii) 1.1 shares for each share issued pursuant to a stock award that is not an Appreciation Award (a &#147;Full Value
Award&#148;) granted under the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
2018 Plan. As part of such fungible share counting structure, the number of shares of our common stock available for issuance under the 2018 Plan will be increased by (i)&nbsp;one share for each
share that becomes available again for issuance under the terms of the 2018 Plan subject to an Appreciation Award and (ii) 1.1 shares for each share that becomes available again for issuance under the terms of the 2018 Plan subject to a Full Value
Award. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Awards subject to forfeiture/clawback</I>. Awards granted under the 2018 Plan will be subject to recoupment in accordance with any clawback policy that we are required to adopt pursuant to the listing standards of
any national securities exchange or association on which our securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, we may impose other clawback,
recovery or recoupment provisions in an award agreement, including a reacquisition right in respect of previously acquired shares or other cash or property upon the occurrence of cause. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Repricing is not allowed</I>. The 2018 Plan prohibits the repricing of outstanding stock options and stock appreciation rights and the cancellation of any outstanding stock options or stock appreciation rights that
have an exercise or strike price greater than the then-current fair market value of our common stock in exchange for cash or other stock awards under the 2018 Plan without prior stockholder approval. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Stockholder approval is required for additional shares</I>. The 2018 Plan does not contain an annual &#147;evergreen&#148; provision. The 2018 Plan authorizes a fixed number of shares, so that stockholder approval is
required to issue any additional shares, allowing our stockholders to have direct input on our equity compensation programs. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>No liberal change in control definition</I>. The change in control definition in the 2018 Plan is not a &#147;liberal&#148; definition. A change in control transaction must actually occur in order for the change in
control provisions in the 2018 Plan to be triggered. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>No discounted stock options or stock appreciation rights</I>. All stock options and stock appreciation rights granted under the 2018 Plan must have an exercise or strike price equal to or greater than the fair market
value of our common stock on the date the stock option or stock appreciation right is granted. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Administration by independent committee</I>. The 2018 Plan will be administered by the members of our Compensation Committee, all of whom are <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> directors&#148;
within the meaning of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> under the Exchange Act and &#147;independent&#148; within the meaning of the Nasdaq listing standards. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Material amendments require stockholder approval</I>. Consistent with Nasdaq rules, the 2018 Plan requires stockholder approval of any material revisions to the 2018 Plan. In addition, certain other amendments to the
2018 Plan require stockholder approval. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Limit on <FONT STYLE="white-space:nowrap">non-employee</FONT> director awards and other awards</I>. The maximum number of shares subject to stock awards granted during any calendar year to any of our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors, taken together with any cash fees paid by the Company to such <FONT STYLE="white-space:nowrap">non-employee</FONT> director during such calendar year, may not exceed $500,000 in total value
(calculating the value of any such stock awards based on the grant date fair value of the stock awards for financial reporting purposes). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Restrictions on dividends</I>. The 2018 Plan provides that (i)&nbsp;no dividends or dividend equivalents may be paid with respect to any shares of our common stock subject to an award before the date such shares have
vested, (ii)&nbsp;any dividends or dividend equivalents that are credited with respect to any such shares will be subject to all of the terms and conditions applicable to such shares under the terms of the applicable award agreement (including any
vesting conditions), and (iii)&nbsp;any dividends or dividend equivalents that are credited with respect to any such shares will be forfeited to us on the date such shares are forfeited to or repurchased by us due to a failure to vest.
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Approval </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Proposal 2 is approved by our stockholders, the 2018 Plan will become effective as of the date of the annual meeting and no additional
awards will be granted under the 2013 Plan (although all outstanding awards granted under the 2013 Plan will continue to be subject to the terms and conditions as set forth in the agreements evidencing such awards and the terms of the 2013 Plan). In
the event that our stockholders do not approve this Proposal 2, the 2018 Plan will not become effective and the 2013 Plan will continue to be effective in accordance with its terms. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overhang </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides
certain additional information regarding our equity incentive program. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of&nbsp;March&nbsp;19,&nbsp;2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to outstanding stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,212,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average exercise price of outstanding stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average remaining term of outstanding stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.05 years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to outstanding full value awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,674,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock available for grant under the 2013 Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,388,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock available for grant under other equity incentive
plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of Record Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,011,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Per-share</FONT> closing price of common stock as reported on
Nasdaq Global Market</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Burn Rate </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides detailed information regarding the activity related to our equity incentive plans for fiscal year 2017. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal&nbsp;Year&nbsp;2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to stock options granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,335,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total number of shares of common stock subject to full value awards granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">669,091</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average number of shares of common stock outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,245,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Burn Rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of the 2018 Equity Incentive Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The material features of the 2018 Plan are described below. The following description of the 2018 Plan is a summary only and is qualified in
its entirety by reference to the complete text of the 2018 Plan. Stockholders are urged to read the actual text of the 2018 Plan in its entirety, which is attached to this proxy statement as <B>Exhibit A</B>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Purpose </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2018 Plan is designed to
secure and retain the services of our employees, directors and consultants, provide incentives for our employees, directors and consultants to exert maximum efforts for the success of our company and our affiliates, and provide a means by which our
employees, directors and consultants may be given an opportunity to benefit from increases in the value of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Successor to 2013 Plan
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2018 Plan is intended to be the successor to the 2013 Plan. If the 2018 Plan is approved by our stockholders, no additional awards
will be granted under the 2013 Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Types of Awards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the 2018 Plan provide for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted
stock awards, restricted stock unit awards, other stock awards, and performance awards that may be settled in cash, stock, or other property. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Shares
Available for Awards </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to adjustment for certain changes in our capitalization, the aggregate number of shares of our common
stock that may be issued under the 2018 Plan, or the Share Reserve, will not exceed the sum of (i)&nbsp;the number of unallocated shares remaining available for the grant of new awards under the 2013 Plan as of the effective date of the 2018 Plan,
(ii) 12,000,000 new shares, and (iii)&nbsp;any Prior Plans&#146; Returning Shares (as defined below), as such shares become available from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;Prior Plans&#146; Returning Shares&#148; are shares subject to outstanding stock awards granted under the Prior Plans that, from and
after the effective date of the 2018 Plan, (i)&nbsp;expire or terminate for any reason prior to exercise or settlement, (ii)&nbsp;are forfeited, cancelled or otherwise returned to us because of the failure to meet a contingency or condition required
for the vesting of such shares, or (iii)&nbsp;other than with respect to outstanding stock options and stock appreciation rights granted under the Prior Plans with an exercise or strike price of at least 100% of the fair market value of the
underlying common stock on the date of grant (&#147;Prior Plans&#146; Appreciation Awards&#148;), are reacquired or withheld (or not issued) by us to satisfy a tax withholding obligation in connection with a stock award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of our common stock available for issuance under the 2018 Plan will be reduced by (i)&nbsp;one share for each share of
common stock issued pursuant to a stock option or stock appreciation right with an exercise or strike price of at least 100% of the fair market value of the underlying common stock on the date of grant, and (ii) 1.1 shares for each share of common
stock issued pursuant to a full value award (i.e., any stock award that is not a stock option or stock appreciation right with an exercise or strike price of at least 100% of the fair market value of the underlying common stock on the date of
grant). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If (i)&nbsp;any shares of common stock subject to a stock award are not issued because the stock award expires or otherwise
terminates without all of the shares covered by the stock award having been issued or is settled in cash, (ii)&nbsp;any shares of common stock issued pursuant to a stock award are forfeited back to or repurchased by us because of the failure to meet
a contingency or condition required for the vesting of such shares, or (iii)&nbsp;with respect to a full value award, any shares of common stock are reacquired or withheld (or not issued) by us to satisfy a tax withholding obligation in connection
with the award, then such shares will again become available for issuance under the 2018 Plan (collectively, the &#147;2018 Plan Returning Shares&#148;). For each 2018 Plan Returning Share subject to a full value award, or Prior Plans&#146;
Returning Share subject to a stock award other than a Prior Plans&#146; Appreciation Award, the number of shares of common stock available for issuance under the 2018 Plan will increase by 1.1 shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any shares of common stock reacquired or withheld (or not issued) by us to satisfy the exercise or purchase price of a stock award will no
longer be available for issuance under the 2018 Plan, including any shares subject to a stock award that are not delivered to a participant because the stock award is exercised through a reduction of shares subject to the stock award. In addition,
any shares reacquired or withheld (or not issued) by us to satisfy a tax withholding obligation in connection with a stock option or stock appreciation right granted under the 2018 Plan or a Prior Plans&#146; Appreciation Award, or any shares
repurchased by us on the open market with the proceeds of the exercise or strike price of a stock option or stock appreciation right granted under the 2018 Plan or a Prior Plans&#146; Appreciation Award will no longer be available for issuance under
the 2018 Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Eligibility </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of our (including our affiliates&#146;) approximately 253 employees, six <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and
any consultants as of March&nbsp;19, 2018 are eligible to participate in the 2018 Plan and may receive all types of awards other than incentive stock options. Incentive stock options may be granted under the 2018 Plan only to our employees
(including officers) and employees of our affiliates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Limit </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the 2018 Plan, the maximum number of shares of our common stock subject to stock awards granted during any one calendar year to any of
our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, taken together with any cash fees paid by the Company to such <FONT STYLE="white-space:nowrap">non-employee</FONT> director during such calendar year, will not exceed $500,000 in
total value (calculating the value of any such stock awards based on the grant date fair value of such stock awards for financial reporting purposes). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Administration </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2018 Plan will be
administered by our Board, which may in turn delegate authority to administer the 2018 Plan to a committee. Our Board has delegated concurrent authority to administer the 2018 Plan to our Compensation Committee, but may, at any time, revest in
itself some or all of the power delegated to our Compensation Committee. The Board and the Compensation Committee are each considered to be a Plan Administrator for purposes of this Proposal 2. Subject to the terms of the 2018 Plan, the Plan
Administrator may determine the recipients, the types of awards to be granted, the number of shares of our common stock subject to or the cash value of awards, and the terms and conditions of awards granted under the 2018 Plan, including the period
of their exercisability and vesting. The Plan Administrator also has the authority to provide for accelerated exercisability and vesting of awards. Subject to the limitations set forth below, the Plan Administrator also determines the fair market
value applicable to a stock award and the exercise or strike price of stock options and stock appreciation rights granted under the 2018 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan Administrator may also delegate to one or more officers the authority to designate employees who are not officers to be recipients of
certain stock awards and the number of shares of our common stock subject to such stock awards. Under any such delegation, the Plan Administrator will specify the total number of shares of our common stock that may be subject to the stock awards
granted by such officer. The officer may not grant a stock award to himself or herself. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Repricing; Cancellation and
<FONT STYLE="white-space:nowrap">Re-Grant</FONT> of Stock Awards </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the 2018 Plan, the Plan Administrator does not have the
authority to reprice any outstanding stock option or stock appreciation right by reducing the exercise or strike price of the stock option or stock appreciation right or to cancel any outstanding stock option or stock appreciation right that has an
exercise or strike price greater than the then-current fair market value of our common stock in exchange for cash or other stock awards without obtaining the approval of our stockholders. Such approval must be obtained within 12 months prior to such
an event. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stock Options </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock
options may be granted under the 2018 Plan pursuant to stock option agreements. The 2018 Plan permits the grant of stock options that are intended to qualify as incentive stock options, or ISOs, and nonstatutory stock options, or NSOs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exercise price of a stock option granted under the 2018 Plan may not be less than 100% of the fair market value of the common stock
subject to the stock option on the date of grant and, in some cases (see &#147;Limitations on Incentive Stock Options&#148; below), may not be less than 110% of such fair market value. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term of stock options granted under the 2018 Plan may not exceed ten years and, in some
cases (see &#147;Limitations on Incentive Stock Options&#148; below), may not exceed five years. Except as otherwise provided in a participant&#146;s stock option agreement or other written agreement with us or one of our affiliates, if a
participant&#146;s service relationship with us or any of our affiliates (referred to in this Proposal 2 as &#147;continuous service&#148;) terminates (other than for cause and other than upon the participant&#146;s death or disability), the
participant may exercise any vested stock options for up to three&nbsp;months following the participant&#146;s termination of continuous service. Except as otherwise provided in a participant&#146;s stock option agreement or other written agreement
with us or one of our affiliates, if a participant&#146;s continuous service terminates due to the participant&#146;s disability or death (or the participant dies within a specified period, if any, following termination of continuous service), the
participant, or his or her beneficiary, as applicable, may exercise any vested stock options for up to 12&nbsp;months following the participant&#146;s termination due to the participant&#146;s disability or for up to 18 months following the
participant&#146;s death. Except as explicitly provided otherwise in a participant&#146;s stock option agreement or other written agreement with us or one of our affiliates, if a participant&#146;s continuous service is terminated as a result of the
participant&#146;s retirement (as defined in the 2018 Plan), then the participant may exercise his or her vested option, but only within such period of time ending on the earlier of (i)&nbsp;the date twenty-four months following such termination of
continuous service, and (ii)&nbsp;the expiration of the term of the option, and if a participant&#146;s continuous service is terminated for cause (as defined in the 2018 Plan), all stock options held by the participant will terminate upon the
participant&#146;s termination of continuous service and the participant will be prohibited from exercising any stock option from and after such termination date. Except as otherwise provided in a participant&#146;s stock option agreement or other
written agreement with us or one of our affiliates, the term of a stock option may be extended if the exercise of the stock option following the participant&#146;s termination of continuous service (other than for cause and other than upon the
participant&#146;s death or disability) would be prohibited by applicable securities laws or if the sale of any common stock received upon exercise of the stock option following the participant&#146;s termination of continuous service (other than
for cause) would violate our insider trading policy. In no event, however, may a stock option be exercised after its original expiration date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Acceptable forms of consideration for the purchase of our common stock pursuant to the exercise of a stock option under the 2018 Plan will be
determined by the Plan Administrator and may include payment: (i)&nbsp;by cash, check, bank draft or money order payable to us; (ii)&nbsp;pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board; (iii)&nbsp;by
delivery to us of shares of our common stock (either by actual delivery or attestation); (iv) by a net exercise arrangement (for NSOs only); or (v)&nbsp;in other legal consideration approved by the Plan Administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock options granted under the 2018 Plan may become exercisable in cumulative increments, or &#147;vest,&#148; as determined by the Plan
Administrator at the rate specified in the stock option agreement. Shares covered by different stock options granted under the 2018 Plan may be subject to different vesting schedules as the Plan Administrator may determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan Administrator may impose limitations on the transferability of stock options granted under the 2018 Plan in its discretion.
Generally, a participant may not transfer a stock option granted under the 2018 Plan other than by will or the laws of descent and distribution or, subject to approval by the Plan Administrator, pursuant to a domestic relations order or an official
marital settlement agreement. However, the Plan Administrator may permit transfer of a stock option in a manner that is not prohibited by applicable tax and securities laws. In addition, subject to approval by the Plan Administrator, a participant
may designate a beneficiary who may exercise the stock option following the participant&#146;s death.&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Limitations on Incentive
Stock Options </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate fair market value, determined at the time of grant, of shares of our common stock with respect to ISOs
that are exercisable for the first time by a participant during any calendar year under all of our stock plans may not exceed $100,000. The stock options or portions of stock options that exceed this limit or otherwise fail to qualify as ISOs are
treated as NSOs. No ISO may be granted to any person who, at the time of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any affiliate unless the following conditions are satisfied: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the exercise price of the ISO must be at least 110% of the fair market value of the common stock subject to the ISO on the date of grant; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the term of the ISO must not exceed five years from the date of grant. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to adjustment
for certain changes in our capitalization, the aggregate maximum number of shares of our common stock that may be issued pursuant to the exercise of ISOs under the 2018 Plan is 9,000,000 shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stock Appreciation Rights </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock
appreciation rights may be granted under the 2018 Plan pursuant to stock appreciation right agreements. Each stock appreciation right is denominated in common stock share equivalents. The strike price of each stock appreciation right will be
determined by the Plan Administrator, but will in no event be less than 100% of the fair market value of the common stock subject to the stock appreciation right on the date of grant. The Plan Administrator may also impose restrictions or conditions
upon the vesting of stock appreciation rights that it deems appropriate. The appreciation distribution payable upon exercise of a stock appreciation right may be paid in shares of our common stock, in cash, in a combination of cash and stock, or in
any other form of consideration determined by the Plan Administrator and set forth in the stock appreciation right agreement. Stock appreciation rights will be subject to the same conditions upon termination of continuous service and restrictions on
transfer as stock options under the 2018 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock Awards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock awards may be granted under the 2018 Plan pursuant to restricted stock award agreements. A restricted stock award may be
granted in consideration for cash, check, bank draft or money order payable to us, the participant&#146;s services performed for us or any of our affiliates, or any other form of legal consideration acceptable to the Plan Administrator. Shares of
our common stock acquired under a restricted stock award may be subject to forfeiture to or repurchase by us in accordance with a vesting schedule to be determined by the Plan Administrator. Rights to acquire shares of our common stock under a
restricted stock award may be transferred only upon such terms and conditions as are set forth in the restricted stock award agreement. A restricted stock award agreement may provide that any dividends paid on restricted stock will be subject to the
same vesting conditions as apply to the shares subject to the restricted stock award. Upon a participant&#146;s termination of continuous service for any reason, any shares subject to restricted stock awards held by the participant that have not
vested as of such termination date may be forfeited to or repurchased by us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock Unit Awards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock unit awards may be granted under the 2018 Plan pursuant to restricted stock unit award agreements. Payment of any purchase
price may be made in any form of legal consideration acceptable to the Plan Administrator. A restricted stock unit award may be settled by the delivery of shares of our common stock, in cash, in a combination of cash and stock, or in any other form
of consideration determined by the Plan Administrator and set forth in the restricted stock unit award agreement. Restricted stock unit awards may be subject to vesting in accordance with a vesting schedule to be determined by the Plan
Administrator. Dividend equivalents may be credited in respect of shares of our common stock covered by a restricted stock unit award, provided that any additional shares credited by reason of such dividend equivalents will be subject to all of the
same terms and conditions of the underlying restricted stock unit award. Except as otherwise provided in a participant&#146;s restricted stock unit award agreement or other written agreement with us or one of our affiliates, restricted stock units
that have not vested will be forfeited upon the participant&#146;s termination of continuous service for any reason. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Performance Awards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2018 Plan allows us to grant performance stock awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A performance stock award is a stock award that is payable (including that may be granted, may vest, or may be exercised) contingent upon the
attainment of <FONT STYLE="white-space:nowrap">pre-determined</FONT> performance goals during a performance period. A performance stock award may require the completion of a specified period of continuous service. The length of any performance
period, the performance goals to be achieved during the performance period, and the measure of whether and to what degree such performance goals have been attained will be determined by the Plan Administrator in its discretion. In addition, to the
extent permitted by applicable law and the performance stock award agreement, the Plan Administrator may determine that cash may be used in payment of performance stock awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Performance goals under the 2018 Plan will be based on any one or more of the following performance criteria: (i)&nbsp;earnings (including
earnings per share and net earnings); (ii) earnings before interest, taxes and depreciation; (iii)&nbsp;earnings before interest, taxes, depreciation and amortization; (iv)&nbsp;total stockholder return; (v)&nbsp;return on equity or average
stockholder&#146;s equity; (vi)&nbsp;return on assets, investment, or capital employed; (vii)&nbsp;stock price; (viii)&nbsp;margin (including gross margin); (ix) income (before or after taxes); (x) operating income; (xi)&nbsp;operating income after
taxes; <FONT STYLE="white-space:nowrap">(xii)&nbsp;pre-tax</FONT> profit; (xiii)&nbsp;operating cash flow; (xiv)&nbsp;sales or revenue targets; (xv)&nbsp;increases in revenue or product revenue; (xvi)&nbsp;expenses and cost reduction goals;
(xvii)&nbsp;improvement in or attainment of working capital levels; (xiii)&nbsp;economic value added (or an equivalent metric); (xix) market share; (xx)&nbsp;cash flow; (xxi)&nbsp;cash flow per share; (xxii)&nbsp;share price performance;
(xxiii)&nbsp;debt reduction; (xxiv)&nbsp;implementation or completion of projects or processes; (xxv)&nbsp;customer satisfaction; (xxvi)&nbsp;stockholders&#146; equity; (xxvii)&nbsp;capital expenditures; (xxiii)&nbsp;debt levels;
(xxix)&nbsp;operating profit or net operating profit; (xxx)&nbsp;workforce diversity; (xxxi)&nbsp;growth of net income or operating income; (xxxii)&nbsp;billings; and (xxxiv)&nbsp;other measures of performance selected by the Plan Administrator.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Performance goals may be based on a company-wide basis, with respect to one or more business units, divisions, affiliates or business
segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. The Plan Administrator is authorized to make appropriate adjustments in the method of
calculating the attainment of performance goals for a performance period as follows: (i)&nbsp;to exclude restructuring and/or other nonrecurring charges; (ii)&nbsp;to exclude exchange rate effects, as applicable, for
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> dollar denominated net sales and operating earnings; (iii)&nbsp;to exclude the effects of changes to generally accepted accounting standards required by the Financial Accounting Standards Board;
(iv)&nbsp;to exclude the effects of any items that are &#147;unusual&#148; in nature or occur &#147;infrequently&#148; as determined under generally accepted accounting principles; (v)&nbsp;to exclude the effects to any statutory adjustments to
corporate tax rates; and (vi)&nbsp;to make other appropriate adjustments selected by the Plan Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Plan
Administrator retains the discretion to reduce or eliminate the compensation or economic benefit due upon the attainment of any performance goals and to define the manner of calculating the performance criteria it selects to use for a performance
period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Stock Awards </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other
forms of stock awards valued in whole or in part by reference to, or otherwise based on, our common stock may be granted either alone or in addition to other stock awards under the 2018 Plan. Subject to the terms of the 2018 Plan, the Plan
Administrator will have sole and complete authority to determine the persons to whom and the time or times at which such other stock awards will be granted, the number of shares of our common stock to be granted and all other terms and conditions of
such other stock awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Clawback Policy </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards granted under the 2018 Plan will be subject to recoupment in accordance with any clawback policy that we are required to adopt pursuant
to the listing standards of any national securities exchange or association on which our securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, the
Plan Administrator may impose other clawback, recovery or recoupment provisions in an award agreement as the Plan Administrator determines necessary or appropriate, including a reacquisition right in respect of previously acquired shares of our
common stock or other cash or property upon the occurrence of cause. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Changes to Capital Structure </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of certain capitalization adjustments, the Plan Administrator will appropriately adjust: (i)&nbsp;the class(es) and maximum number
of securities subject to the 2018 Plan; (ii)&nbsp;the class(es) and maximum number of securities that may be issued pursuant to the exercise of ISOs; and (iii)&nbsp;the class(es) and number of securities and price per share of stock subject to
outstanding stock awards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Transactions </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a transaction (as defined in the 2018 Plan and described below), the Board of Directors will have the discretion to take one or
more of the following actions with respect to outstanding stock awards (contingent upon the closing or completion of such transaction), unless otherwise provided in the stock award agreement or other written agreement with the participant or unless
otherwise provided by the Board of Directors at the time of grant: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">arrange for the surviving or acquiring corporation (or its parent company) to assume or continue the award or to substitute a similar stock award for the award (including an award to acquire the same consideration paid
to our stockholders pursuant to the transaction); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">arrange for the assignment of any reacquisition or repurchase rights held by us with respect to the stock award to the surviving or acquiring corporation (or its parent company); </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">accelerate the vesting (and, if applicable, the exercisability) of the stock award and provide for its termination prior to the effective time of the transaction; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us with respect to the award; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">cancel or arrange for the cancellation of the stock award, to the extent not vested or exercised prior to the effective time of the transaction, in exchange for such cash consideration, if any, as the Board of Directors
may consider appropriate; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">make a payment, in such form as may be determined by the Board of Directors, equal to the excess, if any, of (i)&nbsp;the value of the property the participant would have received upon the exercise of the stock award
immediately prior to the effective time of the transaction, over (B)&nbsp;any exercise price payable in connection with such exercise. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Board of Directors is not obligated to treat all stock awards or portions of stock awards in the same manner. The Board of Directors may take different actions with respect to the vested and unvested portions of a stock award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the 2018 Plan, a transaction will be deemed to occur in the event of a corporate transaction or a change in control. A
corporate transaction generally means the consummation of (i)&nbsp;a sale or other disposition of all or substantially all of our consolidated assets, (ii)&nbsp;a sale or other disposition of at least 90% of our outstanding securities, (iii)&nbsp;a
merger, consolidation or similar transaction following which we are not the surviving corporation, or (iv)&nbsp;a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock
outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A change of control generally means (i)&nbsp;the acquisition by a person or entity of more
than 50% of our combined voting power other than by merger, consolidation or similar transaction; (ii)&nbsp;a consummated merger, consolidation or similar transaction immediately after which our stockholders cease to own more than 50% of the
combined voting power of the surviving entity; (iii)&nbsp;a consummated sale, lease or exclusive license or other disposition of all or substantially of our consolidated assets; (iv)&nbsp;the complete dissolution or liquidation of the Company; or
(v)&nbsp;when a majority of the board of directors becomes comprised of individuals whose nomination, appointment, or election was not approved by a majority of the board members or their approved successors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Change in Control </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the 2018 Plan, a
stock award may be subject to additional acceleration of vesting and exercisability upon or after a change in control (as defined in the 2018 Plan and described below) as may be provided in the participant&#146;s stock award agreement, in any other
written agreement with us or one of our affiliates or in our director compensation policy, but in the absence of such provision, no such acceleration will occur. The acceleration of vesting of an award in the event of a corporate transaction or a
change in control event under the 2018 Plan may be viewed as an anti-takeover provision, which may have the effect of discouraging a proposal to acquire or otherwise obtain control of us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Plan Amendments and Termination </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan
Administrator will have the authority to amend or terminate the 2018 Plan at any time. However, except as otherwise provided in the 2018 Plan or an award agreement, no amendment or termination of the 2018 Plan may materially impair a
participant&#146;s rights under his or her outstanding awards without the participant&#146;s consent. We will obtain stockholder approval of any amendment to the 2018 Plan as required by applicable law and listing requirements. No incentive stock
options may be granted under the 2018 Plan after the tenth anniversary of the date the 2018 Plan was adopted by our Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Federal Income Tax
Consequences </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the principal United States federal income tax consequences to participants and us with
respect to participation in the 2018 Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state or foreign jurisdiction in which a participant may reside. The information is based upon current
federal income tax rules and therefore is subject to change when those rules change. Because the tax consequences to any participant may depend on his or her particular situation, each participant should consult the participant&#146;s tax adviser
regarding the federal, state, local and other tax consequences of the grant or exercise of an award or the disposition of stock acquired the 2018 Plan. The 2018 Plan is not qualified under the provisions of Section&nbsp;401(a) of the Code and is not
subject to any of the provisions of the Employee Retirement Income Security Act of 1974. Our ability to realize the benefit of any tax deductions described below depends on our generation of taxable income as well as the requirement of
reasonableness and the satisfaction of our tax reporting obligations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Nonstatutory Stock Options </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, there is no taxation upon the grant of an NSO if the stock option is granted with an exercise price equal to the fair market value
of the underlying stock on the grant date. Upon exercise, a participant will recognize ordinary income equal to the excess, if any, of the fair market value of the underlying stock on the date of exercise of the stock option over the exercise price.
If the participant is employed by us or one of our affiliates, that income will be subject to withholding taxes. The participant&#146;s tax basis in those shares will be equal to his or her fair market value on the date of exercise of the stock
option, and the participant&#146;s capital gain holding period for those shares will begin on that date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the requirement of
reasonableness, the provisions of Section&nbsp;162(m)&nbsp;of the Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Incentive Stock Options </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2018 Plan provides for the grant of stock options that are intended to qualify as &#147;incentive stock options,&#148; as defined in
Section&nbsp;422 of the Code. Under the Code, a participant generally is not subject to ordinary income tax upon the grant or exercise of an ISO. If the participant holds a share received upon exercise of an ISO for more than two years from the date
the stock option was granted and more than one year from the date the stock option was exercised, which is referred to as the required holding period, the difference, if any, between the amount realized on a sale or other taxable disposition of that
share and the participant&#146;s tax basis in that share will be long-term capital gain or loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, however, a participant disposes of a
share acquired upon exercise of an ISO before the end of the required holding period, which is referred to as a disqualifying disposition, the participant generally will recognize ordinary income in the year of the disqualifying disposition equal to
the excess, if any, of the fair market value of the share on the date of exercise of the stock option over the exercise price. However, if the sales proceeds are less than the fair market value of the share on the date of exercise of the stock
option, the amount of ordinary income recognized by the participant will not exceed the gain, if any, realized on the sale. If the amount realized on a disqualifying disposition exceeds the fair market value of the share on the date of exercise of
the stock option, that excess will be short-term or long-term capital gain, depending on whether the holding period for the share exceeds one year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the alternative minimum tax, the amount by which the fair market value of a share of stock acquired upon exercise of an ISO
exceeds the exercise price of the stock option generally will be an adjustment included in the participant&#146;s alternative minimum taxable income for the year in which the stock option is exercised. If, however, there is a disqualifying
disposition of the share in the year in which the stock option is exercised, there will be no adjustment for alternative minimum tax purposes with respect to that share. In computing alternative minimum taxable income, the tax basis of a share
acquired upon exercise of an ISO is increased by the amount of the adjustment taken into account with respect to that share for alternative minimum tax purposes in the year the stock option is exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are not allowed a tax deduction with respect to the grant or exercise of an ISO or the disposition of a share acquired upon exercise of an
ISO after the required holding period. If there is a disqualifying disposition of a share, however, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant, subject to the requirement of
reasonableness, the provisions of Section&nbsp;162(m) of the Code, and provided that either the employee includes that amount in income or we timely satisfy our reporting requirements with respect to that amount. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock Awards </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, the
recipient of a restricted stock award will recognize ordinary income at the time the stock is received equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If,
however, the stock is not vested when it is received (for example, if the employee is required to work for a period of time in order to have the right to sell the stock), the recipient generally will not recognize income until the stock becomes
vested, at which time the recipient will recognize ordinary income equal to the excess, if any, of the fair market value of the stock on the date it becomes vested over any amount paid by the recipient in exchange for the stock. A recipient may,
however, file an election with the Internal Revenue Service, within 30&nbsp;days following his or her receipt of the stock award, to recognize ordinary income, as of the date the recipient receives the award, equal to the excess, if any, of the fair
market value of the stock on the date the award is granted over any amount paid by the recipient for the stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The recipient&#146;s
basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock award will be the amount paid for such shares plus any ordinary income recognized either when the stock is received or when the
stock becomes vested. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m) of the
Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock award. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock Unit Awards </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally,
the recipient of a restricted stock unit award structured to comply with the requirements of Section&nbsp;409A of the Code or an exception to Section&nbsp;409A of the Code will recognize ordinary income at the time the stock is delivered equal to
the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. To comply with the requirements of Section&nbsp;409A of the Code, the stock subject to a restricted stock unit award
may generally only be delivered upon one of the following events: a fixed calendar date (or dates), separation from service, death, disability or a change in control. If delivery occurs on another date, unless the restricted stock unit award
otherwise complies with or qualifies for an exception to the requirements of Section&nbsp;409A of the Code (including delivery upon achievement of a performance goal), in addition to the tax treatment described above, the recipient will owe an
additional 20% federal tax and interest on any taxes owed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The recipient&#146;s basis for the determination of gain or loss upon the
subsequent disposition of shares acquired from a restricted stock unit award will be the amount paid for such shares plus any ordinary income recognized when the stock is delivered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m) of the Code, and the satisfaction of a tax reporting
obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock unit award. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stock Appreciation Rights </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, if
a stock appreciation right is granted with an exercise price equal to the fair market value of the underlying stock on the grant date, the recipient will recognize ordinary income equal to the fair market value of the stock or cash received upon
such exercise. Subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m) of the Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income
realized by the recipient of the stock appreciation right.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Plan Benefits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Future benefits under the 2018 Plan are discretionary for our employees, including executive officers, and consultants, and therefore are not
currently determinable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Equity awards for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors would be made under the 2018
Plan, if approved by stockholders, pursuant to the Director Compensation Policy. Under the Director Compensation Policy, on the date of each annual meeting, each person who continues to serve as a <FONT STYLE="white-space:nowrap">non-employee</FONT>
member of the Board of Directors following such annual meeting will be granted an equity award with the intended equity value of $150,000. All option grants will have an exercise price per share equal to the fair market value of our common stock on
the date of grant.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Director Compensation Policy, annual <FONT STYLE="white-space:nowrap">non-employee</FONT> director cash
compensation is paid each year in arrears in cash, or at each director&#146;s election, in fully vested restricted stock units of our Common Stock that would be issued under the 2018 Plan, if approved by stockholders. The number of shares subject to
each such stock award is determined by dividing the value of the cash which would otherwise have been paid to a <FONT STYLE="white-space:nowrap">non-employee</FONT> director under the Director Compensation Policy by our closing stock price on the
date of payment.&nbsp;Because our closing stock price typically changes on a daily basis, it is therefore, not possible to determine the number of shares subject to each such stock award at this time. For additional information regarding our
compensation policy for <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, see the section entitled, &#147;Compensation of Directors&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Securities Authorized For Issuance Under Equity Compensation Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Securities Authorized For Issuance Under Equity Compensation Plans&#148; on page 67 of this proxy statement for certain information
with respect to all of our equity compensation plans in effect as of December&nbsp;31, 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Required Vote and Board of Directors Recommendation
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this Proposal 2, stockholders are requested to approve the 2018 Plan. Approval of Proposal 2 requires the affirmative vote of a
majority of the shares present or represented by proxy and entitled to vote at the Annual Meeting. Abstentions will be counted toward the tabulation of votes cast on Proposal 2 and will have the same effect as &#147;Against&#148; votes. Broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> are counted towards a quorum, but will have no effect on the outcome of the vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD
OF DIRECTORS RECOMMENDS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A VOTE &#147;FOR&#148; PROPOSAL 2. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT TO EMPLOYEE STOCK PURCHASE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;21, 2018, our
Board of Directors amended the MannKind Corporation 2004 Employee Stock Purchase Plan (the &#147;Purchase Plan&#148;), subject to stockholder approval, to, among other things, increase the number of shares of common stock authorized for issuance
under the Purchase Plan by 3,000,000 shares. We refer to the Purchase Plan, as amended by the Board of Directors on February&nbsp;21, 2018, as the &#147;Amended Purchase Plan&#148; throughout this proxy statement. References in this proposal to our
Board of Directors include the Compensation Committee of the Board, where applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A description of the material terms of the Amended
Purchase Plan are summarized below. The key differences between the terms of the Purchase Plan and the Amended Purchase Plan are as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Amended Purchase Plan provides that an additional 3,000,000 shares may be issued pursuant to purchase rights granted under the Amended Purchase Plan. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In the event of a sale or other disposition of at least 50% of the outstanding securities of the Company, any surviving corporation may continue or assume purchase rights outstanding under the Amended Purchase Plan or
may substitute similar rights. If the surviving corporation does not assume such rights or substitute similar rights in connection with such transaction, then the participants&#146; accumulated payroll deductions will be used to purchase shares of
common stock immediately prior to such transaction under the ongoing offering and the participants&#146; rights under such ongoing offering will terminate immediately after such purchase. Under the Purchase Plan, the threshold was 90%.
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this Proposal 3, our Board of Directors is requesting stockholder approval of the Amended Purchase Plan, including the
increase to the number of shares of common stock authorized for issuance under the Purchase Plan by 3,000,000 shares. The Board of Directors believes that the Amended Purchase Plan is an integral part of our long-term compensation philosophy and the
Amended Purchase Plan is necessary to continue providing the appropriate levels and types of equity compensation for our employees. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why We Are Asking
Our Stockholders to Approve the Amended Purchase Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;19, 2018, 160,063 shares were available for future issuance
under the Purchase Plan without giving effect to the approval of the Amended Purchase Plan. Without replenishment, we believe such amount may be insufficient to meet our anticipated employee recruiting and retention needs beyond the second quarter
of 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Aspects of Our Purchase Plan Designed to Protect Our Stockholders&#146; Interests </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended Purchase Plan includes certain provisions that are designed to protect our stockholders&#146; interests and to reflect corporate
governance best practices including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Stockholder approval is required for additional shares.</I> The Amended Purchase Plan does not contain an annual &#147;evergreen&#148; provision. Thus, stockholder approval is required each time we need to increase
the share reserve allowing our stockholders the ability to have a say on our equity compensation programs. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Submission of amendments to the Amended Purchase Plan to stockholders.</I> The Amended Purchase Plan requires stockholder approval for material amendments to the Amended Purchase Plan, including as noted above, any
increase in the number of shares reserved for issuance under the Amended Purchase Plan. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Broad-based eligibility for equity awards.</I> The vast majority of our employees are eligible to participate in the Amended Purchase Plan. By doing so, we tie our employee&#146;s interests with stockholder interests
and motivate our employees to act as owners of the business. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General Amended Purchase Plan Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2004, the Board of Directors originally adopted the Purchase Plan. There were 400,000 shares of MannKind common stock initially reserved for
issuance under the Purchase Plan. In addition, the Purchase Plan contained an evergreen provision providing for an annual increase in the shares available for purchase under the Purchase Plan equal to the lesser of 1% of the outstanding shares of
common stock on the record date for each Annual Meeting of Stockholders; 140,000 shares; or a number determined by the Board of Directors, as of the date of each annual meeting of stockholders beginning with annual meeting of stockholders in 2005.
Pursuant to the evergreen provision, an additional 1,286,140 shares of MannKind common stock were made available for purchase under the Purchase Plan between 2005 and 2014. The evergreen provision terminated after the annual increase in 2014. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2017, all employees as a group purchased 199,578 shares at a weighted average price of $1.21 per share under the Purchase Plan.&nbsp;As of
March&nbsp;19, 2018, an aggregate of 1,526,077 shares of MannKind common stock had been purchased under the Purchase Plan and 160,063 shares of common stock remained available for future purchase under the Purchase Plan. A total of 123,011,353
shares of MannKind common stock were outstanding as of March&nbsp;19, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Securities Authorized For Issuance Under Equity Compensation Plans
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Securities Authorized For Issuance Under Equity Compensation Plans&#148; on page 67 of this proxy statement for certain
information with respect to all of our equity compensation plans in effect as of December&nbsp;31, 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>R<SMALL>EQUIRED</SMALL> V<SMALL>OTE</SMALL>
<SMALL>AND</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> R<SMALL>ECOMMENDATION</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this Proposal 3,
stockholders are requested to approve the Amended Purchase Plan. Approval of Proposal 3 requires the affirmative vote of the holders of a majority of the shares present or represented by proxy and entitled to vote at the Annual Meeting. Abstentions
will be counted toward the tabulation of votes cast on Proposal 3 and will have the same effect as &#147;Against&#148; votes. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> are counted toward a quorum, but will have no effect on the
outcome of the vote. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A VOTE IN FAVOR OF PROPOSAL 3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of the Amended Purchase Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The material features of the Amended Purchase Plan are outlined below. This summary is qualified in its entirety by reference to the complete
text of the Amended Purchase Plan. Stockholders are urged to read the actual text of the Amended Purchase Plan in its entirety, which is appended to this proxy statement as <B>Exhibit B</B> and may be accessed from the SEC&#146;s website at
www.sec.gov. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Purpose </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of
the Amended Purchase Plan is to provide a means by which employees of MannKind (and any related corporations designated by the Board of Directors to participate in the Amended Purchase Plan) may </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be given an opportunity to purchase MannKind common stock through payroll deductions, to assist MannKind in retaining the services of its employees, in recruiting new employees and to provide
incentives for such persons to exert maximum efforts for the Company&#146;s success. As of March&nbsp;19, 2018, approximately 253 employees were eligible to participate in the Amended Purchase Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights to purchase common stock granted under the Amended Purchase Plan are intended to qualify as options issued under an &#147;employee
stock purchase plan&#148; as that term is defined in Section&nbsp;423(b) of the Code. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Administration </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors administers the Amended Purchase Plan and has the final power to construe and interpret both the Amended Purchase Plan
and the rights granted under it. The Board of Directors has the power to delegate administration of the Amended Purchase Plan to a committee composed of not fewer than two members of the Board. The Board of Directors has delegated administration of
the Amended Purchase Plan to the Compensation Committee. The Compensation Committee has the power, subject to the provisions of the Amended Purchase Plan, to determine when and how rights to purchase MannKind common stock will be granted and the
provisions of each offering of such rights (which need not be identical). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stock Subject to Amended Purchase Plan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;19, 2018, the Amended Purchase Plan had 160,063 shares of MannKind common stock available for future purchase under the
Amended Purchase Plan. Subject to this Proposal 3, an additional 3,000,000 shares of MannKind common stock will be made available for future purchases under the Amended Purchase Plan beginning 2018. If purchase rights granted under the Amended
Purchase Plan expire, lapse or otherwise terminate without being exercised, the shares of MannKind common stock not purchased under such rights again become available for issuance under the Amended Purchase Plan. A total of 123,011,353 shares of
MannKind common stock were outstanding as of March&nbsp;19, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Offerings </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended Purchase Plan is implemented by offerings of purchase rights to all eligible employees from time to time by the Compensation
Committee. The maximum length for an offering under the Amended Purchase Plan is 27 months. Currently, under the Amended Purchase Plan, each offering is typically six months long and is divided into one &#147;purchase period.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Eligibility </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any person, other than a
part-time or seasonal employee, who is customarily employed at least 20 hours per week and 5 months per calendar year by MannKind (or by any parent or subsidiary of MannKind designated by the Board of Directors) on the first day of an offering is
eligible to participate in that offering, provided such employee has been continuously employed by MannKind or the designated parent or subsidiary for such period preceding the grant as our Board of Directors or the Compensation Committee may
require, but in no event will the required period of continuous employment be greater than two years. We exclude from participation those of our employees who are employed in jurisdictions outside of the United States if, as of the offering date of
the offering, the grant of such purchase rights would not be in compliance with the applicable laws of any jurisdiction in which the employee resides or is employed. Officers of MannKind who are &#147;highly compensated&#148; as defined in the Code
may be eligible to participate in the offerings, unless our Board of Directors or the Compensation Committee provides otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No
employee is eligible to participate in the Amended Purchase Plan if, immediately after the grant of purchase rights, the employee would own, directly or indirectly, stock possessing 5% or more of the total combined voting power or value of all
classes of stock of MannKind or of any parent or subsidiary of MannKind </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(including any stock which such employee may purchase under all outstanding rights and options). In addition, no employee may accrue the right to purchase more than $25,000 worth of MannKind
common stock (determined at the fair market value of the shares at the time such rights are granted) under all employee stock purchase plans of MannKind and any parent and subsidiaries in any calendar year. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Participation in the Amended Purchase Plan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Eligible employees enroll in the Amended Purchase Plan by delivering to MannKind, prior to the date selected by our Board of Directors or the
Compensation Committee as the offering date for the offering, an agreement authorizing payroll deductions of up to 20% of such employees&#146; total compensation during the offering. Our Board of Directors may provide that each person who, during
the course of an offering, first becomes eligible to participate in the Amended Purchase Plan will, on a date or dates specified in the offering which coincides with the day on which such person becomes eligible to participate or which occurs
thereafter, receive a purchase right under that offering. Our Board of Directors may provide that each person who, during the course of an offering, first becomes eligible to participate in the Amended Purchase Plan will, on a date or dates
specified in the offering which coincides with the day on which such person becomes eligible to participate or which occurs thereafter, receive a purchase right under that offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Purchase Price </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purchase price per
share at which shares of common stock are sold in an offering under the Amended Purchase Plan is the lower of (i)&nbsp;85% of the fair market value of a share of common stock on first day of the offering or (ii)&nbsp;85% of the fair market value of
a share of common stock on the purchase date, as set by our Board of Directors or the Compensation Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Payment of Purchase Price; Payroll
Deductions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purchase price of the shares is accumulated by payroll deductions over the offering. At any time during the offering, a
participant may reduce or terminate his or her payroll deductions as our Board of Directors provides in the offering. A participant may increase or begin such payroll deductions after the beginning of the offering only as provided for in the
offering. All payroll deductions made for a participant are credited to his or her account under the Amended Purchase Plan and deposited with the general funds of MannKind. A participant may make additional payments into such account only if
specifically provided for in the offering and only if the participant has not had the maximum amount withheld during the offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Purchase of Stock
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By executing an agreement to participate in the Amended Purchase Plan, the employee is entitled to purchase shares under the Amended
Purchase Plan. In connection with offerings made under the Amended Purchase Plan, our Board of Directors or the Compensation Committee specifies a maximum number of shares of common stock an employee may be granted the right to purchase and the
maximum aggregate number of shares of MannKind common stock that may be purchased pursuant to such offering by all participants. If the aggregate number of shares to be purchased upon exercise of purchase rights granted in the offering would exceed
the maximum aggregate number of shares of MannKind common stock available, our Board of Directors or the Compensation Committee would make a pro rata allocation of available shares in a uniform and equitable manner. Unless the employee&#146;s
participation is discontinued, his or her right to purchase shares is exercised automatically on the purchase date, as set by our Board of Directors, at the applicable price. See &#147;Withdrawal&#148; below. In addition, unless otherwise
specifically provided in the offering, the amount, if any, of accumulated payroll deductions remaining in any participant&#146;s account after the purchase of shares on the final purchase date of an offering will be distributed in full to the
participant at the end of such offering, without interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Withdrawal </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While each participant in the Amended Purchase Plan is required to sign an agreement authorizing payroll deductions, the participant may
withdraw from a given offering by terminating his or her payroll deductions and by delivering to MannKind a notice of withdrawal from the Amended Purchase Plan. Such withdrawal may be elected at any time during the offering except as provided by our
Board of Directors in the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon any withdrawal from an offering by the employee, MannKind will distribute to the employee his or
her accumulated payroll deductions without interest, less any accumulated deductions previously applied to the purchase of shares of common stock on the employee&#146;s behalf during such offering, and such employee&#146;s interest in the offering
will be automatically terminated. The employee is not entitled to again participate in that offering. However, an employee&#146;s withdrawal from an offering will not have any effect upon such employee&#146;s eligibility to participate in subsequent
offerings under the Amended Purchase Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Termination of Employment </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchase rights granted pursuant to any offering under the Amended Purchase Plan terminate immediately upon cessation of an employee&#146;s
employment for any reason, and MannKind will distribute to such employee all of his or her accumulated payroll deductions, without interest. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Restrictions on Transfer </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchase rights
granted under the Amended Purchase Plan are not transferable and may be exercised only by the person to whom such rights are granted. A participant may designate a beneficiary who is to receive any shares and cash, if any, from the
participant&#146;s account under the Amended Purchase Plan in the event of such participant&#146;s death after the offering but prior to delivery to the participant of the shares and cash, or who is to receive the cash from the participant&#146;s
account in the event of such participant&#146;s death during an offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Adjustment Provisions </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transactions not involving receipt of consideration by MannKind, such as a reincorporation, combination, reclassification, stock dividend or
stock split, may change the type, class and number of shares of common stock subject to the Amended Purchase Plan and to outstanding purchase rights. In that event, the Amended Purchase Plan will be appropriately adjusted in the type, class and
maximum number of shares subject to the Amended Purchase Plan and the outstanding purchase rights granted under the Amended Purchase Plan will be appropriately adjusted in the type, class, number of shares and purchase limits of such purchase
rights. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Effect of Certain Transactions </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of (i)&nbsp;a dissolution, liquidation or sale of all or substantially all of the securities or assets of MannKind, (ii)&nbsp;a
merger or consolidation in which MannKind is not the surviving corporation, (iii)&nbsp;a reverse merger in which MannKind is the surviving corporation but the shares of common stock outstanding immediately preceding the merger are converted by
virtue of the merger into other property, whether in the form of securities, cash or otherwise, or (iv)&nbsp;a sale or other disposition of at least 50% of the outstanding securities of the Company, any surviving corporation may continue or assume
purchase rights outstanding under the Amended Purchase Plan or may substitute similar rights. If any surviving corporation does not assume such rights or substitute similar rights, then the participants&#146; accumulated payroll deductions will be
used to purchase shares of common stock immediately prior to such transaction under the ongoing offering and the participants&#146; rights under such ongoing offering will terminate immediately after such purchase. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Duration, Amendment and Termination </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
Board of Directors or the Compensation Committee may suspend or terminate the Amended Purchase Plan at any time. Unless terminated earlier, the Amended Purchase Plan will terminate at the time that all of the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shares of common stock reserved for issuance under the Amended Purchase Plan have been issued under the terms of the Amended Purchase Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors or the Compensation Committee may amend the Amended Purchase Plan at any time. Any amendment of the Amended Purchase
Plan must be approved by the stockholders within 12 months of its adoption by the Board of Directors or the Compensation Committee if the amendment would (i)&nbsp;increase the number of shares of common stock reserved for issuance under the Amended
Purchase Plan, (ii)&nbsp;modify the requirements relating to eligibility for participation in the Amended Purchase Plan (to the extent such modification requires stockholder approval in order for the Amended Purchase Plan to obtain employee stock
purchase plan treatment under Section&nbsp;423 of the Code or to comply with the requirements of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act, or &#147;Rule
<FONT STYLE="white-space:nowrap">16b-3&#148;);</FONT> or (iii)&nbsp;modify the Amended Purchase Plan in any other way if such modification requires stockholder approval in order for the Amended Purchase Plan to obtain employee stock purchase plan
treatment under Section&nbsp;423 of the Code or to comply with the requirements of Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchase rights granted before amendment or termination of the Amended Purchase Plan will not be altered or impaired by any amendment or
termination of the Amended Purchase Plan without consent of the employee to whom such rights were granted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Federal Income Tax Information
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchase rights granted under the Amended Purchase Plan are intended to qualify for favorable federal income tax treatment associated
with rights granted under an employee stock purchase plan which qualifies under provisions of Section&nbsp;423 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A participant
will be taxed on amounts withheld for the purchase of shares of common stock as if such amounts were actually received. Otherwise, no income will be taxable to a participant until disposition of the acquired shares, and the method of taxation will
depend upon the holding period of the acquired shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the stock is disposed of more than two years after the beginning of the
offering period and more than one year after the stock is transferred to the participant, then the lesser of (i)&nbsp;the excess of the fair market value of the stock at the time of such disposition over the purchase price or (ii)&nbsp;the excess of
the fair market value of the stock as of the beginning of the offering period over the purchase price (determined as of the beginning of the offering period) will be treated as ordinary income. Any further gain or any loss will be taxed as a
long-term capital gain or loss. At present, such capital gains generally are subject to lower tax rates than ordinary income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the
stock is sold or disposed of before the expiration of either of the holding periods described above, then the excess of the fair market value of the stock on the purchase date over the purchase price will be treated as ordinary income at the time of
such disposition. The balance of any gain will be treated as capital gain. Even if the stock is later disposed of for less than its fair market value on the exercise date, the same amount of ordinary income is attributed to the participant, and a
capital loss is recognized equal to the difference between the sales price and the fair market value of the stock on such purchase date. Any capital gain or loss will be short-term or long-term, depending on how long the stock has been held. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no federal income tax consequences to MannKind by reason of the grant or exercise of purchase rights under the Purchase Plan.
MannKind is entitled to a deduction to the extent amounts are taxed as ordinary income to a participant (subject to the requirement of reasonableness and the satisfaction of tax reporting obligations). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Plan Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participation in the
Amended Purchase Plan is voluntary and each eligible employee will make his or her own decision whether and to what extent to participate in the plan. It is therefore not possible to determine the benefits or amounts that will be received in the
future by individual employees or groups of employees under the Amended Purchase Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADVISORY VOTE ON EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &#147;Dodd-Frank Act&#148;) and Section&nbsp;14A of the Exchange
Act enables the Company&#146;s stockholders to vote to approve, on an advisory or <FONT STYLE="white-space:nowrap">non-binding</FONT> basis, the compensation of the Company&#146;s named executive officers as described in the &#147;Compensation
Discussion and Analysis&#148; section of this proxy statement (commonly referred to as a &#147;say on pay&#148; proposal). This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named
executive officers and the philosophy, policies and practices described in this proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation of our named executive
officers is disclosed in the Compensation Discussion and Analysis, the compensation tables, and the related narrative disclosure contained in this proxy statement. As discussed in those disclosures, the Company believes that its compensation
policies and decisions are appropriately designed to attract and retain the individuals needed to support the Company&#146;s business strategy and to compete effectively with pharmaceutical and biotechnology companies while aligning with the
long-term interests of the Company&#146;s stockholders </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Applying these philosophies, the Board of Directors has set specific compensation
goals designed to help the Company achieve our short and long-term business and performance goals. Our executive compensation program emphasizes <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance.</FONT></FONT> The
compensation package for our executive officers includes both cash and equity incentive plans that align our executives&#146; compensation with our short-term and long-term performance goals and objectives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors believes that the base salaries of our executive officers should be set at approximately the median base salary levels
of executive officers in our competitive market. The annual cash incentive awards under our bonus plan are intended to compensate our executive officers for achieving our annual goals at the corporate level. The goals for the Company are established
so that target attainment is not assured. The attainment of payment for performance at or above target levels requires significant effort on the part of our named executive officers. Our named executive officers&#146; target annual cash incentive
awards are expressed as a percentage of base salary and reflects what we believe are market competitive levels. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Long-term equity
incentives are intended to reward executives for growth in stockholder value. In 2017, our long-term equity incentive awards to our named executive officers reflected the grant guidelines we adopted in 2017, and are based on our determination of
appropriate and competitive annual award values. The guidelines for executive officers seek to deliver the majority of the award value in stock options. We believe this approach to equity compensation aligns with the interests of stockholders and
encourages both stock price growth and retention. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have limited perquisite benefits (e.g. automobile allowances) for certain of our
named executive officers and we currently do not provide any deferred compensation programs or supplemental pensions to any of our named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our pay practices are reasonable and in the best interests of our Company and our stockholders. To that end, we do not use tax
<FONT STYLE="white-space:nowrap">gross-ups,</FONT> guaranteed bonuses, &#147;single-trigger&#148; benefits payable upon a change in control without a corresponding separation from service, or similar pay practices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the 2017 Annual Meeting of Stockholders, our stockholders indicated their preference that the Company solicit a <FONT
STYLE="white-space:nowrap">non-binding</FONT> advisory vote on the compensation of the named executive officers every year. The Board has adopted a policy that is consistent with that preference. In accordance with that policy, this year, we are
again </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
asking our stockholders to support the compensation of the Company&#146;s named executive officers as described in this proxy statement by casting a
<FONT STYLE="white-space:nowrap">non-binding</FONT> advisory vote &#147;FOR&#148; the following resolution: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, that the
Company&#146;s stockholders approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Company&#146;s Proxy Statement for the 2018 Annual Meeting of Stockholders pursuant to the compensation disclosure rules
of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the 2017 Summary Compensation Table and the other related tables and disclosure.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While this advisory vote on executive compensation is <FONT STYLE="white-space:nowrap">non-binding,</FONT> the Board of Directors and the
Compensation Committee, which is responsible for designing and administering the Company&#146;s executive compensation program, will review the voting results and consider the outcome of the vote when making future compensation decisions for named
executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the Board decides to modify its policy regarding the frequency of soliciting <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">say-on-pay</FONT></FONT> votes, the next scheduled <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> vote will be at the 2019 Annual Meeting of Stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>R<SMALL>EQUIRED</SMALL> V<SMALL>OTE</SMALL> <SMALL>AND</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL>
R<SMALL>ECOMMENDATION</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of Proposal 4 requires the affirmative vote of a majority of the shares present or represented
by proxy and entitled to vote at the Annual Meeting. Abstentions will be counted toward the tabulation of votes cast on the proposal and will have the same effect as &#147;Against&#148; votes. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT>
are counted towards a quorum, but will have no effect on the outcome of the vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors recommends that you vote in
favor of the compensation of the Company&#146;s named executive officers as described in this proxy statement, including the disclosures under &#147;Compensation Discussion and Analysis,&#148; the compensation tables and the narrative discussion
following the compensation tables. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL>
R<SMALL>ECOMMENDS</SMALL> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A <SMALL>VOTE</SMALL> <SMALL>FOR</SMALL> P<SMALL>ROPOSAL</SMALL> 4 </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RATIFICATION OF SELECTION OF DELOITTE&nbsp;&amp; TOUCHE LLP AS INDEPENDENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee of the Board of Directors has selected Deloitte&nbsp;&amp; Touche LLP (&#147;Deloitte&#148;), as the Company&#146;s
independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2018 and has directed management to submit the selection of Deloitte for ratification by the stockholders at the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Deloitte has served as the Company&#146;s independent auditor since 2001. Representatives of Deloitte are expected to be present at the Annual
Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholder ratification of the selection of Deloitte as our independent registered public accounting firm is not required by our Amended and
Restated Bylaws or otherwise. The Board of Directors is seeking such ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection of Deloitte as our independent registered public accounting firm, the Audit
Committee of the Board of Directors will consider whether to retain that firm for the fiscal year ending December&nbsp;31, 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>R<SMALL>EQUIRED</SMALL> V<SMALL>OTE</SMALL> <SMALL>AND</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL>
R<SMALL>ECOMMENDATION</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of Proposal 5 requires the affirmative vote of a majority of the shares present or represented
by proxy and entitled to vote at the Annual Meeting. Abstentions will be counted toward the tabulation of votes cast on the proposal and will have the same effect as &#147;Against&#148; votes. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT>
are counted towards a quorum, but will have no effect on the outcome of the vote. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL>
<SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> R<SMALL>ECOMMENDS</SMALL> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A V<SMALL>OTE</SMALL> <SMALL>FOR</SMALL> PROPOSAL 5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>P<SMALL>RINCIPAL</SMALL> A<SMALL>CCOUNTING</SMALL> F<SMALL>EES</SMALL> <SMALL>AND</SMALL> S<SMALL>ERVICES</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table represents aggregate fees billed to the Company for the fiscal years ended December&nbsp;31, 2017 and 2016 by Deloitte and
its subsidiaries, the affiliates of Deloitte&nbsp;&amp; Touche LLP, Deloitte Touche Tohmatsu Limited and its member firm (collectively, the Deloitte entities). All entities which collectively represent the Company&#146;s principal accounting firm.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,143,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,347,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,649</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,244,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,442,874</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Represents the aggregate fees billed for professional services rendered for the reviews and audit of our consolidated financial statements and internal control over financial reporting including related regulatory
filings and related comfort letters on such. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Represents the aggregate fees for professional services rendered for tax compliance, tax advice and tax planning. These fees in 2017 and 2016 represent fees for 1) tax compliance services including the preparation of
federal, foreign, state and local tax returns, extensions and estimated tax payments and 2) tax planning services including advice and coordination related to the <FONT STYLE="white-space:nowrap">wind-up</FONT> of the Netherlands and German tax
structures and entities, state nexus analysis and ownership analysis under Section&nbsp;382. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All fees described above were <FONT
STYLE="white-space:nowrap">pre-approved</FONT> by the Audit Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>P<SMALL>RE</SMALL>-<SMALL>APPROVAL</SMALL> P<SMALL>OLICIES</SMALL> <SMALL>AND</SMALL>
P<SMALL>ROCEDURES</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee has adopted a policy and procedures for the
<FONT STYLE="white-space:nowrap">pre-approval</FONT> of audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services rendered by our independent registered public accounting firm, Deloitte and the Deloitte entities. The policy generally <FONT
STYLE="white-space:nowrap">pre-approves</FONT> specified services in the defined categories of audit services, audit-related services, tax services and other services up to specified amounts. <FONT STYLE="white-space:nowrap">Pre-approval</FONT> may
also be given on an individual explicit <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis before the independent principal accounting firm is engaged to provide each service. The <FONT
STYLE="white-space:nowrap">pre-approval</FONT> of services may be delegated to one or more of the Audit Committee&#146;s members, but the decision must be reported to the full Audit Committee at its next scheduled meeting. The delegation of <FONT
STYLE="white-space:nowrap">pre-approval</FONT> of services is limited to <FONT STYLE="white-space:nowrap">non-audit</FONT> services, as set forth in the Audit Committee Charter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee has considered whether the provision by the Deloitte entities of the <FONT STYLE="white-space:nowrap">non-audit</FONT>
services described above was allowed under <FONT STYLE="white-space:nowrap">Rule&nbsp;2-01(c)(4)</FONT> of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-X</FONT> and was compatible with maintaining the independence of the registered public
accountants and has concluded that the Deloitte entities were and are independent of us in all respects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information regarding the ownership of the Company&#146;s common stock as of March&nbsp;19, 2018 by:
(i)&nbsp;each person, entity or group known to the Company to be the beneficial owner of more than 5% of the Company&#146;s common stock; (ii)&nbsp;each director and nominee for director; (iii)&nbsp;each of the executive officers named in the
Summary Compensation Table, who we refer to as the named executive officers; and (iv)&nbsp;all current executive officers and directors of the Company as a group. Unless otherwise indicated in the footnotes to the table below and subject to
community property laws where applicable, we believe that each of the stockholders named in the table has sole voting and investment power with respect to the shares indicated as beneficially owned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Applicable percentages are based on 123,011,353 shares outstanding on March&nbsp;19, 2018, adjusted as required by rules promulgated by the
SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. In addition, the rules include shares of common stock issuable pursuant
to the exercise of stock options or warrants that are either immediately exercisable or exercisable on or before May&nbsp;18, 2018, which is 60&nbsp;days after March&nbsp;19, 2018. These shares are deemed to be outstanding and beneficially owned by
the person holding those options or warrants for the purpose of computing the percentage ownership of that person, but they are not treated as outstanding for the purpose of computing the percentage ownership of any other person. Certain of the
options in this table are exercisable at any time but, if exercised, are subject to a lapsing right of repurchase until the options are fully vested. Unless otherwise indicated, the address for each person or entity listed in the table is
c/o&nbsp;MannKind Corporation, 30930&nbsp;Russell Ranch Road, Suite&nbsp;301, Westlake Village, California 91362. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Beneficial Ownership</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:134.80pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name and Address of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent&nbsp;of&nbsp;Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Greater than 5% Stockholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Mann Group LLC(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,514,751</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12744 San Fernando Road</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sylmar, CA 91342</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Alfred E. Mann Living Trust(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,699,309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12744 San Fernando Road</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sylmar, CA 91342</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Named Executive Officers and Directors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Castagna, PharmD (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven B. Binder</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew J. Pfeffer (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">597,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rosabel R. Alinaya(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stuart A. Tross (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,786</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Thomson(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">304,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph Kocinsky(8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald J. Consiglio(9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael A. Friedman(10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kent Kresa(11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">238,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David H. MacCallum(12)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Henry L. Nordhoff(13)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James S. Shannon(14)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current executive officers and directors as a group&nbsp;(15&nbsp;persons)(15)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,191,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Less than 1%. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">The Alfred E. Mann Living Trust (the &#147;Trust&#148;) is the sole member and manager of The Mann Group LLC (&#147;The Mann Group&#148;). </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Includes (i)&nbsp;the shares held by The Mann Group as described in footnote (1)&nbsp;above and (ii)&nbsp;184,558 shares held of record by the Trust. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Includes 2,743 shares which Mr.&nbsp;Castagna has the right to acquire within 60&nbsp;days of March&nbsp;19, 2018 pursuant to the exercise of outstanding options. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Includes 17,210 shares which Mr.&nbsp;Pfeffer has the right to acquire within 60&nbsp;days of March&nbsp;19, 2018 pursuant to the exercise of outstanding options. On May&nbsp;25, 2017, Mr.&nbsp;Pfeffer ceased to be the
Chief Executive Officer and Chief Financial Officer upon the appointment of Michael Castagna as the Chief Executive Officer and member of the Board of Directors. In August 2017, Mr.&nbsp;Pfeffer resigned from the Board of Directors.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">Includes 2,911 shares which Ms.&nbsp;Alinaya has the right to acquire within 60 days of March&nbsp;19, 2018 pursuant to the exercise of outstanding options. On May&nbsp;25, 2017, Ms.&nbsp;Alinaya was Acting Chief
Financial Officer until the appointment of Steven B. Binder as Chief Financial Officer on July&nbsp;17, 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">Includes 3,333 shares which Mr.&nbsp;Tross has the right to acquire within 60&nbsp;days of March&nbsp;19, 2018 pursuant to the exercise of outstanding options. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">Includes 4,621 shares which Mr.&nbsp;Thomson has the right to acquire within 60&nbsp;days of March&nbsp;19, 2018 pursuant to the exercise of outstanding options. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">Includes 4,315 shares which Mr.&nbsp;Kocinsky has the right to acquire within 60&nbsp;days of March&nbsp;19, 2018 pursuant to the exercise of outstanding options. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top">Includes 1,989 options and 348 restricted stock units which Mr.&nbsp;Consiglio has the right to acquire within 60&nbsp;days of March&nbsp;19, 2018 pursuant to the exercise of outstanding options and vesting of
restricted stock units. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top">Includes 2,364 options and 348 restricted stock units which Dr.&nbsp;Friedman has the right to acquire within 60&nbsp;days of March&nbsp;19, 2018 pursuant to the exercise of outstanding options and vesting of restricted
stock units. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top">Includes 1,929 options and 348 restricted stock units which Mr.&nbsp;Kresa has the right to acquire within 60&nbsp;days of March&nbsp;19, 2018 pursuant to the exercise of outstanding options and vesting of restricted
stock units. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top">Includes 2,128 options and 348 restricted stock units which Mr.&nbsp;MacCallum has the right to acquire within 60 days of March&nbsp;19, 2018 pursuant to the exercise of outstanding options and vesting of restricted
stock units. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top">Includes 2,128 options and 348 restricted stock units which Mr.&nbsp;Nordhoff has the right to acquire within 60&nbsp;days of March&nbsp;19, 2018 pursuant to the exercise of outstanding options and vesting of restricted
stock units. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top">Includes 2,256 options and 348 restricted stock units which Dr.&nbsp;Shannon has the right to acquire within 60&nbsp;days of March&nbsp;19, 2018 pursuant to the exercise of outstanding options and vesting of restricted
stock units. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top">Includes the shares described in notes&nbsp;(3) and (5)&nbsp;through (14) above, and 2,000 shares owned by another executive officer. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE OFFICERS OF THE REGISTRANT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth our current executive officers and their ages: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="58%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position(s)</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael&nbsp;E.&nbsp;Castagna,&nbsp;Pharm.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer and Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven B. Binder</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Kendall, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Medical Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph Kocinsky</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Technology Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick McCauley</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Commercial Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David B. Thomson, Ph.D., J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General Counsel and Secretary</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stuart A. Tross, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief People and Workplace Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rosabel R. Alinaya</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Investor Relations and Treasury</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Courtney Barton</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vice President, Chief Compliance and Privacy Officer</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Michael E. Castagna, Pharm.D.</I> has served as our Chief Executive Officer and as one of our directors
since May 2017. Mr.&nbsp;Castagna also served as our Chief Commercial Officer from March 2016 until May 2017. From November 2012 until he joined the Company, Mr.&nbsp;Castagna was at Amgen, Inc., where he initially served as Vice President, Global
Lifecycle Management and was most recently Vice President, Global Commercial Lead for Amgen&#146;s Biosimilar Business Unit. From 2010 to 2012, he was Executive Director, Immunology, at Bristol-Myers Squibb Co. Before BMS, Mr.&nbsp;Castagna served
as Vice President&nbsp;&amp; Head, Biopharmaceuticals, North America, at Sandoz. He has also held positions with commercial responsibilities at EMD (Merck) Serono, Pharmasset and DuPont Pharmaceuticals. He received his pharmacy degree from
University of the Sciences-Philadelphia College of Pharmacy, a Doctor of Pharmacy from Massachusetts College of Pharmacy&nbsp;&amp; Sciences and an MBA from The Wharton School of Business at the University of Pennsylvania. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Steven B. Binder</I> has been our Chief Financial Officer since July 2017. Prior to joining us, Mr.&nbsp;Binder was at Stryker Corporation,
where he served as Vice President and Chief Financial Officer for Stryker&#146;s International Group, based in Singapore. Prior to Stryker, Mr.&nbsp;Binder served in a series of senior leadership roles at Bristol-Myers Squibb Company, as Vice
President, Finance over different geographic operating units: United States (2012-2013), Europe (2008-2011), AsiaPacific (2005-2007), and Japan (2003-2005). Prior to his international roles at Bristol-Myers Squibb, Mr.&nbsp;Binder served in three
senior leadership roles for Oncology Therapeutics Network, a U.S. based independent subsidiary of BMS: Vice President, Strategic Development from 2001 through 2003, Vice President, Customer Operations from 2000 through 2001, and Chief Financial
Officer from 1997 through 2000. Before OTN, Mr.&nbsp;Binder progressed through three finance and accounting roles for BMS Worldwide Medicines Group after joining the company in 1992. Mr.&nbsp;Binder also was with Deloitte&nbsp;&amp; Touche from 1984
through 1992. Mr.&nbsp;Binder received a B.S. degree in Accounting and Business Administration from Muhlenberg College and is a Certified Public Accountant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>David Kendall, M.D. </I>has been our Chief Medical Officer since February 2018. Dr.&nbsp;Kendall has over 30 years of experience in
diabetes and metabolism research, clinical management, research, and policy advocacy. Prior to joining us, he served as Research Physician and Vice President of Global Medical Affairs for Lilly Diabetes, and led all medical affairs activities and
guided research and development strategy across multiple geographies. Prior to Eli Lilly, Dr.&nbsp;Kendall served as Chief Scientific and Medical Officer at the American Diabetes Association, where he was responsible for all medical affairs, medical
education, research, outcomes, and medical policy activities. Earlier in his career, Dr.&nbsp;Kendall served as Medical Director at the International Diabetes Center, and the Park Nicollet Clinic, as well as at Amylin Pharmaceuticals.
Dr.&nbsp;Kendall received his M.D. and completed his Post Graduate Medical Training at the University of Minnesota, and earned a B.A. in Biology from St. Olaf College. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Joseph Kocinsky</I> has been our Chief Technology Officer since October 2015<I>.</I> Mr.&nbsp;Kocinsky has over 28 years of experience in
the pharmaceutical industry in technical operations and product development. Prior to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
joining us in 2003, he held a variety of technical and management positions with increased responsibility at Schering-Plough Corp. Mr.&nbsp;Kocinsky holds a bachelor&#146;s degree in chemical
engineering and a master&#146;s degree in Biomedical Engineering from New Jersey Institute of Technology and a master&#146;s degree in business administration from Seton Hall University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Patrick McCauley</I> has been our Chief Commercial Officer since July 2017. Prior to joining us, Mr. McCauley was at Astellas Pharma in a
series of senior sales and compliance leadership roles from 2005 through 2017. Prior to Astellas, Mr. McCauley was a member of the U.S. commercialization team and held a sales leadership role with Yamanouchi Pharma before the merger of Yamanouchi
and Fujisawa Pharma to create Astellas in 2005. Before Astellas/Yamanouchi, Mr.&nbsp;McCauley spent thirteen years with DuPont Pharmaceuticals and one year with Bristol-Myers Squibb which acquired DuPont Pharmaceuticals in 2001. He received a MBA
degree from the Kellogg School of Management at Northwestern University, a JD from the South Texas College of Law, and a BA in Economics from the University of Notre Dame. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>David B. Thomson, Ph.D., J.D.</I> has been our General Counsel and Corporate Secretary since January 2002. Prior to joining us, he
practiced corporate/commercial and securities law at a major Toronto law firm. Earlier in his career, Mr.&nbsp;Thomson was a post-doctoral fellow at the Rockefeller University. Mr.&nbsp;Thomson obtained his bachelor&#146;s degree, master&#146;s
degree and Ph.D. from Queens University and obtained his J.D. from the University of Toronto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Stuart A. </I><I>Tross</I><I>, Ph.D.</I>
has been our Chief People and Workplace Officer since December 2016, with responsibilities for human resources, information technology, corporate communications and west coast facilities. From 2006 to 2016 he served in various roles of increasing
responsibility at Amgen, Inc., most recently as Senior Vice President and Chief Human Resources Officer responsible for human resources and security on a global basis. From 1998 to 2006 he served in a series of leadership roles at Bristol-Myers
Squibb Co, most recently as Vice President and Global Head of Human Resources for Mead Johnson Company. Mr.&nbsp;Tross received a B.S. degree from Cornell University and M.S. and Ph.D. degrees in Industrial-Organizational Psychology from the Georgia
Institute of Technology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Rosabel R. Alinaya</I> has been our Senior Vice President, Investor Relations and Treasury since July 2017.
Ms.&nbsp;Alinaya also served as Principal Accounting Officer from January 2016 to July 2017 with responsibility for finance, accounting, tax, treasury, investor relations and risk management. Previously, she was our Vice President, Finance since
March 2011 after serving as our Corporate Controller since June 2003. Ms.&nbsp;Alinaya began her career at Deloitte&nbsp;&amp; Touche LLP, graduating from California State University, Northridge and is a Certified Public Accountant. She is also a
member of the American Institute of Certified Public Accountants and a member of the California Society of Certified Public Accountants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Courtney Barton</I> has been our Vice President, Chief Compliance and Privacy Officer since March 2017. Ms.&nbsp;Barton began her
compliance and ethics career at Winn-Dixie Stores, Incorporated before transitioning to roles in the pharmaceutical and medical device sector with Bausch + Lomb, Allergan, KYTHERA (Allergan) and Anacor (Pfizer). She has also held positions with
Merrill Lynch and Janus, including an international appointment. A graduate of Syracuse University, Ms.&nbsp;Barton holds Bachelor&#146;s degrees in Political Science and International Relations and is a Certified Compliance and Ethics Professional
(CCEP) and Certified Information Privacy Professional (CIPP US/E). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Executive officers serve at the discretion of our Board of Directors.
There are no family relationships between any of our directors and executive officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPENSATION OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Annual Retainers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors receives an annual retainer for service on the Board of Directors and an additional retainer for his service on one of our three standing committees, as described below under the subheading <FONT
STYLE="white-space:nowrap">&#147;Non-Employee</FONT> Director Compensation Program&#148;. In 2017, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors had an option to receive their annual retainer in cash or common stock of the Company
pursuant to our director compensation program, subject to limits described below, as discussed below under the subheading <FONT STYLE="white-space:nowrap">&#147;Non-Employee</FONT> Director Compensation Program&#148;. In the fiscal year ended
December&nbsp;31, 2017, the total annual retainer earned by <FONT STYLE="white-space:nowrap">non-employee</FONT> directors was $405,500, of which $207,500 was paid in cash and $198,000 was received in the form of stock options. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Awards </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each <FONT
STYLE="white-space:nowrap">non-employee</FONT> director of the Company also receives annual equity awards under our 2013 Equity Incentive Plan (&#147;the 2013 Plan&#148;) pursuant to our <FONT STYLE="white-space:nowrap">non-employee</FONT> director
compensation program, as described below under the subheading <FONT STYLE="white-space:nowrap">&#147;Non-Employee</FONT> Director Compensation Program.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning director compensation received for the fiscal year ended December&nbsp;31, 2017 by our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Director Compensation Table </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees<BR>Earned&nbsp;or<BR>Paid in<BR>Cash<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Restricted<BR>Stock<BR>Awards<BR>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald J. Consiglio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">113,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael A. Friedman, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,500</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kent Kresa</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David H. MacCallum</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Henry L. Nordhoff</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James S. Shannon</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">These amounts reflect the grant date fair value of all option grants to
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors in 2017. The Company uses the Black-Scholes option valuation model to estimate the grant date fair value of <FONT STYLE="white-space:nowrap">non-employee</FONT> director stock options.
Option valuation models require the input of assumptions, including the expected life of the stock-based awards, the estimated stock price volatility, the risk-free interest rate and the expected dividend yield. The expected volatility assumption is
based on an assessment of the historical volatility, with consideration of implied volatility, derived from an analysis of historical trade activity. Reference Note 13 &#147;Stock award plans&#148; in the notes to our financial statements for the
period ended December&nbsp;31, 2017, included in Part IV of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2017 filed with the SEC on February&nbsp;27, 2018, which identifies the
assumptions made in the valuation of option. All <FONT STYLE="white-space:nowrap">non-employee</FONT> directors received a stock option to purchase 30,000 shares of our common stock upon <FONT STYLE="white-space:nowrap">re-election</FONT> to the
Board of Directors on May&nbsp;18, 2017, which is the maximum award permitted under the 2013 Plan. Options granted to these <FONT STYLE="white-space:nowrap">non-employee</FONT> directors vest monthly over a period of three years. The exercise price
per share represents the fair market value of our common stock on the date of each grant (based on the closing sales price reported on the Nasdaq Global Market on the date of grant). We have no consulting agreements with any of our directors
pursuant to which stock awards were issued. As of December&nbsp;31, 2017, our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors had option grants outstanding to purchase 389,345 shares of our common stock as follows: Ronald J.
Consiglio, 63,541 shares; Michael A. Friedman, M.D. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
77,060 shares; Kent Kresa, 61,380 shares; David H. MacCallum, 68,541 shares; Henry L. Nordhoff, 68,541 shares; and James Shannon 50,282 shares. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">These amounts reflect the grant date fair value of all restricted stock awards to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors in 2017. Restricted stock units are valued based on the market price on
the grant date. Reference Note&nbsp;13 &#147;Stock award plans&#148; in the notes to our financial statements for the period ended December&nbsp;31, 2017, included in Part&nbsp;IV of our Annual Report on
<FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ended December&nbsp;31, 2017 filed with the SEC on February&nbsp;27, 2018, which identifies the assumptions made in the valuation of restricted stock awards. Restricted stock
awards granted to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors vest annually over a period of three years. As of December&nbsp;31, 2017, our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors had restricted stock grants
outstanding to receive 154,159 shares of our common stock as follows: Ronald J. Consiglio, 32,259 shares; Michael A. Friedman, M.D. 4,031 shares; Kent Kresa, 36,395 shares; David H. MacCallum, 25,285 shares; Henry L. Nordhoff, 25,783 shares; and
James Shannon 18,406 shares. For 2017, Mr.&nbsp;Consiglio, Mr.&nbsp;Nordhoff and Dr.&nbsp;Friedman elected to receive their annual retainer in cash. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation program (the &#147;director compensation plan&#148;)
in effect in 2017, each of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors receives an annual retainer of $50,000 for service on the Board of Directors. The chair of the Nominating and Corporate Governance Committee receives, in
addition to the annual retainer, a retainer of $5,000 per year for his or her service as the Nominating and Corporate Governance Committee chair and <FONT STYLE="white-space:nowrap">non-chair</FONT> Nominating and Corporate Governance Committee
members receive an additional retainer of $5,000 per year. The chair of the Compensation Committee receives, in addition to the annual retainer, a retainer of $12,500 per year for his or her service as the Compensation Committee chair and <FONT
STYLE="white-space:nowrap">non-chair</FONT> Compensation Committee members receive an additional retainer of $7,500 per year. The chair of the Audit Committee receives, in addition to the annual retainer, a retainer of $15,000 per year for his or
her service as the Audit Committee chair and <FONT STYLE="white-space:nowrap">non-chair</FONT> Audit Committee members receive an additional retainer of $10,000 per year. Our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors do not
receive fees for attending Board or committee meetings. Additionally, the Chairman receives an additional annual retainer of $32,500. As of a result of Mr.&nbsp;Kresa&#146;s appointment to the position of Chairman of the Board in February 2016, we
do not currently have a lead independent director and expect to keep the lead independent director position vacant for so long as the Chairman and Chief Executive Officer positions continue to be occupied by separate individuals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The members of the Board of Directors are also eligible for reimbursement for their expenses incurred in attending Board of Directors meetings
in accordance with Company policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-employee</FONT> directors have an option to receive their annual
retainer in cash or common stock of the Company. If a <FONT STYLE="white-space:nowrap">non-employee</FONT> director elects to receive his annual retainer in common stock, two awards of restricted stock units will be granted. One of these awards will
consist of that number of shares that equals 100% of the annual retainer, based on the closing price on the day immediately prior to the grant date. This award will vest (i.e., the shares will be delivered) on the earliest to occur of (i)&nbsp;the
retirement or removal of the <FONT STYLE="white-space:nowrap">non-employee</FONT> director from the Board of Directors; (ii)&nbsp;his or her death; or (iii)&nbsp;five years from the grant date. The other award will consist of that number of shares
that equals 15% of the annual retainer, based on the same closing price. This award will vest upon the earliest to occur of (i)&nbsp;the retirement or removal of the <FONT STYLE="white-space:nowrap">non-employee</FONT> director from the Board of
Directors, provided that such retirement or removal occurs more than one year after the grant date; (ii)&nbsp;his or her death; or (iii)&nbsp;five years from the grant date. <FONT STYLE="white-space:nowrap">Non-employee</FONT> directors who elect
not to participate in this program will receive the full annual retainer shortly after the date of the stockholder meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each <FONT
STYLE="white-space:nowrap">non-employee</FONT> director of the Company also receives annual equity awards under the 2013 Plan. Only <FONT STYLE="white-space:nowrap">non-employee</FONT> directors of the Company or an affiliate of such directors (as
defined in the Code) are eligible to receive equity awards pursuant to the director compensation program. Options granted under the 2013 Plan pursuant to the director compensation program are intended by the Company not to qualify as incentive stock
options under the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the director compensation program, each of our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors automatically receives on the date of each of our annual stockholder meetings an equity award determined by dividing $150,000 by the <FONT STYLE="white-space:nowrap">20-day</FONT> trailing
average closing price of the Company&#146;s common stock reported on Nasdaq as of the trading day immediately preceding the date of the applicable annual meeting of stockholders (the &#147;Total Award&#148;). An amount equal to 1/3 of the Total
Award rounded up to the nearest 100 shares is in the form of a restricted stock unit, and an amount equal 2/3 of the Total Award rounded up to the nearest 100 shares is in the form of a stock option at an exercise price equal to 100% of fair market
value of the Company&#146;s common stock on the date of grant; provided, however, that a maximum of 30,000 shares of our common stock may be granted to any one <FONT STYLE="white-space:nowrap">non-employee</FONT> director during any one calendar
year pursuant to stock awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each such annual equity award vests in 36 equal monthly installments commencing one month from the date of
grant.&nbsp;If a <FONT STYLE="white-space:nowrap">non-employee</FONT> director has not been serving as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director for the entire period beginning from the preceding annual stockholders meeting,
then the number of shares subject to such annual equity award shall be reduced proportionately for each full quarter prior to the date of such annual equity award during which such person did not serve as a
<FONT STYLE="white-space:nowrap">non-employee</FONT> director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, each person who is elected or appointed for the first time to
be a <FONT STYLE="white-space:nowrap">non-employee</FONT> director of the Company will automatically receive, on the date of his or her initial election or appointment to the Board of Directors, an option to purchase 50,000&nbsp;shares of the
Company&#146;s common stock as an initial grant. All initial grant options vest in equal annual installments over three years. No other options are provided for under the director compensation program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exercise price of options granted pursuant to the director compensation program cannot be less than 100% of the fair market value of the
common stock subject to the option on the date of the option grant. Acceptable consideration for the purchase of the Company&#146;s common stock upon exercise of options granted pursuant to the director compensation program will be determined by the
Board of Directors and may include cash or common stock previously owned by the optionee or may be paid through a broker assisted exercise or net exercise feature. An optionee whose service relationship with the Company or any of our affiliates,
whether as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director or subsequently as an employee, director or consultant to either the Company or one of our affiliates, ceases for any reason may exercise options for the term provided in the
option agreement to the extent the options were exercisable on the date of termination. The term of options granted pursuant to the director compensation program is 10 years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>OMPENSATION</SMALL> D<SMALL>ISCUSSION</SMALL> <SMALL>AND</SMALL> A<SMALL>NALYSIS</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are pleased to present our report on executive compensation. The report&#146;s objective is to assist our stockholders in understanding the
objectives and procedures used by the Compensation Committee of our Board of Directors in establishing its recommendations to the Board of Directors regarding the compensation of our executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for
patients with diseases such as diabetes and pulmonary arterial hypertension. Our compensation program is designed to attract and retain the individuals needed to support our business strategy and to allow us to compete effectively with
pharmaceutical and biotechnology companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee is responsible for establishing and administering our policies
governing the compensation for our executive officers. The Compensation Committee is composed entirely of independent directors within the meaning of applicable SEC and Nasdaq rules. The Compensation Committee&#146;s responsibilities and duties are
outlined in detail in the Compensation Committee charter, which is available on our website at <I><U>www.mannkindcorp.com.</U></I> A primary responsibility of the Compensation Committee is to make recommendations regarding the compensation for our
executive officers, including the determination and confirmation of annual corporate goal achievement for purposes of awarding bonuses, to the full Board of Directors for its approval. As part of this process, the Compensation Committee has
historically invited our Chief Executive Officer to attend Compensation Committee meetings or portions thereof to obtain his insight and guidance, though the Chief Executive Officer is not a member of the Compensation Committee. The Compensation
Committee engages outside consulting firms to assist in developing compensation levels and practices and to provide external market data. The Compensation Committee engaged Mercer LLC to benchmark the compensation levels of seven executive positions
relative to a group of peer companies for fiscal year 2017 compensation. The Compensation Committee may select, or receive advice from, a compensation consultant, legal counsel or other adviser to the Compensation Committee, other than <FONT
STYLE="white-space:nowrap">in-house</FONT> legal counsel and certain other types of advisers, only after taking into consideration six factors, prescribed by the SEC and Nasdaq, that bear upon the adviser&#146;s independence; however, there is no
requirement that any adviser be independent. The Compensation Committee conducted an independence assessment with respect to Mercer&#146;s role in recommending or determining the amount and form of executive compensation for fiscal year ended
December&nbsp;31, 2017 and considered the required six factors.&nbsp;After conducting this assessment, the Compensation Committee concluded that Mercer&#146;s role in recommending or determining the amount and form of execution compensation for the
fiscal year ended December&nbsp;31, 2017 did not raise any conflict of interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee meets outside the presence of
our Chief Executive Officer in order to consider the appropriate compensation for our Chief Executive Officer. The Compensation Committee relies on compensation data provided by Mercer in setting CEO compensation and met without the CEO in setting
his compensation. Neither of the individuals serving as CEO in 2017 maintain personal or business relationships (including any interlocking relationships) with any of the Compensation Committee members (outside of their relationship within the
Company) that would impair the Compensation Committee members&#146; ability to remain independent and assess the CEO&#146;s compensation without any conflict of interest. Thus, the determination of the CEO compensation was made without undue
influence from the CEO. During 2017, for all other named executive officers, the Compensation Committee met outside the presence of all executive officers except our Chief Executive Officer. The annual performance of each of our executive officers
is considered by the Compensation Committee when making decisions regarding base salary, targets for and payments under our bonus plan and grants of equity incentive awards. When making recommendations regarding individual executive officers, the
Compensation Committee considers the importance of the position to us, the past compensation history of the executive officer and the contributions made by the individual in the past and the contributions we expect the executive officer to make in
the future towards the success of our business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Philosophy and Objectives </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee oversees our executive compensation within the context of a compensation philosophy. This philosophy is to provide
compensation and benefits programs designed to attract, engage, motivate, and retain a high caliber workforce that enables us to compete with companies in the pharmaceutical and biotechnology industries and to reward individual and corporate
performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that a well-designed compensation program for our executive officers should: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">align the goals of the executive officer with the goals of our stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">recognize individual initiative and achievement; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provide total compensation that enables us to compete with companies in the pharmaceutical and biotechnology industries;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">align compensation with our short-term and long-term corporate objectives and strategy, focusing executive officer behavior on the fulfillment of those objectives. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In keeping with this philosophy, our executive compensation program is designed to achieve the following objectives: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">attract talented and experienced executives; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">motivate and reward executives whose knowledge, skills and performance are critical to our success; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">retain executives and employees who are instrumental in accomplishing our corporate goals; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">align the interests of our executives and stockholders by motivating executives to increase stockholder value and rewarding executives when stockholder value increases; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provide a competitive compensation package which is weighted towards <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance,</FONT></FONT> and in which total compensation is primarily
determined by the Company&#146;s and the individual&#146;s achievement of results; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">ensure fairness among the executive management team by recognizing the contributions each executive makes to our success; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">foster a shared commitment among executives by aligning the Company&#146;s and their individual goals;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">compensate our executives to manage our business to meet our long-term objectives. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competitive Market
Assessment </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee periodically reviews competitive market data to determine if our compensation levels remain at
targeted levels and our pay practices are appropriate. These assessments include a review of base salary, annual incentives, and long-term incentives. These components are evaluated against a group of peer companies. MannKind also considers industry
specific and general published survey compensation data where peer group data is not robust. Specifically, we utilized the Radford Global Life Sciences Executive Survey, the SIRS Executive Compensation Survey and the Kenexa CompAnalyst Executive
Survey. For the past eight years, the Compensation Committee has engaged Mercer to benchmark the compensation levels of senior executive positions relative to a group of peer companies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Peer Group </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of our annual peer
group review process, we have developed a peer group for benchmarking purposes, by considering companies in the same industry with similar company characteristics, such as revenue </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and number of employees. All companies in the peer group are either biotechnology or pharmaceutical companies. Companies were selected with various revenue sizes because we are recruiting from
and competing for executive talent with companies that are generating revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For compensation considerations in 2017, the peer group
consisted of eleven companies.&nbsp;Based on data compiled and reviewed by the Compensation Committee in early 2017, three of the companies had revenue of less than $10 million, four between $10&nbsp;million and $100&nbsp;million, and four between
$100&nbsp;million and $200&nbsp;million.&nbsp;Based on the prospects and characteristics of MannKind at that time, the Compensation Committee believed that those peer companies were appropriate. The 2017 peer group consisted of the following 11
companies: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Arena Pharmaceuticals Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Innoviva Inc.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ACADIA Pharmaceuticals Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lexicon Pharmaceuticals Inc.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cti Biopharma Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Momenta Pharmaceuticals</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Celldex Therapeutics Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nektar Therapeutics</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exelixis Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rigel Pharmaceuticals Inc.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Geron Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As per our annual process, in February 2018 our Compensation Committee revised our peer group to consist of
ten companies.&nbsp;Based on data compiled and reviewed by the Compensation Committee in February 2018, one of the companies has revenue of less than $10M, six between $10&nbsp;million and $100&nbsp;million, and three between $100&nbsp;million and
$200&nbsp;million.&nbsp;Based on the prospects and characteristics of MannKind at that time, the Compensation Committee believed that those peer companies were appropriate.&nbsp;The 2018 peer group consists of the following 10 companies: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Arena Pharmaceuticals Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Macrogenics Inc.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ACADIA Pharmaceuticals Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Momenta Pharmaceuticals</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acceleron Pharma Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Newlink Genetics Corporation</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intersect Ent Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rigel Pharmaceuticals Inc.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lexicon Pharmaceuticals Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vanda Pharmaceuticals Inc.</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market Positioning </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee reviews executive compensation at least annually, establishes competitive compensation levels and designs the
compensation program to provide pay commensurate with individual and corporate performance. With support from Mercer, we have positioned total compensation levels for executives at the 50th&nbsp;percentile of our peer group on the basis that we
believe this target to be an appropriate level of compensation to attract and retain qualified and capable executives. However, compensation may fall above or below this level under a range of circumstances, such as individual performance, tenure
with the Company or retention concerns. We supplement the peer group data with the survey data described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe our executive
compensation packages are reasonable when considering our business strategy, the revenue potential of our business, our compensation philosophy and the competitive market pay data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the factors listed above, we also consider, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our business need for the executive officer&#146;s skills; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the contributions that the executive officer has made or we believe will make to our success; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the transferability of the executive officer&#146;s managerial skills to other potential employers;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the relevance of the executive officer&#146;s experience to other potential employers, particularly in the pharmaceutical and biotechnology industries. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Pay-for-Performance</FONT></FONT>
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our executive compensation program emphasizes
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance.</FONT></FONT> As described below, both our short term and long term incentive plans are now tied to the financial metric of sales generated; however, we also
include other metrics such as progress through the FDA approval process and our ability to obtain partnerships and to develop candidates for commercialization. The compensation package for our commercial organization includes both cash and equity
incentives based on performance incentivizing strong sales objectives. The compensation package for our executive officers include both cash and equity incentive plans that align an executive&#146;s compensation with our short-term and long-term
performance goals and objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The annual cash incentive awards under our bonus plan are intended to compensate our executive officers
for achieving our annual goals at the corporate level and for achieving individual annual performance objectives. The goals for our company and individual measures are established so that target attainment is not assured. The attainment of payment
for performance at or above target levels requires significant effort on the part of our executives. Long-term equity incentives are intended to reward executives for growth in stockholder value. As described below, our current compensation
guidelines for executive officers seek to deliver a majority of the award value in stock options. We believe that this equity along with our performance-based bonus plan, places a significant portion of our executive compensation at risk,
encouraging corporate performance and stock price growth. Additional details of the plan are described below under &#147;Bonus Plan&#148; and &#147;Long-Term Incentives.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consideration of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> Results </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At our 2017 Annual Meeting of Stockholders, 89.8% of the votes cast on the proposal approved, on an advisory basis, the compensation of our
named executive officers. The Compensation Committee considered this result and, in light of this support and the continuing success of our compensation programs, the Compensation Committee did not implement significant changes to our executive
compensation program during 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>OMPENSATION</SMALL> C<SMALL>OMPONENTS</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to provide a total compensation package that is tied to stockholder value creation and the achievement of strategic corporate goals,
our executive compensation package is comprised of several components. These components are designed to work together to create a balanced approach to compensation, rewarding both short-term and long-term performance and fostering sufficient
retentive effect to secure the services of our executive officers while we execute on our plans. Currently, our compensation structure for executive officers includes a combination of base salary, bonus, stock options and restricted stock awards,
401(k), medical and other benefits, severance and change in control and other post termination provisions. Each component is described in further detail below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Base Salary </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Base salaries are designed
to provide compensation for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> management of the Company assuming satisfactory levels of performance. This component is designed to provide consistent and steady
cash flow for the executive and represents only a portion of total compensation. Salary levels are based primarily upon the competitive market for the executive officers&#146; services. Base salaries for our executives are intended to fall at the
median of the competitive market. Individual performance, responsibility, and the importance of each role in our organization can also impact base salary levels. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Bonus Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of our executive
officers are eligible to receive annual performance-based cash bonuses. The annual cash incentive awards under our bonus plan are intended to compensate our executive officers for achieving our annual goals at the corporate level. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For 2017, the corporate goals were based on achievement of certain operational goals.
Because we were still in the process of supporting the launch of our first product, the use of traditional performance standards, such as profit levels and return on equity, were not appropriate in our evaluation of executive officer performance.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our bonus plan is funded based on the achievement of overall corporate goals, based on a careful review by the Compensation Committee of
the accomplishments of the Company during the previous year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For 2017, there were four corporate objectives, as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Achieve Afrezza sales commitment </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Complete/progress on identified Afrezza clinical development studies and regulatory filings (e.g., label enhancement studies, pediatric study, long-term safety study) </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Secure targeted business development opportunities (e.g., <FONT STYLE="white-space:nowrap">in-licensing,</FONT> <FONT STYLE="white-space:nowrap">out-licensing,</FONT> partnering, international expansion)
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Bolster the financial and operational stability of MannKind Corporation (e.g., financial controls, financing options, analyst coverage) </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2018, the Board determined that these objectives were achieved at the level of 90%; accordingly, 90% of the target bonus
opportunity for each executive officer was paid as a discretionary bonus for 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each eligible position, including the executive
officers, is assigned a target bonus opportunity expressed as a percentage of base salary, which reflects market competitive levels. Target bonus opportunities are generally positioned at the 50th&nbsp;percentile of the market. The target bonuses
for the executive officers for 2017 were as follows: Mr.&nbsp;Castagna, 60%; Mr.&nbsp;Binder, 50%; Mr.&nbsp;Tross, 50%; Mr.&nbsp;Thomson, 50%; Mr.&nbsp;Kocinsky, 50%; Mr.&nbsp;McCauley, 50%; Ms.&nbsp;Alinaya, 30%; and Ms.&nbsp;Barton, 25%. Payments
of target bonuses are not guaranteed and are subject to funding and corporate and individual performance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Long-Term Incentives </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to provide a significant retention incentive and to ensure a strong link to the long-term interests of stockholders, we provide a
portion of our total compensation in the form of equity compensation &#151; specifically, stock options (both performance-based and time-based vesting types) and restricted stock units. &nbsp;&nbsp;Executive officers, as well as all full-time
employees, are eligible to receive awards. &nbsp;&nbsp;Based on market data and in consultation with our external compensation consultant, the Company has developed equity guidelines that target the annual long term incentive award at 200% of base
salary for the CEO and at 100% of median salary for all other named executive officers. &nbsp;&nbsp;This percentage can be modified at the discretion of the Compensation Committee for a range of reasons, including but not limited to, company
performance, individual employee performance, financial position of the company, number of shares available for grant under the equity incentive plan, the volatility of the stock price, and similar factors. &nbsp;&nbsp;For 2017, the equity value
delivered to all of the named executive officers was less than the established equity targets noted above. Equity compensation is typically delivered in stock options, which have no intrinsic value unless the stock price appreciates.
&nbsp;&nbsp;Awards of restricted stock units foster equity ownership and encourage retention. We target equity compensation at the median of the competitive market. &nbsp;&nbsp;The awards are made at the discretion of the Compensation Committee,
after taking into consideration the grant guidelines. &nbsp;&nbsp;Equity awards are granted under the 2013 Plan, which is administered by the Compensation Committee pursuant to a delegation of concurrent authority by our Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our policy with regard to the timing of grants of equity compensation is to issue equity awards in connection with an employee&#146;s hire
date or promotion date as well as in connection with an annual grant of equity awards that generally occurs in May of each year. All employee grants are approved by the Compensation Committee at its regularly scheduled quarterly meeting with the
grant date on or after the approval date. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
timing of grant dates is not based on any favorable or unfavorable <FONT STYLE="white-space:nowrap">non-public</FONT> information anticipated to be disclosed at a later date. All stock option
awards are granted with an exercise price equal to the closing sale price of our common stock on the Nasdaq Global Market on the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2017, our Compensation Committee awarded stock options that vest based upon the achievement of specified quarterly product sales and which
expire ten years from the date of grant. Our time-based stock options typically vest over a four-year period, with 25% of the award vesting after one year and 1/48 of the award vesting monthly thereafter. As with the performance-based options, the
time-based options also expire ten years from the date of grant. Awards of restricted stock units typically vest 25%&nbsp;per year over four years. The vesting of all awards ceases when an employee is no longer providing continuous service to the
Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We provide
a competitive benefits package to all full-time employees, which includes health and welfare benefits, such as medical, dental, vision care, life insurance benefits, and a 401(k) savings plan. Executives, including the named executive officers,
receive additional benefits, including executive medical reimbursement insurance, additional life insurance, as well as additional short-term and long-term disability insurance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2017, Messrs. Castagna, Thomson and Pfeffer also received an automobile allowance of $1,200 per month. This allowance was eliminated on
December&nbsp;31, 2017. We have no other structured perquisite benefits (e.g. club memberships or financial planning services) for any executive officer, including the named executive officers, and we currently do not provide any deferred
compensation programs or supplemental pensions to any executive officer, including the named executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employee Stock Purchase Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to encourage stock ownership and provide greater incentives to contribute to our success at all levels, we provide all employees,
including executive officers, the ability to purchase our common stock at a discount under our Purchase Plan. The Purchase Plan is designed to comply with Section&nbsp;423 of the Code and provides all employees with the opportunity to purchase up to
$25,000 of common stock annually at a purchase price that is the lower of 85% of the fair market value of the common stock on either the date of purchase or the commencement of the offering period. The executives&#146; rights under the Purchase Plan
are identical to those of all other employees. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Severance Provisions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently, we have no severance agreements with our executive officers, except with Mr.&nbsp;Thomson. The terms of the agreement and amounts
that may be realized are detailed under the heading &#147;Potential Payments Upon Termination or Change of Control.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Change of Control Provisions
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into change of control agreements with each of our executive officers in order to ensure that we have the continued
dedication of these executives and in order to provide them with reasonable compensation and benefit arrangements in the event of termination of their employment following a change of control. We believe that it is imperative to diminish any
distraction of our executives arising from the personal uncertainty and insecurity that arises in the absence of any assurance of job security, thereby allowing executives to focus on corporate objectives and strategy. The terms of these agreements
and amounts that may be realized are detailed under the heading &#147;Potential Payments Upon Termination or Change of Control.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Tax
Considerations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;162(m) of the Internal Revenue Code (&#147;Section&nbsp;162(m)&#148;) generally provides that publicly
held companies may not deduct compensation paid to certain of their top executive officers to the extent such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compensation exceeds $1&nbsp;million per officer in any year. The exemption from the deduction limit under Section&nbsp;162(m) for &#147;performance-based compensation&#148; has been repealed,
effective for taxable years beginning after December&nbsp;31, 2017, such that compensation paid to our &#147;covered employees&#148; in excess of $1&nbsp;million will not be deductible unless it qualifies for transition relief applicable to certain
arrangements in place as of November&nbsp;2, 2017. The Compensation Committee will continue to monitor the applicability of Section&nbsp;162(m) of the Code to its ongoing compensation arrangements. Because of ambiguities and uncertainties as to the
application and interpretation of Section&nbsp;162(m) and the regulations issued thereunder, including the uncertain scope of the transition relief under the legislation repealing the &#147;performance-based compensation&#148; exemption from the
deduction limit, no assurance can be given that any compensation that may have been (or if granted under a binding written contract in place as of November&nbsp;2, 2017 may be) intended to satisfy the requirements for exemption from
Section&nbsp;162(m), in fact will be exempt. In determining the form and amount of compensation for our named executive officers, the Compensation Committee may continue to consider all elements of the cost of such compensation, including the
potential impact of Section&nbsp;162(m). While the Compensation Committee considers the deductibility of awards as one factor in determining executive compensation, the Compensation Committee may also look at other factors in making its decisions,
and retains the flexibility to award compensation that it determines to be consistent with the goals of our executive compensation program even if the awards are not deductible by us for tax purposes.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>S<SMALL>UMMARY</SMALL> C<SMALL>OMPENSATION</SMALL> T<SMALL>ABLE</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows for the year ended December&nbsp;31, 2017 compensation awarded to, or earned by: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the individuals who served as our principal executive officer or principal financial officer for any portion of 2017; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our three most highly compensated executive officers in 2017, other than the individuals listed above, who were serving as executive officers as of December&nbsp;31, 2017. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These individuals constitute our named executive officers for the year ended December&nbsp;31, 2017.&nbsp;The following table also includes compensation
awarded to, or earned by, the aforementioned named executive officers for the fiscals year ended December&nbsp;31, 2016 and 2015 to the extent such individuals were also deemed to be named executive officers for such years. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:97.90pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name and Principal Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus</B><br><B>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Restricted<BR>Stock<BR>Awards<BR>($)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive&nbsp;Plan<BR>Compensation<BR>($)(4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)(5)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Michael E. Castagna, Pharm.D(6)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">458,718</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">606,160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">247,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(7)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,333,234</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">315,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,209,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,755,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Steven B. Binder(8)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">176,923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">190,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,581</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(9)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">515,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>Chief Financial Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Matthew J. Pfeffer(10)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">575,426</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,004</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(11)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">746,656</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>Chief Executive Officer and</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">490,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,703,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">176,526</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,403,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>Chief Financial Officer (Former)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">508,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,720</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,221,754</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Rosabel R. Alinaya(12)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">304,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,664</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(13)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">519,586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:9pt; font-family:Times New Roman"><I>Acting Chief Financial<BR>Officer (Former)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stuart A. Tross</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">365,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">410,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">164,250</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(14)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,042,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>Chief People and Workplace Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">David&nbsp;Thomson,&nbsp;Ph.D.,&nbsp;J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">435,839</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">193,936</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,234</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(15)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">817,085</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>General&nbsp;Counsel&nbsp;and&nbsp;Secretary</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">424,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">767,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127,428</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,915</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,353,891</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">440,359</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">294,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,122,930</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Joseph Kocinsky</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">380,481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">171,216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(16)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">707,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>Chief Technology Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Includes amounts earned but deferred at the election of the named executive officer, such as salary deferrals under our 401(k) Plan established under Section 401(k) of the Code. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Amounts represent sign-on bonuses. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Restricted stock awards are valued based on the market price of the stock on the grant date. Reference Note 13 &#147;Stock award plans&#148; in the notes to our financial statements for the period ended December 31,
2017, included in Part IV, Item 15 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 filed with the SEC on February 27, 2018, which identifies the assumptions made in the valuation of equity awards. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Non-equity incentive plan compensation is based on individual performance in the achievement of corporate objectives. Performance is compared to these objectives annually. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">Amounts include employer contributions credited under our 401(k) Plan and the incremental cost of perquisites received by the named executive officers. Under the 401(k) Plan, which is open to substantially all of our
employees, we make matching contributions based on each participant&#146;s voluntary salary deferrals, subject to the provisions of the 401(k) Plan and limits of the Code. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">On May 25, 2017, Mr. Michael Castagna was appointed as Chief Executive Officer and a member of the Board of Directors. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">Includes $14,400 in auto allowance, $5,000 in contributions under the 401(k) Plan, $1,074 in medical benefits and $174 in other taxable income. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">Mr. Steven B. Binder was appointed Chief Financial Officer on July 17, 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top">Includes $11,798 in temporary living expenses, $2,051 in contributions under the 401(k) Plan and $4,732 in medical benefits. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top">On May 25, 2017, Mr. Matthew J. Pfeffer ceased to be the Chief Executive Officer and Chief Financial Officer upon the appointment of Michael Castagna as the Chief Executive Officer and member of the Board of Directors.
In August 2017, Mr. Pfeffer resigned from the Board of Directors. Mr. Pfeffer remains employed by the Company. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top">Includes $9,969 in auto allowance, $5,399 in contributions under the 401(k) Plan, $11,234 in medical benefits, $174 in other taxable income and $450 in airline club membership fees and travel benefits.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top">Ms. Rosabel R. Alinaya was acting Chief Financial Officer from May 25, 2017 until the appointment of Mr. Steven B. Binder as Chief Financial Officer on July 17, 2017. Ms. Alinaya continues to serve as our Senior Vice
President, Investor Relations and Treasury. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top">Includes $5,399 in contributions under the 401(k) Plan, $10,091 in medical benefits, and $174 in other taxable income. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top">Includes $2,629 in contributions under the 401(k) Plan, $10,365 in medical benefits and $174 in other taxable income. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top">Includes $14,400 in auto allowance, $4,590 in contributions under the 401(k) Plan, $17,069 in medical benefits, and $174 in other taxable income. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top">Includes $4,940 in medical benefits and $174 in other taxable income. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>G<SMALL>RANTS</SMALL>
<SMALL>OF</SMALL> P<SMALL>LAN</SMALL>-<SMALL>BASED</SMALL> A<SMALL>WARDS</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;1, 2017, we filed with the Secretary of
State of the State of Delaware a Certificate of Amendment to our Amended and Restated Certificate of Incorporation (the &#147;Charter Amendment&#148;) to (i)&nbsp;implement a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-five</FONT></FONT> reverse stock split of our outstanding common stock (the &#147;Reverse Stock Split&#148;), without any change in par value per share, and (ii)&nbsp;reduce
the authorized number of shares of our common stock from 700,000,000 to 140,000,000 shares, as previously authorized and approved at a special meeting of stockholders on March&nbsp;1, 2017. The Charter Amendment became effective at 5:01 p.m. Eastern
Time on March&nbsp;2, 2017 (the &#147;Effective Time&#148;). No fractional shares were issued in connection with the Reverse Stock Split. Instead, we issued one full share of the post-Reverse Stock Split common stock to any stockholder of record who
was entitled to receive a fractional share as a result of the process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the Reverse Stock Split, proportionate adjustments
were made to the per share exercise price and the number of shares issuable upon the exercise or vesting of all stock options, restricted stock units and warrants issued by us and outstanding immediately prior to the Effective Time, which resulted
in a proportionate decrease in the number of shares of our common stock reserved for issuance upon exercise or vesting of such stock options, restricted stock units and warrants, and, in the case of stock options and warrants, a proportionate
increase in the exercise price of all such stock options and warrants. In addition, the number of shares authorized for future grant under our equity incentive/compensation plans immediately prior to the Effective Time were reduced proportionately.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We grant options and restricted stock units to our employees, including the named executive officers, under the 2013 Plan. All options
granted to our named executive officers are nonstatutory stock options that do not qualify as incentive stock options within the meaning of Section&nbsp;422 of the Code. As of December&nbsp;31, 2017, 1,231,740 options were outstanding under the 2004
Plan, 5,795,035 options and 1,135,216 restricted stock units were outstanding under the 2013 Plan and an additional 1,509,343&nbsp;shares of common stock were available for issuance under the 2013 Plan. Options generally expire ten years from date
of grant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exercise price per&nbsp;share of each option granted to our named executive officers was
equal to the fair market value on the date of the grant. The exercise price is payable in cash, shares of our common stock previously owned by the optionee or pursuant to the net exercise of the option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;3, 2017, our common stock began trading on The Nasdaq Global Market on a split-adjusted basis. All references to shares of
common stock, all per share data, and all warrant, stock option and restricted stock unit activity for all periods presented in this proxy statement have been adjusted to reflect the Reverse Stock Split on a retroactive basis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>2004 Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors adopted and our stockholders approved the 2004 Plan, effective July 2004. The terms of the equity awards granted under
the 2004 plan, including vesting requirements, were determined by our Board of Directors, subject to the provisions of the 2004 Plan. Following the adoption of the 2013 Plan in May 2013, no additional awards have been granted under the 2004 Plan,
and all awards granted under the 2004 Plan that are repurchased, forfeited, expire or are cancelled become available for grant under the 2013 Plan in accordance with its terms. However, all stock options granted under the 2004 Plan continue to be
governed by the terms of the 2004 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>2013 Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors, or a duly authorized committee thereof, has the authority to administer the 2013 Plan. Our Board of Directors has
delegated concurrent authority to administer the 2013 Plan to the Compensation Committee, but may, at any time, revert in itself some or all of the power previously delegated to the Compensation Committee. Our Board of Directors or its authorized
committee is referred to herein as the &#147;Plan Administrator.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock options vest at the rate specified by the Plan Administrator
and may have a term up to a maximum of ten years or, in some cases, five years. Unless the terms of an optionee&#146;s stock option agreement provide otherwise, if an optionee&#146;s service terminates for any reason other than disability, death,
retirement or cause, the optionee may generally exercise any vested options for a period of three months following the cessation of service. The option term may be extended in the event that exercise of the stock option following such a termination
of service is prohibited by applicable securities laws or our insider trading policy. If an optionee&#146;s service terminates due to disability or death, or an optionee dies within a certain period following cessation of service, the optionee or a
beneficiary may generally exercise any vested options for a period of 12 months in the event of disability and 18 months in the event of death. If the cessation of service is due to retirement, the optionee may generally exercise any vested options
for a period of 24 months. In the event of a termination for cause, options generally terminate immediately upon the termination of the individual for cause. In no event may an option be exercised beyond the expiration of its term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, an optionholder may not transfer a stock option other than by will or the laws of descent and distribution or a domestic relations
order with the approval of the Plan Administrator or a duly authorized officer. Additionally, an optionholder may, with the approval of the Plan Administrator or a duly authorized officer, designate a beneficiary who may exercise the stock option
following the optionholder&#146;s death. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Transactions.</I> In the event of a transaction (as defined in the 2013 Plan and described
below), the Board of Directors will have the discretion to take one or more of the following actions with respect to outstanding stock awards (contingent upon the closing or completion of such transaction), unless otherwise provided in the stock
award agreement or other written agreement with the participant or unless otherwise provided by the Board of Directors at the time of grant: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">arrange for the surviving or acquiring corporation (or its parent company) to assume or continue the award or to substitute a similar stock award for the award (including an award to acquire the same consideration paid
to our stockholders pursuant to the transaction); </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">arrange for the assignment of any reacquisition or repurchase rights held by us with respect to the stock award to the surviving or acquiring corporation (or its parent company); </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">accelerate the vesting (and, if applicable, the exercisability) of the stock award and provide for its termination prior to the effective time of the transaction; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us with respect to the award; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">cancel or arrange for the cancellation of the stock award, to the extent not vested or exercised prior to the effective time of the transaction, in exchange for such cash consideration, if any, as the Board of Directors
may consider appropriate; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">make a payment, in such form as may be determined by the Board of Directors, equal to the excess, if any, of (i)&nbsp;the value of the property the participant would have received upon the exercise of the stock award
immediately prior to the effective time of the transaction, over (B)&nbsp;any exercise price payable in connection with such exercise. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Board of Directors is not obligated to treat all stock awards or portions of stock awards in the same manner. The Board of Directors may take different actions with respect to the vested and unvested portions of a stock award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the 2013 Plan, a transaction will be deemed to occur in the event of a corporate transaction or a change in control. A
corporate transaction generally means the consummation of (i)&nbsp;a sale or other disposition of all or substantially all of our consolidated assets, (ii)&nbsp;a sale or other disposition of at least 90% of our outstanding securities, (iii)&nbsp;a
merger, consolidation or similar transaction following which we are not the surviving corporation, or (iv)&nbsp;a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock
outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A change
of control generally means (i)&nbsp;the acquisition by a person or entity of more than 50% of our combined voting power other than by merger, consolidation or similar transaction; (ii)&nbsp;a consummated merger, consolidation or similar transaction
immediately after which our stockholders cease to own more than 50% of the combined voting power of the surviving entity; (iii)&nbsp;a consummated sale, lease or exclusive license or other disposition of all or substantially of our consolidated
assets; (iv)&nbsp;the complete dissolution or liquidation of the Company; or (v)&nbsp;when a majority of the board of directors becomes comprised of individuals whose nomination, appointment, or election was not approved by a majority of the board
members or their approved successors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Change in Control.</I> Under the 2013 Plan, a stock award may be subject to additional
acceleration of vesting and exercisability upon or after a change in control, as may be provided in the stock award agreement or other written agreement with the participant. In the absence of such provision, no such acceleration will occur. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the equity awards granted to the named executive officers during the fiscal
year ended December&nbsp;31, 2017. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Grants of Plan-Based Awards in Fiscal 2017(1) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All&nbsp;Other<BR>Stock&nbsp;Awards:<BR>Number of<BR>Shares of<BR>Stock&nbsp;or&nbsp;Units<BR>(#)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Option&nbsp;Awards:<BR>Number of<BR>Securities<BR>Underlying<BR>Options<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise<BR>or Base<BR>Price of<BR>Options<BR>Awards<BR>Options<BR>($/Sh)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date&nbsp;Fair<BR>Value of<BR>Stock&nbsp;and<BR>Option<BR>Awards<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Castagna, Pharm.D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/25/17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/29/17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">191,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">205,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/29/17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">231,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">249,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven B. Binder</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/24/17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">180,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">190,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew J. Pfeffer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rosabel R. Alinaya</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/25/17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/29/17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,920</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stuart A. Tross</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/16/17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">148,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/16/17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">148,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/16/17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/25/17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">113,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Thomson, Ph.D., J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/25/17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph Kocinsky</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/25/17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">All equity awards were granted under the 2013 Plan. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The shares subject to these restricted stock units vest annually over a four-year period. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">The shares subject to these options have exercise prices equal to the fair market value of our common stock on the date of grant and vest over a four-year period with a <FONT STYLE="white-space:nowrap">one-year</FONT>
25% cliff vesting and monthly thereafter over the following three years. These options expire ten years from the date of grant. Vesting ceases should the executive officer no longer provide continuous service to us. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">The shares subject to these options will vest upon achievement of specified business development milestones related to quarterly product sales at an annualized rate. These options expire ten years from the date of
grant. Reference Note 13 &#147;Stock award plans&#148; in the notes to our financial statements for the period ended December&nbsp;31, 2017, included in Part IV, Item 15 of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for
the fiscal year ended December&nbsp;31, 2017 filed with the SEC on February&nbsp;27, 2018, which identifies the assumptions made in the valuation of equity awards in accordance with ASC 718. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Outstanding Equity Awards at Fiscal Year End </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth summary information regarding the outstanding equity awards at December&nbsp;31, 2017 granted to each of our
named executive officers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="30%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="16" ALIGN="center"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of&nbsp;Shares<BR>or Units<BR>of Stock<BR>That<BR>Have&nbsp;Not<BR>Vested<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value<BR>of&nbsp;Shares<BR>or Units<BR>of Stock<BR>That<BR>Have&nbsp;Not<BR>Vested<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan</B><br><B>Awards:<BR>Number<BR>of<BR>Unearned<BR>Shares,<BR>Units or<BR>Other<BR>Rights<BR>That<BR>Have
Not<BR>Vested<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan</B><br><B>Awards:<BR>Market<BR>or<BR>Payout</B><br><B>Value&nbsp;of<BR>Unearned<BR>Shares,<BR>Units
or<BR>Other<BR>Rights<BR>That<BR>Have Not<BR>Vested<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Michael E. Castagna, PharmD,</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,805</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(19)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(19)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/14/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(20)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(23)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/25/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">231,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(24)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/29/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">191,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(32)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/29/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Steven B. Binder</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">180,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(31)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/17/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Matthew J. Pfeffer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(7)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/28/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(11)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/28/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/13/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/19/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/19/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,380</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/2/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(6)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(10)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/17/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(22)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/17/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(9)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/16/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(16)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/23/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(13)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/22/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(8)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(8)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/20/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(12)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,434</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(14)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(14)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(15)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,735</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(17)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(17)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/10/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(18)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(18)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Rosabel Alinaya</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(33)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/2/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/19/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/19/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(29)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/19/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/2/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(34)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/2/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(6)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(10)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/17/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(9)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/16/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(22)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/17/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(16)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/23/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(13)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/22/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(8)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">387</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(8)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/20/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(12)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(14)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(14)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(15)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,993</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(36)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,167</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(18)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/12/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(35)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,479</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(18)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(18)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(24)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/29/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(23)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/25/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Stuart A. Tross</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(25)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(25)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/23/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(27)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(26)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/23/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(23)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/25/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="16" ALIGN="center"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of&nbsp;Shares<BR>or Units<BR>of Stock<BR>That<BR>Have&nbsp;Not<BR>Vested<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value<BR>of&nbsp;Shares<BR>or Units<BR>of Stock<BR>That<BR>Have&nbsp;Not<BR>Vested<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan</B><br><B>Awards:<BR>Number<BR>of<BR>Unearned<BR>Shares,<BR>Units or<BR>Other<BR>Rights<BR>That<BR>Have
Not<BR>Vested<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan</B><br><B>Awards:<BR>Market<BR>or<BR>Payout</B><br><B>Value&nbsp;of<BR>Unearned<BR>Shares,<BR>Units
or<BR>Other<BR>Rights<BR>That<BR>Have Not<BR>Vested<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">David Thomson</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/13/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/19/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,380</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/2/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(6)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(10)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/17/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(22)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/17/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(9)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/16/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(16)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/23/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(13)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/22/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(8)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(8)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/20/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(12)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,434</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(14)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(14)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(15)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,735</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,232</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(18)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(18)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(23)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/25/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Joseph Kocinsky</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/19/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(28)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/10/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(29)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/19/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/19/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(6)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(9)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/16/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(16)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/23/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(13)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/22/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(8)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(8)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/20/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">620</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(12)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,438</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,628</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(14)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(14)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(15)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,802</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(30)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(30)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/19/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,232</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(18)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(18)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(23)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/25/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Performance based <FONT STYLE="white-space:nowrap">non-qualified</FONT> option grant on May&nbsp;19, 2016, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;13, 2008. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;19, 2009. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;19, 2010. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 25% each anniversary thereafter; being fully vested on the second anniversary of the vesting determination date. The vesting commencement date is
March&nbsp;3, 2011. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;18, 2011. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
April&nbsp;21, 2008. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;21, 2014. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;16, 2012. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of four vesting determination dates over two years; being fully vested on the second year anniversary of the vesting determination date. The vesting commencement date is May&nbsp;17, 2012.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top">Performance based <FONT STYLE="white-space:nowrap">non-qualified</FONT> option grant on April&nbsp;28, 2008, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top">Restricted Stock Unit Award: 25% vest on each year anniversary of the vesting determination date; shares shall fully vest on the fourth year anniversary of the vesting determination date. The vesting commencement date
is August&nbsp;21, 2014. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;22, 2013. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;27, 2015. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top">Restricted Stock Unit Award: 25% vest on each year anniversary of the vesting determination date; shares shall fully vest on the fourth year anniversary of the vesting determination date. The vesting commencement date
is August&nbsp;27, 2015. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top">Performance based <FONT STYLE="white-space:nowrap">non-qualified</FONT> option grant on May&nbsp;23, 2013, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(17)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
January&nbsp;10, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(18)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
February&nbsp;18, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(19)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
March&nbsp;14, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(20)</TD>
<TD ALIGN="left" VALIGN="top">Restricted Stock Unit Award: 25% vest on each year anniversary of the vesting determination date; shares shall fully vest on the fourth year anniversary of the vesting determination date. The vesting commencement date
is March&nbsp;14, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(21)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;10, 2015. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(22)</TD>
<TD ALIGN="left" VALIGN="top">Performance based <FONT STYLE="white-space:nowrap">non-qualified</FONT> option grant on May&nbsp;17, 2012, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(23)</TD>
<TD ALIGN="left" VALIGN="top">Performance based <FONT STYLE="white-space:nowrap">non-qualified</FONT> option grant on May&nbsp;25, 2017, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(24)</TD>
<TD ALIGN="left" VALIGN="top">Performance based <FONT STYLE="white-space:nowrap">non-qualified</FONT> option grant on May&nbsp;29, 2017, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(25)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
December&nbsp;23, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(26)</TD>
<TD ALIGN="left" VALIGN="top">Performance based <FONT STYLE="white-space:nowrap">non-qualified</FONT> option grant on February&nbsp;16, 2017, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(27)</TD>
<TD ALIGN="left" VALIGN="top">Restricted Stock Unit Award: 25% vest on each year anniversary of the vesting determination date; shares shall fully vest on the fourth year anniversary of the vesting determination date. The vesting commencement date
is the vesting determination date, which is December&nbsp;23, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(28)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
April&nbsp;26, 2010. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(29)</TD>
<TD ALIGN="left" VALIGN="top">Performance based <FONT STYLE="white-space:nowrap">non-qualified</FONT> option grant on August&nbsp;19, 2010, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(30)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
October&nbsp;19, 2015. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(31)</TD>
<TD ALIGN="left" VALIGN="top">Performance based <FONT STYLE="white-space:nowrap">non-qualified</FONT> option grant on August&nbsp;24, 2017, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(32)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
May&nbsp;29, 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(33)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
July&nbsp;2, 2008. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(34)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
March&nbsp;14, 2011. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(35)</TD>
<TD ALIGN="left" VALIGN="top">Restricted Stock Unit Award: 25% vest on each year anniversary of the vesting determination date; shares shall fully vest on the fourth year anniversary of the vesting determination date. The vesting commencement date
is February&nbsp;18, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(36)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
January&nbsp;12, 2016. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>O<SMALL>PTION</SMALL> E<SMALL>XERCISES</SMALL> <SMALL>AND</SMALL> S<SMALL>TOCK</SMALL>
V<SMALL>ESTED</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table contains information relating to the exercise of options and vesting of stock by the named
executive officers during the fiscal year ended December&nbsp;31, 2017. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Option Exercises and Stock Vested in Fiscal 2017 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares&nbsp;Acquired<BR>on Exercise<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value<BR>Realized&nbsp;on<BR>Exercise<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares&nbsp;Acquired<BR>on Vesting<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value<BR>Realized&nbsp;on<BR>Vesting<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Castagna, PharmD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven B. Binder</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew J. Pfeffer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rosabel R. Alinaya</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,905</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stuart Tross</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Thomson,&nbsp;Ph.D.,&nbsp;J.D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph Kocinsky</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Stock awards acquired on vesting represent restricted stock awards that vest annually over a four-year period. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Estimated Potential Payments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into a severance agreement with Mr.&nbsp;Thomson, and change of control agreements with each named executive officer other than
Mr.&nbsp;Pfeffer, our former Chief Executive Officer and Chief Financial Officer. The table below sets forth the estimated current value of payments and benefits to each of the named executive officers upon termination or change of control. The
amounts shown assume that the triggering event occurred on December&nbsp;31, 2017 and do not include other benefits earned during the term of the named executive officer&#146;s employment that are available to all salaried employees, such as accrued
vacation and benefits paid by insurance providers under life and disability policies. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="21%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Triggering Event</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Termination<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change&nbsp;in<BR>Control<BR>($)(4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael&nbsp;E.&nbsp;Castagna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lump sum cash payment</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,221,054</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Continuing health and welfare benefits(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Value of extending exercisability term of stock options(2)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intrinsic value of accelerated unvested stock options(3)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,489,920</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven B. Binder</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lump sum cash payment</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">787,628</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Continuing health and welfare benefits(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Value of extending exercisability term of stock options(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Intrinsic value of accelerated unvested stock options(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,484</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">859,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stuart A. Tross</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lump sum cash payment</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">877,792</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Continuing health and welfare benefits(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Value of extending exercisability term of stock options(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Intrinsic value of accelerated unvested stock options(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,808</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">945,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David&nbsp;Thomson, Ph.D.,&nbsp;J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lump sum cash payment</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">954,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,115,497</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Continuing health and welfare benefits(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Value of extending exercisability term of stock options(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Intrinsic value of accelerated unvested stock options(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,078</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,089,033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,197,736</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph Kocinsky</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lump sum cash payment</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">978,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Continuing health and welfare benefits(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Value of extending exercisability term of stock options(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Intrinsic value of accelerated unvested stock options(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,078</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,054,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Represents the estimated cost of providing or paying for continuing medical and dental coverage for 18&nbsp;months. The amounts for medical and dental insurance coverage are based on rates charged to our employees for
post-employment coverage provided in accordance with the Consolidated Omnibus Reconciliation Act of 1985, or COBRA. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Represents the fair value of the stock options held by the named executive officer that would be exercisable for a period ending on the earlier of 18&nbsp;months following the triggering event or the end of the original
term of the option. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Per SEC rules, the intrinsic value of accelerated unvested stock options shown in the table above was calculated using the closing price of our common stock of $2.32 on December&nbsp;31, 2017. The intrinsic value is the
aggregate spread between $2.32 and the exercise price of the accelerated options, if less than $2.32. Accelerated options with exercise prices equal or greater than $2.32 have no intrinsic value. Each of the named executive officer also has an
extended exercise period ending on the earlier of 18&nbsp;months following the triggering event or the end of the original term of the option. There is no fair value calculated for this extended exercise period. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Represents estimated current value of payments and benefits payable upon termination without cause or resignation for good reason following a change of control. The terms of change of control agreements with our named
executive officers are detailed under the heading &#147;Change of Control Agreements&#148; below. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Executive Severance
Agreements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into an executive severance agreement with Mr.&nbsp;Thomson. This agreement is for a period of two
years and will be automatically renewed for additional <FONT STYLE="white-space:nowrap">one-year</FONT> periods unless either party gives notice to terminate the agreement at least 90&nbsp;days prior to the end of its initial term or any subsequent
term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The agreement provides that Mr.&nbsp;Thomson is an &#147;at will&#148; employee and that his employment with us may be terminated
at any time by him or by us. Under the agreement, in the event we terminate Mr.&nbsp;Thomson&#146;s employment without cause (as defined below) or he terminates his employment with us for good reason (as defined below), then he is generally entitled
to receive the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the portion of his annual base salary earned through the termination date that was not paid prior to his termination, if any; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any compensation previously deferred by him and any accrued paid <FONT STYLE="white-space:nowrap">time-off</FONT> to which he is entitled under our policy; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on the condition he executes and does not revoke a general release and settlement agreement, or release, in favor of us, then he will become entitled to receive: </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">his annual base salary on the date of termination for a period of 18&nbsp;months following his termination, subject to certain limitations; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an amount equal to the average annual bonus received by him for the three years prior to his termination (or the prior period up to three years during which he was one of our executive officers and received a bonus);
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in the event he met the performance criteria for earning an annual bonus prior to his termination, a portion of the annual bonus earned for the year based on the number of days worked during the year; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in the event that he did not meet the performance criteria for earning an annual bonus prior to his termination, but the Board determines that all such criteria could have been satisfied if he remained employed for the
full fiscal year, then a portion of his average annual bonus for the three years prior to his termination, based on the number of days worked during the year; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">health insurance and, under certain circumstances, life, disability and other insurance benefits for a period expiring on the earlier of 18&nbsp;months following his termination or until he qualifies for related
benefits from another employer. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the executive severance agreements provide that, on the condition that Mr.&nbsp;Thomson
executes and does not revoke a release, each vested stock option held by him on the date of termination will be exercisable for a period ending on the earlier of 18&nbsp;months following that date or the end of the original term of the option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under his agreement, Mr.&nbsp;Thomson may be terminated for cause if he, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">refuses to carry out or satisfactorily perform any of his lawful duties or any lawful instruction of our Board of Directors or senior management; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">violates any local, state or federal law involving the commission of a crime other than a minor traffic offense; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">is grossly negligent, engages in willful misconduct or breaches a fiduciary obligation to us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">engages in any act that materially compromises his reputation or ability to represent us with investors, customers or the public;&nbsp;or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reaches a mandatory retirement age established by us. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Mr.&nbsp;Thomson&#146;s
agreement, good reason includes, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a reduction of his annual base salary to a level below his salary as of October&nbsp;10, 2007; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a material diminution in his position, authority, duties or responsibilities with us, subject to certain limitations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an order by us to relocate him to an office located more than 50&nbsp;miles from his current residence and worksite; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any <FONT STYLE="white-space:nowrap">non-renewal</FONT> of the executive severance agreement by us, on the condition that he may terminate the agreement for good reason only during the
<FONT STYLE="white-space:nowrap">30-day</FONT> period after he receives notice from us that we intend to terminate the agreement;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any material violation of the executive severance agreement by us. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under
Mr.&nbsp;Thomson&#146;s agreement, he must inform us if he intends to terminate his agreement for good reason. We have 30&nbsp;days from the date we receive notice of his intent to terminate the agreement for good reason to cure the default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, on October&nbsp;24, 2017, the Company entered into a transition and separation agreement (the &#147;Transition Agreement&#148;)
with Matthew J. Pfeffer, the Company&#146;s former Chief Executive Officer and Chief Financial Officer, regarding the terms of Mr.&nbsp;Pfeffer&#146;s transition and separation from the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Transition Agreement, Mr.&nbsp;Pfeffer provided the Company with a general release of claims and will remain employed with the
Company to provide transition and other services through February&nbsp;1, 2019, subject to his earlier resignation or termination by the Company. Mr.&nbsp;Pfeffer reports to the Company&#146;s principal executive officer during the term of the
Transition Agreement, serving in <FONT STYLE="white-space:nowrap">a&nbsp;non-executive&nbsp;capacity.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the term of the
Transition Agreement, and in lieu of any severance benefits Mr.&nbsp;Pfeffer may have been entitled to receive pursuant to the terms of his Executive Severance Agreement or Change of Control Agreement with the Company, Mr.&nbsp;Pfeffer will be
entitled to receive his current annual base salary of $490,350. Pursuant to the Transition Agreement, Mr.&nbsp;Pfeffer was eligible to receive an annual bonus for 2017 pursuant to the standard bonus compensation structure applicable to the
Company&#146;s executive officers, and accordingly received a bonus for 2017 of $79,615. If Mr.&nbsp;Pfeffer remains employed with the Company through February&nbsp;1, 2019, remains in compliance with the Transition Agreement and all Company
policies, and provides the Company with an effective general release of claims within 21 days after that date, the Company will pay Mr.&nbsp;Pfeffer a severance payment in the amount of $345,000. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Change of Control Agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into change of control agreements with each named executive officer. Each agreement is for a period of two years and will be
automatically renewed for additional <FONT STYLE="white-space:nowrap">one-year</FONT> periods unless either party gives notice to terminate the agreement at least 90&nbsp;days prior to the end of its initial term or any subsequent term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the agreements, a change of control will be deemed to occur upon: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction that results in a person or group acquiring beneficial ownership of 50% or more of our voting stock, other than us or one of our employee benefit plans; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any merger, consolidation or reorganization of us in which our stockholders immediately prior to the transaction hold less than 50% of the voting power of the surviving entity following the transaction, subject to
certain limitations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction in which we sell all or substantially all of our assets, subject to certain limitations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our liquidation;&nbsp;or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any reorganization of our Board of Directors in which our incumbent directors (as defined in the agreements) cease for any reason to constitute a majority of the members of our Board. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The agreements provide that in the event of a change of control, the employee is generally entitled to maintain the same position, authority
and responsibilities held before the change of control, as well as the following compensation and benefits during the period ending on the earlier of two&nbsp;years following the change of control or the termination of his or her employment with us:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">his or her annual base salary in an amount equal or greater to his or her annual salary as of the date the change of control occurs; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an annual bonus in an amount equal to the average annual bonus received by him or her for the three years prior to his or her termination (or the prior period up to three years during which he was one of our executive
officers and received a bonus); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">medical, dental and other insurance, and any other benefits we may offer to our executives;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">prompt reimbursement for all reasonable employment expenses incurred by him or her in accordance with our policies and procedures. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the change of control agreements, we may terminate an executive with or without cause (as defined below) and the executive may terminate
his or her employment with us for good reason (as defined below) or any reason at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT> period following a change of control. In the event we terminate an executive without cause or an
executive terminates his or her employment with us for good reason, he or she is generally entitled to receive the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the portion of his or her annual base salary earned through the termination date that was not paid prior to his termination, if any; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any compensation previously deferred by the employee and any accrued paid <FONT STYLE="white-space:nowrap">time-off</FONT> that the employee is entitled to under our policy; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on the condition the employee executes and does not revoke a release, then the employee will become entitled to received: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">continuation of the employee&#146;s annual base salary on the date of termination for a period of 18&nbsp;months following his or her termination, subject to certain limitations; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an amount equal to 150% of his or her average annual bonus received by the employee for the three years prior to his or her termination (or the prior period up to three years during which the employee was one of our
executive officers and received a bonus); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in the event the employee met the performance criteria for earning an annual bonus prior to his or her termination, a portion of the annual bonus earned for the year based on the number of days worked during the year;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in the event that the employee did not meet the performance criteria for earning an annual bonus prior to his or her termination, but the Board determines that all such criteria could have been satisfied if the employee
remained employed for the full fiscal year, then a portion of his or her average annual bonus for the three years prior to his or her termination, based on the number of days worked during the year; and </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on the condition the employee executes a release, health insurance and, under certain circumstances, life, disability and other insurance benefits for a period expiring on the earlier of 18&nbsp;months following his or
her termination or until he qualifies for related benefits from another employer. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the agreements provide that,
on the condition the employee executes and does not revoke a release, each equity award held by him or her as of the termination date will become fully vested and exercisable at any point during the term of the option, subject to certain
limitations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the agreements, in the event we terminate an employee with cause or an employee terminates his or her employment with
us without good reason, his or her agreement will terminate without any further obligation to either party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The change of control
agreements provide that an employee may be terminated for cause if he or she, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">refuses to carry out or satisfactorily perform any of his or her lawful duties or any lawful instruction of our Board of Directors or senior management; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">violates any local, state or federal law involving the commission of a crime other than a minor traffic offense; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">is grossly negligent, engages in willful misconduct or breaches a fiduciary obligation to us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">engages in any act that materially compromises his reputation or ability to represent us with investors, customers or the public;&nbsp;or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reaches a mandatory retirement age established by us before a change of control occurs. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under
the agreements, good reason includes, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a material diminution in the employee&#146;s position, authority, duties or responsibilities with us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an order by us to relocate the employee to an office located more than 50&nbsp;miles from the employee&#146;s current residence and worksite; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any <FONT STYLE="white-space:nowrap">non-renewal</FONT> of the change of control agreement by us, on the condition that the employee may terminate the agreement for good reason only during the <FONT
STYLE="white-space:nowrap">30-day</FONT> period after he receives notice from us that we intend to terminate the agreement;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any material violation of the change of control agreement by us. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the change of control
agreements, an employee must inform us if he or she intends to terminate his or her agreement for good reason. We have 30&nbsp;days from the date we receive notice of the employee&#146;s intent to terminate the agreement for good reason to cure the
default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The executive severance agreements and the change of control agreements with Mr.&nbsp;Thomson provide that in the event such
executive becomes entitled to benefits under both agreements, compensation payments and other benefits will be coordinated to ensure the executive is entitled to receive the benefits described above without duplicating coverage. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><I>CEO</I></B></TD>
<TD ALIGN="left" VALIGN="top"><B><I>Pay Ratio</I></B> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required by Section&nbsp;953(b) of the Dodd-Frank Wall Street
Reform and Consumer Protection Act, and Item 402(u) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> we are providing the following information about the relationship of the annual total compensation of our median employee and the annual
total compensation of Mr.&nbsp;Michael Castagna, our Chief Executive Officer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The annual total compensation for 2017 was $143,397 for our median employee and $1,581,656
for our CEO. The resulting ratio of our CEO&#146;s pay to the pay of our median employee for 2017 is 11 to 1. We identified the median employee by examining the 2017 total compensation for all individuals, excluding our CEO, who were employed by us
on December&nbsp;31, 2017. We included all employees, as all our employees are <FONT STYLE="white-space:nowrap">US-based.</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
measuring the median employees&#146; annual total compensation, we used the same methodology as we used for our CEO.&nbsp;We used the actual base salary in 2017, the actual cash bonus paid in 2018 for performance in 2017, the value of the equity
awards received in 2017, and the value of all other compensation, including auto allowance, contributions under the 401(k) plan and medical benefits. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides certain information with respect to all of our equity compensation plans in effect as of December&nbsp;31, 2017.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Equity Compensation Plan Information </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:49.10pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Plan Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Securities&nbsp;to&nbsp;be<BR>Issued Upon Exercise of<BR>Outstanding Options,<BR>Warrants and Rights<BR>(#)(a)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-Average<BR>Exercise Price of<BR>Outstanding&nbsp;Options,<BR>Warrants and Rights<BR>($)(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Securities<BR>Remaining&nbsp;Available&nbsp;for<BR>Issuance Under Equity<BR>Compensation Plans<BR>(Excluding Securities<BR>Reflected in
Column (a)<BR>(#)(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by security holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,131,784</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,669,406<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans not approved by security holders(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Includes 1,509,343 shares available for issuance under the 2013 Plan and 160,063 shares available for purchase under our Employee Stock Purchase Plan </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2017, we did not have any equity compensation plans that were not approved by our security holders. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPENSATION COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the SEC and shall not be
incorporated by reference into any filing of MannKind under the Securities Act or the Exchange Act, except to the extent MannKind specifically incorporates this report by reference. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee has reviewed and discussed with management the Compensation Discussion and Analysis contained in this proxy
statement. Based on this review and discussion, the Compensation Committee has recommended to our Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement and incorporated into our Annual Report on <FONT
STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ended December&nbsp;31, 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kent Kresa, Compensation Committee Chairman</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael&nbsp;A.&nbsp;Friedman,&nbsp;Compensation&nbsp;Committee Member</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James&nbsp;S.&nbsp;Shannon,&nbsp;Compensation&nbsp;Committee Member</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the SEC and shall not be
incorporated by reference by any general statement incorporating by reference this proxy statement into any filing of MannKind under the Securities Act or the Exchange Act, except to the extent MannKind specifically incorporates this report by
reference. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee oversees the Company&#146;s financial reporting process on behalf of the Board of Directors. The
Company&#146;s management has the primary responsibility for the financial statements, for maintaining effective internal control over financial reporting, and for assessing the effectiveness of internal control over financial reporting. In
fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed the audited financial statements in the Annual Report with Company management, including a discussion on the quality, not just the acceptability, of the accounting
principles; the reasonableness of significant judgments; and the clarity of the disclosures within the financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit
Committee recognizes the importance of maintaining the independence of the Company&#146;s independent auditor, both in fact and appearance. In fulfilling its oversight responsibility as to the audit process, the Audit Committee obtained from
Deloitte&nbsp;&amp; Touche LLP the written disclosures and the letter describing all relationships between MannKind and its independent auditors that might bear on the auditors&#146; independence consistent with applicable requirements of the Public
Company Accounting Oversight Board (&#147;PCAOB&#148;) Rule 3526, <I>Communication with Audit Committees Concerning Independence</I>. The Audit Committee has discussed Deloitte&#146;s independence with Company management and Deloitte, and considered
the compatibility of <FONT STYLE="white-space:nowrap">non-audit</FONT> services with the independent auditor&#146;s independence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Audit Committee Charter provides that one duty of the Audit Committee is to determine whether to retain or to terminate MannKind&#146;s existing auditors or to appoint and engage new auditors for the ensuing year. In performing that duty, the Audit
Committee evaluated the performance of Deloitte in performing the examination of MannKind&#146;s financial statements for the fiscal year ended December&nbsp;31, 2017, considered the auditors&#146; technical expertise and knowledge of the
Company&#146;s operation and industry, and considered auditors&#146; independence, objectivity, and professional skepticism. Based on this evaluation, the Audit Committee determined to engage Deloitte as MannKind&#146;s independent auditors for the
fiscal year ending December&nbsp;31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee discussed with Deloitte the matters required to be discussed by the
applicable Public Company Accounting Oversight Board (&#147;PCAOB&#148;) standards. In addition, with and without management present, the Audit Committee discussed and reviewed MannKind&#146;s financial statements and the results of Deloitte&#146;s
audit of MannKind&#146;s financial statements and internal control. Based upon the Audit Committee&#146;s discussion with management and Deloitte and the Audit Committee&#146;s review of MannKind&#146;s financial statements, the representations of
MannKind&#146;s management and the independent auditors&#146; report to the Audit Committee, the Audit Committee recommended to the Board of Directors that MannKind include the audited financial statements in its Annual Report on <FONT
STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ended December&nbsp;31, 2017, for filing with the SEC. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Audit Committee</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald J. Consiglio, Audit Committee Chair</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David H. MacCallum, Audit Committee Member</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Henry L. Nordhoff, Audit Committee Member</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;16(a) of the Exchange Act requires our directors, executive officers and any persons beneficially holding more than 10% of our
common stock to report their initial ownership of our common stock and any subsequent changes in that ownership to the SEC. Our executive officers, directors and greater than 10% stockholders are required by SEC regulation to furnish us with copies
of all Section&nbsp;16(a) forms they file. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Specific due dates for these reports have been established and we are required to identify
those persons who failed to timely file these reports. To our knowledge, based solely on a review of the copies of such reports furnished to us and written representations from our directors and officers that no other reports were required, during
the fiscal year ended December&nbsp;31, 2017, all of our directors, officers and greater than 10% stockholders complied with the Section&nbsp;16(a) filing requirements, except for one late filing for Mr.&nbsp;Michael Castagna as described below.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;29, 2017, in connection with his appointment as our Chief Executive Officer, our board of directors granted Mr.&nbsp;Castagna
an option to purchase 191,000 shares of our common stock under the 2013 Plan, with 25% of such shares vesting one year after May&nbsp;25, 2017 and the balance vesting in equal monthly installments over the following 36 months. In accordance with the
2013 Plan, the options have an exercise price of $1.52 per share, which was equal to the closing price of our common stock as reported on The Nasdaq Global Market on May&nbsp;26, 2017.&nbsp;Due to an administrative oversight, the equity award was
not timely reported on Form 4 within the <FONT STYLE="white-space:nowrap">48-hour</FONT> time window, but was instead filed on June&nbsp;14, 2017. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RELATED-PERSON TRANSACTIONS POLICY AND PROCEDURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s Related-Person Transactions Policy sets forth the policies and procedures regarding the identification, review,
consideration and approval or ratification of &#147;related-persons transactions.&#148; For purposes of the Company&#146;s policy only, a &#147;related-person transaction&#148; is a transaction, arrangement or relationship (or any series of similar
transactions, arrangements or relationships) in which the Company and any &#147;related person&#148; are, were or will be participants involving an amount that exceeds $120,000. Transactions involving compensation for services provided to the
Company as an employee, consultant or director are not covered by this policy. A related person is any executive officer, director, or more than 5% beneficial stockholder of the Company, including any of their immediate family members, and any
entity owned or controlled by such persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the policy, where a transaction has been identified as a related-person transaction,
management must present information regarding the proposed related-person transaction to the Audit Committee (or, where Audit Committee approval would be inappropriate, to another independent body of the Board) for consideration and approval or
ratification. The presentation must include a description of, among other things, the material facts, the interests, direct and indirect, of the related persons, the benefits to the Company of the transaction and whether any alternative transactions
were available. To identify related-person transactions in advance, the Company relies on information supplied by its executive officers, directors and significant stockholders. In considering related-person transactions, the Audit Committee takes
into account the relevant available facts and circumstances including, but not limited to (a)&nbsp;the risks, costs and benefits to the Company, (b)&nbsp;the impact on a director&#146;s independence in the event the related person is a director,
immediate family member of a director or an entity with which a director is affiliated, (c)&nbsp;the terms of the transaction, (d)&nbsp;the availability of other sources for comparable services or products and (e)&nbsp;the terms available to or
from, as the case may be, unrelated third parties or to or from employees generally. In the event a director has an interest in the proposed transaction, the director must recuse himself or herself form the deliberations and approval. The policy
requires that, in determining whether to approve, ratify or reject a related-person transaction, the Audit Committee consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, the best interests of the
Company and its stockholders, as the Audit Committee determines in the good faith exercise of its discretion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTAIN TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a description of transactions or series of transactions since January&nbsp;1, 2017 to which we have been a party, in which
the amount involved in the transaction or series of transactions exceeded $120,000, and in which any of our directors, executive officers or persons who we knew held more than five percent of any class of our capital stock, including their immediate
family members, had or will have a direct or indirect material interest, other than compensation arrangements, which are described under &#147;Management.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>RANSACTIONS</SMALL> <SMALL>WITH</SMALL> <SMALL>THE</SMALL> M<SMALL>ANN</SMALL> G<SMALL>ROUP</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are the borrower under a loan arrangement with The Mann Group, which is one of our principal stockholders and of which Mr.&nbsp;Mann, our
former Chief Executive Officer, was the sole member and manager.&nbsp;Outstanding principal amounts due on July&nbsp;1, 2021 bear interest at a fixed rate of 5.84%, are due and payable quarterly in arrears on the first day of each calendar quarter
for the preceding quarter. All or any portion of accrued and unpaid interest that becomes due and payable may be <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">paid-in-kind</FONT></FONT> and capitalized as additional borrowings at
any time upon agreement of the parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2017, the largest outstanding principal amount under the Loan Arrangement
was $79.7&nbsp;million. As of March&nbsp;31, 2018, the outstanding principal amount under the Loan Arrangement was $71.5&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2017, interest of $10.7&nbsp;million was repaid under the Loan Arrangement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For additional details regarding the terms of the Loan Arrangement, please refer to Note 6 to our consolidated financial statements contained
in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2017, as filed with the SEC on February&nbsp;27, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In May 2015, we entered into a sublease agreement with the Alfred Mann Foundation for Scientific Research (the &#147;Mann Foundation&#148;), a
California Not For Profit Corporation. The lease is for approximately 12,500 square feet of office space in Valencia, California and expired in April 2017.&nbsp;We subleased this space until August 2017 when we moved our principal executive offices
to Westlake Village, California.&nbsp;Lease payments to the Mann Foundation for the year ended December&nbsp;31, 2017 were $0.2&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>RANSACTION</SMALL> <SMALL>WITH</SMALL> <SMALL>THE</SMALL> K<SMALL>RESA</SMALL> F<SMALL>AMILY</SMALL> F<SMALL>OUNDATION</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;10, 2017 we entered into a securities purchase agreement with the Kresa Family Foundation, of which Kent Kresa, the
Company&#146;s Chairman of the Board, is the President. Pursuant to the terms of the securities purchase agreement, we sold the Kresa Family Foundation an aggregate of 166,600 shares of our common stock in a registered direct offering at a purchase
price of $6.00 per share, resulting in net proceeds to us of $999,600. The offering of shares of common stock was made pursuant to our effective registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3&nbsp;(File</FONT> <FONT
STYLE="white-space:nowrap">No.&nbsp;333-210792),&nbsp;previously</FONT> filed with and declared effective by the Securities and Exchange Commission, and a prospectus supplement thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HOUSEHOLDING OF PROXY MATERIALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Notices of
Internet Availability of Proxy Materials or other Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice of Internet Availability of Proxy Materials or other Annual Meeting materials
addressed to those stockholders. This process, which is commonly referred to as &#147;householding,&#148; potentially means extra convenience for stockholders and cost savings for companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This year, a number of brokers with account holders who are MannKind stockholders will be &#147;householding&#148; our proxy materials. A
single Notice of Internet Availability of Proxy Materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker
that they will be &#147;householding&#148; communications to your address, &#147;householding&#148; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in
&#147;householding&#148; and would prefer to receive a separate Notice of Internet Availability of Proxy Materials, please notify your broker, direct your written request to MannKind Corporation, Investor Relations, 30930 Russell Ranch Road, Suite
301, Westlake Village, California 91362 or contact David Thomson at <FONT STYLE="white-space:nowrap">(818)&nbsp;661-5000.</FONT> Stockholders who currently receive multiple copies of the Notices of Internet Availability of Proxy Materials at their
address and would like to request &#147;householding&#148; of their communications should contact their broker. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNUAL REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A COPY OF OUR ANNUAL REPORT ON <FONT STYLE="white-space:nowrap">FORM&nbsp;10-K</FONT> FOR THE FISCAL YEAR ENDED DECEMBER&nbsp;31, 2017, FILED
WITH THE SEC ON FEBRUARY&nbsp;27, 2018, IS AVAILABLE WITHOUT CHARGE UPON WRITTEN REQUEST TO: MANNKIND CORPORATION, INVESTOR RELATIONS, 30930 RUSSELL RANCH ROAD, SUITE 301, WESTLAKE VILLAGE, CALIFORNIA 91362. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER MATTERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board
of Directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on
such matters in accordance with their best judgment. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g536430g09k79.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Thomson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Corporate Vice President, General Counsel and Secretary</I></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Westlake Village, California </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March 29, 2018 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>M<SMALL>ANN</SMALL>K<SMALL>IND</SMALL> C<SMALL>ORPORATION</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2018 E<SMALL>QUITY</SMALL> I<SMALL>NCENTIVE</SMALL> P<SMALL>LAN</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>DOPTED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL>:
F<SMALL>EBRUARY</SMALL>&nbsp;21, 2018 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> S<SMALL>TOCKHOLDERS</SMALL>:
[M<SMALL>AY</SMALL> 16, 2018] </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>G<SMALL>ENERAL</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Successor to and
Continuation of Prior Plans.</B> The Plan is intended as the successor to and continuation of the MannKind Corporation 2013 Equity Incentive Plan (the &#147;<B><I>2013 Plan</I></B>&#148;) and the MannKind Corporation 2004 Equity Incentive Plan (the
&#147;<B><I>2004 Plan</I></B>&#148;, and together with the 2013 Plan, the &#147;<B><I>Prior Plans</I></B>&#148;). Following the Effective Date, no additional stock awards may be granted under the Prior Plans. Any unallocated shares remaining
available for grant under the Prior Plans as of 12:01 a.m., Pacific Time on the Effective Date (the &#147;<B><I>Prior Plans&#146; Available Reserve</I></B>&#148;) will cease to be available under the such Prior Plans at such time and will be added
to the Share Reserve (as further described in Section&nbsp;3(a) below) and be then immediately available for grant and issuance pursuant to Stock Awards granted under the Plan. In addition, from and after 12:01&nbsp;a.m., Pacific Time<B> </B>on the
Effective Date, all outstanding stock awards granted under the Prior Plans will remain subject to the terms of such Prior Plans, as applicable; <I>provided, however</I>, that any shares subject to outstanding stock awards granted under the Prior
Plans that (i)&nbsp;expire or terminate for any reason prior to exercise or settlement, (ii)&nbsp;are forfeited, cancelled or otherwise returned to the Company because of the failure to meet a contingency or condition required for the vesting of
such shares, or (iii)&nbsp;other than with respect to outstanding options and stock appreciation rights granted under the Prior Plans, with respect to which the exercise or strike price is at least one hundred percent (100%) of the Fair Market Value
of the Common Stock subject to the option or stock appreciation right on the date of grant (the &#147;<B><I>Prior Plans&#146; Appreciation Awards</I></B>&#148;), are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding
obligation in connection with a stock award (collectively, the &#147;<B><I>Prior Plans&#146; Returning Shares</I></B>&#148;) will immediately be added to the Share Reserve (as further described in Section&nbsp;3(a) below) as and when such shares
become Prior Plans&#146; Returning Shares and become available for issuance pursuant to Awards granted hereunder. All Stock Awards granted on or after 12:01&nbsp;a.m., Pacific Time<B> </B>on the Effective Date will be subject to the terms of this
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Eligible Award Recipients.</B> Employees, Directors and Consultants are eligible to receive
Stock Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Available Stock Awards.</B> The Plan provides for the grant of the following types of
Stock Awards: (i)&nbsp;Incentive Stock Options, (ii)&nbsp;Nonstatutory Stock Options, (iii)&nbsp;Stock Appreciation Rights, (iv)&nbsp;Restricted Stock Awards, (v)&nbsp;Restricted Stock Unit Awards, (vi)&nbsp;Performance Stock Awards, and
(vii)&nbsp;Other Stock Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Purpose.</B> The Plan, through the granting of Stock Awards, is
intended to help the Company and any Affiliate secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and provide a means by which
the eligible recipients may benefit from increases in value of the Common Stock. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>A<SMALL>DMINISTRATION</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Administration by
Board.</B> The Board will administer the Plan. The Board may delegate administration of the Plan to a Committee or Committees, as provided in Section&nbsp;2(c). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Powers of Board.</B> The Board will have the power,
subject to, and within the limitations of, the express provisions of the Plan: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;To determine (A)&nbsp;who
will be granted Stock Awards; (B)&nbsp;when and how each Stock Award will be granted; (C)&nbsp;what type of Stock Award will be granted; (D)&nbsp;the provisions of each Stock Award (which need not be identical), including when a person will be
permitted to exercise or otherwise receive cash or Common Stock under the Stock Award; (E)&nbsp;the number of shares of Common Stock subject to, or the cash value of, a&nbsp;Stock Award; and (F)&nbsp;the Fair Market Value applicable to a Stock
Award. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;To construe and interpret the Plan and Stock Awards granted under it, and to establish, amend
and revoke rules and regulations for administration of the Plan and Stock Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or in any Stock Award Agreement, in a manner and to the
extent it will deem necessary or expedient to make the Plan or Stock Award fully effective. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;To settle
all controversies regarding the Plan and Stock Awards granted under it. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;To accelerate, in whole or in
part, the time at which a Stock Award may be exercised or vest (or the time at which cash or shares of Common Stock may be issued in settlement thereof). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or a Stock Award
Agreement, suspension or termination of the Plan will not materially impair a Participant&#146;s rights under his or her then-outstanding Stock Award without his or her written consent except as provided in subsection (viii)&nbsp;below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(vi)</B>&nbsp;&nbsp;&nbsp;&nbsp;To amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by
adopting amendments relating to Incentive Stock Options and certain nonqualified deferred compensation under Section&nbsp;409A of the Code and/or to make the Plan or Stock Awards granted under the Plan compliant with the requirements for Incentive
Stock Options or exempt from or compliant with the requirements for nonqualified deferred compensation under Section&nbsp;409A of the Code, subject to the limitations, if any, of applicable law. However, if required by applicable law or listing
requirements, and except as provided in Section&nbsp;9(a) relating to Capitalization Adjustments, the Company will seek stockholder approval of any amendment of the Plan that (A)&nbsp;materially increases the number of shares of Common Stock
available for issuance under the Plan, (B)&nbsp;materially expands the class of individuals eligible to receive Stock Awards under the Plan, (C)&nbsp;materially increases the benefits accruing to Participants under the Plan, (D)&nbsp;materially
reduces the price at which shares of Common Stock may be issued or purchased under the Plan, or (E)&nbsp;materially expands the types of Stock Awards available for issuance under the Plan. Except as provided in the Plan (including
Section&nbsp;2(b)(viii)) or a Stock Award Agreement, no amendment of the Plan will materially impair a Participant&#146;s rights under an outstanding Stock Award without the Participant&#146;s written consent. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(vii)</B>&nbsp;&nbsp;&nbsp;&nbsp;To submit any amendment to the Plan for stockholder approval, including, but not limited to, amendments to
the Plan intended to satisfy the requirements of (A)&nbsp;Section&nbsp;422 of the Code regarding incentive stock options or <FONT STYLE="white-space:nowrap">(B)&nbsp;Rule&nbsp;16b-3.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(viii)</B>&nbsp;&nbsp;&nbsp;&nbsp;To approve forms of Stock Award Agreements for use under the Plan and to amend the terms of any one or
more Stock Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Stock Award Agreement, subject to any specified limits in the Plan that are not subject to Board
discretion; <I>provided, however,</I> that a Participant&#146;s rights under any Stock Award will not be impaired by any such amendment unless (A)&nbsp;the Company requests the consent of the affected Participant, and (B)&nbsp;such Participant
consents in writing. Notwithstanding the foregoing, (1)&nbsp;a Participant&#146;s rights will not be deemed to have been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not
materially impair the Participant&#146;s rights, and (2)&nbsp;subject to the limitations of applicable law, if any, the Board may amend the terms of any one or more Stock Awards without the affected Participant&#146;s consent (A)&nbsp;to maintain
the qualified status of the Stock Award as an Incentive Stock Option under Section&nbsp;422 of the Code; (B)&nbsp;to change the terms of an Incentive Stock Option, if such change results in impairment of the Stock Award solely because it impairs the
qualified status of the Stock Award as an Incentive Stock Option under Section&nbsp;422 of the Code; (C)&nbsp;to clarify the manner of exemption from, or to bring </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Stock Award into compliance with, Section&nbsp;409A of the Code; or (D)&nbsp;to comply with other applicable laws or listing requirements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ix)</B>&nbsp;&nbsp;&nbsp;&nbsp;Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to
promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Stock Awards. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(x)</B>&nbsp;&nbsp;&nbsp;&nbsp;To adopt such procedures and <FONT STYLE="white-space:nowrap">sub-plans</FONT> as are necessary or
appropriate to permit participation in the Plan by Employees, Directors or Consultants who are foreign nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or
any Stock Award Agreement that are required for compliance with the laws of the relevant foreign jurisdiction). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;Delegation to Committee. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>General.</B> The Board may delegate some or all of the administration of the Plan to a Committee or
Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the
power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee, as applicable). Any
delegation of administrative powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Committee may, at any time, abolish the subcommittee
and/or revest in the Committee any powers delegated to the subcommittee. The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously
delegated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> Compliance.</B> The Committee may
consist solely of two or more <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors, in accordance with Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Delegation to an Officer.</B> The Board may delegate to one or more Officers the authority to do one or
both of the following (i)&nbsp;designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by applicable law, other Stock Awards) and, to the extent permitted by applicable law, the terms of such Stock
Awards, and (ii)&nbsp;determine the number of shares of Common Stock to be subject to such Stock Awards granted to such Employees; <I>provided, however</I>, that the Board resolutions regarding such delegation will specify the total number of shares
of Common Stock that may be subject to the Stock Awards granted by such Officer and that such Officer may not grant a Stock Award to himself or herself. Any such Stock Awards will be granted on the form of Stock Award Agreement most recently
approved for use by the Committee or the Board, unless otherwise provided in the resolutions approving the delegation authority. The Board may not delegate authority to an Officer who is acting solely in the capacity of an Officer (and not also as a
Director) to determine the Fair Market Value pursuant to Section&nbsp;13(t)(iii) below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Effect of
Board&#146;s Decision.</B> All determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Repricing; Cancellation and <FONT STYLE="white-space:nowrap">Re-Grant</FONT> of Stock Awards.</B> Neither
the Board nor any Committee will have the authority to (i)&nbsp;reduce the exercise, purchase or strike price of any outstanding Option or SAR under the Plan, or (ii)&nbsp;cancel any outstanding Option or SAR that has an exercise price or strike
price greater than the then-current Fair Market Value of the Common Stock in exchange for cash or other Stock Awards under the Plan, unless the stockholders of the Company have approved such an action within 12 months prior to such an event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Dividends and Dividend Equivalents. </B>Dividends or dividend equivalents may be paid or credited, as
applicable, with respect to any shares of Common Stock subject to a Stock Award, as determined by the Board and contained in the applicable Stock Award Agreement; <I>provided, however</I>, that (i)&nbsp;no dividends or dividend
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equivalents may be paid with respect to any such shares before the date such shares have vested under the terms of such Stock Award Agreement, (ii)&nbsp;any dividends or dividend equivalents that
are credited with respect to any such shares will be subject to all of the terms and conditions applicable to such shares under the terms of such Stock Award Agreement (including, but not limited to, any vesting conditions), and (iii)&nbsp;any
dividends or dividend equivalents that are credited with respect to any such shares will be forfeited to the Company on the date, if any, such shares are forfeited to or repurchased by the Company due to a failure to meet any vesting conditions
under the terms of such Stock Award Agreement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>S<SMALL>HARES</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;Share Reserve. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;Subject to Section&nbsp;9(a) relating to Capitalization Adjustments, the aggregate number of shares of
Common Stock that may be issued pursuant to Stock Awards from and after the Effective Date will not exceed (A) [13,388,179] shares (which number is the sum of (i)&nbsp;the number of shares
([1,388,179]<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>) subject to the Prior Plans&#146; Available Reserve and (ii)&nbsp;an additional 12,000,000 new shares), <I>plus</I> (B)&nbsp;the Prior Plans&#146; Returning Shares, if any, which
become available for grant under this Plan from time to time (such aggregate number of shares described in (A)&nbsp;and (B) above, the &#147;<B><I>Share Reserve</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;For clarity, the Share Reserve in this Section&nbsp;3(a) is a limitation on the number of shares of Common
Stock that may be issued pursuant to the Plan. Accordingly, this Section&nbsp;3(a) does not limit the granting of Stock Awards except as provided in Section&nbsp;7(a). Shares may be issued in connection with a merger or acquisition as permitted by
NASDAQ Listing Rule 5635(c) or, if applicable, NYSE Listed Company Manual Section&nbsp;303A.08, AMEX Company Guide Section&nbsp;711 or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;Subject to Section&nbsp;3(b), the number of shares of Common Stock available for issuance under
the Plan will be reduced by: (A)&nbsp;one share for each share of Common Stock issued pursuant to an Option or SAR with respect to which the exercise or strike price is at least 100% of the Fair Market Value of the Common Stock subject to the Option
or SAR on the date of grant; and (B)&nbsp;one and one tenths (1.1) shares for each share of Common Stock issued pursuant to a Full Value Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;Reversion of Shares to the Share Reserve. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(</B><B>i</B><B>)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Shares Available For Subsequent Issuance.</B><B> </B>If (A)&nbsp;any shares of Common Stock
subject to a Stock Award are not issued because such Stock Award or any portion thereof expires or otherwise terminates without all of the shares covered by such Stock Award having been issued or is settled in cash (<I>i.e.</I>, the Participant
receives cash rather than stock), (B) any shares of Common Stock issued pursuant to a Stock Award are forfeited back to or repurchased by the Company because of the failure to meet a contingency or condition required for the vesting of such shares,
or (C)&nbsp;with respect to a Full Value Award, any shares of Common Stock are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with such Full Value Award, such shares will again become
available for issuance under the Plan (collectively, the &#147;<B><I>2018 Plan Returning Shares</I></B>&#148;). For each (1) 2018 Plan Returning Share subject to a Full Value Award or (2)&nbsp;Prior Plans&#146; Returning Share subject to a stock
award other than a Prior Plans&#146; Appreciation Award, the number of shares of Common Stock available for issuance under the Plan will increase by one and one tenths (1.1) shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Shares Not Available For Subsequent Issuance. </B>Any shares of Common Stock reacquired or withheld (or
not issued) by the Company to satisfy the exercise or purchase price of a Stock Award will no longer be available for issuance under the Plan, including any shares subject to a Stock Award that are not </P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents the Prior Plans&#146; Available Reserve as of March&nbsp;19, 2018. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
delivered to a Participant because such Stock Award is exercised through a reduction of shares subject to such Stock Award (<I>i.e</I>., &#147;net exercised&#148;). In addition, any shares
reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with an Option or Stock Appreciation Right or a Prior Plans&#146; Appreciation Award, or any shares repurchased by the Company on the open
market with the proceeds of the exercise or strike price of an Option or Stock Appreciation Right or a Prior Plans&#146; Appreciation Award will no longer be available for issuance under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Incentive Stock Option Limit. </B>Subject to the Share Reserve and Section&nbsp;9(a) relating to
Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options will be 9,000,000 shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Source of Shares.</B> The stock issuable under the Plan will be shares of authorized but unissued or
reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>E<SMALL>LIGIBILITY</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Eligibility for
Specific Stock Awards.</B> Incentive Stock Options may be granted only to employees of the Company or a &#147;parent corporation&#148; or &#147;subsidiary corporation&#148; thereof (as such terms are defined in Sections&nbsp;424(e) and 424(f) of the
Code). Stock Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants; provided, however, that Stock Awards may not be granted to Employees, Directors and Consultants who are providing Continuous Service only
to any &#147;parent&#148; of the Company, as such term is defined in Rule 405, unless (i)&nbsp;the stock underlying such Stock Awards is treated as &#147;service recipient stock&#148; under Section&nbsp;409A of the Code (for example, because the
Stock Awards are granted pursuant to a corporate transaction such as a spin off transaction) or (ii)&nbsp;the Company, in consultation with its legal counsel, has determined that such Stock Awards are otherwise exempt from or alternatively comply
with the distribution requirements of Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Ten Percent Stockholders.</B> A
Ten Percent Stockholder will not be granted an Incentive Stock Option unless the exercise price of such Option is at least 110% of the Fair Market Value on the date of grant and the Option is not exercisable after the expiration of five years from
the date of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;Limitation on Grants to <FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Directors.</B> The maximum number of shares of Common Stock subject to Stock Awards granted under the Plan or otherwise during any one calendar year to any <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director, taken together with any cash
fees paid by the Company to such <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director during such calendar year for service on the Board, will not exceed $500,000 in total value (calculating the value of any such Stock Awards based on the
grant date fair value of such Stock Awards for financial reporting purposes). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>P<SMALL>ROVISIONS</SMALL> R<SMALL>ELATING</SMALL> <SMALL>TO</SMALL> O<SMALL>PTIONS</SMALL> <SMALL>AND</SMALL> S<SMALL>TOCK</SMALL> A<SMALL>PPRECIATION</SMALL> R<SMALL>IGHTS</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Option or SAR will be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be
separately designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued for shares of Common Stock purchased on exercise of each type of
Option. If an Option is not specifically designated as an Incentive Stock Option, or if an Option is designated as an Incentive Stock Option but some portion or all of the Option fails to qualify as an Incentive Stock Option under the applicable
rules, then the Option (or portion thereof) will be a Nonstatutory Stock Option. The provisions of separate Options or SARs need not be identical; <I>provided, however</I>, that each Stock Award Agreement will conform to (through incorporation of
provisions hereof by reference in the applicable Stock Award Agreement or otherwise) the substance of each of the following provisions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Term.</B> Subject to the provisions of Section&nbsp;4(b) regarding Ten Percent Stockholders, no Option or
SAR will be exercisable after the expiration of ten years from the date of its grant or such shorter period specified in the Stock Award Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Exercise Price.</B> Subject to the provisions of
Section&nbsp;4(b) regarding Ten Percent Stockholders, the exercise or strike price of each Option or SAR will be not less than 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date the Stock Award is granted.
Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair Market Value of the Common Stock subject to the Stock Award if such Stock Award is granted pursuant to an assumption of or
substitution for another option or stock appreciation right pursuant to a Corporate Transaction and in a manner consistent with the provisions of Section&nbsp;409A of the Code and, if applicable, Section&nbsp;424(a) of the Code. Each SAR will be
denominated in shares of Common Stock equivalents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Purchase Price for Options.</B> The purchase price
of Common Stock acquired pursuant to the exercise of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set forth below. The Board will
have the authority to grant Options that do not permit all of the following methods of payment (or that otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular method of
payment. The permitted methods of payment are as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;by cash, check, bank draft or money order
payable to the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;pursuant to a program developed under Regulation T as promulgated by the
Federal Reserve Board that, prior to the issuance of the Common Stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the
Company from the sales proceeds; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;by delivery to the Company (either by actual delivery or attestation)
of shares of Common Stock; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;if an Option is a Nonstatutory Stock Option, by a &#147;net exercise&#148;
arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price; <I>provided,
however</I>, that the Company will accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued. Shares of
Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that (A)&nbsp;shares issuable upon exercise are used to pay the exercise price pursuant to the &#147;net exercise,&#148; (B) shares are
delivered to the Participant as a result of such exercise, and (C)&nbsp;shares are withheld to satisfy tax withholding obligations; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;in any other form of legal consideration that may be acceptable to the Board and specified in the applicable
Stock Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Exercise and Payment of a SAR.</B> To exercise any outstanding SAR, the
Participant must provide written notice of exercise to the Company in compliance with the provisions of the Stock Award Agreement evidencing such SAR. The appreciation distribution payable on the exercise of a SAR will be not greater than an amount
equal to the excess of (A)&nbsp;the aggregate Fair Market Value (on the date of the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant is vested under such SAR, and
with respect to which the Participant is exercising the SAR on such date, over (B)&nbsp;the aggregate strike price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date. The appreciation
distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the Stock Award Agreement evidencing such SAR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Transferability of Options and SARs.</B> The Board may, in its sole discretion, impose such limitations
on the transferability of Options and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the restrictions set forth in this Section&nbsp;5(e) on the transferability of Options and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
SARs will apply. Notwithstanding the foregoing or anything in the Plan or a Stock Award Agreement to the contrary, no Option or SAR may be transferred to any financial institution without prior
stockholder approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Restrictions on Transfer.</B> An Option or SAR will not be transferable except
by will or by the laws of descent and distribution (and pursuant to Sections 5(e)(ii) and 5(e)(iii) below) and will be exercisable during the lifetime of the Participant only by the Participant. Subject to the foregoing paragraph, the Board may
permit transfer of the Option or SAR in a manner that is not prohibited by applicable tax and securities laws. Except as explicitly provided in the Plan, neither an Option nor a SAR may be transferred for consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Domestic Relations Orders.</B> Subject to the approval of the Board or a duly authorized Officer, an
Option or SAR may be transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument as permitted by Treasury Regulations
<FONT STYLE="white-space:nowrap">Section&nbsp;1.421-1(b)(2).</FONT> If an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Beneficiary Designation.</B> Subject to the approval of the Board or a duly authorized Officer, a
Participant may, by delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, upon the death of the Participant, will thereafter be entitled to exercise the Option or SAR and
receive the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, upon the death of the Participant, the executor or administrator of the Participant&#146;s estate will be entitled to exercise the
Option or SAR and receive the Common Stock or other consideration resulting from such exercise. However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation would be
inconsistent with the provisions of applicable laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Vesting Generally.</B> The total number of
shares of Common Stock subject to an Option or SAR may vest and become exercisable in periodic installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when it may or may not
be exercised (which may be based on the satisfaction of Performance Goals or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section&nbsp;5(f) are subject to
any Option or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination of Continuous Service.</B> Except as otherwise provided in the applicable Stock Award
Agreement or other agreement between the Participant and the Company or an Affiliate, if a Participant&#146;s Continuous Service terminates (other than for Cause and other than upon the Participant&#146;s death or Disability), the Participant may
exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i)&nbsp;the date
three months following such termination of Continuous Service (or such longer or shorter period specified in the Stock Award Agreement), and (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the Stock Award Agreement. If,
after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR (as applicable) will terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Extension of Termination Date.</B> Except as otherwise provided in the applicable Stock Award Agreement
or other agreement between the Participant and the Company or an Affiliate,<B> </B>if the exercise of an Option or SAR following the termination of the Participant&#146;s Continuous Service (other than for Cause and other than upon the
Participant&#146;s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or SAR will terminate on the earlier
of (i)&nbsp;the expiration of a total period of time (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#146;s Continuous Service during which the exercise of the Option
or SAR would not be in violation of such registration </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
requirements, or (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the applicable Stock Award Agreement. In addition, unless otherwise provided in a Participant&#146;s
Stock Award Agreement, if the sale of any Common Stock received upon exercise of an Option or SAR following the termination of the Participant&#146;s Continuous Service (other than for Cause) would violate the Company&#146;s insider trading policy,
then the Option or SAR will terminate on the earlier of (i)&nbsp;the expiration of a period of time (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#146;s Continuous
Service during which the sale of the Common Stock received upon exercise of the Option or SAR would not be in violation of the Company&#146;s insider trading policy, or (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the
applicable Stock Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Disability of Participant.</B> Except as otherwise provided in the
applicable Stock Award Agreement or other agreement between the Participant and the Company or an Affiliate, if a Participant&#146;s Continuous Service terminates as a result of the Participant&#146;s Disability, the Participant may exercise his or
her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i)&nbsp;the date 12&nbsp;months
following such termination of Continuous Service (or such longer or shorter period specified in the Stock Award Agreement), and (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the Stock Award Agreement. If, after
termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR (as applicable) will terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Death of Participant.</B> Except as otherwise provided in the applicable Stock Award Agreement or other
agreement between the Participant and the Company or an Affiliate, if (i)&nbsp;a Participant&#146;s Continuous Service terminates as a result of the Participant&#146;s death, or (ii)&nbsp;the Participant dies within the period (if any) specified in
the Stock Award Agreement for exercisability after the termination of the Participant&#146;s Continuous Service (for a&nbsp;reason other than death), then the Participant&#146;s Option or SAR may be exercised (to the extent that the Participant was
entitled to exercise such Option or SAR as of the date of death) by the Participant&#146;s estate, by a&nbsp;person who acquired the right to exercise the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or
SAR upon the Participant&#146;s death, but only within such period of time ending on the earlier of (i)&nbsp;the date 18 months following the date of death (or such longer or shorter period specified in the Stock Award Agreement), and (ii)&nbsp;the
expiration of the term of such Option or SAR as set forth in the Stock Award Agreement. If, after the Participant&#146;s death, the Option or SAR (as applicable) is not exercised within the applicable time frame, the Option or SAR (as applicable)
will terminate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination due to Retirement.</B> Except as otherwise provided in the applicable
Award Agreement or other agreement between the Participant and the Company, if a Participant&#146;s Continuous Service terminates as a&nbsp;result of the Participant&#146;s Retirement, the Participant may exercise his or her Option or SAR (to the
extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i)&nbsp;the date twenty-four (24)&nbsp;months following such
termination of Continuous Service (or such longer or shorter period specified in the Award Agreement), and (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after termination of Continuous Service,
the Participant does not exercise his or her Option or SAR within the applicable time frame, the Option or SAR (as applicable) will terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(l)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination for Cause.</B> Except as explicitly provided otherwise in a Participant&#146;s Stock Award
Agreement or other individual written agreement between the Participant and the Company or an Affiliate, if a&nbsp;Participant&#146;s Continuous Service is terminated for Cause, the Participant&#146;s Option or SAR will terminate immediately upon
such termination of Continuous Service, and the Participant will be prohibited from exercising his or her Option or SAR from and after the time of such termination of Continuous Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(m)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Employees.</B> If an Option or SAR is granted to an
Employee who is a <FONT STYLE="white-space:nowrap">non-exempt</FONT> employee for purposes of the Fair Labor Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any shares of Common Stock until at least six months
following the date of grant of the Option or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
SAR (although the Stock Award may vest prior to such date). Consistent with the provisions of the Worker Economic Opportunity Act, (i)&nbsp;if such
<FONT STYLE="white-space:nowrap">non-exempt</FONT> employee dies or suffers a Disability, (ii)&nbsp;upon a Corporate Transaction in which such Option or SAR is not assumed, continued, or substituted, (iii)&nbsp;upon a Change in Control, or
(iv)&nbsp;upon the Participant&#146;s retirement (as such term may be defined in the Participant&#146;s Stock Award Agreement, in another agreement between the Participant and the Company or an Affiliate, or, if no such definition, in accordance
with the Company&#146;s or Affiliate&#146;s then current employment policies and guidelines), the vested portion of any Options and SARs may be exercised earlier than six&nbsp;months following the date of grant. The foregoing provision is intended
to operate so that any income derived by a <FONT STYLE="white-space:nowrap">non-exempt</FONT> employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay. To the extent permitted and/or
required for compliance with the Worker Economic Opportunity Act to ensure that any income derived by a <FONT STYLE="white-space:nowrap">non-exempt</FONT> employee in connection with the exercise, vesting or issuance of any shares under any other
Stock Award will be exempt from the employee&#146;s regular rate of pay, the provisions of this Section&nbsp;5(l) will apply to all Stock Awards and are hereby incorporated by reference into such Stock Award Agreements. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>P<SMALL>ROVISIONS</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCK</SMALL> A<SMALL>WARDS</SMALL> O<SMALL>THER</SMALL> <SMALL>THAN</SMALL> O<SMALL>PTIONS</SMALL> <SMALL>AND</SMALL> SAR<SMALL>S</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Restricted Stock Awards.</B> Each Restricted Stock Award Agreement will be in such form and will contain
such terms and conditions as the Board deems appropriate. To the extent consistent with the Company&#146;s bylaws, at the Board&#146;s election, shares of Common Stock underlying a Restricted Stock Award may be (i)&nbsp;held in book entry form
subject to the Company&#146;s instructions until any restrictions relating to the Restricted Stock Award lapse, or (ii)&nbsp;evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board. The terms and
conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need not be identical. <I></I>Each Restricted Stock Award Agreement will conform to (through
incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Consideration.</B> A Restricted Stock Award may be awarded in consideration for (A)&nbsp;cash, check, bank
draft or money order payable to the Company, (B)&nbsp;past services to the Company or an Affiliate, or (C)&nbsp;any other form of legal consideration (including future services) that may be acceptable to the Board, in its sole discretion, and
permissible under applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Vesting</B>. Shares of Common Stock awarded under the Restricted
Stock Award Agreement may be subject to forfeiture to the Company in accordance with a vesting schedule to be determined by the Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination of Participant&#146;s Continuous Service.</B> If a Participant&#146;s Continuous Service
terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant as of the date of termination of Continuous Service under the terms of the Restricted Stock
Award Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Transferability.</B> Rights to acquire shares of Common Stock under the Restricted
Stock Award Agreement will be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine in its sole discretion, so long as Common Stock awarded under the
Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award Agreement. Notwithstanding the foregoing or anything in the Plan or a Restricted Stock Award Agreement to the contrary, no Restricted Stock Award may be
transferred to any financial institution without prior stockholder approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Restricted Stock Unit
Awards. </B>Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time,
and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical. Each Restricted Stock Unit Award </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance of each of the following provisions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Consideration.</B> At the time of grant of a Restricted Stock Unit Award, the Board will determine the
consideration, if any, to be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be paid (if any) by the Participant for each share of Common Stock subject to a
Restricted Stock Unit Award may be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Vesting. </B>At the time of the grant of a Restricted Stock Unit Award, the Board may impose such
restrictions on or conditions to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Payment.</B> A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock,
their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Additional Restrictions. </B>At the time of the grant of a Restricted Stock Unit Award, the Board, as it
deems appropriate, may impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination of Participant&#146;s Continuous Service. </B>Except as otherwise provided in the
applicable Restricted Stock Unit Award Agreement, such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&#146;s termination of Continuous Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;Performance Stock Awards. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Performance Stock Awards.</B> A Performance Stock Award is a Stock Award that is payable (including that
may be granted, vest or be exercised) contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Stock Award may, but need not, require the Participant&#146;s completion of a specified period of Continuous
Service. The length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively determined by the Board,
in its sole discretion. In addition, to the extent permitted by applicable law and the applicable Stock Award Agreement, the Board may determine that cash may be used in payment of Performance Stock Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Discretion.</B> The Board retains the discretion to reduce or eliminate the compensation or economic
benefit due upon the attainment of any Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for a Performance Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Other Stock Awards.</B> Other forms of Stock Awards valued in whole or in part by reference to, or
otherwise based on, Common Stock, including the appreciation in value thereof (<I>e.g</I>., options or stock appreciation rights with an exercise price or strike price less than 100% of the Fair Market Value of the Common Stock at the time of grant)
may be granted either alone or in addition to Stock Awards granted under Section&nbsp;5 and this Section&nbsp;6. Subject to the provisions of the Plan (including, but not limited to, Section&nbsp;2(g)), the Board will have sole and complete
authority to determine the persons to whom and the time or times at which such Other Stock Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards and all other
terms and conditions of such Other Stock Awards. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Availability of Shares.</B> The Company will keep available at all times the number of shares of Common
Stock reasonably required to satisfy then-outstanding Stock Awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Securities Law Compliance.</B> The Company will seek to
obtain from each regulatory commission or agency having jurisdiction over the Plan the authority required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the Stock Awards; <I>provided, however</I>, that this
undertaking will not require the Company to register under the Securities Act the Plan, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts and at a reasonable cost, the Company is
unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to
issue and sell Common Stock upon exercise of such Stock Awards unless and until such authority is obtained. A&nbsp;Participant will not be eligible for the grant of a Stock Award or the subsequent issuance of cash or Common Stock pursuant to the
Stock Award if such grant or issuance would be in violation of any applicable securities law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>No
Obligation to Notify or Minimize Taxes. </B>The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising a Stock Award. Furthermore, the Company will have no duty or obligation to warn
or otherwise advise such holder of a pending termination or expiration of a Stock Award or a possible period in which the Stock Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of a Stock Award to
the holder of such Stock Award. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>M<SMALL>ISCELLANEOUS</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Use of Proceeds from
Sales of Common Stock. </B>Proceeds from the sale of shares of Common Stock issued pursuant to Stock Awards will constitute general funds of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Corporate Action Constituting Grant of Stock Awards.</B> Corporate action constituting a grant by the
Company of a Stock Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Stock Award is
communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (<I>e.g</I>., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (<I>e.g</I>.,
exercise price, vesting schedule or number of shares) that are inconsistent with those in the Stock Award Agreement or related grant documents as a result of a clerical error in the papering of the Stock Award Agreement or related grant documents,
the corporate records will control and the Participant will have no legally binding right to the incorrect terms in the Stock Award Agreement or related grant documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Stockholder Rights.</B> No Participant will be deemed to be the holder of, or to have any of the rights
of a holder with respect to, any shares of Common Stock subject to a Stock Award unless and until (i)&nbsp;such Participant has satisfied all requirements for exercise of, or the issuance of shares of Common Stock under, the Stock Award pursuant to
its terms, and (ii)&nbsp;the issuance of the Common Stock subject to such Stock Award has been entered into the books and records of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>No Employment or Other Service Rights.</B> Nothing in the Plan, any Stock Award Agreement or any other
instrument executed thereunder or in connection with any Stock Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Stock Award was
granted or will affect the right of the Company or an Affiliate to terminate (i)&nbsp;the employment of an Employee with or without notice and with or without cause, (ii)&nbsp;the service of a Consultant pursuant to the terms of such
Consultant&#146;s agreement with the Company or an Affiliate, or (iii)&nbsp;the service of a&nbsp;Director pursuant to the bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or
the Affiliate is incorporated, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Change in Time Commitment.</B> In the event a
Participant&#146;s regular level of time commitment in the performance of his or her services for the Company or any Affiliate is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a
change in status from a full-time Employee to a part-time Employee) after the date of grant of any Stock Award to the Participant, the Board </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
has the right in its sole discretion to (x)&nbsp;make a corresponding reduction in the number of shares or cash amount subject to any portion of such Stock Award that is scheduled to vest or
become payable after the date of such change in time commitment, and (y)&nbsp;in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Stock Award. In the event of any such reduction, the
Participant will have no right with respect to any portion of the Stock Award that is so reduced or extended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Incentive Stock Option Limitations.</B> To the extent that the aggregate Fair Market Value (determined at
the time of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other
limit established in the Code) or otherwise does not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with
such rules will be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of the applicable Option Agreement(s). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Investment Assurances.</B> The Company may require a Participant, as a condition of exercising or
acquiring Common Stock under any Stock Award, (i)&nbsp;to give written assurances satisfactory to the Company as to the Participant&#146;s knowledge and experience in financial and business matters and/or to employ a purchaser representative
reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the
Stock Award; and (ii)&nbsp;to give written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Stock Award for the Participant&#146;s own account and not with any present intention of selling
or otherwise distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative if (A)&nbsp;the issuance of the shares upon the exercise or acquisition of Common Stock under the
Stock Award has been registered under a then currently effective registration statement under the Securities Act, or (B)&nbsp;as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met
in the circumstances under the then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with
applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Withholding Obligations.</B> Unless prohibited by the terms of a Stock Award Agreement, the Company may,
in its sole discretion, satisfy any federal, state or local tax withholding obligation relating to a Stock Award by any of the following means or by a combination of such means: (i)&nbsp;causing the Participant to tender a cash payment;
(ii)&nbsp;withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Stock Award; <I>provided, however, </I>that no shares of Common Stock are withheld with a value
exceeding the maximum amount of tax that may be required to be withheld by law (or such other amount as may be permitted while still avoiding classification of the Stock Award as a liability for financial accounting purposes); (iii) withholding cash
from a Stock Award settled in cash; (iv)&nbsp;withholding payment from any amounts otherwise payable to the Participant; or (v)&nbsp;by such other method as may be set forth in the Stock Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Electronic Delivery.</B> Any reference herein to a &#147;written&#148; agreement or document will include
any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#146;s intranet (or other shared electronic medium controlled by the Company to which the Participant has
access). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Deferrals.</B> To the extent permitted by applicable law, the Board, in its sole
discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Stock Award may be deferred and may establish programs and procedures for deferral elections to
be made by Participants. Deferrals by Participants will be made in accordance with Section&nbsp;409A of the Code. Consistent with Section&nbsp;409A of the Code, the Board may provide for distributions while a Participant is still an
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employee or otherwise providing services to the Company or an Affiliate. The Board is authorized to make deferrals of Stock Awards and determine when, and in what annual percentages, Participants
may receive payments, including lump sum payments, following the Participant&#146;s termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Compliance with Section</B><B></B><B>&nbsp;409A of the Code. </B>Unless otherwise expressly provided
for in a Stock Award Agreement, the Plan and Stock Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Stock Awards granted hereunder exempt from Section&nbsp;409A of the Code, and, to the
extent not so exempt, in compliance with Section&nbsp;409A of the Code. To the extent that the Board determines that any Stock Award granted hereunder is not exempt from and is therefore subject to Section&nbsp;409A of the Code, the Stock Award
Agreement evidencing such Stock Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section&nbsp;409A(a)(1) of the Code, and, to the extent applicable, the Plan and Stock Award Agreements will be
interpreted in accordance with the requirements of Section&nbsp;409A of the Code. Notwithstanding anything to the contrary in this Plan (and unless the Stock Award Agreement specifically provides otherwise), if the shares of Common Stock are
publicly traded and a Participant holding a Stock Award that constitutes &#147;deferred compensation&#148; under Section&nbsp;409A of the Code is a &#147;specified employee&#148; for purposes of Section&nbsp;409A of the Code, no distribution or
payment of any amount will be made upon a &#147;separation from service&#148; before a date that is six&nbsp;months following the date of such Participant&#146;s &#147;separation from service&#148; (as defined in Section&nbsp;409A of the Code
without regard to alternative definitions thereunder) or, if earlier, the date of the Participant&#146;s death. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(l)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Clawback/Recovery.</B> All Stock Awards granted under the Plan will be subject to recoupment in
accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#146;s securities are listed or as is otherwise required by the
Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in a Stock Award Agreement as the Board determines necessary or appropriate,
including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of Cause. No recovery of compensation under such a clawback policy will be an event giving rise
to a right to resign for &#147;good reason&#148; or &#147;constructive termination&#148; (or similar term) under any agreement with the Company or an Affiliate. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>A<SMALL>DJUSTMENTS</SMALL> <SMALL>UPON</SMALL> C<SMALL>HANGES</SMALL> <SMALL>IN</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL>; O<SMALL>THER</SMALL> C<SMALL>ORPORATE</SMALL> E<SMALL>VENTS</SMALL>.
</B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Capitalization Adjustments.</B> In the event of a Capitalization Adjustment, the
Board will appropriately and proportionately adjust: (i)&nbsp;the class(es) and maximum number of securities subject to the Plan pursuant to Section&nbsp;3(a), (ii) the class(es) and maximum number of securities that may be issued pursuant to the
exercise of Incentive Stock Options pursuant to Section&nbsp;3(c), and (iii)&nbsp;the class(es) and number of securities and price per share of stock subject to outstanding Stock Awards. The Board will make such adjustments, and its determination
will be final, binding and conclusive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Dissolution or Liquidation.</B> Except as otherwise provided
in the Stock Award Agreement, in the event of a dissolution or liquidation of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the
Company&#146;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the shares of Common Stock subject to the Company&#146;s repurchase rights or subject to a forfeiture condition may be
repurchased or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is providing Continuous Service, <I>provided, however</I>, that the Board may, in its sole discretion, cause some or all Stock Awards to become
fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated) before the dissolution or liquidation is completed but contingent on its completion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Corporate Transactions.</B> The following provisions
will apply to Stock Awards in the event of a Transaction unless otherwise provided in the Stock Award Agreement or any other written agreement between the Company or any Affiliate and the Participant or unless otherwise expressly provided by the
Board at the time of grant of a Stock Award. In the event of a Transaction, then, notwithstanding any other provision of the Plan, the Board may take one or more of the following actions with respect to Stock Awards, contingent upon the closing or
completion of the Transaction: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;arrange for the surviving corporation or acquiring corporation (or the
surviving or acquiring corporation&#146;s parent company) to assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award to acquire the same consideration paid to the
stockholders of the Company pursuant to the Transaction); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;arrange for the assignment of any
reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to the Stock Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#146;s parent company); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;accelerate the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the
Stock Award may be exercised) to a date prior to the effective time of such Transaction as the Board determines (or, if the Board does not determine such a date, to the date that is five (5)&nbsp;days prior to the effective date of the Transaction),
with such Stock Award terminating if not exercised (if applicable) at or prior to the effective time of the Transaction; <I>provided, however</I>, that the Board may require Participants to complete and deliver to the Company a notice of exercise
before the effective date of a Transaction, which exercise is contingent upon the effectiveness of such Transaction; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by the Company
with respect to the Stock Award; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;cancel or arrange for the cancellation of the Stock Award, to the
extent not vested or not exercised prior to the effective time of the Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(vi)</B>&nbsp;&nbsp;&nbsp;&nbsp;make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A)&nbsp;the
value of the property the Participant would have received upon the exercise of the Stock Award immediately prior to the effective time of the Transaction, over (B)&nbsp;any exercise price payable by such holder in connection with such exercise. For
clarity, this payment may be zero ($0) if the value of the property is equal to or less than the exercise price. Payments under this provision may be delayed to the same extent that payment of consideration to the holders of the Company&#146;s
Common Stock in connection with the Transaction is delayed as a&nbsp;result of escrows, earn outs, holdbacks or any other contingencies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board need
not take the same action or actions with respect to all Stock Awards or portions thereof or with respect to all Participants. The Board may take different actions with respect to the vested and unvested portions of a Stock Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Change in Control.</B> A Stock Award may be subject to additional acceleration of vesting and
exercisability upon or after a Change in Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between the Company or any Affiliate and the Participant, but in the absence
of such provision, no such acceleration will occur. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>T<SMALL>ERMINATION</SMALL> <SMALL>OR</SMALL> S<SMALL>USPENSION</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board may suspend or terminate the Plan at any time. No Incentive Stock Option will be granted after<B>
</B>the tenth anniversary of the earlier of (i)&nbsp;the date the Plan is adopted by the Board, or (ii)&nbsp;the date the Plan is approved by the stockholders of the Company. No Stock Awards may be granted under the Plan while the Plan is suspended
or after it is terminated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>No Impairment of Rights. </B>Suspension or termination
of the Plan will not materially impair rights and obligations under any Stock Award granted while the Plan is in effect except with the written consent of the affected Participant or as otherwise permitted in the Plan. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>E<SMALL>FFECTIVE</SMALL> D<SMALL>ATE</SMALL> <SMALL>OF</SMALL> P<SMALL>LAN</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Plan will become effective on the Effective Date. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>C<SMALL>HOICE</SMALL> <SMALL>OF</SMALL> L<SMALL>AW</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The laws of the State of
Delaware will govern all questions concerning the construction, validity and interpretation of this Plan, without regard to that state&#146;s conflict of laws rules. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>D<SMALL>EFINITIONS</SMALL>. </B>As used in the Plan, the following definitions will apply to the capitalized terms indicated below:<B> </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp; &#147;<B><I>Affiliate</I></B>&#148; means, at the time of determination, any &#147;parent&#148; or
&#147;subsidiary&#148; of the Company as such terms are defined in Rule 405. The Board will have the authority to determine the time or times at which &#147;parent&#148; or &#147;subsidiary&#148; status is determined within the foregoing definition.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Board</I></B>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Capitalization Adjustment</I></B>&#148; means any change that is made in, or other events that
occur with respect to, the Common Stock subject to the Plan or subject to any Stock Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation,
stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity
restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities
of the Company will not be treated as a Capitalization Adjustment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Cause</I></B>&#148;<B><I>
</I></B>will have the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and, in the absence of such agreement, such term means, with respect to a&nbsp;Participant, the occurrence of any
of the following events: (i)&nbsp;such Participant&#146;s commission of any felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof; (ii)&nbsp;such Participant&#146;s attempted
commission of, or participation in, a fraud or act of dishonesty against the Company; (iii)&nbsp;such Participant&#146;s intentional, material violation of any contract or agreement between the Participant and the Company or of any statutory duty
owed to the Company; (iv)&nbsp;such Participant&#146;s unauthorized use or disclosure of the Company&#146;s confidential information or trade secrets; or (v)&nbsp;such Participant&#146;s gross misconduct. The determination that a termination of the
Participant&#146;s Continuous Service is either for Cause or without Cause will be made by the Company, in its sole discretion. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for
the purposes of outstanding Awards held by such Participant will have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp; &#147;<B><I>Change in Control</I></B>&#148; means the occurrence, in a single transaction or in a series of
related transactions, of any one or more of the following events: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;any Exchange Act Person becomes the
Owner, directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the combined voting power of the Company&#146;s then outstanding securities other than by virtue of a merger, consolidation or similar
transaction. Notwithstanding the foregoing, a&nbsp;Change in Control will not be deemed to occur (A)&nbsp;on account of the acquisition of securities of the Company directly from the Company, (B)&nbsp;on account of the acquisition of securities of
the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#146;s securities in a transaction or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, or (C)&nbsp;solely because the level of Ownership
held by any Exchange Act Person (the &#147;<B><I>Subject Person</I></B>&#148;) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company
reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject
Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated
percentage threshold, then a Change in Control will be deemed to occur; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;there is consummated a merger,
consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own,
directly or indirectly, either (A)&nbsp;outstanding voting securities representing more than fifty percent (50%) of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B)&nbsp;more
than fifty percent (50%) of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding
voting securities of the Company immediately prior to such transaction; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;the stockholders of the
Company approve or the Board approves a plan of complete dissolution or liquidation of the Company, or a complete dissolution or liquidation of the Company will otherwise occur, except for a liquidation into a parent corporation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of
the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than fifty percent
(50%) of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such
sale, lease, license or other disposition; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;individuals who, on the date the Plan is adopted by the
Board, are members of the Board (the &#147;<B><I>Incumbent Board</I></B>&#148;) cease for any reason to constitute at least a majority of the members of the Board; <I>provided, however</I>, that if the appointment or election (or nomination for
election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member will, for purposes of this Plan, be considered as a member of the Incumbent Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing definition or any other provision of this Plan, (A)&nbsp;the term Change in Control will not include a sale of
assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company, and (B)&nbsp;the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any
Affiliate and the Participant will supersede the foregoing definition with respect to Awards subject to such agreement; <I>provided, however</I>, that if no definition of Change in Control or any analogous term is set forth in such an individual
written agreement, the foregoing definition will apply. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Code</I></B>&#148; means the
Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Committee</I></B>&#148; means a committee of one or more Directors to whom authority has been
delegated by the Board in accordance with Section&nbsp;2(c). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Common Stock</I></B>&#148;
means the common stock of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Company</I></B>&#148; means MannKind Corporation, a
Delaware corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Consultant</I></B>&#148; means any person,
including an advisor, who is (i)&nbsp;engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii)&nbsp;serving as a member of the board of directors of an Affiliate and is
compensated for such services. However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#147;Consultant&#148; for purposes of the Plan.<B><I> </I></B>Notwithstanding the foregoing, a
person is treated as a Consultant under this Plan only if a Form <FONT STYLE="white-space:nowrap">S-8</FONT> Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#146;s securities to
such person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Continuous Service</I></B>&#148; means that the Participant&#146;s service
with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Director or
Consultant or a change in the Entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#146;s service with the Company or an Affiliate, will not terminate a Participant&#146;s
Continuous Service; <I>provided, however,</I> that<I> </I>if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#146;s Continuous Service
will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of
Continuous Service. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#146;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i)&nbsp;any
leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii)&nbsp;transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a
leave of absence will be treated as Continuous Service for purposes of vesting in a Stock Award only to such extent as may be provided in the Company&#146;s or Affiliate&#146;s leave of absence policy, in the written terms of any leave of absence
agreement or policy applicable to the Participant, or as otherwise required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(l)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Corporate Transaction</I></B>&#148; means the consummation, in a single transaction or in a
series of related transactions, of any one or more of the following events: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;a sale, lease or other
disposition of all or substantially all of the assets of the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;a sale or other disposition of at
least ninety percent (90%) of the outstanding securities of the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;a merger, consolidation or
similar transaction in which the Company is not the surviving corporation; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;a reverse merger,
consolidation or similar transaction in which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted by virtue of the merger,
consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the
foregoing definition or any other provision of this Plan, the term Corporate Transaction will not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(m)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Director</I></B>&#148; means a member of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(n)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Disability</I></B>&#148; means, with respect to a Participant, the inability of such Participant
to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than
12&nbsp;months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(o)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Effective Date</I></B>&#148; means the
effective date of this Plan document, which is the date of the annual meeting of stockholders of the Company held in 2018, provided this Plan is approved by the Company&#146;s stockholders at such meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(p)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Employee</I></B>&#148; means any person employed by the Company or an Affiliate. However,
service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#147;Employee&#148; for purposes of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(q)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Entity</I></B>&#148; means a corporation, partnership, limited liability company or other
entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(r)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended,
and the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(s)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Exchange Act
Person</I></B>&#148;<B><I> </I></B>means any natural person, Entity or &#147;group&#148; (within the meaning of Section&nbsp;13(d) or 14(d) of the Exchange Act), except that &#147;Exchange Act Person&#148; will not include (i)&nbsp;the Company or
any Subsidiary of the Company, (ii)&nbsp;any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company,
(iii)&nbsp;an underwriter temporarily holding securities pursuant to an offering of such securities, (iv)&nbsp;an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of
stock of the Company; or (v)&nbsp;any natural person, Entity or &#147;group&#148; (within the meaning of Section&nbsp;13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the
Company representing more than fifty percent (50%) of the combined voting power of the Company&#146;s then outstanding securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(t)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Fair Market Value</I></B>&#148; means, as of any date, the value of the Common Stock determined
as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;If the Common Stock is listed on any established stock exchange or traded on any established
market, the Fair Market Value of a share of Common Stock will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in
the Common Stock) on the date of determination, as reported in a source the Board deems reliable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date
of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board
in good faith and in a manner that complies with Sections 409A and 422 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(u)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Full
Value Award</I></B>&#148; means a Stock Award that is not an Option or SAR with respect to which the exercise or strike price is at least 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Incentive Stock Option</I></B>&#148; means an option granted pursuant to Section&nbsp;5 that is
intended to be, and that qualifies as, an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(w)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director</I></B>&#148;<B> </B>means a
Director who either (i)&nbsp;is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity
other than as a Director (except for an amount as to which disclosure would not be required under Item&nbsp;404(a) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated pursuant to the Securities Act (&#147;<B><I>Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT></I></B>&#148;)), does not possess an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> and is not engaged in a
business relationship for which disclosure would be required pursuant to Item&nbsp;404(b) of Regulation <FONT STYLE="white-space:nowrap">S-K;</FONT> or (ii)&nbsp;is otherwise considered a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT>
director&#148; for purposes of Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(x)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Nonstatutory Stock Option</I></B>&#148; means
any option granted pursuant to Section&nbsp;5 that does not qualify as an Incentive Stock Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(y)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Officer</I></B>&#148; means a person who is an officer of the Company within the meaning of
Section&nbsp;16 of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(z)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Option</I></B>&#148; means an Incentive Stock Option
or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(aa)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Option Agreement</I></B>&#148; means a written agreement between the Company and an
Optionholder evidencing the terms and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(bb)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Optionholder</I></B>&#148; means a person to whom an Option is granted pursuant to the Plan or,
if applicable, such other person who holds an outstanding Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(cc)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Other Stock
Award</I></B>&#148; means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;6(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(dd)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Other Stock Award Agreement</I></B>&#148;<B><I> </I></B>means a written agreement between the
Company and a holder of an Other Stock Award evidencing the terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ee)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Own,</I></B>&#148;<B><I> </I></B>&#147;<B><I>Owned,</I></B>&#148;<B><I>
</I></B>&#147;<B><I>Owner,</I></B>&#148;<B><I> </I></B>&#147;<B><I>Ownership</I></B>&#148;<B> </B>A person or Entity will be deemed to &#147;Own,&#148; to have &#147;Owned,&#148; to be the &#147;Owner&#148; of, or to have acquired
&#147;Ownership&#148; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting,
with respect to such securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ff)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Participant</I></B>&#148; means a person to whom a Stock
Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Stock Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(gg)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Criteria</I></B>&#148; means the one or more criteria that the Board shall select
for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that shall be used to establish such Performance Goals may be based on any one of, or combination of, the following: (i)&nbsp;earnings (including
earnings per share and net earnings); (ii) earnings before interest, taxes and depreciation; (iii)&nbsp;earnings before interest, taxes, depreciation and amortization; (iv)&nbsp;total stockholder return; (v)&nbsp;return on equity or average
stockholder&#146;s equity; (vi)&nbsp;return on assets, investment, or capital employed; (vii)&nbsp;stock price; (viii)&nbsp;margin (including gross margin); (ix) income (before or after taxes); (x) operating income; (xi)&nbsp;operating income after
taxes; <FONT STYLE="white-space:nowrap">(xii)&nbsp;pre-tax</FONT> profit; (xiii)&nbsp;operating cash flow; (xiv)&nbsp;sales or revenue targets; (xv)&nbsp;increases in revenue or product revenue; (xvi)&nbsp;expenses and cost reduction goals;
(xvii)&nbsp;improvement in or attainment of working capital levels; (xiii)&nbsp;economic value added (or an equivalent metric); (xix) market share; (xx)&nbsp;cash flow; (xxi)&nbsp;cash flow per share; (xxii)&nbsp;share price performance;
(xxiii)&nbsp;debt reduction; (xxiv)&nbsp;implementation or completion of projects or processes; (xxv)&nbsp;customer satisfaction; (xxvi)&nbsp;stockholders&#146; equity; (xxvii)&nbsp;capital expenditures; (xxiii)&nbsp;debt levels;
(xxix)&nbsp;operating profit or net operating profit; (xxx)&nbsp;workforce diversity; (xxxi)&nbsp;growth of net income or operating income; (xxxii)&nbsp;billings; and (xxxiv)&nbsp;other measures of performance selected by the Board. Partial
achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the Stock Award Agreement. The Board shall, in its sole discretion, define the manner of calculating the
Performance Criteria it selects to use for such Performance Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(hh)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance
Goals</I></B>&#148; means, for a Performance Period, the one or more goals established by the Board for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more
business units, divisions, Affiliates, or business segments, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. The Board is authorized at any time in its sole
discretion, to adjust or modify the calculation of a Performance Goal for such Performance Period in order to prevent the dilution or enlargement of the rights of Participants, (a)&nbsp;in the event of, or in anticipation of, any unusual or
extraordinary corporate item, transaction, event or development; (b)&nbsp;in recognition of, or in anticipation of, any other unusual or nonrecurring events affecting the Company, or the financial statements of the Company in response to, or in
anticipation of, changes in applicable laws, regulations, accounting principles, or business conditions; or (c)&nbsp;in view of the Board&#146;s assessment of the business strategy of the Company, performance of comparable organizations, economic
and business conditions, and any other circumstances deemed relevant. Specifically, the Board is authorized to make adjustment in the method of calculating attainment of Performance Goals and objectives for a Performance Period as follows:
(i)&nbsp;to exclude the dilutive effects of acquisitions or joint ventures; (ii)&nbsp;to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such
divestiture; and (iii)&nbsp;to exclude the effect of any change in the outstanding shares of common stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, <FONT
STYLE="white-space:nowrap">spin-off,</FONT> combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends. In addition, the Board is authorized to make adjustment
in the method of calculating attainment of Performance Goals and objectives for a Performance Period as follows: (i)&nbsp;to exclude restructuring and/or other nonrecurring charges; (ii)&nbsp;to exclude exchange rate effects, as applicable, for <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> dollar denominated net sales and operating earnings; (iii)&nbsp;to exclude the effects of changes to generally accepted accounting standards required by the Financial Accounting Standards Board;
(iv)&nbsp;to exclude the effects of any items that are &#147;unusual&#148; in nature or occur &#147;infrequently&#148; as determined under generally accepted accounting principles; (v)&nbsp;to exclude the effects to any statutory adjustments to
corporate tax rates; and (vi)&nbsp;to make other appropriate adjustments selected by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Period</I></B>&#148; means the period of time selected by the Board over which the
attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#146;s right to and the payment of a Performance Stock Award. Performance Periods may be of varying and overlapping duration, at the sole
discretion of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(jj)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Stock Award</I></B>&#148; means a Stock Award granted
under the terms and conditions of Section&nbsp;6(c)(i). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(kk)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Plan</I></B>&#148; means this
MannKind Corporation 2018 Equity Incentive Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ll)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted Stock Award</I></B>&#148;
means an award of shares of Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;6(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(mm)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted Stock Award Agreement</I></B>&#148; means a written agreement between the Company
and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(nn)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted Stock Unit Award</I></B>&#148;<B><I> </I></B>means a right to receive shares of
Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;6(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(oo)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted Stock Unit Award Agreement</I></B>&#148;<B><I> </I></B>means a written agreement
between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(pp)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Retirement&#148; </I></B>means a Participant&#146;s voluntary termination of Continuous Service
after the Participant attains age fifty-five&nbsp;(55). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(qq)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Rule
<FONT STYLE="white-space:nowrap">16b-3</FONT></I></B>&#148; means Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act or any successor to <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3,</FONT> as in effect from
time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(rr)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Rule 405</I></B>&#148; means Rule 405 promulgated under the Securities Act.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ss)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(tt)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Stock Appreciation Right</I></B>&#148; or &#147;<B><I>SAR</I></B>&#148;<B><I> </I></B>means a
right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section&nbsp;5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(uu)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Stock Appreciation Right Agreement</I></B>&#148; means a written agreement between the Company
and a holder of a Stock Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(vv)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Stock Award</I></B>&#148; means any right to receive Common Stock granted under the Plan,
including an Incentive Stock Option, a Nonstatutory Stock Option, a Stock Appreciation Right, a Restricted Stock Award, a&nbsp;Restricted Stock Unit Award, a Performance Stock Award or any Other Stock Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ww)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Stock Award Agreement</I></B>&#148; means a written agreement between the Company and a
Participant evidencing the terms and conditions of a Stock Award grant. Each Stock Award Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(xx)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Subsidiary</I></B>&#148; means, with respect to the Company, (i)&nbsp;any corporation of which
more than 50% of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or
might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii)&nbsp;any partnership, limited liability company or other entity in which the Company has a direct or
indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(yy)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Ten Percent Stockholder</I></B>&#148; means a person who Owns (or is deemed to Own pursuant to
Section&nbsp;424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(zz)</B>&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Transaction</I></B>&#148; means a Corporate Transaction or a Change in Control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>M<SMALL>ANN</SMALL>K<SMALL>IND</SMALL> C<SMALL>ORPORATION</SMALL> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2004 E<SMALL>MPLOYEE</SMALL> S<SMALL>TOCK</SMALL> P<SMALL>URCHASE</SMALL> P<SMALL>LAN</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>DOPTED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL>
M<SMALL>ARCH</SMALL>&nbsp;23, 2004 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> <SMALL>STOCKHOLDERS</SMALL>
M<SMALL>ARCH</SMALL>&nbsp;23, 2004 </B></P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>MENDED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL>
<SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> F<SMALL>EBRUARY</SMALL>&nbsp;21, 2018 </B></P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>MENDED</SMALL> P<SMALL>LAN</SMALL>
A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> S<SMALL>TOCKHOLDERS</SMALL> [M<SMALL>AY</SMALL> 16], 2018 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>P<SMALL>URPOSE</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The purpose of the Plan is to
provide a means by which Employees of the Company and certain designated Related Corporations may be given an opportunity to purchase shares of the Common Stock of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Company, by means of the Plan, seeks to retain the services of such Employees, to secure and retain the
services of new Employees and to provide incentives for such persons to exert maximum efforts for the success of the Company and its Related Corporations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Company intends that the Purchase Rights be considered options issued under an Employee Stock Purchase
Plan. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>D<SMALL>EFINITIONS</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in the Plan and any Offering, unless otherwise
specified, the following terms have the meanings set forth below: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Board&#148;</I></B><I>
</I>means the Board of Directors of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Code&#148;</I></B><I> </I>means the
Internal Revenue Code of 1986, as amended<I>.</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Committee&#148;</I></B><I> </I>means a
committee appointed by the Board in accordance with Section&nbsp;3(c) of the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Common
Stock&#148;</I></B> means the common stock of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Company&#148;</I></B> means
MannKind Corporation, a Delaware corporation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Contributions&#148;</I></B> means the payroll
deductions and other additional payments that a Participant contributes to fund the exercise of a Purchase Right. A Participant may make payments not through payroll deductions only if specifically provided for in the Offering, and then only if the
Participant has not already had the maximum permitted amount withheld through payroll deductions during the Offering. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Corporate Transaction&#148;</I></B> means the occurrence, in a single transaction or in a series
of related transactions, of any one or more of the following events: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;a sale, lease, license or other
disposition of all or substantially all of the consolidated assets of the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;a sale or other
disposition of at least fifty percent (50%) of the outstanding securities of the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;a merger,
consolidation or similar transaction following which the Company is not the surviving corporation; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;a merger, consolidation or similar transaction following
which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction
into other property, whether in the form of securities, cash or otherwise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Director&#148;</I></B><I> </I>means a member of the Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Eligible Employee&#148;</I></B><I> </I>means an Employee who meets the requirements set forth in
the Offering for eligibility to participate in the Offering, provided that such Employee also meets the requirements for eligibility to participate set forth in the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Employee&#148;</I></B><I> </I>means any person, including Officers and Directors, who is employed
for purposes of Section&nbsp;423(b)(4) of the Code by the Company or a Related Corporation. Neither service as a Director nor payment of a director&#146;s fee shall be sufficient to make an individual an Employee of the Company or a Related
Corporation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Employee Stock Purchase Plan&#148;</I></B><I> </I>means a plan that grants
Purchase Rights intended to be options issued under an &#147;employee stock purchase plan,&#148; as that term is defined in Section&nbsp;423(b) of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(l)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Exchange Act&#148;</I></B><I> </I>means the Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(m)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Fair Market Value&#148;</I></B><I> </I>means the value of a security, as determined in good faith
by the Board. If the security is listed on any established stock exchange or traded on the Nasdaq National Market or the Nasdaq SmallCap Market, the Fair Market Value of the security, unless otherwise determined by the Board,<I> </I>shall be the
closing sales price (rounded up where necessary to the nearest whole cent) for such security (or the closing bid, if no sales were reported) as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the
relevant security of the Company) on the Trading Day prior to the relevant determination date, as reported in <I>The Wall Street Journal</I> or such other source as the Board deems reliable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(n)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Offering&#148;</I></B><I> </I>means the grant of Purchase Rights to purchase shares of Common
Stock under the Plan to Eligible Employees. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(o)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Offering Date&#148;</I></B> means a date
selected by the Board for an Offering to commence. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(p)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;</B><B><I>Officer</I></B><B>&#148;
</B>means<B> </B>a person who is an officer of the Company within the meaning of Section&nbsp;16 of the Exchange Act and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(q)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Participant&#148;</I></B><I> </I>means an Eligible Employee who holds an outstanding Purchase
Right granted pursuant to the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(r)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Plan&#148;</I></B><I> </I>means this MannKind
Corporation 2004 Employee Stock Purchase Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(s)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Purchase Date&#148;</I></B><I> </I>means one
or more dates during an Offering established by the Board on which Purchase Rights shall be exercised and as of which purchases of shares of Common Stock shall be carried out in accordance with such Offering. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(t)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Purchase Period&#148;</I></B> means a period of time specified within an Offering beginning on
the Offering Date or on the next day following a Purchase Date within an Offering and ending on a Purchase Date. An Offering may consist of one or more Purchase Periods. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(u)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Purchase Right&#148;</I></B><I> </I>means an option to purchase shares of Common Stock granted
pursuant to the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Related Corporation&#148;</I></B><I> </I>means any parent corporation
or subsidiary corporation, whether now or hereafter existing, as those terms are defined in Sections 424(e) and (f), respectively, of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(w)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Securities Act&#148;</I></B><I> </I>means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(x)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;</B><B><I>Trading Day</I></B><B>&#148; </B>means any day on which the exchange(s) or market(s) on
which shares of Common Stock are listed, whether it be an established stock exchange, the Nasdaq National Market, the Nasdaq SmallCap Market or otherwise, is open for trading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>A<SMALL>DMINISTRATION</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board shall
administer the Plan unless and until the Board delegates administration to a Committee, as provided in Section&nbsp;3(c). Whether or not the Board has delegated administration, the Board shall have the final power to determine all questions of
policy and expediency that may arise in the administration of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board (or the Committee)
shall have the power, subject to, and within the limitations of, the express provisions of the Plan: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;To
determine when and how Purchase Rights to purchase shares of Common Stock shall be granted and the provisions of each Offering of such Purchase Rights (which need not be identical). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;To designate from time to time which Related Corporations of the Company shall be eligible to participate in
the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;To construe and interpret the Plan and Purchase Rights, and to establish, amend and revoke
rules and regulations for the administration of the Plan. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan, in a manner and to the extent it shall deem necessary or expedient to make the Plan
fully effective. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;To amend the Plan as provided in Section&nbsp;15. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;Generally, to exercise such powers and to perform such acts as it deems necessary or expedient to promote the
best interests of the Company and its Related Corporations and to carry out the intent that the Plan be treated as an Employee Stock Purchase Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(vi)</B>&nbsp;&nbsp;&nbsp;&nbsp;To adopt such procedures and <FONT STYLE="white-space:nowrap">sub-plans</FONT> as are necessary or
appropriate to permit participation in the Plan by Employees who are foreign nationals or employed outside the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board may delegate administration of the Plan to a Committee of the Board composed of one (1)&nbsp;or
more members of the Board. If administration is delegated to a Committee, the Committee shall have, in connection with the administration of the Plan, the powers theretofore possessed by the Board, subject, however, to such resolutions, not
inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The Board may abolish the Committee at any time and revest in the Board the administration of the Plan. If administration is delegated to a Committee,
references to the Board in this Plan and in the Offering document shall thereafter be deemed to be to the Board or the Committee, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;All determinations, interpretations and constructions made by the Board in good faith shall not be subject
to review by any person and shall be final, binding and conclusive on all persons. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>S<SMALL>HARES</SMALL> <SMALL>OF</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of Section&nbsp;14(a) relating to adjustments upon changes in Common Stock, the stock that may be sold pursuant to
Purchase Rights granted under the Plan shall not exceed in the aggregate four million six hundred eighty-six thousand one hundred forty (4,686,140) shares of Common Stock. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>G<SMALL>RANT</SMALL> <SMALL>OF</SMALL> P<SMALL>URCHASE</SMALL> R<SMALL>IGHTS</SMALL>; O<SMALL>FFERING</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board may from time to time grant or provide for the grant of Purchase Rights to purchase shares of
Common Stock under the Plan to Eligible Employees in an Offering (consisting of one or more Purchase Periods) on an Offering Date or Offering Dates selected by the Board. Each Offering shall be in such form and shall contain such terms and
conditions as the Board shall deem appropriate, which shall comply with the requirement of Section&nbsp;423(b)(5) of the Code that all Employees granted Purchase Rights shall have the same rights and privileges. The terms and conditions of an
Offering shall be incorporated by reference into the Plan </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and treated as part of the Plan. The provisions of separate Offerings need not be identical, but each Offering shall include (through incorporation of the provisions of this Plan by reference in
the document comprising the Offering or otherwise) the period during which the Offering shall be effective, which period shall not exceed twenty-seven (27)&nbsp;months beginning with the Offering Date, and the substance of the provisions contained
in Sections 6 through 9, inclusive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;If a Participant has more than one Purchase Right outstanding under
the Plan, unless he or she otherwise indicates in agreements or notices delivered hereunder: (i)&nbsp;each agreement or notice delivered by that Participant shall be deemed to apply to all of his or her Purchase Rights under the Plan, and
(ii)&nbsp;a Purchase Right with a lower exercise price (or an earlier-granted Purchase Right, if different Purchase Rights have identical exercise prices) shall be exercised to the fullest possible extent before a Purchase Right with a higher
exercise price (or a later-granted Purchase Right if different Purchase Rights have identical exercise prices) shall be exercised. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>E<SMALL>LIGIBILITY</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;Purchase Rights may be
granted only to Employees of the Company or, as the Board may designate as provided in Section&nbsp;3(b), to Employees of a Related Corporation. Except as provided in Section&nbsp;6(b), an Employee shall not be eligible to be granted Purchase Rights
under the Plan unless, on the Offering Date, such Employee has been in the employ of the Company or the Related Corporation, as the case may be, for such continuous period preceding such Offering Date as the Board may require, but in no event shall
the required period of continuous employment be greater than two (2)&nbsp;years. In addition, the Board may provide that no Employee shall be eligible to be granted Purchase Rights under the Plan unless, on the Offering Date, such Employee&#146;s
customary employment with the Company or the Related Corporation is more than twenty (20)&nbsp;hours per week and/or more than five (5)&nbsp;months per calendar year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board may provide that each person who, during the course of an Offering, first becomes an Eligible
Employee shall, on a date or dates specified in the Offering which coincides with the day on which such person becomes an Eligible Employee or which occurs thereafter, receive a Purchase Right under that Offering, which Purchase Right shall
thereafter be deemed to be a part of that Offering. Such Purchase Right shall have the same characteristics as any Purchase Rights originally granted under that Offering, as described herein, except that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;the date on which such Purchase Right is granted shall be the &#147;Offering Date&#148; of such Purchase
Right for all purposes, including determination of the exercise price of such Purchase Right; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;the
period of the Offering with respect to such Purchase Right shall begin on its Offering Date and end coincident with the end of such Offering; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;the Board may provide that if such person first becomes an Eligible Employee within a specified period of
time before the end of the Offering, he or she shall not receive any Purchase Right under that Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;No Employee shall be eligible for the grant of any Purchase Rights under the Plan if, immediately after any
such Purchase Rights are granted, such Employee owns stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or of any Related Corporation. For purposes of this Section&nbsp;6(c),
the rules of Section&nbsp;424(d) of the Code shall apply in determining the stock ownership of any Employee, and stock which such Employee may purchase under all outstanding Purchase Rights and options shall be treated as stock owned by such
Employee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;As specified by Section&nbsp;423(b)(8) of the Code, an Eligible Employee may be granted
Purchase Rights under the Plan only if such Purchase Rights, together with any other rights granted under all Employee Stock Purchase Plans of the Company and any Related Corporations, do not permit such Eligible Employee&#146;s rights to purchase
stock of the Company or any Related Corporation to accrue at a rate which exceeds twenty five </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thousand dollars ($25,000) of Fair Market Value of such stock (determined at the time such rights are granted, and which, with respect to the Plan, shall be determined as of their respective
Offering Dates) for each calendar year in which such rights are outstanding at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;Officers of
the Company and any designated Related Corporation, if they are otherwise Eligible Employees, shall be eligible to participate in Offerings under the Plan. Notwithstanding the foregoing, the Board may provide in an Offering that Employees who are
highly compensated Employees within the meaning of Section&nbsp;423(b)(4)(D) of the Code shall not be eligible to participate. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>P<SMALL>URCHASE</SMALL> R<SMALL>IGHTS</SMALL>; P<SMALL>URCHASE</SMALL> P<SMALL>RICE</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;On each Offering Date, each Eligible Employee, pursuant to an Offering made under the Plan, shall be granted
a Purchase Right to purchase up to that number of shares of Common Stock purchasable either with a percentage or with a maximum dollar amount, as designated by the Board, but in either case not exceeding twenty percent (20%), of such Employee&#146;s
Earnings (as defined by the Board in each Offering) during the period that begins on the Offering Date (or such later date as the Board determines for a particular Offering) and ends on the date stated in the Offering, which date shall be no later
than the end of the Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board shall establish one (1)&nbsp;or more Purchase Dates during an
Offering as of which Purchase Rights granted pursuant to that Offering shall be exercised and purchases of shares of Common Stock shall be carried out in accordance with such Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;In connection with each Offering made under the Plan, the Board may specify a maximum number of shares of
Common Stock that may be purchased by any Participant on any Purchase Date during such Offering. In connection with each Offering made under the Plan, the Board may specify a maximum aggregate number of shares of Common Stock that may be purchased
by all Participants pursuant to such Offering. In addition, in connection with each Offering that contains more than one Purchase Date, the Board may specify a maximum aggregate number of shares of Common Stock that may be purchased by all
Participants on any Purchase Date under the Offering. If the aggregate purchase of shares of Common Stock issuable upon exercise of Purchase Rights granted under the Offering would exceed any such maximum aggregate number, then, in the absence of
any Board action otherwise, a pro rata allocation of the shares of Common Stock available shall be made in as nearly a uniform manner as shall be practicable and equitable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;The purchase price of shares of Common Stock acquired pursuant to Purchase Rights shall be not less than the
lesser of: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;an amount equal to eighty-five percent (85%) of the Fair Market Value of the shares of Common
Stock on the Offering Date; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;an amount equal to eighty-five percent (85%) of the Fair Market Value of
the shares of Common Stock on the applicable Purchase Date. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>P<SMALL>ARTICIPATION</SMALL>; W<SMALL>ITHDRAWAL</SMALL>; T<SMALL>ERMINATION</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;A Participant may elect to authorize payroll deductions pursuant to an Offering under the Plan by completing
and delivering to the Company, within the time specified in the Offering, an enrollment form (in such form as the Company may provide). Each such enrollment form shall authorize an amount of Contributions expressed as a percentage of the submitting
Participant&#146;s Earnings (as defined in each Offering) during the Offering (not to exceed the maximum percentage specified by the Board). Each Participant&#146;s Contributions shall remain the property of the Participant at all times prior to the
purchase of Common Stock, but such Contributions may be commingled with the assets of the Company and used for general corporate purposes except where applicable law requires that Contributions be deposited with an independent third party. To the
extent provided in the Offering, a Participant may begin making Contributions after the beginning of the Offering. To the extent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provided in the Offering, a Participant may thereafter reduce (including to zero) or increase his or her Contributions. To the extent specifically provided in the Offering, in addition to making
Contributions by payroll deductions, a Participant may make Contributions through the payment by cash or check prior to each Purchase Date of the Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;During an Offering, a Participant may cease making Contributions and withdraw from the Offering by
delivering to the Company a notice of withdrawal in such form as the Company may provide. Such withdrawal may be elected at any time prior to the end of the Offering, except as provided otherwise in the Offering. Upon such withdrawal from the
Offering by a Participant, the Company shall distribute to such Participant all of his or her accumulated Contributions (reduced to the extent, if any, such Contributions have been used to acquire shares of Common Stock for the Participant) under
the Offering, and such Participant&#146;s Purchase Right in that Offering shall thereupon terminate. A Participant&#146;s withdrawal from an Offering shall have no effect upon such Participant&#146;s eligibility to participate in any other Offerings
under the Plan, but such Participant shall be required to deliver a new enrollment form in order to participate in subsequent Offerings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;Purchase Rights granted pursuant to any Offering under the Plan shall terminate immediately upon a
Participant ceasing to be an Employee for any reason or for no reason (subject to any post-employment participation period required by law) or other lack of eligibility. The Company shall distribute to such terminated or otherwise ineligible
Employee all of his or her accumulated Contributions (reduced to the extent, if any, such Contributions have been used to acquire shares of Common Stock for the terminated or otherwise ineligible Employee) under the Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;Purchase Rights shall not be transferable by a Participant otherwise than by will, the laws of descent and
distribution, or a beneficiary designation as provided in Section&nbsp;13. During a Participant&#146;s lifetime, Purchase Rights shall be exercisable only by such Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise specified in an Offering, the Company shall have no obligation to pay interest on
Contributions. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>E<SMALL>XERCISE</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;On each Purchase Date during
an Offering, each Participant&#146;s accumulated Contributions shall be applied to the purchase of shares of Common Stock up to the maximum number of shares of Common Stock permitted pursuant to the terms of the Plan and the applicable Offering, at
the purchase price specified in the Offering. No fractional shares shall be issued upon the exercise of Purchase Rights unless specifically provided for in the Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;If any amount of accumulated Contributions remains in a Participant&#146;s account after the purchase of
shares of Common Stock and such remaining amount is less than the amount required to purchase one share of Common Stock on the final Purchase Date of an Offering, then such remaining amount shall be held in such Participant&#146;s account for the
purchase of shares of Common Stock under the next Offering under the Plan, unless such Participant withdraws from such next Offering, as provided in Section&nbsp;8(b), or is not eligible to participate in such Offering, as provided in
Section&nbsp;6, in which case such amount shall be distributed to such Participant after the final Purchase Date, without interest. If the amount of Contributions remaining in a Participant&#146;s account after the purchase of shares of Common Stock
is at least equal to the amount required to purchase one (1)&nbsp;whole share of Common Stock on the final Purchase Date of the Offering, then such remaining amount shall be distributed in full to such Participant at the end of the Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;No Purchase Rights may be exercised to any extent unless the shares of Common Stock to be issued upon such
exercise under the Plan are covered by an effective registration statement pursuant to the Securities Act and the Plan is in material compliance with all laws applicable to the Plan. If on a Purchase Date during any Offering hereunder the shares of
Common Stock are not so registered or the Plan is not in such compliance, no </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Purchase Rights or any Offering shall be exercised on such Purchase Date, and the Purchase Date shall be delayed until the shares of Common Stock are subject to such an effective registration
statement and the Plan is in such compliance, except that the Purchase Date shall not be delayed more than twelve (12)&nbsp;months and the Purchase Date shall in no event be more than twenty-seven (27)&nbsp;months from the Offering Date. If, on the
Purchase Date under any Offering hereunder, as delayed to the maximum extent permissible, the shares of Common Stock are not registered and the Plan is not in such compliance, no Purchase Rights or any Offering shall be exercised and all
Contributions accumulated during the Offering (reduced to the extent, if any, such Contributions have been used to acquire shares of Common Stock) shall be distributed to the Participants. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall seek to obtain from each federal, state, foreign or other regulatory commission or agency having jurisdiction over the Plan
such authority as may be required to issue and sell shares of Common Stock upon exercise of the Purchase Rights. If, after commercially reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority
that counsel for the Company deems necessary for the lawful issuance and sale of shares of Common Stock under the Plan, the Company shall be relieved from any liability for failure to issue and sell shares of Common Stock upon exercise of such
Purchase Rights unless and until such authority is obtained. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>U<SMALL>SE</SMALL> <SMALL>OF</SMALL> P<SMALL>ROCEEDS</SMALL> <SMALL>FROM</SMALL> S<SMALL>HARES</SMALL> <SMALL>OF</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proceeds from the sale of shares of Common Stock pursuant to Purchase Rights shall constitute general funds of the Company. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>R<SMALL>IGHTS</SMALL> <SMALL>AS</SMALL> <SMALL>A</SMALL> <SMALL>STOCKHOLDER</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A
Participant shall not be deemed to be the holder of, or to have any of the rights of a holder with respect to, shares of Common Stock subject to Purchase Rights unless and until the Participant&#146;s shares of Common Stock acquired upon exercise of
Purchase Rights are recorded in the books of the Company (or its transfer agent). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>D<SMALL>ESIGNATION</SMALL> <SMALL>OF</SMALL> B<SMALL>ENEFICIARY</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;A Participant may file a written designation of a beneficiary who is to receive any shares of Common Stock
and/or cash, if any, from the Participant&#146;s account under the Plan in the event of such Participant&#146;s death subsequent to the end of an Offering but prior to delivery to the Participant of such shares of Common Stock or cash. In addition,
a Participant may file a written designation of a beneficiary who is to receive any cash from the Participant&#146;s account under the Plan in the event of such Participant&#146;s death during an Offering. Any such designation shall be on a form
provided by or otherwise acceptable to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Participant may change such designation of
beneficiary at any time by written notice to the Company. In the event of the death of a Participant and in the absence of a beneficiary validly designated under the Plan who is living at the time of such Participant&#146;s death, the Company shall
deliver such shares of Common Stock and/or cash to the executor or administrator of the estate of the Participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its sole discretion, may
deliver such shares of Common Stock and/or cash to the spouse or to any one or more dependents or relatives of the Participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate.
</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>A<SMALL>DJUSTMENTS</SMALL> <SMALL>UPON</SMALL> C<SMALL>HANGES</SMALL> <SMALL>IN</SMALL> S<SMALL>ECURITIES</SMALL>; C<SMALL>ORPORATE</SMALL> T<SMALL>RANSACTIONS</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;If any change is made in the shares of Common Stock, subject to the Plan, or subject to any Purchase Right,
without the receipt of consideration by the Company (through merger, consolidation, reorganization, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate
structure or other transaction not involving the receipt of consideration by the Company), the Plan shall be appropriately adjusted in the type(s), class(es) and maximum number of shares of Common Stock subject to the Plan pursuant to
Section&nbsp;4(a), and the outstanding Purchase Rights shall be appropriately adjusted in the type(s), class(es), number of shares and purchase limits of such outstanding Purchase Rights. The Board shall make such adjustments, and its determination
shall be final, binding and conclusive. (Notwithstanding the foregoing, the conversion of any convertible securities of the Company shall not be treated as a &#147;transaction not involving the receipt of consideration by the Company.&#148;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;In the event of a Corporate Transaction, then: (i)&nbsp;any surviving or acquiring corporation may continue
or assume Purchase Rights outstanding under the Plan or may substitute similar rights (including a right to acquire the same consideration paid to stockholders in the Corporate Transaction) for those outstanding under the Plan, or (ii)&nbsp;if any
surviving or acquiring corporation does not continue or assume such Purchase Rights or does not substitute similar rights for Purchase Rights outstanding under the Plan, then, the Participants&#146; accumulated Contributions shall be used to
purchase shares of Common Stock within ten (10)&nbsp;business days prior to the Corporate Transaction under the ongoing Offering, and the Participants&#146; Purchase Rights under the ongoing Offering shall terminate immediately after such purchase.
</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>A<SMALL>MENDMENT</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board at any time, and from time to time, may amend the Plan. However, except as provided in
Section&nbsp;14 relating to adjustments upon changes in securities and except as to amendments solely to benefit the administration of the Plan, to take account of a change in legislation or to obtain or maintain favorable tax, exchange control or
regulatory treatment for Participants or the Company or any Related Corporation, no amendment shall be effective unless approved by the stockholders of the Company to the extent stockholder approval is necessary for the Plan to satisfy the
requirements of Section&nbsp;423 of the Code or other applicable laws or regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;It is expressly
contemplated that the Board may amend the Plan in any respect the Board deems necessary or advisable to provide Employees with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated
thereunder relating to Employee Stock Purchase Plans or to bring the Plan and/or Purchase Rights into compliance therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;The rights and obligations under any Purchase Rights granted before amendment of the Plan shall not be
impaired by any amendment of the Plan except: (i)&nbsp;with the consent of the person to whom such Purchase Rights were granted, or (ii)&nbsp;as necessary to comply with any laws or governmental regulations (including, without limitation, the
provisions of the Code and the regulations promulgated thereunder relating to Employee Stock Purchase Plans). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>T<SMALL>ERMINATION</SMALL> <SMALL>OR</SMALL> S<SMALL>USPENSION</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board in its discretion may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan
shall terminate at the time that all of the shares of Common Stock reserved for issuance under the Plan, as increased and/or adjusted from time to time, have been issued under the terms of the Plan. No Purchase Rights may be granted under the Plan
while the Plan is suspended or after it is terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;Any benefits, privileges, entitlements and
obligations under any Purchase Rights while the Plan is in effect shall not be impaired by suspension or termination of the Plan except (i)&nbsp;as expressly provided in the Plan or with the consent of the person to whom such Purchase Rights were
granted, (ii)&nbsp;as necessary to comply with any laws, regulations, or listing requirements, or (iii)&nbsp;as necessary to ensure that the Plan and/or Purchase Rights comply with the requirements of Section&nbsp;423 of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>E<SMALL>FFECTIVE</SMALL> D<SMALL>ATE</SMALL> <SMALL>OF</SMALL> P<SMALL>LAN</SMALL>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Plan shall become effective as determined by the Board, but no Purchase Rights shall be exercised unless and until the Plan has been approved by the stockholders of the Company within twelve (12)&nbsp;months before or after the date the Plan is
adopted by the Board. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>18.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>M<SMALL>ISCELLANEOUS</SMALL> P<SMALL>ROVISIONS</SMALL>. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Plan and Offering do not constitute an employment contract. Nothing in the Plan or in the Offering shall
in any way alter the at will nature of a Participant&#146;s employment or be deemed to create in any way whatsoever any obligation on the part of any Participant to continue in the employ of the Company or a Related Corporation, or on the part of
the Company or a Related Corporation to continue the employment of a Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The provisions of the
Plan shall be governed by the laws of the State of California<B> </B>without resort to that state&#146;s conflicts of laws rules. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g536430g48t25.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">ANNUAL MEETING OF STOCKHOLDERS OF MANNKIND CORPORATION
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Date: May 16, 2018 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Time: 10:00 A.M. (Pacific Time) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Place: MannKind Corporation, 30930 Russell Ranch Road, Suite 301, Westlake Village, CA 91362
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Please make your marks like this: Use dark black pencil or pen only </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Board of
Directors Recommends a Vote FOR all nominees in proposal 1, and FOR proposals 2 through 5. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">1: To elect the seven nominees named herein as directors to serve for
the ensuing year and until their successors are elected; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">01 Kent Kresa 02 Michael Castagna 03 Ronald J. Consiglio 04 Michael A. Friedman, MD 05 David H. MacCallum
06 Henry L. Nordhoff 07 James S. Shannon, MD, MRCP (UK) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Recommend Directors For Withhold For For For For For For For </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">2: To approve the MannKind Corporation 2018 Equity Incentive Plan; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">3: To approve an amendment
to the MannKind </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Corporation 2004 Employee Stock Purchase </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Plan to, among other
things, increase the </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">number of shares authorized for issuance </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">under the 2004
Employee Stock Purchase </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Plan by 3,000,000 shares; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">4: To approve, on an
advisory basis, the </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">compensation of the named executive officers </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">of MannKind,
as disclosed in MannKind&#146;s </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">proxy statement for the Annual Meeting; and
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">5: To ratify the selection by the Audit Committee </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">of the Board of Directors
of Deloitte &amp; Touche </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">LLP as the independent registered public </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">accounting
firm of MannKind for its fiscal </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">year ending December 31, 2018. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For Against
Abstain For For For For </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Authorized Signatures - This section must be completed for your Instructions to be executed. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Please Sign Here Please Date Above </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Please Sign Here Please Date Above </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Please sign exactly as your name(s) appears on your stock certificate. If held in joint tenancy, all persons should sign. Trustees, administrators, etc., should include title and
authority. Corporations should provide full name of corporation and title of authorized officer signing the proxy. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Annual Meeting of MannKind Corporation to be
held on Thursday, May 16, 2018 for Holders as of March 19, 2018 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">This proxy is being solicited on behalf of the Board of Directors </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">INTERNET VOTE BY: TELEPHONE </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Go To </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">www.proxypush.com/mnkd </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Cast your vote online. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">View Meeting Documents. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">OR MAIL </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">866-437-3716 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Use any touch-tone telephone. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Have your Proxy Card/Voting Instruction Form ready. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Follow the simple recorded instructions.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">OR Mark, sign and date your Proxy Card/Voting Instruction Form. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Detach your
Proxy Card/Voting Instruction Form. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Return your Proxy Card/Voting Instruction Form in the postage-paid envelope provided. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The undersigned hereby appoints David Thomson and Rosabel R. Alinaya, and each of them, with power to act without the other and with power of substitution, as proxies and
attorneys-in-fact and hereby authorizes them to represent and vote, as provided on the other side, all the shares of MannKind Corporation Common Stock which the undersigned is entitled to vote, and, in their discretion, to vote upon such other
business as may properly come before the Annual Meeting of Stockholders of the MannKind Corporation to be held May 16, 2018 or at any adjournment or postponement thereof, with all powers which the undersigned would possess if present at the Meeting.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER. IF NO DIRECTION IS GIVEN, THIS PROXY WILL BE VOTED
FOR ALL NOMINEES IN PROPOSAL 1, AND FOR PROPOSALS 2 THROUGH 5. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">All votes must be received by 5:00 P.M., Eastern Daylight Time, May 15, 2018. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">PROXY TABULATOR FOR MANNKIND CORPORATION c/o MEDIANT COMMUNICATIONS P.O. BOX 8016 CARY, NC 27512-9903 EVENT # CLIENT # </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Please separate carefully at the perforation and return just this portion in the envelope provided. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g536430g90j31.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Proxy &#151; MannKind Corporation </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Annual Meeting of Stockholders </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">May 16, 2018, 10:00 a.m. (Pacific Time) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">This Proxy is Solicited on Behalf of the Board of Directors </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The undersigned hereby appoints
David Thomson and Rosabel R. Alinaya, and each of them, with power to act without the other and with power of substitution, as proxies and attorneys-in-fact and hereby authorizes them to represent and vote, as provided on the other side, all the
shares of MannKind Corporation Common Stock which the undersigned is entitled to vote, and, in their discretion, to vote upon such other business as may properly come before the Annual Meeting of Stockholders of the MannKind Corporation to be held
May 16, 2018 or at any adjournment or postponement thereof, with all powers which the undersigned would possess if present at the Meeting. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The purpose of the
Annual Meeting is to take action on the following: </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">1. To elect the seven nominees named herein as directors to serve for the ensuing year and until their
successors are elected; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">01 Kent Kresa 05 David H. MacCallum 02 Michael Castagna 06 Henry L. Nordhoff 03 Ronald J. Consiglio 07 James S. Shannon, MD, MRCP (UK) 04
Michael A. Friedman, MD </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">2. To approve the MannKind Corporation 2018 Equity Incentive Plan; </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">3. To approve an amendment to the MannKind Corporation 2004 Employee Stock Purchase Plan to, among other things, increase the number of shares authorized for issuance under the
2004 Employee Stock Purchase Plan by 3,000,000 shares; </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">4. To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as
disclosed in MannKind&#146;s proxy statement for the Annual Meeting; and </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">5. To ratify the selection by the Audit Committee of the Board of Directors of Deloitte
&amp; Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2018. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">THIS PROXY, WHEN PROPERLY EXECUTED,
WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER. IF NO DIRECTION IS GIVEN, THIS PROXY WILL BE VOTED FOR ALL NOMINEES IN PROPOSAL 1, AND FOR PROPOSALS 2 THROUGH 5. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Please separate carefully at the perforation and return just this portion in the envelope provided. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">To attend the meeting and vote your shares in person, please mark this box. </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g536430g09k79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g536430g09k79.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[17D4&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "    .$))300E       0S<_Z?:C'O@D%<':N
MKP7#3CA"24T$.@     !=0   !     !       +<')I;G1/=71P=70    '
M     $-L<E-E;G5M     $-L<E,     4D="0P    !.;2 @5$585    !$
M00!D &\ 8@!E "  4@!' $( (  H #$ .0 Y #@ *0       $EN=&5E;G5M
M     $EN=&4     0VQR;0    !-<$)L8F]O; $    /<')I;G13:7AT965N
M0FET8F]O;      +<')I;G1E<DYA;65415A4    (@!< %P 4 !( %@ 1@!"
M %4 +0!- %< 10 M $8 4  Q #  7 !! %H ,  Q #4 ,0 M %@ 10!2 $\
M6  M #$ .       #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\
M9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M
M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M
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M9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$"+6
M"G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,
M    3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M        4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN
M9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,
M969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!2
M96-T5&]P;&]N9P      .$))30/M       0 \     !  $#P     $  3A"
M24T$)@      #@             _@   .$))300-       $    'CA"24T$
M&0      !    !XX0DE- _,       D           $ .$))32<0       *
M  $          3A"24T$"       $     $   )    "0      X0DE-!!X
M      0     .$))300:      ,U    !@             !G@  !M@
M     0                         !              ;8   !G@
M               !                         !     !        ;G5L
M;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !G@    !2
M9VAT;&]N9P  !M@    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L
M:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M    !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T
M960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD
M<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE
M9G1L;VYG          !"=&]M;&]N9P   9X     4F=H=&QO;F<   ;8
M W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M   !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O
M;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M
M#T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M   /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E
M;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T
M;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E
M=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M     C_P        .$))3004       $     SA"24T$#      +NP    $
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MU67.8RY\X]K&.:6TY%[*FT4?9Z'M9=D44_:LI_Z2FFS_  M7A"22GW>WK_\
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M &( 90 @ %  : !O '0 ;P!S &@ ;P!P "  0P!3 #8    ! #A"24T$(@
M   !?DU- "H    (  P!   #     0<,   ! 0 #     0*O   ! @ #
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M   &V* #  0    !   !G@         & 0,  P    $ !@   1H !0    $
M  %N 1L !0    $   %V 2@  P    $  @   @$ !     $   %^ @( !
M  $              $@    !    2     $X0DE- _T       @      0
M /_A 8!-30 J    "  , 0   P    $'#    0$  P    $"KP   0(  P
M  ,   "> 08  P    $  @   1(  P    $      14  P    $  P   1H
M!0    $   "D 1L !0    $   "L 2@  P    $  @   3$  @   !X   "T
M 3(  @   !0   #2AVD !     $   #H   !(  (  @ "    \     !   #
MP     %!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$V.C T.C(Q
M(#$Q.C$P.C Y      20   '    !# R,C&@ 0 #     ?__  "@ @ $
M 0  !MB@ P $     0   9X         !@$#  ,    !  8   $:  4    !
M   !;@$;  4    !   !=@$H  ,    !  (   (!  0    !   !?@("  0
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M 0$! 0$! 0$!_\  $0@ +0#  P$1  (1 0,1 ?_$ !T  0 " @,! 0
M       )"@<(! 4& 0O_Q  M$  !! ,  @$$ @(!!0$    $ @,%!@$'"  )
M"A$2%!43%B$B,A<9(S%"0?_$ !0! 0                    #_Q  4$0$
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M+B:Z(R@@R;DS:C2=RQHH:$.,H8<,EP6"%$,_Q$J=6T,\$(7&O1WNU]H/L.Z
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M=3PPQY_GG8FTB11VVG9*^]"[H",/>;Q],F&,ZUN&O(O\AU7^[C8D<*%G/^J
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MG 9"E8F*GHTR'G(R/F8B186+(14J$-(QIXSG^'!S 3&WA2F%X_YLOM+;5_\
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M3^J>@(7H7\QDT:7ZHM-;VGK^W"M#+'<A+ ?2=:T^[5HM:L!N"6T5RXH '$?
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%$MD/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g536430g48t25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g536430g48t25.jpg
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M P,# P,# P,# P,# P,# P,# P,# P/_P  1" *" S0# 1$  A$! Q$!_\0
MP@ !  (# 0$! 0$           <(!08)! ,""@$! 0$! 0 # 0$
M   ! @,$!08'"!   00# 0 !! $# 04""0$9!0,$!@<  0(("1$2$Q05(187
M(C$CEQA80231,I)3TY75UM<*49$S)3=WMQFT>)@Y-5E"-%1TE-1UM3;8>1$!
M  (! @0$! 0$! 4$ P$   $1 B$2,4%1 V$B! 7P<1,&@:&QP9'1,@?A\4(4
M4F)R(Q8S0U,5@B07LO_:  P# 0 "$0,1 #\ _OXP& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MRTF->#.>&&>.S.(G&>4Q</7F&C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M758?541'OR;73-T?ACI5KUI;?2C3M/KOE/O?2?)F8J:2[A# 8# 8# 8# 8#
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M&!4'V#Y" ^R8_5<)F-C6# H77ML#+9,LZQ,+Q252\G&XM+!$2%)S9BNF5B[
M+)9$W,*=M>.U72HY)'>^..^^L-8Y;=84$"_"A !\<JL63OV?&I!35@>9)1"9
MFI&0;0YU#/,T085^'K"2])/E.)#'9E$X\$T2[4VGU_* F+[CC\J.N<-?4GH]
M SX68+$'3.2UK?LY@T^!UEXS QB1HQ",G @:Y/&JZJ02[5(657[#OW-J@N6[
M&3A=])H.=M_V4G*;KK:NA]2>?C^;]-OA8@S,A5$C;>EKM;2VC1%(<UJ29*#1
M@#4PK#T5*_3\XF,]A(E9A&YZI;%GR]SVHP62;M C)-%)GK>T_OV3?X0GNJ_
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MG3X!5<IC85@T#RHU+C\U3(2&2.TNEGRXEERBT:II]<]EWUPT;K0?Q$^:ZBE
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M5\A\A\Z6ENL$>((@&CX625@*1:*-7+5]RH[UTY[Z[5ZWO(NW&ZKA,_HS5O\
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MY:IL^M\_A^W!W(B(X5K+DI>GJ"[KIH#W5%)EZEL></[(\2_+G,/1E(]R^(O
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MPUY;MPZ:K9/KEMQSI#72?.]<_7G7T,-FUKZ?TU_36OZ:UK_LP& P& P& P&
MP& P& P& P& P& P& P& P& P& P&!S"^4/U*]\OU_2#\;4-=W(5G-SKM8\
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MVQ?Z1;CWJ.WB6VFUT\CINBYUCA'Y<7]%OA2Q[=!5QY^\L>DP-AO_ $K /%5
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M$RU#6T*@MAG)12I N<*S"+\Q1A21N:5@XA;^)E[(&S).-&VD6+O"0(,.<[=
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M(\H(H:?*](()]<I?8+:M9OBVFK8L0Y9TIW*^9%('%%.2" LRT:"=JT'.R<Z
M_B9JBG*G',R_D=!Y)K:F_P"3!MD&W'X-\;5Z$93$4U87X%I@&6%% Q.7B=AK
M?[N9DW%HP 8LF>V<3D?(O^='0-I*=,/Y/2J:S[3_ /GW@UVX'.B*[!;MOLNZ
M6G<_&M3/ZPEDM/KD=,A(GH.FS<'H8HT7;\5,-I!DZVV_L+2 \JSK<9PRZ=LN
M6J[S>]=N^E])H\IRC=+;X5Y'\X>63"5V-#W<'C55U\0"<.IB_@K*&5_7 /\
MN5X.9<RDE&64ABT)K\!(WK)DSY,-Q+8;PCRLBITU143I,S.BLI)_\8;KJ2D7
M?LBKFR,ELN8VJ\6W?E6-V8XM-4 Z9,,-65X_&QB0U<$HY9M>NN]MEWCOO:G6
ME/IP7S]&^3[XWP;@+_*4O:\UCD];Q!E!8E(9>_"209%HDZ@K&M3?\)MM%4R7
M:KZ')+[2;.%G Y%P^=]M46:CG3A 1EU66I;R?#:$-%#E>GBK)>3D!+N8-G(2
M&[2.MQPR2_M,?Y)E'&4G[Y+2N2=%^UGY DNV[1X:->T&>]H82<IGBUJ0^&*?
MF9I1><FK$F<(U-Y+/V%/')&PU5HTY,"\IE,FUP$& QI<FV)3F6+&^-D"#Q=D
M];H)-%$&7*C10;ICYLX]\<5<3:^<1Y0G*RP_S$RC#&!MB^X@5<$^(4[B9&*.
MI :(1!Q(6I(22A U;MP%=AU'^D>D7NW+=3I+9-TZ^+XRGQI6DQY;#3DCL)S$
M-S.;SL[ ]F G<6DYZ<6-(K1=KO\ E>-K&PB@N22AT@@X"/13QT)ZTP?K/6NM
MI[+NEX(GXRBT.F,$G ZT+1(FH0;+'UM2!*KR["4DBL9A$!X(%Q_=:(LPQL76
MU?#XXU)@N!!+@3V[XZ7Z6>NUEAN7'PR8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8%*?D+\T3+U[Y1G%"0&0QR+2B43"E)$S-2S970)NTK*\
M*ZM N@Z_A61 A^P_$0U=NV^Q+KG]I5/[]\\?=UHUC,1E<\'*"8_$=ZAE=TW8
MOS.Z+8TR>L#Y+[MJ^0=%Y\M9!">_(3YZ<4NUA4ZB/,/YC<?BE7E23I^J68&"
M3HDWTCQPR1[_ ";Q3<9XUXZ?DO%Z6\$V!=OQ2@/ 0*45^-GPRHO+M;O9*;1-
M=5VZ<4=)JE+RKKENS$N3'8<Z/@#M%FGTSUOK;A+2W''/W_:9QRB,]RI=F?$A
M:$9O6Y[R\M-/-,+&./7/A'U32-(;9'*L@BBOEJGK$K&QXA,G4!@1=C#%YV_L
M5P28/Q8LKKI9+ZNTM=*=;T6,XJLKX2A)7X/?0CCSV6JU6WJ=YE9;XYK2\QJO
M$TYKV"0O2P_:??K]%^DJH#T_4JD<LKT#Z>])\E^N=:<:9?7?X]1KZD7>O']J
M?[;'PX^K+2C;R=2E?RI,[>*^U/6'IXE4QB>WU'*25C_J3SU"Z?;A'5A0Z+"+
M,($*QE,00**LM,&X^2C^5&BZC72^])U/J1'"ZJ(693^+.W0=>^SXJ*<>5Y=O
MT+Y5\$>?(;!YQ"YMJH]_\IT&*0^P0DGCP]=>0PV'3%N0Z3B[L22(E8RK^!]K
M\KEFGRJ3?&G'293=5GD#VO"OC L[RJIZ.%AO4I^-W(&IZV^))*YVE4 B6GC+
MNIX>1M>01D/8=C$*XB;IJ(5F#T4F;7[2T[TCVJDG]Q)RQWW6CFL5^%WUVSH*
MPX9 B7ER*6#-?6DI]+0Q9&UO2*TGH4Z?\XP.J(I/*T]-OXR2MA[9<+LB+.C$
MA3+"WPVP@K]P/?\ 332WTX-_4QN]:IU.]8^3_3%C1;PK.*ME-3SKT)XYFO4P
MD+>TGLDK*N[>?2?SC85#3DAP3@$6F9.$N^B,]Z-LFZ MPV^U'IIO\7/7*G)C
M'*(F;X2T7X[OCBL?Q;/X7()184,F8&*_'?Y8\@K< D3S8J[L*D9O<$RF,H1:
MD6*;-&&%%+-31%ZVOT]^B'>UTD_KKZESSC*/&[4RL#X.[+G]KV':3ZS:Q1=2
M?T/\E=OBAO.I9^!]'O7E,!HC0@F4;T#^G16H[2&]G"&DM+(<IJ?5KVJK]><+
M'<B(KY?D_;3XA_7Z]V^)9%*[<IZ75?Y#U\=SZ+(OYK<#-[ .?*U;J0V_(K65
M7LXWS7!->[)1I(TC*C"O!OALW2&=<-V^M]ZB_4QJ>LW^;+.OBE]GUQ2'BT#0
MMF>:.;K\WB/><"D9BR1,H-5KJ.^V+*[F*,]"QMS"3J$XD5<C6K?2\?-L&XPR
MNHISVZ2X3X[4)OQF9N)J:_)8JJ?C/N"!>OH3Z&*6%7!"*QCW9[6]4/0S'B2)
M2!Y#?3'EZ"4;$0+9#L,D(0E .2Q9P])<?FY9)L5N.6ZJBFM\:K,Y1,5X0N)Z
M'\MS.X/7_@#T0!D48%Q7R3*/19R< R_\K_<$E;7'2CVLP*,4_38N!WYQ9ASI
MP\_<6;\_K:W^/???^G"1E6,QU<N_/OQF>DO(=\^B/7%>PGRJ!E<8\WW_ %IY
MOJVK))Z2DL*L696=<:%S!SLWA%AERO5)@F^PC0<K%X63<"E";X@034;\J\\:
MC<YQE$8S?%?[Y&O-WJ'V!Y=AE,5+(JQACR4SBORGI>'3N56%%(S9U0"Q[TC8
M%&-YK5XPU,P@2>2/EDP)N&72*SD%RZ;Z6UIQU]U9QG''*Y_!S8]/?$I[$OUY
MKB.OO'-5 +K\C4-X_O:)0UW:;.(TA#_/GII_=T8-^< W,%0YF#4G#E4@_P#$
MF?X!%B]XTIPMVAK?.&L<\8ZS-W^2\/J/X[[3OV__ &!:48M@%703T=\8KOPY
M$R3#<@_OF%6*YG=DRKB=NOTF[5EN*HLIFW2^C9YR_P!J)JZUQSK[.]QF,HB(
MCI-LA\7GB.Z/)#CT;+;H_P &Q8G>)>C^0E/^;59.O4,#84E2\>J1U*&*LGC$
M*7ZF%KO NRQCE$6EPGURCQTNY4Y[5RF>4953K'A@P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P.?OK+QQ,_2UP5)-QUOR6M8E5L L5MH;#9 4 R
M(U9!F95-)84\_=;,G;47'T&$'),"KM#?)3L>269H_P"Y=N.N36.41%*E _'W
MRHQP8)##O:4/48B)94KQDFH_/\)L8C 0?\<7!MDWE;EW+Q VVTDQ>M7KATB9
M[:\DU^VSM9=/HUNPZ)=\Y>;OD<@URU]);S]:Q^PJDBVY^C((:-5?N3$J;F]2
M/H$M(ER$"%-#)#M^1&.>.FW8A(%P)VW9IJMWBZ6B3.-:1JB4OXZ^4UK%BX^*
M^XV;B1'P3-JZ(2B3F5$ ,A:QVM'?!F*JL:D[<,6^K%&2A95LKPJDZ!D6K/OC
MZ)_:D7=A?!M%2>1?D?@D[@#F0^OHX7K8+?\ -K,EL>'.#?[A2MY?*QTC:5CI
MJ9A9!J491YE_.,_N[<,^G7<CX<<*-N@H_CHDY8UPU9XU0WR+RZ96<2CGHQ[!
M(FQ]$G>*I&28B,:+ITSPFWE068/T([&IM_>'\%-IC( B$7)*ATY!&0P3MX]8
MK(=?F%X\XY-XIGSY[V%'R9VZ/2PDL@/JB5Q&)1N(2(J0!/[$=5S4L*C5BS'^
M8K,"]6[U(8G))$HT;J;38OY!]G/[O*7/? F<>4<T'K^0OE$#M1S.+>VV)+C1
MZ$FB+V:28P_((?VNZ/.RC$>HTJ723L/)?Y-%%\Q=<](N4D$_KTG^+G71=V'1
MC"7B'Y)A?4Z)0WVQPX,3BEZY *N)%*9"@Z%W9&34?+S*:-B0^N7*']F2@2B1
M -!S5DP=#6':;KA?IZJJHG",L.<-U]&>)_;-LRC4NKGTW&ZPDJU>4L*_GDGL
MT?-0EE5^8#&9-,QT,T.X DQY!ZR7[29KJ)</^.N47FM);ZUHD98QQALXKRS[
MN+5MZ8B]C^F&94M92=7KTLUCTXF A*MEH=(6IT\,U.V$'$304D7$,FX5R^1T
M_P"R^D.R+AL@N[<H=TO&XJ$.*>%/D4CT'3!P#V(V9R$+!U@\4*R2:R\PX&&C
M;WS\7DP=<ZXKUV94A"A:MI!^G]-=%&S0FF@DNEPLYUP7=CTT7HOVB[@N?PYZ
M"H%\;CS^W;6JVX(4',FI Z<13969)2%M&-OBS&$!WXD"@V?M^-H<BWJXY#G\
M.UR':6W2YF)B,HGDY#3OXY_=\QL+T-8Z,+H-MU?T,])0E"JR'H:9O*6J-2^Z
MW[@"=GU7$TZ&Y6C=W+]<:<3.1;[73ES=T\019"NEOS;-QGC%<79#U+3ES6/6
MM;#*3DL;"SJO99LXNSE4GET/B\I%D:@LNJ7XLD?AH:0F6O EW82)UKQL<Z27
M>!T4^M(==\ND#G$Q'%2,'X]^3.,22/BPWM@'W5D9G]2$&K9_V6<RXC!85%TP
M,C#.=O804%HL'RK;A3^(44<_R_2G2KXGIRG^=8UNPZ:O9?WDCY'9I>4_L>G?
M4L<A8$KHT.@J9*<S)ES&XT^W!"X *VKL=5Y:)!U@$CAZFB3OMZ67D;-WWI7]
M377:'18RQJIA(%->3/:$&NXE8=B>GO\ ),&FE-'XC,X64D)[\@ZU',ELDM%I
MK&.V<2#L=1&+1B4,0C8-OAMWK>U2"SAPY;-]=DF<:TC56X'X5^3R-0R/L8[Z
MZBXJ7!(3"H.R)$['L.7N!+*'BFR[I;4D*U8S[E363SYGV550(BOV&PMYT(VY
M<H-^%E2[L.FB?:S\K^]0-]4O:U@^E DGBL/>6*-M^%IRV3N^+3"RQR(> "X7
M7%>1UA VD;.CNRB,7XX?-DDU-#=%5&NOOV2<L:J(11'?-/ROR(HTD[CU8VK4
M)W/K!)N8!() VF!OMAN82Y.(GU"H^MG H;'R$"5'#=0U)9ZU9;YT7T4T2^K=
M(MX=&Z/_ !_\@SX-_:1/U<VE(#B./!K$@;FYY@8:$W1%F:(.I*F(J?A2P>BK
M_P#W3!=1X)5C;5CPFAR\X>KIH$W8]&X33R][UXKZBH=4?IL'#"%>>>N*ZEA=
MT=/.$7EI-XV2%/)NLU(P&3/;&;R%15FBV7)NQ;B-+-.B2*)%=;IKH1ECSCF\
M]\4!\@4ILAF \^^B"M=P:*^=*_C+:Q9[*V9K^Z[*TWO@/.^R<*%0-VL8EA_3
M^'/%Y.HL*Y [::5',7RBCANF(G'G'-ME*^<O>,*W-WEA^M$9@7D5-3N%QE5_
MOF1A(78BL-ID;4LY:Q]>!QAL2<Q.4AIHY,+**<]G$B;+M9'[]=\-Q,X\HYH5
M5\9?(=(!#IC*_6R2H]WT'%MX=NP927'BXBF[L4P88D9JUJN(2683/@ZXBBC,
M_P!MQB_#)D[9](_C_P!;LN[#HO7XVBOH",5>=WZ0EQN53@K94Y[CG!_H'LH%
MJB/$]0FJ$RW,<</ _$IE<&B[.2'M(KK<\GC;SC77///*?!G*KTX+9X9,!@,!
M@,!@,!@:):!:? :VGINJHB*GUF"8A(B-?P<Y(N(B&ETQ9BG3B.1PI*%6C]*/
ML#!9-)!5WTCWRAQWOO>OIK>]%BKUX*?>#;3])V964=+7A#A*:S]A('DMF#N?
MK;F0FST#_3635B^ISJFH!_CX5"">G@ULW6)DW3=L/1_*Z)]K=$%2Y1$3HOYA
MDP& P& P& P*4?(TS-?\C7JB31FP;%K"55K1%KVO%)E5TS*063C)16E?R.81
M[[S0GM-=<*H6%)?NLU/J@\;ZZ25UOCK>L-8_U0XQQ7TMZ4\]^D/(L3CEYR:R
M*UL*@/C$;VC%+[-26TSTD/>T?0]Z0Z9S>,2YS*!"\6E G237;=59J3069#6C
M'E)%%+[MG2HRQF?G^4,Y\>/R.^B+"N+QA3=B3ZKUZTN.CPCMHJ2;2NRK+F-E
MN*_L^Q9%&)79V[#)'JYL]H.B;4P"'R&/*!)+#$GZS8OHDVX:83+&*F>=O/Z
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M]2^AO8'@R,2><UK7,,-2'SK_ )#JFJ7O);=GR"[OCL]%^@I0<U.F<[/")54
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M!-IKTW>D^JKY'13QZ"',ZC\_WBM6D@@*JK&PAQJ-B+7 Q:7<_P &<,=,^;#
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MU-F+"15P#).Y67!V%*^T",'.K..F3-)BR1[XD3G7UY3;-T>3>4:.PV&# 8#
M8# 8$?VC:]8TC!CEFW%8,-JVNXRD@M()O/I&)B<6#INW2+%I_('#;ID/;=O'
MSE-!'GI372JRG/'&M]=:UL1$SI'%SC)V;[)NKRF6O7S[Z"\]@!KH'.),&DZ-
M3%)DNJ)@) \V=(QXDI.R,3=*F',;51VX7&/4T4U-ZTGM7C[\-U$95,,9\-OR
M'G_D2\T3"8V )%![:I:X)72MB;!I=-1,C5"M!1Z+31F/WOO@6I(XL>;?N-D^
MMHIDF[G:.N$.DD^!GCMG3@ZWX8/K@?Y]=?\ S=?_ #\!]=?_ #=?_/P'UU_M
M^NOIK_;OZ_[,#_<#_/KK_P";K_Y^!_OUUO\ V;^N P& P/Y.K DMNQSY);M\
MA1B86"^<51?WICY1XVQ;RB1N5%H!*?!(N/5S%^&>R"G[D*#>MIB^5:B.N.AO
M[;76N$=;YY^AVTV;O"OS_D@3R)#JCG5>3F%Q*;26<PBP/@@HGV#Z"Y"7[9D@
M5Y]PBS]AED;1DQ\7/U341M0NNT==$V:;EER]3'<)NFO2:&N<+-W<\=U?@Q<>
MKF,<RKX>HAP?K'F,VA\8"OHJPV'J7V'Z*J6$2RV)7(?++J46&.ED7F!,])+2
M?=EG6QP=?K0;:#IW]B:'/.LA<^:=>/3YI^_^41R^11R]J]6$S1C%>(M\>?L.
MSA3LEZ,G-!$8Q+H59-!=A[%J1E$2HQC;/H&+LWKE.+14GVBQ,+.E4E5N.=?;
MW4[7#\86:XK*?G_E?KJM&%X3 9YPL&D(Y\L!N#RHQ(QYI&]*NC(KS.P"%6C<
MZV9#:O-&YD%G9V/<*(C%Y(&4^]/7"G6]DTV7SX.]%&F"L@IRLCARSX)=1@M"
M8Z_)VY5XYH(KJR'KH:@JXF<)%L)-,V0^,GU.MN&:*18EQPCWSK3A77^O9SGB
ME3"& P& P&!QYE/R%RL44/MUIM3T95CKIBE*09N'F(\A7!&0]R%Y%(%(YK9M
MGUWS+9\_CL5?$'7 T&T9MFJ?*G*BJ2K=58)\\L^PC5VSS4&**1Z0+;$SWL]N
M,PJ314I6$F@!R+C^0$W45E5B0PR-L0!+&QV-DV!AOM^(40<<L^DG/*B0="L!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@0]:]!U-=_0'NS8KU(
ME8RF60#K('Y/'5T&9U00N8&.5XN:"K$PY%Y'Q[E5FZZ6:].A[5?\?YFZ/?!8
MF8X-!D'C+S3* 2D;,UBV6$JC& 7M)G)YJ(=[#CVUF,4Q?\J(DC MR/=CKCD[
M1XCI?2;]F9<-W.ED=\\<C=*2V5)58/L43;+.'L$;"!56I20J2?LD^UVE6+'1
MDE4A_+%1]V+58=FP[9?:O:'3GZI:Y_+]F^N=BYJN2O< ^.CQ95W*?,#H<!'^
M6]AUI:+#21^;/?XF6TT0/%:HT#V3D[W8**5V0E!)4/'6?X(\QZ?K_B9<Z5[^
MI=V4\99L[X@H0G75/4X(CS^)5'3D_EL^#P2-R.4C6Y)Q-HC;48D(9U(FIY"6
MM!!%S<)-XLD@^YX5U_W3KG;/OM'8W3=\VZGO)_GN2M$F!:MA_;)*3'I9MJP,
M24,@Y)2EH)82@>02#&A_!.)25D!8HD +C2H-ZFS1Y6:=Z3XUHERT:,>'J("!
M9>.,AC4H+3:P)989:5N)=,P<E'E)':%CVDS:0\K'9(,>U^Q"%+1*H:X J#>7
MR;E;MWRMVX7WV7=+,F?$_F(^[:O2-8)?F&,V \!P/EL[#-8DR8@PT84;0AB'
ME#!E!DC<:CS(<7T(39?S;!MPW(?LI:^S9-TLT)\D^>P9.-%Q5?<M'<2*@CH9
M+4IFJHSHQ%A,7"Q4D:"KR-4-*'<590L9T+[)H/-C733ERV_$YZ[5Z&Z6YQ6C
MJYA-@3.S8PQDHR56$2<&ICQJPK#>10R;=#0 9<YW7Y"5.H"S-="(NP;:=MQB
M+CA!OKCGO7/7>NA<U341WD[SX*:),65=-.6K=4:JV27/2I[^KH+(;)E0=LU[
M>G7"C9@).6](U6S;C?+=#@GTCQQRBDW32%R\[[R'YS)N-.']9#W7&H%S6G8Y
M4W*=@UXDG!B=9(I.H]H[H$\/MZZ-.P21I5MV:2$N5&O+O2/>^-C=*))/\?\
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M^A^S^K^#B1FB_#+7'[:GW?@TG]_U_P!7W?3GZ"9F>*2\(8# 8# 8# 8# 8#
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MC-\>OX85K?QG3_J#TLSF%RV<WC!V\O3,!(1&G*W,^9B,M>U' V<1:PR1S"1
MF3']79K8QMKZ(:=:5I-1CRXTI%8]Y^K(YYZB\7FWJ.0OHIKY3?D)J2\?1=I7
ME+?*@=Q'JC'6^XIF(R6YJ:C9@Q2,0.2R/MTQ8B.M&3!T0:,A//7#9PHDK&HB
M+TC_ $QXOZ3/$\^+6GY \R6.>$V0#,S:BZQDA(7<!!F7M%L[*1$4Z5ZGAA@"
MB[0S)G/7?Y73SD8._;4[VKTV0Z[VEQ7'+3*86?PA@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,#GW\C_EYYZ@I> C(I  ,XLZL_2/F"U8&Z-/1HQQ$&<&]$5;)K+D
M@4@7>,V+<DWJP.8X^S>^EG*?72"//2JO'.S6,U/A4MFNBD7EM>9;LK7BJWKL
M[(IS8A:,QJUI:%L;DH1=V*1(L9D#*2&0RD=%8[(!SA5Z%%;69] !SE-CRU9?
MB_6X$34Q+" J^]. ["OM...GD?BR]>60&I[;Z01U:K&9E89!&WGQK!J_'K.'
M<(3KM >?;R/:P]DD26>-E.=O>$^-MAII:IH>@_?3,W ) A*ILQ<N&];"IV<?
MGXB[G*K"*V3?\C$"#G/^9"C=_$8NQG;+;[E<Y)U7C)XCQMD14;J-VQJ\%A:-
MJ"]4+<JR;VT,MW\H.L[P@\S,';O&2,,K-IJGY[(NI,!C,?D3?H/ I,>A,A[
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MLS-7HF#"& P& P& P& P& P& P& P& P&!QV\==3YAZ.+EFK2HB;:QAM@E+
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M0_/,>>D(X>I8',V0\>2''FW*K;5U3NRH>TXV]^ULIN-O>/N3^Y;ZDQJKGJC
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MAT@FKS&_-&L0LV'A?AN*PZWX:'],0<#'O3;]L-Z4&7'44??,B-L2*QI!'6$
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MT.9L>A.M&.1VU63Y9XF3%C23$1&G5"*?OWT"3KES-P,2K5\@)#O%2)9>-'&
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MZVHIMD@CRBHN9RQVKT89,!@0SZ*J7_/5"W%2?\US'-6Q6\PK[9_IALIH-S+
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MHV2R4;8][&&U><3(HQC@AC(S"Q1<MI(BLBKM?M%=;OK[OO5WT6KC2;=>,,&
MP(IL*BJ6MI^P*6C5%>6&2%"78$8_F<0!21X/"/Y%%9<]$LW!9DZ5;CG<H@P8
M@HCQO7';P6U5WK[T4]\EB9C@YAMY4O;LJM"05K\5%>6E'X?=MTUAU9!RT*$B
MI27R>L[8LJ-S21]A#85V:9)EYV:D;Y/;OO;A7HNY6Z^G3I7?<:X<<DS^9HE0
M]\K6D L'PS5E*3_S?:KB DXD_9U=8C9F4GE$53(%ST>DD4%\C>49!6,H#"W:
M?V\+<\#N$5-?1%+[:3,QPFUW*_I.GZH)RPU6-80.OB\[7&N9H2AT5#1QY*G
M;1#^*6/.!3-JH44'[+.ND=K;ZWQTY5ZU_53O>S,S,\4GX0P& P&!_,7[H^.J
M/?)GZ\&VMXX]Q6'2$HJ:Y(Q&_7HL8)LAO%F,EJ1A.ZD8SNCSQ6/LH2V](0@>
M2+Q)51@]7:Z;O.57':2S---Y';'+9C64/Z*::JN&T74M:TM7:+UO!:F@T7KJ
M)($R;@R43CT.#M  K10L[Z[=$R6VC#G;A=3?WJK?=UU_7>\KE,S,W/%)>$,"
MBGFJL&\/M&?%&?L![>[3;V9H\5^M*U) 2C;]Z\A30W_>*BMA2QL]*19_'>>6
M_#04!1&N3;Y/2'*;A%!$U,Z<%Z\,F!YE&3-;M519HV5462206[402[[50;J*
M+((J]=<;Z42165Z[XYW]=<]=;WK^N]X'RY%C>/R_8.8\?G=JOU_M:-^?S/ED
M=MEGJOT3U^1VJWW^/I3?U[ZX_P!.]_3^F!^U&#%9'ANLS:*H))=HIH*-T5$4
MT5$.FJB7"?7&^.$E&W?2?7.M?3?&]\[_ *;^F!^?XT=M=!SM@R_9;++N&SC]
M5#\[==TE^!TL@K^/\B2SE#_0IUSO6^^/Z;WO6!\$P@5']?\ $(%I?J:<::_C
M8-./UM.G:3]UIO\ :EK\.G+]#A=3[?I]ZW'/>_KUK6\".K+HRJK@'AA-B1)O
M(!8$H@78C>"1L*Q6<-VG3#EJ7: "8I"0A%6/7X5AI#ER/72^G"J/?.M:T6)F
M."2%A EP1:%W P<N68)K(L2BS)LJ19(N.>N%TFCWM+IRV37X[WKOGCKG76M[
MUOZ_7"'0<1WPZ2Z%CNDW[U(D^3Z8MM\/"+?IMV@_=<;2^UP]1[9([X5[^O?.
MTN-ZWK[>?H'ZX%"TUUW*8UAPY<K\.7+CAFWY7<.4^-)IN%U=)Z45733YUSSW
MUO?6M:^FM_3 _P V)%[_  :V-'[TU7;NFWU9M]_KNFK?]1JY0^J?^Y7;-?\
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MH-2;4ST^+FMRI26E2L+F+_A^^>C1W:9_M)4@MLB\X:BXK7B\,N\L^KY YFB
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M(N4UQNB[:J3^.B]D8=8,3C$QJ]-*;1"'@.GDL.2F4'&A0!#]@V!87*74!X(
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M0(<2804X2]/6M%GK)T!C(/A]T'BP=!;EBUWKIJFGPT4-Y.LN&# 8# 8# 8#
M8# 8# 8# 8# 8# 8# XD?,?\8.O>E3H&1\YF3605E+HA:H>"CH]%Y6)D)6!"
MY*%;#U099%@Y/B_X:8DUU _3U/;MSWO]99NJIUI6Q$3-3HWCW)PX1;^,_P!
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M %%5$F?"^E&BJB6N5M<_=]W/7T.,Q4TG#"& P& P& P& P& P& P& P& P&
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M*A23 P+>\;59DA;QN08.T^>^D]J-GC119NOQI3C?.]\=;U]=;U_MU@>_ 8#
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MX[V2;CBV=U7=*!XLN.<P*L6$-'"W3987N)1=*/-0XQC).GC/0W@=^ARQ9#I
M7^]'E/[.$GSO7V_:NM]PN6%B33ST2-"F\*"58L?>P2*2\/H#'8ZB24KS@Q_,
MPHLT4:CTUTX^V/*?N#]:WSPBZZ_,GSSWO[L&KZD!/GV6!IC9IH#5)T&HU,")
M].#L?C#MHN/J>0D6QAC+#A5CU^P-@,FC#G?7+M3I%@Y9==\_;TG]VAK&C$0,
M9YGM>+KR."1:I95&3Q)+1%5K#8[SR[-0ANI'6Z1T8^$-WJ)F)LE=LTTWB/#A
MBW4TGSKA/O6MC6&&,>?/-827@;@(P>,,'\*B[N.QU!HT^D4"AR#]XD[<C(4-
M3Z!<.E7,F<)*.$FF^O\ OO6^_P#5OGK0N>#>"6J,@<PCQ)Z*KZ/3V2;>@8V2
M;1X0C*R?/!'CHF+8/V _HKTW2)R;\CA/7>D^.WG:BGT^_OK!K/R2]PHFIK?2
M??"G.NU$]]<=:[UI1)3I)7C>^=[UKM-7C?/6O]NNM;UO^NL(_> P& P& P&
MP.8WR."M2<SY%AL=KV>3>W)/=4W2J4E /2LD\L$H66$T':9N7&7MC1:.2HFY
M8$H"P)#OX_\ 3[X74=\[ZZY^SZZ-X<^E*4%ZHMNL;!\WR7T;3M^&((KZFH $
M&5/_ "GVE>(2/6,>L$6,KJ6%:KD%4Q@5,6$:E:[9THV5>)Z^G'WZUUOGZ8:N
M)B:JZZ/Z$,.1@,!@?SV@*DN&S)A?\I\[4[?P:O.O4OI@.Z_@_E6M.E0IN?1^
MZ)D&LN5B:L U/)14)'2N>,B!!)DD\5YXX<:Z_P!/W?3#K<1$75UT7E^.$9S'
M->KX@<@$YA%J1;T(%96Z\GWI"0^I2LRDQ'SW2)V-R!I9DFC\8*<CV=<E0HSD
M?TS3Y:*,.]:WU]WUPQERK@Z6X9,!@,!@,"J,"]G4A/2UD,^2)^$ *SM(W2CZ
MPK1!J5Q6\LM&.3$] 3D,KR8RIP.&S4T/ED;=,]I,]]]*J<Z_%]^NM8:G&86-
MCTNBDNX+*123QZ3\ 31"-G.X\:&FN TB$J:2* "W0URYT.-#5>M<N&JWV+H]
M;^G?.MX9;#@> H-:&!KX4^TXVR(M5V3K35Z]'.=MW*?22ND'XYPT?LUOLZW]
MJJ*J:O&_Z\]:WK6\"F/FN84A,9W(BE4@;S35>BCCG<HL&<62=A!H?Q)&J#KN
M/1^;V5)41;AR0YTHVW_$,%DFO/:>OQ<;VET:FXC5=W#)@,!@,!@,!@<J?ELK
M>76+3] ])5C-KSHN#>LJEGOK2CJ[$/)1*;1\^!!TO;DA?$"'+)D;/ 1NP2$?
M.E8R@FY5,#Q:J?+=Q]OX>S>$U/2:<5)WY%LBUV3=AY_\J/JR\D65\N_FNP?/
M-!^B_-\L)U=!H?'O)-GQ>^+BGOEU9W&S5<4'/[:6141%/E(ZDJ^WI[M%MIYQ
MRI'2,HCC.NWE\^KL9\.U-36B*E]55]/H RK8ZQ]V^@W+<!#((8JZC7L?7;0G
MB.2;SC6QGMXI#*;D0A%)PW:HORB/9C9%;ETI^7?*=<\YN8GP==<,& P*K^LO
M.$J]+Q.MXU$O1UT>:G4"NJN[9)R2D3#0,;G02#OG+LA5TH6=HK<.85+N7'.G
MB/TZXZ[02VHFLGSTEV6)ISU]3^*[TM>W?23V$C8LZA]\J-R$F:.Y8+8DB6Z8
MH*M$?/:JXQ;>^^.%KTY/)+]+?;ILV:)+]?7A7C#<91$1U2=&O.GHP[Z;6E4Z
MCA$!3[F[&<\D(T7<IMV"D7$4:^O6@(_R'XF+T^Z9ET9[7"JHQQPT9<KB>FW\
M>BQ%L^527%>*3O E97IYY@PJG+R$/I*;6 #3:-L,#3!W&& P!#:QCP2IW -(
MFNG&WL'6>O0H[H>ARQ-,P?157K;Y\Z^HRJ=85%)4'ZMKRNSA"2=S96#1:>32
M52MGU:A\]8-@0 NE5?\ >(4N^B!LFW?]S ?'S8]D89,@"_XWRI$D.&+J.%NB
MW$RW?S%1-_$C'GVXWC&=1P"((1IPB$E]H2MT8"UH\F'NDF>!F )POUV<[<1Z
MS:YYUV];J.G*+-O]-Z_CN/QB9C6/CDVF2><?14VO&PB,CCK\'4<MLV"$)+P/
MN@RD(E<.A5P28KLORUYF:TE&]%:@+#VSUCQR,:\N&S@>BU_21;+NR7%>)Y.\
MW^BH?>U861<;!Y('$;IF2QF06@]MC4R;E>Y-6WED2#B R.*E7:VG<;E=9RCM
M^3TW23=JN-.^5W/9!QM(93%:( EOD7V5M[;! !!WKZ5R^.\!U+&W?KIJ<.67
M%I5ZOE4!M6/#^I>.8 (PS6L^,)[9OD^U1>TM;:"NU&"#G@N['X_!-M>>4KVA
M-\0:3#V1R!53'[MO^Q28X%8,=;ANM6#?-OV2^E$G;*E2[\D/L"M9O'Q"@]!I
MVLF_"+:7[9(Z1=N"3E%>.C(2FJKDL.=7UQ'>)O.ZMKJYHRQ"0?4Z.P5S9\5F
MDG:6MZ*@PPR;(1T=US'9ET,;#%>GR(Q0<Q<"DW22*SA+0N(CQ1^4\U^W5XF_
M@Q H?(/G57D5'U@-KS78<=R0EY1K"G_[<07Z*,)4F8&61$BA+LSM)!'?3I,C
MPKMZX<:2+>-VM];WD?FW+C@[1V<D\9H41YVE-62P!$SX!%><M'U@UJ9'P"3J
MR$'(I7U$B0"+N>';H6\'/E..^DNW?^]PS&51XVKDX\N>EQ[BKG+/L^2-;F]@
MRTT12N4BGQ 928]0 9O_ 'V4'D9 FE- IGSN,[B[40ARY0')]\COUD&;QTX1
M+NAK%?43Z-B<_J:$3<]+52MA6:;?S;MO8LUEK2.^98HY@-PU]$W!E%3D6T(T
M^7@#2J'3U;M!Y+D),Z,]=N%'CSEN69B?DL!:%7^B&,_]$\5M3U;V$*MV4-[7
MCL^F,U_@>HH2 >7A]+H0L-H*\#SV*62ZF$1:]C3HY;AFS$&WO73QJZ2YX5,Q
M6EH-CWE3TCJ/%')\#*U4@ X8+B4$U=2K-V^@*_M*96E,Z^:="YHI&1A>1^8B
M;&+IN'3WM)MSKL:F_P"&FNG79K='+XT(UY"]&1CSN$(QV-!@?H>IU8D&IF/.
MIRQ+MAL=ZU9PF8N2,Z7Z6TH]<!/04@_+UWO:C[L$QZ[^JG7'7(W1?@PUR>'K
M>+-[&K.*15U)JV:P0;&X6F1M30X!,JPA%8TE':\H]K"7)UHTCT@CUEP(K(]E
M%D&K'GMS]W[O79!VBC",HX\VPS[S%ZH55E<VC9N21J2AUI<I7A9K9TF)K1*.
M'K9]ZR-TDA&0A,DF6=-J]M2NT.&Z31ZZ^UBDU:ZZ[')<\TB<?C\&4HJ$3"V/
M(=\QB*Q&2Q?F;7T/D-6P2QYP7/E1=>@'U,_N[2+R]Z])MP:QB)FUVR?77X.E
M.NOQ?72G/71)XQ\FER[R)ZL;Q:3:BJDJ>2 N<BTS1'<7:4V'*3]G/_8#A<A)
MT'TO!D$HRA$YS7OYMA2PE^-V-:NF";MP%3'N"Q.//XX,F,\<WU'14D[B\8=1
MIU'7-[R6) 8];CP<'D$OG/M5Q=?!,2WXD"8]-_,*87[%(.S*;=1FJLLV7_73
M654[&Z/CY,5-O*'IFR(1;\;G5>DI2YLZD;YCL51*^@'38+7SV;23U <90$Z$
M'&-B9F\F'4^A'"2ZB78Q@D,^Y1RAL.P1=0C*(IO2/G#U+S8?)A)E(FPQ:PE3
ME<%.[D539TC!6]M6#*9I%C,8;R!PTE/=M5,;"1IJD@F21&J#OIWVU21274J7
M%,S&/)]\,/(UMTB1>&$I1+"_G(G%W"MEKR(J*?1RNO."=O&Q<HE#F0?QA7_)
MT-DY-':VE4G3[K]K2?7[._N&Z+MX[N\Q>H#$JLQM7TDG9Q<I6TN!PRX#-R;!
MD%(L_P#,DZKMK49*.!EP+5A+RGH0N.F'$@:BT&[;A+E7]M)PT2;]B)CX^;%6
M!XQNU6<6(;KY61#1G)*8+U=I.\)JS0%I!@WD%.H%MC5)5TAPH",PJP5^=.>%
M=<K/UE5]*=$-[ZG,C*/C\76L&^)$1_[18(XCSS]XLW_C'3T>06_49%7K(<0_
M9%N'3/\ $:'-TGJ:?W_E13<<IJ\\J\]\\UAE\!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,""+^K>86$"ASROB,<8S>NIXSGL:1F.BVHJ5><QF50UX..K ON+
MMF^@\R<N$>T.%.OVFZ7/7/V===<EB:5?K?QI/H:QL0*4FT1?,"'EUMYCA1 <
MQDW"I(4-:&N ,JD\?+DR@B&$A6S*J3]&/J?AD:RG3]]]''""2)J<HG7Q1XZ^
M/28-$F0P-88LL,3D0 LB3GY2<3*7Q-]J TG%#$^B\G.D"AMS/HD]IU746VZ=
M:1'#Y"[;IJMTN-(JC=#76OQT6,!;5X*C,OJ@<%BIB"R$FBA%R XAP?CM4417
MLK)@B3=DZ=-]3YW6AI4FGQTT[?<EDE':KGKA5'L;DK^=_&EH4*4GIT9+JP_N
MLE2BM<12;MXR:=G#,KU)I)+P4FLUJY<-.#(J%+'D @]HBY[5V%&I<Z51UURW
M0$Y1*8!?GN=$/-%D4++C\18D;(CMNNG$BC2)I^P"3BZI]9LZ.M$1I33!R5B$
M65F+%LU4[60=DDT5]J\-ONXUA+UM7VTO%MX702)RB:S*GQTLE42E0-Z]C@&0
MH[KO2X"V  @#!2>T6;\X)G3*QF:,Q?ON&;Q^W"-T^45>.&W+4L91'R:Z=^.J
M6]R9 A$)57<9#H/IYMLW1 D?J&C<BL>:SD+$XV*TW49Q=-MN8_[YZ(7&??\
M@50=MB22[7L8-W5'U:^$[E-G3A8ZA'ZB2 V?"G+ HCRDO*K)9P=[$ES5JE]Q
MXX89MYO.E *RR[A9?\CAUUSVKS]NON[+.44OWY$\_P @\[P.01>1%(R]=%Y
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M0=->CQ00$&#2)OIDGM%ET7>LFR+DETT2ZWREM;KO\?._IS]-8&Q8# 8# 8#
MYH?(B&;S$]Y&KP35*MD6;-;HG#>L"R7I^W_)NZ]*@:#M.2R>0[LJD8])IJYT
M7A(H@)_C^6VVSC]_ZJ]<ZX^N&\-+GE_%3204A/Z7GGG&8WMY]='H@OZFH",!
MG'?RR>W;ZYB<^E-@# L#G6ZFM:L@$$F6HC)':#S]9ZZ3Y_W?W\_7KG6L-;KX
M=.D._6'(P& P. D7HNQ;EE5^S:C//SJ/PGKU+Z7CSSKGY:_<5&\R6<1.YIA'
M+!G&JGJVL#L%A&IM,AKTGIDP=*I\:<_7>]=;WK4==VWCTZ0NO\=0EK$^_6$
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M -)Z^VV0VJU;KZ;]+=C;_%[)'\@7FJ%\2B82&EI:%D>I2Y3#;<QFKTI)9R(
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M?PZ':"J:'*B7:(C_ +KQOG>M\MO]UK_1_IP/.0B<6+,.!16-1\F+3*Z.<#2
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M+-54BJ;ENWZ_9WINAI,;I>9YXV\YOEF3AQ G.UFBHG:ZJ<TGJ2IQD' PF-H
MI8JG)^59C&'PRMP6R LKT\8%'(M%P\177UTIT7=+2X3X.HR,Q<H#.-I1+3)N
M72*6D9DK.)['I&BH?EEI2;H''7T?EC-S#8SPA<DB8N1PE5DQ(-RSS]E'O]I7
M6QNEODI\LUW-;R W;)^RI%Q%X%&(4!AR10P,BR#B)S,G-PI\N-%%F8^4.!9A
MZ@LQ;DVSI >[9(NF^N''.N]$N8BGO%^4J$"GH1(AL$Y;OJ\B$=@\8:;D4K6
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M.$7#)JV3113WMMRGP2LKI'4L]+?':P'$)7,:[C'0V/P.7<!#);S[V12E-3O
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M\<,JP>B1'F<ZZBB?H)Z+:NHB)E=C1G1 _)(_WP"CC^'BI:^^H!^PY-CFA62
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M_4@FH>Y#ZUSO6DVO'21)W5KP="\,F P& P& P& P& P& P& P& P& P& P&
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MRL>6,0M"TRDM 224[CS]R=8ZK*P1\3CC-L/A/9N<M">PB3)@S8/1(]X@FW_
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M'LB.'D!C5>B=IM6*I9@Y[>J\_A634':Y[&[*>3:R_@:HX8(D^GWJ>O(R!C$
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MDSRU:^.2&4 8&QD$\7%2,',(Y-XY&JZCNKLC' 3E!D:M*!#:^[9 71%1/;Q
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M@1C*DE+>3*4B\XZ>+AFSA-=Q,):[2X1^YEVL@HX=]&\IT^/YNLF&%+/9%?\
MIV;C:_Z\RSIU#BB),^+G.N#[<&CJ.]#V<X"&6O[+1XD\,*3:NQL:ZUKG7202
M5$U-;^G.]8:QF(XJ"M/$_K*96374NMXU*'ZZTZ%2::'8Q=+@)N*,%)%2\]-C
MPS,4Y&]J*"RS.1AA#]HCLHW%LDT^5D.%&_6C6[&(T3K:%?\ R OX+Y491$J0
M6FL&@L&<7(9'6,,'?W#/A$KK7N;#Y0Q4,1L!)6!Z"BSJ+=RJV-M%GSOKGMFS
MWVD02)$XZVB:)47Z+H#SM4M9(QJ?=GY+Z?AG$KCE&V2SB)\M78[RAJ/$6[JQ
M$E&3*,"DIU D=J**NV/YMMT$^''/;A+GHMQ,WX?NVGFH?DK'"RCWBP7AVSH_
M&FY5<RO98MI55K2 :4JQQ"XA'H7R,;JU_H4!&2=G)B*C-HF:=O$W'_>N5DN!
M9+Q_!B(I1'R8@9E".Y%<I:5 03P3&T"6I@U[3V%KF1?V<[F]@CO[@CS(V4OV
MIHTP,+-]"9!T(DAA_P#CX'+<\/\ 1;PZ)P\M4]ZX@MC\M;CFE@2J O*,CX@Z
M?EUM<2=\WM!:)UOR=4B;08]TW[4[F*<G<*N%PPU8?M1+EJ1(LEF[(63*<>2O
M +RA[TL"85@AZ#LP\0@T,LH'/UW,0M3^#D;)V.B4QIE?@65#-&!=JV6A\"!2
MOKI!7AU_.6,;2XZY_5WUA=V,<&-.>;O?\MJZQH7/W9V2&+'JJ01X7N+7'$85
M& LYD=9]1VPBEKATP#IC9(F<KJHLQ3;EJXY8.&[E7[QW[*;].%XW:=+]\O\
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M"0:LQ(SAVT>.>5TEV3Q+['CSKGMQV9RJ]%Y<,F P& P& P& P& P& P& P&
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M? +.J(N5&/" H3Q$X8*>S1$YM14<3B0M^Y0_[RWY:+$VI?I3U*.NR?2>N!,
ME "1U>P*M+MY,N!OZE7V A).P\;KIPNW4[W(BTSCK)Q)F+EISIOJ-+#7RF^>
M2S/GHDQ46USTG[+COFDL5$2" 2R4.6\'BDY )QUP*TO+&9*S64#G3 .W?+H=
M;>5>!)MY(3^_>M*"NN_Q?51/?.RQCN1*7^3BE8\M;C61-$ #ZO\ ENO!!IB;
M0\>4O%BM==JT5M[6P]R_2<D4M2VIGJG&N>5-JMW3;?/]>_IA=DL&I\EPA&)6
M+/$JO&28)7MBH5Z[A]>W+"9M=_;A3T8/\]JE#%0M&;(E'$4W3A<NFW6>J.'"
M*/#5+GMTNGS@VK,L?5\1+4OZ'N\,$?%HO0'5G*]\L"8MQS/1M<01E/\ DO&B
M":O3%(?)Q+]/3/M;K6M?=KKO_3O#.V;B.JJG_P!L]!Z;B6G4$KM(X4GHJ%;.
M+>EZUU2;;1BIY?;#=12[46"X'^Y68V&KM'@3IGP];*NFBV]]-W*:NS6Q(47^
M08=,H<A:P"DIXM34?:UO_ER?NSL1:JUT2L<#%93PF.C6B*S^? X;%9R(+ER;
M!1-OT)?\+CM$>^544R;>5ZHB5^5V+-V+ITXK2/I=NC?\.$ZYOJNU1H#:5]Q:
MA'"]YDDVW7^"]JF)<W(,^2*3SEZV:O4N.]+M>N.I:[/%NTL^2,1"BX$86A->
M%=/J^@MC/NXCZ1KF0.Y"+L&S["K,&%I$<HP&+7C*>'E>K**L1O37O;IXW8I=
M*N5.>>J;4^DO8$1 4D$]"R6,EP55<V1+818TD<OQO:-51Z*3N:5LXLV3\\=Z
MVXA2<KC#7]Y5#[E1@\C^XOSI!JYZX)MUKF^L^]4=5[Y?%>DY'7!",\G"%;M&
M4&GLJ!0=X$:6Q9D:KZ($I_)"/+H/!T6S*6LBAA-QRJH)3_,W4UTLEUK9(BYI
M')#W2W ]TN.+UH@>,^C'Q"+4BZJ:S(S:D%G%C!I&X;'8+Q/1+(:.%N@->L7\
MN=O5D/U. X(QQSUV[8<H."[>/@U" _(P*L&-O9$#KV-&71&7#J\@<$B-Y0:5
M6<8G)^?$H+'Q,\AZ#)AQ5(]7@,])OGA%VM^DR9+<\IKK\\H]Q9PKBEPCZ]>1
M5*:,;#I>80F5P"@+?OL_'5S\8,(.Q%1%V(MP/CAL6[4:%V<O1()NA;U7AKO2
M7W<.F[9?CM+FIMUTGFB6;>^Y= EK2=R&@1HV*UF%H8ZXEA.\8N)&.Q_I&P.J
M^K-X4Z?QE)O&&#9Z@L[.N'*W28MHE]_&W6]_318QOFR!#WJ8'-WI9K3(:;QF
M(4Z2ONS)/5EYPF=A0-9"IG+XJ0?PHBD+%#K&/"VT%)/7;!%=ATEM#]5-19SU
MI/";5P;AMIA4E1R>X>@I&6 8F(8R4DR"*MTGO<7Z>L/YLZWZ>;X2[0  '*Y)
M3C?TZ41;=<<_Z^M82(N:4\Z^1V%=OI"P95E,':D<L6R8>Z4_EHXFD[BD"G50
MU\,M$?UR\5VYB,^-W0*Z$?TY5513<=;UK\6]87:GR(^H04NCOG61-XH;9H^B
MK$EM=AFSAX.[6C3R)0RW)DX)%^DN]INFCQM4;A!/E#Z]\J/$M]?Z>>_H2N/@
M^'J3TXR\TL*R6<A(T6=6?."D*'NYM9L;J*&A%@]>36Q73\_-I0U>#67+@?"5
M6K9+\>^EG2Z>M[YYUUUH1%H;H[WV'ONRA$%B\.BL<;D1E=%5&<ZNJ% ;8[:6
M%1\-O)NZ!4XU9E34D'B LV0:*N6[W2"JS5TJGUM)'[NC4XU%I@N'U2&IV4RN
M&EH6?+'1\*K*501NP=L$4[+)63:_--<Q8(JYWSI@1BLP, MDE5M;229GFZVO
MKKE36B1C<6CL'[.DLF0ASL/0)]L.NN*&YEYM*R.>Q82.M40!8LY,HA(ML$3C
M^L2\@KIPI(Q#=VW>\N![95)UVR>\_JX-J-H=\B!24G:7C1.I8% #=UU-6EUQ
MP?8'I2$1ERYA=LG' >)#XZW>1K]F8SC7+-3MX+9<;T@HHW1Y75Z7YWR78F6A
M_7[BWY)#@LBJ<O7(RUP5E26GY"O*P<H;2X95,K8QF5,#S <@R?PZ2?A+M2#9
MKWR\;KM-KZ_9Y60VGV2<:8"5^]87#KH;5 9@,MX26L&T:W=3E)X%ZC08[7M=
MT5.!#@YSVY3?#A<_,WV*CHY??'7*9K:::WV<.4N])T(QN+;;9'JHQ$?*D/\
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MDX4ZVF6<)AK 'Y.!1^IH-;#:%U)P.L>35C&0++_FKK=5*)N[+A<UGC3BXS'
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MP[V0?&(M%G;%UPW133;_ +"P]$WEP=:L,*F^N9M$(=$Z^_OJKK9LD&]NBEW
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MR')E)"*)J F"4Z:)B $9X*%D&_?/ T=V@AKG@>:9OG#XR2ZO/_,YX#RZ@[I
M./(TB$)1K[XU G4?DDVND ZJRNXW&HU&9X9-3"0V<+EG7(M)P-;IM.^_S$%&
M.T^OM<4J>7-#(6/>3 V@$"C%=^KU)8&.!8U,_(8@CWR5D:M#1R%2:-2VV8SW
M+VU=FXS&(@9BB*15N?T/D;7L6)<;)J(<L4C6O'3YLW([*\5-ZD,4<!3NP1NI
MS7^=SK2% W(2YX&SK.-1GUYU;<OXDZ#0F"CPHA-6(OC1YJFX>R!PH)1:K=HN
M-IDK*[;!,R'E9T;E-;'-W9Z(MJQ*VI2#\<C7$;DUARF.KGKVMN#_ -MG6[F*
M16-%8)MC('Q,DY6%(,V_ Y+M=5=1KPH/-QX0RU7-/,TQK;T=60N77^5K4Y5$
M[G%GUG-W.F'%;#+(LV^Q5F1  TV*826/3H+8$!E#)ZR6<N>&O*;?]=51'M/O
M!.[2=+M^K7]8TK>-8@(1+:[]*1(W/Y#Y]F==Q42VKJ+683_FC;ZVZBL:*2%W
M8;VND S$]4#CI[P^*\N&BS;AN[:<Z=MN5Q$3&NB/)82\]E96-87+$/6TOE-=
M#Z2'[MF;G*Z+._/!ZZ;<9'*W*#GT"FR?3*:$YJ #)/RL<%&N-"FC1JY7[9_N
M)]#7E23K@J+SSY<J=(;8,Y]"E*T<EI8;@,;&29H07JZ65I&+&]2<RFNWX\:!
M/@3@$=5Q7D=VX?NT%MJ\,7":C=PKK"7,S>EM%G\$\W"_-$ROJT89ZLA\8@,?
MGK:R''4Z%R:X;Q@UM/8F1L&.2/FL["FZ,N"3(BU'MTQS=R,?L.6NVHQ-FV[T
MDJ6)FZBFR69,/+5C';,A\.!7?8$]GR%%IN!] I#^S7,8\[B*]]*5G9<'>FRP
MN)!XK%U+KC_/;ERJGT5(/DAZ+9UUSOC!&Z&(GT,H.2Q.E;2W*O6?H-OZ1"\T
ML,CL2ED=%';C@R@BR+K>02TV!WNJFPP $# I U(-=NQ)#\:BHUSI7KOI/0B9
MX:120./5M-2Z&O*E0!WA>3FZ7IF.?V6QCL6C\G8#+?%>B)$0K9Q_=DI@@R.Z
MJP!2$G O$'3KAVR6'((\[744UUH;9N]-$!5:/\3S(LQ"5U4EZ/!@OSMYHJ>5
MS@C(XJ"#0*L:KEAV<0GF8[E]G"I._E00[$5NY46%C2RQ-$<AKI=UPFEO"SNY
M]9>+Z4N"IIS8((?\AS"NZ?1(>GZL?L$X:*4#5\1C=JMI'.JM>RI9@QZCBL-L
M(GIW'I XYE'+!ZR52&:^G*FAK=:6FFS+<JJUUZM@1 'ZW$7S5)X1(H1&8-JO
MVUUK/9%4<N%F)"7*\2$O5R@?==2!QV7=/'S9JB]*,D4>M/ET&^R5,7PI$]/6
M9XOI>6E]5'/?2D.'1^O*>M@_5?2;C</D#9Z9;^4=#"PV7"'$DZL.#2*OFC28
MBU"#1VQ=:2<]<J?E4WA9W3QKXU6<]26%YJ!7;3;NTH[-Y+;U+E8S*:E#1IT-
M%L#QJ\VMHQ42$>.Y'*8G"2>V^J;)&-(&WK1HT("![A!3M]IJELS%UIPEA(U#
MO/5)Q^JK9#QGT+(7DI;$*T\Z4+(%I&2DU>*3H8^/2F 5O7<R(AAT'[&1>(/.
MW3HL^TT" !2K=H];C=Z15&LRCD2MYOC\Z\_BHN?]44Q(QM1450PT<@WYCR#&
M$"K!L>!5E$K>9RP08=\$4['B1,(H_;<[3?+E&G23E=N[0<<EUUX/GY9D/G<3
M;J(BF(EZ7LWN*LS$<BTFF<B@;BN:G@]K6E+/Y9W!!<DGL6D3F*S(U66R.G[4
M29)+!&K+22GXU-H="8FM:9:JM>)O93Y<]&PUB%5O355>A)F<&R79:.;9@).M
MYZIJTA9<=I]IY$9BU[K.(.1.D-Z4;:XV29KZTX35[$[L?P;M=\VIVKX&CXWF
ME.W^:JN.^>B1[F81M>$O175.>?14 2DQA60OK)%S1P2B_1@.W=<]#/W7SE?K
M;=-=/2BG)(N]VEVUZS[6\7#3DV<3-Y,5O[RE-&^H)B8"=N2PED9A=1V%/8"[
MZZ"O7;MF@.@OBHAL@-02[VLXTAS].]O>NN"Q&5?E\?Q;/YRF5:T?YPL&PV)'
MT[W5-$UBU6:P^WU8=*5Q5=5Q O[B$*56:A:KN*3)N\BJ:;32J1]^IR[:_K.^
MF[E-76$G6:TM4/F,>.V$O>0(30/K=C<O3%R*+P,1)86RFT7!Q*LI>ZW,N#:U
MOHP-EJ00KT8JCTY&%EBCM8</Y<(\=BFV^37FXZ4WJ--/CN3.BYG75+34/4AN
M.US#9;((+"MQ#SE%"%^58-B\5&V)'6[P(]:3&15A9X%B9(M1KI,2V<B_Y9TU
MVWUTD/-SXL+!A/Q]\Q.'QT9&;M3 ^?;8\OE)1(Y,1,IO*"MVM$Q'GFN8I=$C
M=G^7C FT95XPYE[53H@R4'/69I^IID^9ONQYO#6TT5U&/,T3J_S0>(3*^953
M+>S1P'SSS:[\6^B<8_QC6URA89+..$A HENM9;7H=_L.])].^R23D2MOA/M;
MGO":W/"T>$?1WB,KY>XJMNPO +4=BUU(K^XX$!5!$MA+:2%?0'HYX [5</\
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M73=AG8]ZVTLFX253P1NB/"=?X+4U<,JCJV+><08<9'2VL@=2>=9:BZ[<<@4
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M!LKH-6FX+)5:ZB,Y)P%44 JZB)W&9F<?D&CNS8S*H]6(VJTCIH7*8_4A%?\
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ML\($7[I3E)!!'CM597KGCCG?6]:V,<<MT:3Q=0HSKZ1N/ZW_ $WH(*UO6_\
M]P;X8GBYQ&KMIBF_DHN92WK>J^JN#_B?R]P"ZLFP(G!M&^A]W^M]D-"/[G+"
M_P"3_0TZ2_/^#[_P_EX^_P"GW\_6<VJF<8KK/[,1>OHWSU;OHKXZHY5%\TQ9
MTB:>MI:6=1^O;2@TT.-Q*'C;U:V<%%A$;.DB"0UNX=))J+])Z2X45XYZZUOO
MG6ZL1,1-]/WAU/PPY-^.O4'FBL6'I^(63Z)HJO9:Q]U^QW#Z+3BW*_BDC9(/
MKPE#IBL\!GI"P)M4GK53E5'I1+G2B77/?/UYWK>S>43-5$\(;Q2]MU3<'R/7
MB=J2S:]M((+\2^;!),Q7,TC<W%CBO^=O4[S^,?D(R2)M&9#]-RFK^%3OE3\:
MG/7T^WK6]B8F,(OK/[.EF&# 8# 8# X 6!X0]K1R)^GI%1LSD(*=W3[6O*TQ
ML0AMEPZJ=)5M+X18K&J9DWM&+Q$/9?3L1;QF,2601TL??CW8X&LU0:;VIMJY
MCK&6.E]'4KR!5]QUI$[2ZO6:2>:SF:W]<TR8N#DY(3$,'KXI.B_-9!X4Q=[Y
M:PF-I09%DKH.WXXX:.55==:^[?TYKGE,3P6UPCX.FK9\V<,GK=!XS>(+-7;1
MTBFX;.FSA/I)=NX05Y[27072[WSWQUK?/7.]ZWK>MX'*?P?-0SBSY=7(H0*8
M?V4)EP#ELW\SU]4$I"C )B$.@J,SD,%LB0[9_P B+DZ3=FP=!!JKYR+?=JZ0
M<,54>C>3J_A@P& P& P.*$]^8+B'S#Y&HZSHS183XBJ^9S^NY&K/5&+:_2-/
M]QD%><>_!S#W7,)U7,[F@L3TX35+[7VXWWVFCO6D^CILTCK*W4?]YP1G /:%
MKVV%=5Y7/C6_I'3<ID O^8G+DL!CT'J67+3Q4($ <E!Z'"MH_B<-44WFFS=E
MTXZ6WQOK29G;-Q$<98IQ\H7D-*R(O5[25S0P=DUF&ZF4*A:QG1&(QB5";J[\
MXL5IA*D0G\0!CDNOA%2*A"?:G3(F524Y24VEQTKH;,JM#U2_,?YAGD<I%].0
M]DU1*[PELOC(N)&81*S/$+9!O2)CRW#I18<A:@&+"*@;)M1BV&#57'&M<$7/
M;93Z:;+K<EG"86<\_P#O?SQZ6KJS;8K-_/M0"JA:\D-R.75A.8://0W@<=)M
M9M!5SX5FE-8T0;1DASQVPZ5<(KM.T7"**N^>.B3C,34J\1'YE_$<Q>?KM"ET
MA&.P<@D7!^7>?+=BD?4&!//CCU2QVF1-Q5IKMY,O/[!W)@;;7/[!(>T[WQQK
MOI'A4NS+X_@WB5_*SXYBG ;6Y-8DF>FYRO FP:$4[9<M/)/AM-UO?\C-*A \
M;<$EHU%*EMD$6(N6Z:_2*;KM/A-15NXX2)LR:3(/D\&-?'?JKUD!I27]I>8?
M1-@>?EX+*%RD>)3EQ7UUQ^HG4K#+]19P_2;ETCO[J#)-DZ7X=)=,>NMK<]]<
MEV>:(ZPVQ?Y8_&S-.G.B,FGXQ>Y31\"S8$JLF[,C7+Z,7NR\Q&>KD9*BM+5H
MW:W^2;Q;[W^N?N(J_=K7Z_*B_ V9:^"3;_\ D*\O^9; D%86W*I2*E\5I97T
M#(FP6N)Y*!8:L/YD[&!Q@E(@ !_'V1"0RX!V'&#U7/#X@3<-T$$N]JZWHD8S
M.L=6A!/E.\C'RE( V)JQ]';SDDGB(L,I4L\Z(5U(8?;[/S\=87.FV#.$ZQX;
MW>1;QCEP1[Y;=D5N>M*?K?5QH;,OX-,!?++YLLMW%&M-E'TCZ+7G6%5D>9G%
MK)A;@S%+8#7$2A5BU:W0@4A[G@N7N:3.(!MK?QC%YTQ7TJ[;]_K<.2[)CCT)
M)\R?@V.0L?/.+"F<C!$H[!Y>CJ*5189HBE%9O3!;T-_/NAZ0!-=NSAE,!5ST
MB3ZU^R%;_C2<):<K)(=CZ>7!N _Y'ZSE_MBO?'-91T[,U#S*T?[[M-0>>"0B
M+R&!U34EPB8M%2[P!T#L$R3AUPBG)))J^1[#INF^U.5.EM\IDV3&.Z4=13Y<
MJ#1MR\*;N41+*HD%6W_)Z9BIS^UYE*8588L!/*,J_4G9RX=%D HTBPG'H&/(
MFAWY5^0C-^B[<./P]*;2+LFHF.C9O3GR5PRI?+->^H*< "K5C%F7PTHR..IF
M1GM<QM%ZC*IW$)!*2#D!5MFSI<$-,5Z^X:;'QQ_V4X[14;:[26X4V(PN:GHQ
M=G?)2WC%"4U/ZQKZ/W-9]Z&/*T1@+2.S*6B/-AR5>JS)X'&7 #TH6JOEI*(Q
M%W$4(K$_T0"AMFC^I^X-9=/4=8(QUUX0KE1GS7H7I;/F2)AO-[T)7%\LO.$>
MDTT)6@R7E5?6WZ<J&[;@A48&PAO#-,YI"@0JAR;(D<V6&.-.7K;M)AWQI76B
MSVZB==8;G;GRUE:J]_K^-NZ@KTZ!9W=Y=HY0JG>?\??!PAZ=AFY2TGT(H3JO
M'?\ ===U8IK>I,^Y/(;9,N>G'V_Z=IX(PO'=S;G[/^5!IXW]6Q;S](ZE0D$+
M.>8[#OHG9NYOT(="9-&!5J/H77246W%R*3W_ " 2JY0:@_V_3Z1?$&_&FZOU
M_K$QPW8WSM;+P-ZB,^SO)E4^D)'7B%42"?[G30Y7C62]S%O%R\$LF8UR18I2
M50)'.RO*CN)=K??MDA]OY/L^F_M^[=3+';E2'_D-]XDO$JWF\<, TJY6]"69
M+:\ZF?H:\E?/M15[Q%:NEEE?S$KGR4 L3;?@QN+?QK5+;+G\CQVES]_]?IA<
M<=U^#YS#Y3O+M2&Y3#[J,2J%22 U#(;8E!T=7EBG:HD3:!1""2^QQM/6+W$Q
MC:UDXN/L<3UR[8->&[KEWKGGKE=)RB@-DSK#0EOE_P#/@^=E@4@@EUQ*#@O.
M#B^BTTEM63R/FFAU+T*W\U-*:U7I&+I''<Z-6,^;-ARB"RK,@HZ1_7[414Y<
M;&R:_'_%M:OR^>'FX7@XYFT_1;-J2FWH*2H\TU:3US!*XK>:SRM9TYG?\;%G
MK:,'X[8];%@/8M=73YR31X3;)KZ53[Z&S)Z;<^2R Q[PO?\ [0IV%R2>=4-)
M3U?FZNLD7**2DS:QXO88.O3T4E362Q9^>BRC!X<2=?DZ&N-]M^N-ZX^O6]<B
M,)G*,9YHN$?+;$:WC=_:]A53(ZCGGF>ZB-36DRI5*:>CX"Q M*=AM[\VYN:!
MZ\ASV/0)I7TV;[>]&1@]RF_2[;-N'2W:?&QLN8V\X;M?_P KWG^K8-8A&N-O
M;3LVOC<I#O*X<#95#>/I75NT'5-B$2<E?Q9\R$#1:WHJ//!2ZB?21Y-US^GT
MIQI51(1A,SKP>@]\KGG&LME$;E(%0SGB\O2-3#=UM#+3LYF-"><+-B55R>9V
M"NRKP0M"V2,ML$ .=K;2=B$215))L0=HZZ<:&R9X(-=_-?5P&+6/N14M:?5H
M5]>Y2K$Z_CT>EA43+H,Q]R;\3J6A$)]_9O .0)!9"Y9/BHUMPHHU?OD!7"RB
MZG*NB_3G\*_:UG_6?K#T717HGRK2]7T745D1WU-+CE? I?-KRE-=EXS+X? Y
MY:TMT3C(BEI\U= $8#!E-L'*1#\[HJORW4001U^SLSCC$Q,S/!'J_P NOF>%
MQ2(F+47E3<S,3MJ(,6-15M<-M"!43KGU00\EI2F2%F=:@G8!-]:/8L6NDX:<
M\_RI+A%DH_;_ (G:Q=DSP;<P^67QL_?4L+ZDEA#B=V&74?'CR]53@:[KLRWO
M5WYC187$FY$\?XW6(>@6"T4;_N[^BA-/K?UTWUM?1-F7\$Y^[/3)3QUY/N#T
M@#@K:S#-:#(XX$P1Y(^XBUDI*2S6-0QDQ<21,-(>Q"7+F1\J]*Z9.-_1/Z?;
M_7ZZ&,;LJ<[Z.^:F+6U<\P@Y*D9(+KF%>/X-Z.)S*$.Y):DX?V/(%:192RBP
M%512"]G#1>&'+S&C%'R"_6^WR"VE6[=+A15.-3VZB^=K;5W\IOC6SE(BQCDZ
MDZ)V:G:VBP.,F*YFPT\K)[1MFSJ/" E&J@7MOMV%LRG)&/-*)JJ-A' [;ERK
MPU5164K,X90P'H[Y#R/G_P!(.:"<^=YZ2$-/*GI;TTUMPP;CH2%3+KSO%8/)
M7\!KYH/<R*2%R*O4U2;%'A%F*1'+?CTWX(:4[VB6,;B[YM\^/7VAKV_3IBRW
M;2I01T+)68(S#:MLF:6*O$_Y*'QB7#V$XZGU/TJ>C\E<LI%I5-!,6Z'NF.T'
M;1\X27U]A,L=LTBKTM\BDS\R>E8K54L\UDR%-2M,X-"6PVL@0A.9<=B]%V1?
M<W.P"G>0#M>0535H*OD!,I/NS(WH:9/L$^&JZ?7W]EC&XN]521OS>2M/RC;O
MH*0>,)6O+:JD/G=$K#J_M:.2Z$!()ZDJJK+FJ^P)Y81V/P<M'V(Z*6NS8&&8
MT ;=(G$-HH:6;*?M)%^G&ZK^(6UC'R1.I'\DTH\ ]4\R9-X\VD:?][_Y*;N;
M 3ZC555O:W]^G*@YBB6@M*RKBR4X\%/Z.N'#R0C72';))/6E-$V>3<ZE88,!
M@,!@,!@,!@,!@,!@,!@,!@,!@5C]<Z"\4_P^**S-L4&V14#N#/8 A"G4H960
MI9T580%PU:V,5!05P.W)GK=,AP4>-FW0[M?7Y.._LZT7'BH#6G_*=*#<-MDU
MZ$LIEJ(R ?8PQI;G]KMB1&<1FI:CEMCS(_)6(]]T22+0J%C$W7&W:;#AZT(]
M"]K(?K])&IOA3$QNHO/$1BM(D[%])G3CN>B"T*)RL!%AC.$&X7YS:Q*6DJ\)
M.^XJFZA#6#GJ;0Y_>=?KFGZVW+13?2RJ/ZY;G6H30]\W4JRB("]_^9*6<UQ'
M(37$9C)Q9A'S P6%ASFH@?\ &M&_(!0NFH;+U,CPY&<)<*,RI,AO\7*V^>42
M;INJ1XQJ7QCV72@/7J[MVI'H=:%>1$.J^B+5M%@%DUY:#6SE/[AYCR#,UM\0
MEA(TFZ=N5$6+AFBSXW^/?2:HO+C21+">^;K-LIS8;[UD+'?S]="%(6'>@H\Z
M5K?FJI,3L)"11HI(1'2T:46G50K%#0I\CI0]N-:07Y409))HB+C2FKAO/OCI
MN"A$C.>@Y >@%D2"3.8BAQ(]0I607X2*QJ-6%9S:00=A%YD'-_W%!6;1P/VX
M:A19-11'M'7;A%'@7ETU:,"<>.K1%0/^(NXU'!52^5!]1<*6?78HG-S]7'X7
M'V"$JBQ^9!7LR 3K24O;-WGZ'VNWCA3GC;55'22G1?-''JVBVH)1+QDTG,)]
M%FV[1O=XBNI<?C$:96)VS)WBVEX!", DFT<)!_Y$JK;;7CMZXVJV'C5/V.M_
MFTEKN)%].2'3$<\F2.KR9*O/0CR+ IB,YG@!K-G804W@EERP;/W,9F;A82!-
MS]M+*BK":DB#)AI+01_H6T>+/N4_SN]U?-$ZPE$G07@XO8Q?0^[(ZS,(6_%F
M[>*-@\.-<""O;&6QE]$>ER<8)+& !-;@FDW>NNUV(-TU^Q+OA3COE0EY5P2[
MZ<JVA1-PD+)MVZ25>&Y97LD:Q,HX#0)5S&DV36+C"0]D=V%7L,_#&O3#DUS&
MW/3H V)[>$5-IK?K_B$3-5"/^*R\N,)<4VU]>DFAU./RRCWS)CS!^^DZ<CG+
M^P7-<IK?VFYX480PJR=NG4DXZZ<J(HNF2SG2B76T1<]&T1V->#XI6M)UF6M"
M)S"KZ!*+6#7$,FPP7*!B .5@I'#(_&NQI2/O5R_,&_OOOI!#GCLN&3TVT\_&
MGS]W0\VL]6&EU8^8&+&Z[(.WS+Y3%F$I.5])1,0%!"[B!JWX<NF)]!F' &,N
M3!EON7>J#"J)%33M-/\ 231ZZ[Y9NN.Q<Z:/)%H]YVO09"Y P]73)6P[.E0L
MRV?/V<3CTC)37B"B73^,F8JQC[8..'$8M)6S91EQW^N\;/$VR#IQM;GM4:QR
MT2&P^,JM&O0'EW84O*,XVY@:HX4] 0+8-?B'1%U"7[TO'4XUQ'"\ID$?>=([
M,+,]OD.4TM;Z5_'KZC?+I;AA@I#%XU+F&A4KCH*3B^5TW7(V0B!YIAITCSWP
MDYTS)-W+?2Z7*O6N>_M^[G76_IO^N\#2N:-I3CKGOBGZMX[XZUUQWS7\3YZY
MZYW]>>N>M"-;YZYWKZZWK_9A;E*.M:YUKGG6M:UK6M:UKZ:UK7]-:UK7]-:U
MK"-.DE=5],72#Z7P2&RIZU;_ *C9Y)(P$..F[7\G:OZR#@FQ=+(M_P JG77V
M<[US]W6]_3Z[W@N7C"535T9)(&8W6\!CY=KI7EL5"0^/"23?2Z7:*VD'S <W
M=(Z614ZXZ^WK7W<[WK?]-X+;]@1T3I^I39!V6,U=71<J_6Z<OR9.$QI^0>N.
M_P#QUW;QT,5<N5N_^WKOKKK?_P W!<LU&H)!X7MWN'0V*1/;_26GVXU'A +;
MW3?[_P &G>Q;-KMSI'\O7V??]WV_=OZ?[=X+;7@,!@,!@,!@,!@,#GO0E#3J
M"6SU)1GJZ'6*Q8[FHFR(BC')X5DLO5(2!H]:/Y>1,^EYI'Q$WA"K7ABB\:1U
MDDD@Y<H?J)<+))H&IFXX.A&&3 8# 8# X7D/@II1P-GKT9<=B!K+NJ >U(!Z
M"M!$:->EKE:>R9Z/L-P2. 2#UQ' CRHC0=DF$T.00Y=(-N=//S=_3ODZ?4G\
M(K\E^A7B.#-:T]LU88DQJ0QOV]/;4F\VY>,!B*L3YM:HH74)0* TFGTF\;C!
MD,3>MUG.MJ_LK]:W_IXYPSNUB>BDT2^&2,PE3S W"^BYLZ$4D!J,/;"1^#Q@
MJ<] /J8]5.?9L9DKN0)/6'=>'CMZ$GCDVJT;O^7XUSMLGRW[YY<8:^I.NG'_
M ">,)\+<7!SVAYWQ>_9-]2<IFCKA:0455TI./X)(/69_UT!C$./2KDYNK9>*
MELF>@R,H%M^GY4 OM--)BYY3<\#ZFDQ7%87R_P#'%KSK"/7,,*7U*+%1]9+$
MEC/?$(B]?@XH1*Q,[%#DZ9PF++;B#JV)]R:Y?2TVS:"FTB(LF[CM@@II7I6)
M.5S$UP0NG\,=::"LP3B[K"79M0D7!J=: QA)9=M&?CD.?',FK]W*76DE7L..
M=R;OZ:^G!9/2'/\ W;>]93?/'XXVT$Q\*) _3#6KB?L::]2!U=D<NR1V$QIR
MO191"2Q.D:;H^)'JN2'O4#-/V1 @E+LWD?D@PJHNU<D7R;YN2;K?BT7ZFMTM
MB7^.4:;\S^JO,SVYY*F#]+>CY]Z(8RYK$P',CKE]/;9C=T.XRBBZ</!4N1'S
M,*X_&\=(H=J,W>DNTM](Z44)NUB>D*Y[^%^,.)%Y_FQ2]NCDYJN4VA)K"DT@
MH>JI0I/EK:]::]A2I2NQTK1/L*&.JSI5R%X*#."+Q.,O5VR>TW6TWB4I?J2M
M%ZF^.B"^J3GHXU*; DH'_F)\MUUYE)#6 <$3&QMM6%ISFW(Y,TFQ--3D\X<2
M*9Z0?#77T:.6+7\7UYVMWUJLQE5>$H7K_P"*LM6LO\[SJ%^HY# SU4I3$+:3
M6J:;K2JHM;4 E_HD+Z2<5C&(K#N&(JG(3S)@* )RDST5=DHOVJU<K]NU-OL+
M.=W%-5\]_#)!*!W"FHVY'! -6GH>FKPA+ %3-70$@X'4FQNEF CED2:-L=2*
MT99(=74Z_EY,2<:76X&,^6S1KO;GIP6>Y,_P1P7^!>IM5&E6D2N@HR)#O1ES
M7G'Y)8=/5A<0J/@;AJS_  NVKEE )HT[BKO51P!LRYAI9VFX4$DF"3I1LYYV
MHAV7ZLW?@MI6OQK"*T]E=^K!UU2<B!:'I[, -.NH=%F[ 9,+/HJC*&FA9W-6
M7X"Y!@YCWG\,[9,.&K9NR<K.N=?>GVGRD8G*\:57]*?$<?.L_:%DU[8YJSIK
M=M>>L=TY31EE$:_#0:Y_4SZC"3R9*VC^$@1=#(0<\]QI^.0<L]]MU$'7>NU.
MUDDTC49QI$\EWF/C2P8UXV\T^<ZA]!R.@+'\[B:B<,[/AP-K*PDKD<#CG8F8
M#9Y""[T(A.8)83XD^=/QZSIGWVZ[1<:4Y41YULSNC=,S%Q*$U/BQ="O+M+>9
M(1Z;F$>%>;2?GFP:*DA>MH))^XM>5(3:73F0V;)@_6A'][#+7?RO2+Z/+.V[
M 6BS2_1[3ZZ5Z4+OUF:XH[I?X58%2%K^;)M&K^GI""T"*\_DRE<%HE%%'5C6
MOYMJFY*BKRP74X0Z1)180N!O$PX) 6C55NZ=IMM\.$N$N^%"SW+B=-9=!ZU\
MEPFN?3WI7U-P_P!R&:^C>ZBTLV*@0GWUZVJ>N]UWPRBA_AOT;VTE+/Z.7O"B
MG//Y=?;SK?.&9RN(CHJ3=GQ41;TO.8O8WH&[YE8DL P"FX(3?(P^%11O(>*;
M]7CO3HTJN/ ,V[$:I(6#)2'OT&Z?**@9TLK_ /K'>][+&=:1\:4FBH?(%E^;
M*"U2]&^A2S9,!7_I1G$.Y/!(.Y;\W#=UI2*V(99Y5XH&*N>$:L*2=X/1$\I+
M#2;-?\CM!55-/Z$G*YN7Z]4^,9AZ9UY=E3&^G53V[YCE9V=!YL-JZ#6*"DDE
MEU22:I93LI!9TBN"T/<C9<]<MN>=?>V7_'UQO6^-;P1E5Q6DJHROX>]3"_K2
M]%%?44G[GUC0.Q8>V+.*=K V8!=V=2M95$?&NB$G0.L9%4XQ>MNRHJ$+,D03
M'N0%T?M4Z>:<)FHSJ*K1IJ7P?QA2KD*O*^C)$8$Z\_&Z/69$JSCY.*,4D?6X
M+UW6;>,Q,Y(C/ >HZPD@/F,M84Y=D&CF)?C8[>([2TIL?4UNN?[4DII\/L-W
M4]LUH5NPW^>Y/)6O*TF*Q"K:UKJ/!6:MWVY>+F7PJO8B/8QB-I-RMN.!;(3K
ME9)N-8(;57<N>EW"H^I-WXIIL#XWHI._+GL'S#U:TM#C?7=WV)>1>:MP8!X9
M@9RP)Q&)UV(!C'7&QA8:&(1=))+IWK:BR2G7W_U^F$C.LHRZ*E7+\(@^]H!,
M@%C>L9Y*9[;ULVE;-X3R1556Q()/#-A4$'\Z1E0/5K1,5"8@<I6#QQBO#BOX
MR#H04VZ>:UVX<<*(%CN5.D:"GQ,$K.] ?(3+;!-N8!7_ *%BWDZOZH, "0>1
MR+O_  WW6LNMZ?JQ]1@@-B_^4I)4<5'KLUE7#E3899UUOG2B&L&^HBN2/_9_
MQ+W1,G %OYKF8XCU8UR>L9+<!FP2@4(.C,&]9^@J(] R8,Q#(18T1,M(L>I9
M!)FZ8N6Q/M/_ '/?/7+GMRT&.<<_#\E@IE\.L3D7)]Z&OV9@#Y(Q/I"((NH9
M&3C .:F_R'13Y#DUEQ/;H=LLS"S6*)1WE';A';@2KTMWWIQK6\)OGX^5.@=S
M^:PUS7%Y2N$C*2X,CY4LN<V4""#V;%PPE[R<4[.J>="S;AUK;IBT'CYTJ]3[
M;_13IPWXXZ_T==82)J)CJH4\^'BO7@8>&ZNR>IICP4[!\+\Q^,[442G?R&Q7
MY"G3CKG?'VZ5'RV*IQI+6OZ="ENE^O\ O.M;PUO\/BJ8OOX:X"A;].VX,M]?
MHC6U@V',#R$LINL)Z4.")Q[$EOLQ"/P202IB^6I\JSF$R=Q]Z<&(+DB$;[_'
MQTT=ZX=\#ZFDQ\=%OK@\J3?TUY(LCS5?5NKK&;#F!4GNQ(?&P+1^$AXJ\T[-
MK./)B/XX8%>OX[#@HL(\<]-^>G/:*B_72BO6U>S,95E<*5EOA*JMNRN-"NKK
MG]>+V]#?0\3>=,P@8DQ8)^@O6,+]2%6KYJFZ$NST1$MX*SA"P7ITW0)Q)19N
MJKQVI]W)KZDM6JOXEGU,^L/!TGC3P:>I_P HQOUY+YG+%F\9A*<NG]Z6=*)W
M4T CM11,=R-!1VFBMJREX+73729LFBK=LFGTIKKK0G.\9ZS3HS>_C\3>5U5Y
M=BEFSJOI#75">FJ(#=091B-*MFWI9G7+0C.1$C525(@9? U*Y0<"%4-;XY<+
M;[4UO\?&L,Q-17BA/SUXBN_SR</3K7J=_;=K7)>-537TC8DLKB+1GF?5)4-&
M<TO&J[$1<?\ W"D'D#Q **)/SB3Y%X\)<+J_<DW[_3Z+.43I6CUV+\?)2Q?6
MEE^E"/H20IQFVJ2:^=I54CRMH(=Z"U'U'9..D,5K.RRR2TNK9"9RB3[/&.A_
M.MD7[%GRX_(DU0YX$95C5($KOX<X_%?)'HKR_+O14TG!+T7N@!1RTF\#B43?
M1V&^8X74=<5)'A,08N" 9P_:PJGF*)4BLMM0D\<KN=)H:WPEP)S\VZ(2>E\8
M_ _V=)O6X3T'*A+=_.[/NN)5OJ P]^K$+WM;SA%/,)V9*SY_VL9DT(&02'M7
M@^*.FO+) OOI;M=1+[$.1N\NVOCBZ91,:;"Q:-!Y+)%IE(Q,?##9!+W(L:#<
M2LVQ'-FI62+A0R2 @.L=?I*.NFK3CALWZ5VFESKCGG6&&P8# 8# 8# 8# 8#
M 8# 8# 8# 8# @#TN.J I5VVUZ/6[6ND9U5Y5^T>!=21I(#("Q8R?BL5=QS^
M&D"A]K)I*,:LE&:;155QPMOA/[>]\]:+%WIQ4/N&N_%TU>D)V0]%F8M$I#UI
MVC$X8D$?0]MTK4<?J9DZB(1&#&7@GIO7_P"/6U6.]==)*\??O]9ORGI\FHG+
MA3(RR4>/)PL$@W5YRF/L_P"=N.\!$S;LA_ 1^6L.2V4^/ OWC,6>),2<3DX_
M9,.W=-D>R235IPCV02<J)J#S)%:(T?.Z/LV -O2IMW!H\W#6A.Y@P$#A9,2O
M-) 5MJ9N)>HZB?,8?;LHN<=*/(WTPY[9-U]---$]_;Q@UB;I"D;@GCR6P^RH
MTK8MJNJ^IL)!@$PEY49P*&&W%G%)$2&1H U;11$Z2EK<P>Y&N6+8?PZ0*KHL
M>4>GG"J6BSN_%KIP+Y1EL;NU A?$R7GK(DP.R.53(0V%#I1+&D8L%_'+!0:0
MJ$J,-Q$:AZ'05(_H-N="&HYHJ_013VOVZ&NG1O(CKS\K7L$C5L>G^74[BI>^
MG%C&8H*X3$V,G.KU5G]N5TU_=@6DGR+RRX@F-8* F[ N1[!/4AJ?/7#M) FM
MZ0],YH'R4S@\,%3Z\Y)R-D@U6Q(*>.B@#L:H/A<-A3H,2+#G4#<QA5()%ZL:
M*:9%T..RO:+KCI)53[N$Q$ST>X_/O)E9A5_.:-CV %8A+7AL]>34;$.'\>B)
MZ/R:S)7P'7(MXGS&U @DIY=-CBK=HR5V-3[TIO:*/*B[6%9<6I.X'XD%=&R[
M&]966?M(6;KWD:,<C.EWPZL_,1ZF2Y,:[=Q1J-['I5XLY(?S:KC@ H11WWRY
M_ FJEK1YD?QJO_/S.:S1I9'IQ2.M:[LEOW7,=&QY]'9+ (K4;FQ[<7 D)'+Z
MS$R$&;+,;8?+(KCU^GA!@DJBT?OD5%6R$6YZ)PL*=>>K8UYTGMB3:ST79V'^
MEX4)F(N)-P()=G$!I>MK*E,I%*BB3T"[,F.DT8^*2Y_D73T@W0VSWWI5+@E3
M%P^+"L_*Y."3\:.NV<3Z!1JO9+&7$<Y7C;,/7\(]-[:O'0Y(J^B8-AV9>E#?
M9#299VX?HI])-G26TD>$MBYOAJBU>F_%IQHGI/U').&CJ#G.1O*<1@S0-'@C
M)Q#I8>DX%GW4J(^$"3+ZO>#4>4:?HME72SL@&[644[6TI;RZ)@'1'R!5$1MV
MM1]W%Q#B=2X9,WICB/CBLI8R"(7<U9MQK8NP@"[FR9*C<Y+;1RW(]F#*O+]-
M/>N4>TE>B>:=::U'X=X3CD\KJT&U\Z(E:P&U6Q'.R[$";'$ _595R&A2C<B]
M@KE07M -7XXR6("%VJPM-=;^05:-.^>.!YN%.N&&# 8# 8# 8# 8# 8# 8#
M8# 8# 8&+.%> 04L:48E"? @:])=C0;!8J:?\L6RCGIF)&-M;<$23G2?V((<
M:^]53>N=?UW@<JO!\ T%MF42]Y3LGJ7J1QZ6& D:DH>WD&T6Y.%H*P)"0!R8
MD-PTMT6"P\-V]Z:(=K*;8I=I;13_ #<J&\IT=:<,& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MK.,RZ0AI&/B41L>..6H2",IF-.OG]2&D3G&^.W#9AK\G9!--)H\2Y>!<WU>
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MEM1@\S_3A(=0X;7)-$Q_V*I\\IH=]=\ZZWT9QVSG4QI*H_NCY*K+\(>A/&=
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M&(O^L?I4#N(=1FBB';>'-W25=QY2##NDEFRB$A<?1QRY)K\NE^>QNEO1/Q?
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MZVH/E8:?Z+@'Z_6BFE@YEO\ L:WIMS@VXU<<8A_4CE<3 8# 8# 8# 8# 8#
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M*)/FI"XC@JJ#;UCQ!HC:8]@+?!D"1A)F(Z459,&22G34FWQ8N3^LHC*I+RD
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M *=+L_\ 7-$?_&;'T\B\>OZG_/DU_P"G2[/_ %S1'_QFQ]/(O'K^I_SY-?\
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M(P$*:'4!<':V288I.)'R"1&_SRG._P!_]C776MEWY=>#?"GA;R(69VZ-4H*
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MR,>JI_MI,.%_L4>!6:O6ON^FU6B/6_\ 4EQODER]2T"@SCMBJXA<374&.^2
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M?"2**7'*:222?.N$TTT^-:XX3XXUK6M:UK6M:^FL#Z8# 8# 8# 8# 8# 8#
M8# 8# 8# X\>/:Z>Z] J<.X'?=7*5&QLP>*;G;#8%X7S$Y+(H>0;1M5)>H(D
MG,1$GD23_C2PPN51'/8AWQ^TJDNFJJ;RG3DMK[P_^HQ&O_KY49_]D@%FL/ZH
M^;'*?DHQG=R,!@,!@,!@,!@,!@,!@,!@,"]?A'_ZB!G_ .O;?7_V6)5G#/\
MJEUC^F/DN=F0P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M_;K"XZ1,QQI7CW'\=_C&MO&/J^PH-10.,S6$>=+EE<1D@J1SIJ4C\E 5\?*
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MRP9PZ]M^MP2\C.R"9=O>@\;N:2!P Q--M(V[1JQ$"6J39NDBFFFFDGSK6O\
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MQ-PFU22X7(%"#A1=PMUK:BZRG7??7776][(R.!BSA5($%+&UF9,@B(&O2:K
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M8XR^5A5!?MEL_*+L\C;(20,X0(!6?U'[+#)IQPPW]">6)L[-2%1!R+8E9,C
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M3*U)=S)N9)HJJH1[/[LW;?;3;)'3;3+7>E5/R[YX+?EVK7X0P& P& P& P&
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M*\ZBD'*=C&[M$G(1ZP[OZ<,/SM6^Z;L*KD_P/3'S'+)FR/<V]% QO,+,QN(
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MD=</?L;5G&(VS,\7]$6',P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MG/.V*_:[;;E+Z];XX_V8-DW$<Y:RV^2>K"%F>A*^$TUZ5+@_+JDT9W-<H^N
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MW]OV\_UWK B'_)-Y_P#380_XL5]_Z;"U'4_R3>?_ $V$/^+%??\ IL%1U/\
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M-3,QBCV<B#K+.FZ)4+==9D1ZJ[$F]"/44W35VHCVHU,C'+136M_7EP@HGO\
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M6_MWO7]=?77]-_3>$?[@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@0!$/2$
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M,!@,!@,!@,!@,!@,!@,!@,!@,!@,#D]0'_XX?Y'/_O5?C[__ +MZJR<VY_\
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MJQX82.73EP2D!I5KQM-\_=?DZ_U==:Y$S:W.&3 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
H8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g536430g90j31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g536430g90j31.jpg
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M P,# P,# P,# P,# P,# P,# P,# P/_P  1" *" S0# 1$  A$! Q$!_\0
MD  !  (# 0$! 0$           8'! 4("0," 0H! 0$! 0
M   ! @,0  $$ P$  00" @ & @(" P4#! 8'  $""!,1$A0)%18A%S%!(B,D
M&#(E43-A&7%"-!$!  (! P0! @8# 0$!      $1 B$Q$O!!46$B<8&1H<'1
MX?&Q,A,#0F+_V@ , P$  A$#$0 _ /\ ?Q@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,"F/0M_P!7>6Z<FU]70;>QRLJ]:#'LH,#0
M!V4D&J1DZ+C0SAG'HP.+'BKEX:--D.$FK953?2GU^GTUO>BQ$S-1NKWS[[2\
M]>F6TZW6TK.#C582%A%[$A5IP&>4K84,,%X_N6!$C\#MF.0Z5,VAZ,<]/V+K
M\7IJZ:IJ=IJ=?$K]@G&8W='N)+'&>RNG9\*UV!Y:]G-."K%#8;A]SKIET5^5
M?G^.Y><[UM+:WV:4U_\ 'ZX1_/[-&]O7@W4@";(CDG"Y!A_*L/S6"+1)LN[6
M>-?R/G:I-4'B/:G7?/.N.%>-[^FNN?J&U;.6[QN@[:+HNFCI%)RU=-E>%V[E
MNOQRJBN@LEUTFLBLGUKKGKG>^>N=ZWK?TP/M@><\T_:]X7KZ+^HIA++>>C O
MC>UH]2E_]?Z^L-T_BMBRHG_#@@XH6TC"Y"8M7S_A;C\T0F]9\::K]=J\\HJ;
MY-1AE-1Y=[HRR,+\..^3X?C;,6U-OT5R+1NY&B7R.G#4@2;+*\+CFBR._NY[
M6YXYWKZ_Y_QAE]>Y/&TVVWJDA!\,^7;MAT[[+,.6W+X>DX7?LMK[<:2T[9(-
M%>UD_K]Z?"7>^M:USOZ!RW=?O+ROYX/36-V]:#>)E(#2T<OT[QT DI9!Q7<Q
MGCVL8:I''(0011ELKF$]8]"Q0$9MV:(NE$N4&RGRI_<:C&9V6W"+YKV=/)8.
M:*R.,D(1U$DI(TL*(R2O5&;J9P(=90IDW4F T0W)OF44)\J$4FO:W8MRDNV=
M:2<(+)\$I_+P] U+YTJV37-;4M;1VOXF#[D98JV:O3KSL,DX8-EGPH(";D#)
MM)%0FAOO\1!;?'"FN]_3G_."(F9J$(]*>Q*!\F-H5_N>5&V1VRB94174%@T
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M4<769I,./DVKHO.?$+#,?KR\Q0RM*&C4JG,S U_YWA'H&N&YB1SH+'UIGU[
M$.819YZ=R[8T2JVF4L/REP[9+BE!7*9DCK2"6N=HH<CE,S/F?T9WFC]?+3R0
M>C3RI+KL4B*(RYN<NM*9L*S2[M*+PZB^:1J*#;"P&MH1&H\T@+4:+)]$A[=F
M5*OV/:A)=]^3]$1.7+>&7:7E7R][!L'T$85MQS(I1+:5K/S?886LI_#'I"K%
MJDMN7W57\I0;,F)HC%[+!6$?Z=)\E=+L^_XU'CMGUSRMI0D3.*"2+PW0D=JL
MQ0,Z]0V$+8V"3EMJ3EW(YC3D<FL^O^P_0M;V=&O2J_6X&+;CIS";E"BAL:9#
M&;6*ZT13&N!CSOMOSR7E-W",/?U7>9HJ9@9R57;:[1_))X">6WS(Y;68A#V!
M8Z'HTWZXB+2S&^X&/YT8:7L1?%&0^&_U[:PW?8SI-5CQI+D<YGK;LM2Z/UM5
M;?'I>*^J3MLW"PE41D].3B+Q@42@96#AI)2JDEZC;V/<22"GY''!YM.5..R[
M(:3:,R;I-!PMQTHEKZDC.8QXL5IX#I\C=#*>'[TLJ;W5&95YQN*6*%#M<I2,
MX=I>A;E\W1&6RR/QV'"-#65BAK(.OR';5LQ:N#+'7X.F[=%5MLO*:JM$XBO@
M^+Q/R%/O%G%KV7**AEGF\=YGC;.7\PURYKV',:<ZJ%V2CZ\<BT8=/RTA2ZV8
M?[?JN>-DN^M-M-FWVH<DG*\N7>U6UEY)\_\ G/\ LOIGU*=J(#Z!M&)4U$9W
M<DG*04((K^95]18*DEDJ$LN7QV,S"&#Y>-C*I/391YTY_*75WSK7/.]86<IG
M2-E$TY^GGSN#9Q^V:3]7^@%YG^-7SZO/1$+D]$GI"U:0FOK=J)8J.--:B)PJ
M</YU7EPE&ADN59%2;HB@@03=).^.N^BSG.TQ#H,7^NGS[,)"YM$#;-C2ODM.
MY#+U"S.8Q64L"$BUXQ>?KZ/(NCG(!ZX*.F<&:N'[OM1QVYU*^%>U>OAUTST3
MG.W6]L?SSXP\_P#AJ5HJ1GU'8P*&QD)%C).D9Y9-8BZ\ZF<FA,-H)G;TE:)Q
M,%,W!B>H5PV;,FSHMN/\GE'G8]DFNKI-(3E.4;+FN'PO6-TF_5YV22>=#77K
M[R_&_*5@)!7@%%"/P6,=6]TR.P_3T"^4:RQ?=RD?E5>=/&F_QFWVM^?M4^0D
M93%>I<U.OUC>8+/ 6FW"W//BPN>-_;=;R@A%I= ":0,I[$?TZPN *@X;1A\U
M9R&$DJ1'(#6KGY%&BSARF]3<=;3TD7G/^/R52?\ U%4D3AOI%YYKL%)VKZ<'
M6G5!%T=[K<[%:OA-\6^,+^L5(7+(C7G%DR24K\BBS<8,-R%ZQ&D^>6?6VZ*>
M]HQ8SG2^W4/8Z532OJGBW)V>3&)5W#1.F O9^:201%H^RZ5WPS',UC)]ZQ8)
M+..M<II<]J_>IU_C7UWE<]9;*)S")3V/CI9!I1'9I%3":BPF31,V,D4?*(I+
M*-U51QD.Y>#GJ:;A'M/KI)3K6N^=\[_SK>L&R18&H)GP01<.V,FA AS(BO(*
M/MR9)FP7.F^V3TEP'#I.UDE"97L<-<N--T-=K;0;J=_;]O'6]!LUED6Z*KAP
MJF@@@GVLNNMWRDBBBESOM1553O?/"::?'.]]=;WK6M:^N\"KSUZ4C%8>"L.4
M7'5<;@$IZ0XC$X/6%$@\/D?;ENL[;<@I,0+MPI?IPU;**\:;KJ;[33ZZU]=<
M[WHM3MW2P1-X6??-A@*71<V2>QH9-&8\0?%$GSN'&EW+4-+&S1F[677C19TS
M63;/^.=M5U$N^>.^M\]:T2DHP/Q\B?R;1^3CY=<:4VE]_/R:3ZZZYY4WQ]?N
MUQUUSO6M_3Z;WK>!^\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,"DO2-:CK>H>VZ]?0^/SMQ(Z]E[$#&Y*,#%ACR4*QXDG&N]-Y DJ*0>
M(&>T>D%U?LT@KK7?W<_3[M%B:FW@-*?U]>O8/6_D@YYLB4EI6X//OZKF=?KZ
MIV9UE DS'KE&<^3S#^O[!UR\T(G8&1,Z^.N"_:W2@@KT/YTX=*==-]=G2,L=
M;VO]TTE%(_M:$7W#CM=?[-1KM+V+?LP*1<59]7Q"MR=33+USW*0,EF[T7-1D
MGUM+S[KOEFP>QR<H/$>]L^F(DIWI_@B<*U\?HNKV]^M&=>WO;QPV?,"8!YU/
M>+J[J&6SCJMZRL6:'#PJ_K)FAZ&5P7F#Y:1TQ+&<;,-'2,H'CE^DNW/&T>M.
M6W&^"8YQCC7>U-6MY[_:&B.EI^/33UM+$I;?7MUPQ@-:^E*DA,CA8?J:/6WZ
M_I''C$V?, [2B0D:=OG4O"=OW1=XJZ&[>,'C8?T/X+$X>MH_ECS2M_V;,YYZ
M7DUMW#9]44=_ZA2]&)6Z&O*) J_JSV'#:2JXQ/O0KN))N4).'\TS:71]^TC
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M2J_1207R#^TZG*RG,=H&1VM&6]@C_0DODL&<VG7[T=%S1K]EJMAB!-&M>Y2
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M 8# 8# 8# _G7//?.^>N==<]:WSUSUK6^>M;U]-ZWK?UUO6]8']P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M!CHIRZT[[3TN[0'=)*(FKQO6J6^RIWWK(!\;Z?6#Z$ #P_$;Z M6DVC$7/\
M(8[ZPBR4F9SE%Y/+1>R$T \V+&NFBQ$P1<ILUDODWV8;H;1,S.,>';=/,[5-
M5#;/GZ6E[3C-DQME:P.+7#(2 XN3_J,XLFZ0E%'A$U8$'SP_-8=6H$(]?JO4
M$WW/;AHJYVLX76WHDU=]GEU,*0_:'=%=34%9W4V8<3H*XF>H@%L>%#>0AJY
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M%\L!D<?KC$.E>5!ZC;C#?+'[?VN7NL_V(2.P)\./3:U8\!/V\.9R$O#3<9#
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M5+C[L_7]:)"R(K*&?GO2E.GV[P@SG0JKGK%V*@T(A#R.V3&-J_R35U'!D2L
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M'"I*=E$[ELW?1>'.(/&$E!6].2A)32CYX/1:IJK*I:T(N>]1#ZQNU?'&@T=
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M084^@XS??X#0>F[2=KJ\Z(;8]?A8)RN'I)ADP& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P*'])J6:VJ=V1J-G(2<P"3FGY$X$1-8,C)3D&CMOP4Y:8$)R??"Q+P
MB;K >8:)M57+?;O:WP<*<**<]:+%7J\VF49_8C("LUL1@2MN''4+ C*M1P"7
MR2OG,):1&8>D?2Z,EW8D>"/#+<PWC%%&(3VJEIXLHP2:M_PM]O$G'WF_CLYM
M[JG]AC"8S26P(5Z9C0V:1.NA$C.3$[5DHMTK<,.@!]F!>-%@%E1<4I3(.PCI
M99=!V^Y'*N73;?;/L']O");Q[TZ0/0SW^&DT'D34_>LO(EKSMDC)8HRDD "U
MXTBS6[0[&MDFA- NF^A,32J!J_?(M2(F7#R*+Q5!YRU(I#5.#/QKLY.EL\]E
MA4HC1D?L"W67JARR8QX/":]EU,MXI'83KQ+-9,DUE<!V35*"[#;WPW_D^C'8
M[H3USV,1_.VTWVST:^._;^75$[@O[$@-L[C,#EULDJ@ 6(6XJ^4/GT6E\@<N
M'SNH#O!&UW+J:P-<]6+5N\E+1HD_X?Z212<H=-OGX#J;)>%:[M"$J3V$^+^C
M9>;BUOO[3*>.2E<HR&;G*P+Q$_>W5HRF0/F-'CVA)ST)K9X)=,EAR!-JT:)-
M/QT^DN7O#_[A>.GBT]$#/V')P3UZS&:LE28D%0+RJY#-BD#:O=]N+9D*L^C]
M=1)I*)!'FA072JJ"(0NU+A I!YME]PT<02?K]#XW#$@%>>[W;L8>DDUO- =&
MB%%=0J//C,4!:*1.0>M):.M]I9 Q24S@Q(3<>\R/D%$W#\OV^3:[:K?;LVWW
MTF29Q[5U#D"-^/?6"<=IX2;@]X$4("/BL(:"Y'88$JPY>"M^13)XQ.>$IBHM
M,(OQ(:NE78YZZ[?.4>&[/A'A)/IOSR:G*+FJZMT=!(W^Q;A!!S;S^_B49W)H
MOU= *LGU?!)Z_E7(*V>2Q2ACQBRR#?BK>)N[B/3ID@B!:=BD..D6^_H9;J1/
MCVJV+'//_J:O8OYF(!XY=(@E&/!OG2G+9$P*;Q1L4$[A-F0LC=D6C W<D:Q1
MG<CV'.G&AY5CQKE=JV?)#WB#K\/?5[DSC<_5T*9C'N96O/.Z08Q/$CDU?3^F
M+=T_/0C4PJRJIK8S21US?4F<-%N(\7N*KZ;AW0)_L5VZ_)D4EVORFNFATMP3
MXWJYBG56_L'E[B-&&K>Y5)E7]@LYH[W(YU"T($O?>P]X1R,26MA@ ZV<./,H
MI&41_9@433YUVPVW[VQ5?(&.E"Q./VZ_-V=XUD/H.',?ZAZ":6\;)6%)GW4!
M7G <$L2B?$6K@"1G'<J.CK%G3IO')!->7G(CM7KE+3OOM)LBB/[8ZV9RKLY,
MK"%?L+FDQ%QFQR7HVOZ[D+V/227E&LVA*!X*?9U1ZD9SF,CILWDDA)*!'%F=
MUUM!4.)CX=UVEI8</:M-O/D-3.,;5U7\O[%F/KP!:_GVZO2,)O\ EY"J7AN9
M3_<?=U>2JYE'I/Y9Z@@,;#8,+D#(WU;25H2,DU+<M$.>%5UG??RJ,>Q7'!/C
M4Q%+B]!UQ[,D-Z7\8J\Y:$5@S.E9W)ZD6@9N" FDLO&-5K6VZJ!'/Y!%4N8%
M*S=$QQVT?[3'N-?(DY[VT[UQW")QKVU5M>8[BG?L-[,VO=U@(H7E%2S+F:PV
MPF H-'D(QY.]=5N:9Q-!V4>NX>:6G\P M7VV;!-5R@4Y[TMTETYVG2)B,>RG
M048_9_('ZJUB]3-<D]#5TN:"IL:_<UX[C6AE,N56++A6<]!QEE"IDU/N"O;8
M!\O7QO$].NV*@O?)?AV7'-:Y]@I>;*S%&#'HN;2&3/+H(W6)@TOK=I;+21R2
M/&AM-AA)$RY!15K4L>*<-^7S!!?OOOM5LL^VY;:(_>3XWV<ZP"M?V65W%*PC
M,'!S<0:CD8=@8S&7A.N M5B"*"95@B?FIL-(2&BC8,+2&\*B3$>)_P FU0XT
M*(CW_3I7"WC.ZVBD&][%XV[>U,;]2Q)X J&X"D>$WG.Z6+%I-=+C_P!?A MJ
M0XCO;OC8;31:=NHTR($N!NC/&UNE&HG8Y#@7CWI6VJ7]Y*21G887BV"DW=10
M-&:S?6.5":CT7#Q_TS!Y>V:VO%"=B3M5X_2CK@B];%7"CPWV&1Z0[[2=()<=
MB\:I->H![^D(B1<@I%ZBB,>!U/<TB@;.93JK>[-+^@P]9ULI$QDK)!7)<40K
MHS;:)50(PZ6X9*_8^X7TD%68MNA>/ITGZH'W?=U?4G,Z'!60#M2I;XLU%%LH
M19Q,:C*0=)^A*E!R^2"5CN@\MK!:VB@97C2OYB:@MUM=9KM/2Z?),:C2?".-
MVOLN.4E.)O7XBZI&;KNZHC-Z8IZY)77ZMO6K6R,)CT:M*NK&DK$VZC* PG,#
MD@+@MN".G""H]GOE1-G^*CP/C=32AK<HWW1((-;M.D)->MAE"513Z)/)H*FT
M,C5;SZ ]>8N6<=:Q#AL5#RH!?\A]1I;44<JI,DN0RKI%=UH;VR1YBQ.-WIU_
M"VJ<C/O=R=]")RXU/QW9.K[Y&P+B2+ -1E*6$I-O7EQ_#3JL^/NAIN/UM]J9
M[OD*S34)=]]E%%WJ7"BA)XN=)1-?<LCMKB,N _K&'/991T]+TY"X_(Z:$N_]
MJP& >2(RQG5C:5E),:WK0;<DJ/:?H]NE^'6GG:SAFNQ53UE:K&KTW7+_ $OW
M^?E8P&6/W2"Y)V>P;W_)@DJ@3"".XIW?T9<Q%WYDY2>/9'$XLW\_<%VTFTX0
M:D/N6;?X5,)]N>3-X^F\EXKWFV@?E)(7_MTW+HP]F8ZQQPXU A/]I6'6A'Q]
M?$[*FK<\VV->?ZN'.W*CA4'(P!+\ESH@R1?[8*<B.-S:O^N?V"DR4-%3"-^E
MV]:P^& (E=;JNI548JS[!FP\OZ"UJ3T\2<R[7U"K%G,&5(O5U1J[H3M/CXMI
M($D=E^/JUI>;J=]85E8)<\JZG+)C94A]8GY@ G<AA9J#"9*2<5T2I23.!</;
M#VR!>1&_YQP2=B44^7>UW'/:22'+%%"),XS^3DFT_/?M6V82BE) ?I Y^)4E
MP0QR%F%@5ZL7<7U9GE*WX;8!M,?'I(C&"]"EK%5CK6/H.]*H,7ZSI1NS;#5=
M;U6HG&)^_P"J^;!@G[#H_:_<8K^7VV4IT#8!7BL92^(Q67R9V0?H4D<;D[2<
MNIG ECE7M%W<P;((O^'R22:;AOVTWWP&[R)$XUKNW$OIST2XK7RK(I^GZ<G\
MUC?H&[Y_:BU;3&O6MM0J-RFJ[N@L'%PX@2*Q@.PB33HN!;<-V3CM]]'&UG7:
MG/3WK=2)C6JV0DFC^SG<;;0@VTMSF:MWA>13&T("O4).,*@#/GRLA2 "(AWL
MXAKLN:'6NUDBRK)MT'[1<<J+,7B72XWOHOP[/X%K7]@$K=#TCCNYZ\%.(D__
M "RD=G<&YEQ9Q'(1Z?W7K<Y)5V[F4<?FR4A"7/3 @L_?,U.T6C]^]^TDLX%X
M^FHT$_:"4<SDA*#-KARA 1SV9;P@- R,9_K+D[63F,LX"S6N6(K-)8PC;8X@
M?Y"H"#/72Q#:#Y1SH'UW#X=ET^=&7NM&]ZG?6R)MM."*130Z7"Y),84\B<9
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M9UB37S=$:X@X:!B[GM^!&&L@)389(C)KSRJ<LX-)$S(+4%(MZ^L8J6@#=/\
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M(_$'E<T_+WM/!8B,:1)P&--K0F;$I,B*A%MTZ9<I(_C\)NEUW;)!01C%ZKD
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MU?'+>GEDL7MCG(LU&0&H*VH&UBA.,)SVGXC+Y!(#D6OQJDQ8/@@9LJ]8=_\
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MY<#7'>FRS81E4VS"7CTRK2KRJTKN*C%>+ZD-[MI.VCBXI'KB430S8$B@L@:
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M,F P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MK-QQKNY'HPG[5NL)6Y<%._2S.$2FP6+2Y)N=>54T^5@-NR6M.'%'J-6+Y<9
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MOOD-KM1/6NM[[XUKC>N>][ZY^G&]ZYZUKK?U_P"G>^>];_S_ ,MZ_P#S@?O
M8# U[00*'N2+U@,'LGA==-R6=M&39LY*.44N6Z3@BNBGPJ]720YUQSVKOKKG
MC6M:W],#88# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MB'XZ7IDF?2;%Y$W"&Q;3XB!3M=DVX465Y6Z[XT9RF)G1VSADP& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MSX>NW=))Z[[:N$NDE=<*:WSA9B8W6)))$#A\=/2V3E&8.-1<*4D4A-$%=(,
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M#<RS*-3Q,;#AC.0[:H(<\.F: DNV[0Y[7UK\G6M*<:USO!.]K>PCRBMGRWZ
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M2<X-+*LE$F3@1'XP$D<C+$=+=ZTBBP9.'?7>]?%SKO[>M%C=S3XMEMA%2EH
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M  T:'Q*2A-PMW(6*;1/3D<8]M&G^RVSD$5W:L=K,LW2IBPY(R08M';<F0LB
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MC6M](CVRG7*/'^.>-=]?37UZWO8;K 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MG,)I;4X>M(U+ZV#TA71Z'U<N]3B1;F:0*)V;*?3ST.;$PV7RB1F1!F)N@/\
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MVHLLIUWWO?6][PRW& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P*3])!Q\AH&X@A59VW&E*[E+-\LQ>I#G:;984XY5VD\<1B:M4=_;_ (W\
MP<HAUS]>5&J_&^DNBQNX_P# 9\0-<32O <<B@IDN@G-U'T>&PZ.*K+ZV+ <M
ME0-?>8?/,<<H_%Q]_P":OT_>_76DM:TESS]D:R\O2S*P8&K.!V4B"&(^3X[4
M''!9 .0X3[^-3MD3:+,G7":GTW]G?2"_6M;^F_IO_.!YDQOP1849?0-U_NFO
M)@,C9ZO.C<2E%4R)"(RH=0\/B,'HQ1^, VZQ7(RN -HZ5-+;>K.P[B2D4'O
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M+T^T%I&%V[GAR)<([_#2<,D%>S7-DS#]:)*2QJ,PEG<H<9%A4%J\"827J[9
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M.FJ0C:KT[J2$6+[V)L63X0:OIV) "T) R>26BXT D<PF>SWC-G-(3+8R_K<
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M5C[9 >W<=@FI9!%J21??#R6X\Z_PZ#HSRH5G?H?BTA->*T!6->&:8F-=-9K
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M+-51"7-OS&3*S%$7' =&NZ&A-Q0NTS.VP$T?9#[",SC@(*9),'+I9(44(?\
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M-G5 \>WBY2J!2D?CG3B&RIQ.9L75M5'MD,1X9]+<,5?JIS]=?01%Q,^&4/\
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M_3^J:/7/Q"<8W2?JW9()]YBHTC>*DAJV1@[2!RN'+.8/S%Z]F,'BM;F 4#Z
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M1=:;LW!V+I6I_&L^4%5=?5AMQI1/3C3=N2<M(8OFSQ5*:@LN'69)WE5H.HX
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MN5!43"+PIW*G"3IU'3H\_,ZP,/G$!6EQ;V&X2A'*4?JV?R.5!RDKK2$,5$W
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M3@VD;.[*_!I)V\?A&.]-!_1%1+\A/E--OSTDKSU\#?[O@3,3NN3"& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MJOMV3&CQ'@ZZ+0&R* '[;D\HD[H#?L> V89]-QZ!6B:JT+!*Y$WK&HC:V@,
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MX>,BF@VQCEMR,<*+(D^)'+()'E1W?'&]+\/S(QEVE]W*[A)+?76BQNX6_7?
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M?I/>N^.,K,3$6HJ:[DD7,6U'7I?T2+]NQNW(@!\?0Z+R.^2M8.:H%H5XRKI
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MO.M:#*P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M!;>25!6,I:)-]O6Z/#<T[D#WCGG?*+]5!/XT2Y;N_<,F P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P*.]+H_/Y]N1#\Z8C/EKN4)[(5^Q4)S)GKL6OSTXCX],F%_,
M?):W]?CZ>-4^N/NUVKQQ]W6BQNX]_76SDG2-O$E2!\#&V\P7CKRK'];A8C%8
MW,P";4.1+P$U'9],0C\85:B_F?(H<);[=N.5^]_]7/WFLWIGA@P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P&!5UV1^02NI+$C44,R*/20]$S D(=B7.NY&))/FO;=
MJ0$\?VF#]]NFJG>N_HF9%J[YUO2;I!3[5.2QNJ7SE15FTF1F*,DMB.S2$R/M
MB_!PL1#[*$)0LNV9L6#M0(;L>^[F(\AR_+51PY8\_#QMZMM7CKC_ *^52S,2
MZKPR8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# C$S*24+%C96'19.;2=BR[7"Q14
M\SC"9U[KOC7#'N0/VSQF*UWSO>_E42[YU]OT^G^<#A3R1?'I2R[\]*P*S:S3
M8U' W8%U%K#U-(E)MQ>R"WR[FGGM$C$X['ADX;0=EPU):)II=.1'1#8DBNY>
M(;[3C>41$1,;O1+*P8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'\UK6M?36M:U
M]=[^FM?37UWO>][_ ,?\][W]<#^X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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E@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
